,disease_type,sample_type,experimental_strategy,tissue_source_site_label,platform,data_submitting_center_label,portion_is_ffpe
0,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
4,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
5,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Washington University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,UCSF,Illumina HiSeq,Baylor College of Medicine,NO
7,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Greenville Health System,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
8,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
9,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
10,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
11,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
12,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
13,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
14,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,UCSF,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
17,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
18,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
19,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
20,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,LS 454,Baylor College of Medicine,NO
21,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
22,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
23,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
24,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
25,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
26,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Baylor College of Medicine,NO
27,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
28,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
29,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
30,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
31,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
32,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
33,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
34,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
35,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
36,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
37,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
38,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
39,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
40,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
41,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
42,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
43,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
44,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
45,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
46,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
47,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
48,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
49,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
50,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Baylor College of Medicine,NO
51,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Baylor College of Medicine,NO
52,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
53,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
54,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina GA,Washington University School of Medicine,NO
55,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
56,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina GA,Broad Institute of MIT and Harvard,NO
57,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
58,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
59,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
60,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,BC Cancer Agency,Illumina HiSeq,Baylor College of Medicine,NO
61,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
62,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
63,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Imperial College,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
64,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
65,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Washington University,Illumina HiSeq,Baylor College of Medicine,NO
66,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
67,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
68,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
69,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
70,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
71,Ovarian Serous Cystadenocarcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
72,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
73,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Baylor College of Medicine,NO
74,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
75,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
76,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
77,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
78,Ovarian Serous Cystadenocarcinoma,Solid Tissue Normal,WGS,Washington University,Illumina HiSeq,Baylor College of Medicine,NO
79,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
80,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Baylor College of Medicine,NO
81,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Washington University,Illumina GA,Broad Institute of MIT and Harvard,NO
82,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
83,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
84,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,WGS,Duke,Illumina HiSeq,Baylor College of Medicine,NO
85,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
86,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
87,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
88,Ovarian Serous Cystadenocarcinoma,Solid Tissue Normal,WGS,Gynecologic Oncology Group,Illumina GA,Broad Institute of MIT and Harvard,NO
89,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
90,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
91,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
92,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
93,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
94,Ovarian Serous Cystadenocarcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
95,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina GA,Broad Institute of MIT and Harvard,NO
96,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
97,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
98,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Imperial College,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
99,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
100,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
101,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
102,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
103,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
104,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Baylor College of Medicine,NO
105,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
106,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
107,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
108,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
109,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
110,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,WGS,University of Pittsburgh,ABI SOLiD,Baylor College of Medicine,NO
111,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,LS 454,Baylor College of Medicine,NO
112,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
113,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
114,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
115,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,BC Cancer Agency,Illumina HiSeq,Baylor College of Medicine,NO
116,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
117,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
118,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
119,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
120,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
121,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
122,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
123,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
124,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina GA,Broad Institute of MIT and Harvard,NO
125,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
126,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
127,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
128,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
129,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina GA,Washington University School of Medicine,NO
130,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
131,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
132,Ovarian Serous Cystadenocarcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
133,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
134,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Washington University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
135,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
136,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
137,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
138,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
139,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
140,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Washington University,Illumina HiSeq,Baylor College of Medicine,NO
141,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Duke,ABI SOLiD,Baylor College of Medicine,NO
142,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
143,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
144,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
145,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
146,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
147,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,WGS,Duke,Illumina HiSeq,Baylor College of Medicine,NO
148,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
149,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
150,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
151,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Washington University,Illumina GA,Broad Institute of MIT and Harvard,NO
152,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Baylor College of Medicine,NO
153,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
154,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
155,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
156,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
157,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
158,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
159,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina GA,Washington University School of Medicine,NO
160,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
161,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
162,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
163,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
164,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina GA,Broad Institute of MIT and Harvard,NO
165,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
166,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
167,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
168,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
169,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
170,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
171,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
172,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
173,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
174,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
175,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
176,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
177,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
178,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
179,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
180,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
181,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
182,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Imperial College,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
183,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
184,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
185,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Baylor College of Medicine,NO
186,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
187,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
188,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
189,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
190,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,WGS,Duke,ABI SOLiD,Baylor College of Medicine,NO
191,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
192,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,WGS,Duke,ABI SOLiD,Baylor College of Medicine,NO
193,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
194,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
195,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
196,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
197,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Washington University,Illumina HiSeq,Baylor College of Medicine,NO
198,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
199,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
200,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
201,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
202,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
203,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Washington University,ABI SOLiD,Baylor College of Medicine,NO
204,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,ABI SOLiD,Baylor College of Medicine,NO
205,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
206,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
207,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,BC Cancer Agency,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
208,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
209,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
210,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
211,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Duke,ABI SOLiD,Baylor College of Medicine,NO
212,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina GA,Washington University School of Medicine,NO
213,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina GA,Broad Institute of MIT and Harvard,NO
214,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
215,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
216,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
217,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
218,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
219,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
220,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
221,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
222,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
223,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
224,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Duke,ABI SOLiD,Baylor College of Medicine,NO
225,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
226,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
227,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
228,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
229,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
230,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
231,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina GA,Broad Institute of MIT and Harvard,NO
232,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
233,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
234,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
235,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,BC Cancer Agency,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
236,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
237,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
238,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
239,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
240,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
241,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina GA,Washington University School of Medicine,NO
242,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
243,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
244,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,WGS,Duke,ABI SOLiD,Baylor College of Medicine,NO
245,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
246,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
247,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,ABI SOLiD,Baylor College of Medicine,NO
248,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
249,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
250,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
251,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
252,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
253,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
254,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
255,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
256,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
257,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
258,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
259,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
260,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
261,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
262,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
263,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
264,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
265,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
266,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
267,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
268,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
269,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Washington University,Illumina HiSeq,Baylor College of Medicine,NO
270,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
271,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
272,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
273,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
274,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
275,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Baylor College of Medicine,NO
276,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
277,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
278,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
279,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
280,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
281,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
282,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
283,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
284,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
285,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
286,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
287,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
288,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
289,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
290,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
291,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
292,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
293,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
294,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
295,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
296,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
297,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
298,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Imperial College,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
299,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Washington University,Illumina HiSeq,Baylor College of Medicine,NO
300,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Washington University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
301,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
302,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
303,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
304,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
305,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
306,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
307,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
308,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
309,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
310,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
311,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
312,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
313,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
314,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
315,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
316,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
317,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
318,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Imperial College,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
319,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
320,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
321,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Imperial College,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
322,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
323,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
324,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
325,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
326,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
327,Ovarian Serous Cystadenocarcinoma,Solid Tissue Normal,WGS,UCSF,Illumina HiSeq,Baylor College of Medicine,NO
328,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
329,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
330,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
331,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
332,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
333,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,BC Cancer Agency,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
334,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
335,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
336,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
337,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
338,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
339,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
340,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
341,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,WGS,Duke,Illumina HiSeq,Baylor College of Medicine,NO
342,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
343,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
344,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
345,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
346,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Duke,ABI SOLiD,Baylor College of Medicine,NO
347,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
348,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,WGS,Memorial Sloan Kettering,ABI SOLiD,Baylor College of Medicine,NO
349,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,ABI SOLiD,Baylor College of Medicine,NO
350,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
351,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
352,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
353,Ovarian Serous Cystadenocarcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
354,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
355,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
356,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
357,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Washington University,Illumina GA,Broad Institute of MIT and Harvard,NO
358,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
359,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
360,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
361,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,WGS,Memorial Sloan Kettering,ABI SOLiD,Baylor College of Medicine,NO
362,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
363,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
364,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
365,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
366,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
367,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
368,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
369,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
370,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
371,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
372,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
373,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Baylor College of Medicine,NO
374,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
375,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,WGS,Memorial Sloan Kettering,ABI SOLiD,Baylor College of Medicine,NO
376,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,UCSF,Illumina HiSeq,Baylor College of Medicine,NO
377,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
378,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
379,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Baylor College of Medicine,NO
380,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
381,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
382,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina GA,Washington University School of Medicine,NO
383,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
384,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
385,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,ABI SOLiD,Baylor College of Medicine,NO
386,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
387,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
388,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
389,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
390,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,BC Cancer Agency,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
391,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
392,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
393,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
394,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
395,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,WGS,Duke,Illumina HiSeq,Baylor College of Medicine,NO
396,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
397,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
398,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
399,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Washington University,Illumina HiSeq,Baylor College of Medicine,NO
400,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
401,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
402,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Baylor College of Medicine,NO
403,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
404,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
405,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Washington University,Illumina HiSeq,Baylor College of Medicine,NO
406,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
407,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
408,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Washington University,ABI SOLiD,Baylor College of Medicine,NO
409,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,LS 454,Baylor College of Medicine,NO
410,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
411,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
412,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
413,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
414,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Imperial College,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
415,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina GA,Washington University School of Medicine,NO
416,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Washington University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
417,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
418,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
419,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
420,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
421,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
422,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
423,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
424,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
425,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
426,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
427,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
428,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
429,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
430,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,BC Cancer Agency,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
431,Ovarian Serous Cystadenocarcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,ABI SOLiD,Baylor College of Medicine,NO
432,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
433,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
434,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
435,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
436,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
437,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
438,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
439,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,BC Cancer Agency,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
440,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
441,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,BC Cancer Agency,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
442,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
443,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
444,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
445,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
446,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
447,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,BC Cancer Agency,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
448,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina GA,Broad Institute of MIT and Harvard,NO
449,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
450,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Imperial College,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
451,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
452,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
453,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
454,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Washington University,Illumina HiSeq,Baylor College of Medicine,NO
455,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Baylor College of Medicine,NO
456,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
457,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
458,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
459,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
460,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
461,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
462,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Baylor College of Medicine,NO
463,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
464,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
465,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
466,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
467,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
468,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
469,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
470,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
471,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
472,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
473,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
474,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
475,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
476,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
477,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
478,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
479,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
480,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
481,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
482,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
483,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
484,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
485,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
486,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
487,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
488,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
489,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
490,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
491,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
492,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
493,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
494,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
495,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
496,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
497,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
498,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina GA,Washington University School of Medicine,NO
499,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Institute of Human Virology Nigeria,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
500,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
501,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
502,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
503,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Baylor College of Medicine,NO
504,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,ABI SOLiD,Baylor College of Medicine,NO
505,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
506,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
507,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina GA,Washington University School of Medicine,NO
508,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina GA,Washington University School of Medicine,NO
509,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
510,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
511,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
512,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Washington University,Illumina HiSeq,Baylor College of Medicine,NO
513,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
514,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
515,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
516,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
517,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
518,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
519,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
520,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
521,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
522,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Imperial College,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
523,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
524,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Washington University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
525,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
526,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
527,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
528,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
529,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
530,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
531,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,BC Cancer Agency,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
532,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Duke,ABI SOLiD,Baylor College of Medicine,NO
533,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
534,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
535,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
536,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
537,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
538,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
539,Ovarian Serous Cystadenocarcinoma,Solid Tissue Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Baylor College of Medicine,NO
540,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
541,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
542,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
543,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
544,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
545,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
546,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
547,Ovarian Serous Cystadenocarcinoma,Solid Tissue Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Baylor College of Medicine,NO
548,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
549,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
550,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
551,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
552,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
553,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
554,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
555,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
556,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
557,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
558,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
559,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
560,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Imperial College,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
561,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
562,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
563,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
564,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
565,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
566,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
567,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
568,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
569,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
570,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
571,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
572,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
573,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
574,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
575,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
576,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
577,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
578,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,WGS,Duke,ABI SOLiD,Baylor College of Medicine,NO
579,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
580,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
581,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
582,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
583,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
584,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
585,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
586,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
587,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
588,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,BC Cancer Agency,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
589,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
590,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
591,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
592,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
593,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,WGS,Memorial Sloan Kettering,ABI SOLiD,Baylor College of Medicine,NO
594,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
595,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
596,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
597,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Imperial College,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
598,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
599,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
600,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
601,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
602,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
603,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
604,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
605,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
606,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
607,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
608,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
609,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
610,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
611,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
612,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
613,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
614,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
615,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
616,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
617,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
618,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,BC Cancer Agency,Illumina HiSeq,Baylor College of Medicine,NO
619,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
620,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
621,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
622,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
623,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
624,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,WGS,Washington University,ABI SOLiD,Baylor College of Medicine,NO
625,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
626,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
627,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
628,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
629,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
630,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
631,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
632,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
633,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
634,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
635,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
636,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
637,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
638,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
639,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
640,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
641,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
642,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
643,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
644,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
645,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Mayo Clinic - Rochester,Illumina GA,Broad Institute of MIT and Harvard,NO
646,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
647,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
648,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
649,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
650,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
651,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
652,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
653,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
654,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
655,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
656,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
657,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
658,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
659,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
660,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Alabama,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
661,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
662,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
663,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
664,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
665,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,WGS,University of Pittsburgh,ABI SOLiD,Baylor College of Medicine,NO
666,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
667,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
668,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
669,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
670,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
671,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
672,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Duke,ABI SOLiD,Baylor College of Medicine,NO
673,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
674,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
675,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
676,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
677,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
678,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
679,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina GA,Broad Institute of MIT and Harvard,NO
680,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
681,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
682,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
683,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
684,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
685,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,BC Cancer Agency,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
686,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
687,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
688,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
689,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,BC Cancer Agency,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
690,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
691,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
692,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
693,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
694,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
695,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
696,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
697,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
698,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
699,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,BC Cancer Agency,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
700,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
701,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
702,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
703,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Baylor College of Medicine,NO
704,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
705,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
706,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
707,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
708,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
709,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
710,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
711,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Washington University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
712,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
713,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
714,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
715,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
716,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
717,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
718,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
719,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
720,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
721,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
722,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
723,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,BC Cancer Agency,Illumina HiSeq,Baylor College of Medicine,NO
724,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
725,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
726,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
727,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Imperial College,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
728,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
729,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Washington University,Illumina HiSeq,Baylor College of Medicine,NO
730,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
731,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
732,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
733,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
734,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
735,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
736,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
737,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,ABI SOLiD,Baylor College of Medicine,NO
738,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
739,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
740,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
741,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
742,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
743,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
744,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
745,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
746,Ovarian Serous Cystadenocarcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
747,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
748,Ovarian Serous Cystadenocarcinoma,Solid Tissue Normal,WGS,Gynecologic Oncology Group,Illumina GA,Broad Institute of MIT and Harvard,NO
749,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
750,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
751,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
752,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
753,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
754,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
755,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
756,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
757,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
758,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,BC Cancer Agency,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
759,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
760,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,BC Cancer Agency,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
761,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
762,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
763,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
764,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
765,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
766,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
767,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
768,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
769,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Kansas,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
770,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
771,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
772,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
773,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
774,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
775,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Baylor College of Medicine,NO
776,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
777,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
778,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
779,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
780,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
781,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina GA,Broad Institute of MIT and Harvard,NO
782,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
783,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
784,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
785,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
786,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
787,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
788,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
789,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
790,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
791,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
792,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
793,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
794,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
795,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
796,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
797,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
798,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,ABI SOLiD,Baylor College of Medicine,NO
799,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
800,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
801,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
802,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
803,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
804,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Baylor College of Medicine,NO
805,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
806,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
807,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Washington University,Illumina HiSeq,Baylor College of Medicine,NO
808,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
809,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
810,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
811,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
812,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
813,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
814,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
815,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
816,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
817,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
818,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
819,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,ABI SOLiD,Baylor College of Medicine,NO
820,Ovarian Serous Cystadenocarcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,ABI SOLiD,Baylor College of Medicine,NO
821,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
822,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
823,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
824,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Washington University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
825,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
826,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
827,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,WGS,Memorial Sloan Kettering,ABI SOLiD,Baylor College of Medicine,NO
828,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
829,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
830,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
831,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina GA,Broad Institute of MIT and Harvard,NO
832,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
833,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
834,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
835,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
836,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina GA,Broad Institute of MIT and Harvard,NO
837,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
838,Ovarian Serous Cystadenocarcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,LS 454,Baylor College of Medicine,NO
839,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
840,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
841,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
842,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
843,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
844,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
845,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
846,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Baylor College of Medicine,NO
847,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
848,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
849,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
850,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
851,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
852,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
853,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Baylor College of Medicine,NO
854,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
855,Ovarian Serous Cystadenocarcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
856,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
857,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
858,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
859,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
860,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
861,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
862,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
863,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
864,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
865,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
866,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
867,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
868,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
869,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
870,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Washington University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
871,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
872,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
873,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,BC Cancer Agency,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
874,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
875,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
876,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina GA,Washington University School of Medicine,NO
877,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
878,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,BC Cancer Agency,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
879,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
880,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Mayo Clinic - Rochester,Illumina GA,Broad Institute of MIT and Harvard,NO
881,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
882,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
883,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
884,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
885,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
886,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
887,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
888,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
889,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
890,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
891,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
892,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
893,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
894,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
895,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
896,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
897,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
898,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
899,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
900,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,WGS,Duke,ABI SOLiD,Baylor College of Medicine,NO
901,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
902,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,ABI SOLiD,Baylor College of Medicine,NO
903,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,BC Cancer Agency,Illumina HiSeq,Baylor College of Medicine,NO
904,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
905,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
906,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
907,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
908,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,BC Cancer Agency,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
909,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
910,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
911,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
912,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
913,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
914,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,BC Cancer Agency,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
915,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
916,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
917,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
918,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Imperial College,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
919,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
920,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
921,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
922,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
923,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
924,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
925,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
926,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,ABI SOLiD,Baylor College of Medicine,NO
927,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
928,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
929,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
930,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
931,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
932,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
933,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
934,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina GA,Washington University School of Medicine,NO
935,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
936,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
937,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Baylor College of Medicine,NO
938,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
939,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
940,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,UCSF,Illumina HiSeq,Baylor College of Medicine,NO
941,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
942,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
943,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
944,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
945,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
946,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
947,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
948,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
949,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
950,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Baylor College of Medicine,NO
951,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,ABI SOLiD,Baylor College of Medicine,NO
952,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
953,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
954,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
955,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
956,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Duke,ABI SOLiD,Baylor College of Medicine,NO
957,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
958,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
959,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
960,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
961,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
962,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
963,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina GA,Broad Institute of MIT and Harvard,NO
964,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
965,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
966,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,ABI SOLiD,Baylor College of Medicine,NO
967,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
968,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
969,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
970,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Duke,ABI SOLiD,Baylor College of Medicine,NO
971,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
972,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
973,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Duke,ABI SOLiD,Baylor College of Medicine,NO
974,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
975,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
976,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
977,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
978,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
979,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
980,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
981,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
982,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
983,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
984,Ovarian Serous Cystadenocarcinoma,Recurrent Tumor,WGS,Duke,ABI SOLiD,Baylor College of Medicine,NO
985,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
986,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
987,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,BC Cancer Agency,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
988,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
989,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
990,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
991,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
992,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
993,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
994,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
995,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,BC Cancer Agency,Illumina HiSeq,Baylor College of Medicine,NO
996,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
997,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
998,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
999,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1000,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1001,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1002,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1003,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1004,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1005,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1006,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Duke,ABI SOLiD,Baylor College of Medicine,NO
1007,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1008,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Baylor College of Medicine,NO
1009,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1010,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1011,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1012,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1013,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,Washington University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
1014,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1015,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1016,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1017,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1018,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1019,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1020,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1021,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1022,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1023,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,BC Cancer Agency,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1024,Ovarian Serous Cystadenocarcinoma,Blood Derived Normal,WGS,Washington University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
1025,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Imperial College,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1026,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,BC Cancer Agency,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1027,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1028,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1029,Ovarian Serous Cystadenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
1030,Ovarian Serous Cystadenocarcinoma,Primary Tumor,WGS,UCSF,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
1031,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,University of Minnesota,Illumina HiSeq,Baylor College of Medicine,NO
1032,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
1033,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1034,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1035,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Alberta Health Services,Illumina HiSeq,Baylor College of Medicine,NO
1036,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1037,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1038,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Baylor College of Medicine,NO
1039,Liver Hepatocellular Carcinoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
1040,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,Fox Chase,Illumina HiSeq,Baylor College of Medicine,NO
1041,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1042,Liver Hepatocellular Carcinoma,Solid Tissue Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1043,Liver Hepatocellular Carcinoma,Solid Tissue Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1044,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1045,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1046,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1047,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1048,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1049,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1050,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
1051,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1052,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1053,Liver Hepatocellular Carcinoma,Recurrent Tumor,RNA-Seq,Tayside Tissue Bank,Illumina HiSeq,University of North Carolina,NO
1054,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1055,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1056,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
1057,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1058,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,University of Florida,Illumina HiSeq,Baylor College of Medicine,NO
1059,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1060,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1061,Liver Hepatocellular Carcinoma,Solid Tissue Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1062,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
1063,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1064,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1065,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
1066,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Baylor College of Medicine,NO
1067,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
1068,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1069,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1070,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1071,Liver Hepatocellular Carcinoma,Solid Tissue Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1072,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
1073,Liver Hepatocellular Carcinoma,Solid Tissue Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1074,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,University of North Carolina,NO
1075,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
1076,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1077,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
1078,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1079,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
1080,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
1081,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1082,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1083,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1084,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
1085,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1086,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1087,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1088,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1089,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
1090,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1091,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1092,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1093,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1094,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
1095,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1096,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
1097,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
1098,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
1099,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1100,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
1101,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1102,Liver Hepatocellular Carcinoma,Solid Tissue Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1103,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1104,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1105,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,St Joseph's Medical Center (MD),Illumina HiSeq,Baylor College of Medicine,NO
1106,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,"Proteogenex, Inc",Illumina HiSeq,University of North Carolina,NO
1107,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Kansas,Illumina HiSeq,University of North Carolina,NO
1108,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Montefiore Medical Center,Illumina HiSeq,University of North Carolina,NO
1109,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
1110,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1111,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1112,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
1113,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
1114,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1115,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1116,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1117,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
1118,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1119,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
1120,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1121,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,St Joseph's Medical Center (MD),Illumina HiSeq,Baylor College of Medicine,NO
1122,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1123,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1124,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1125,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
1126,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1127,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1128,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1129,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Saint Mary's Health Care,Illumina HiSeq,University of North Carolina,NO
1130,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1131,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
1132,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
1133,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Baylor College of Medicine,NO
1134,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1135,Liver Hepatocellular Carcinoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
1136,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
1137,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1138,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1139,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1140,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
1141,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
1142,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
1143,Liver Hepatocellular Carcinoma,Recurrent Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1144,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Baylor College of Medicine,NO
1145,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1146,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1147,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1148,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1149,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1150,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1151,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1152,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1153,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1154,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1155,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1156,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1157,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1158,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1159,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1160,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Utah,Illumina HiSeq,University of North Carolina,NO
1161,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
1162,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
1163,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1164,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1165,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,St Joseph's Medical Center (MD),Illumina HiSeq,Baylor College of Medicine,NO
1166,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1167,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
1168,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
1169,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
1170,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,Alberta Health Services,Illumina HiSeq,Baylor College of Medicine,NO
1171,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1172,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1173,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
1174,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1175,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1176,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1177,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1178,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1179,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1180,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1181,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Fox Chase,Illumina HiSeq,Baylor College of Medicine,NO
1182,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1183,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1184,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1185,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1186,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1187,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Alberta Health Services,Illumina HiSeq,Baylor College of Medicine,NO
1188,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1189,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
1190,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1191,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1192,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Utah,Illumina HiSeq,University of North Carolina,NO
1193,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1194,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1195,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
1196,Liver Hepatocellular Carcinoma,Recurrent Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1197,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1198,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1199,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1200,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1201,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1202,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1203,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1204,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1205,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1206,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1207,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,"Proteogenex, Inc",Illumina HiSeq,University of North Carolina,NO
1208,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
1209,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Utah,Illumina HiSeq,University of North Carolina,NO
1210,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1211,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1212,Liver Hepatocellular Carcinoma,Solid Tissue Normal,WGS,University of Florida,Illumina HiSeq,Baylor College of Medicine,NO
1213,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1214,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1215,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1216,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
1217,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
1218,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
1219,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1220,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1221,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1222,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1223,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
1224,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1225,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,University of North Carolina,NO
1226,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Baylor College of Medicine,NO
1227,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1228,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1229,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1230,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,University of North Carolina,NO
1231,Liver Hepatocellular Carcinoma,Solid Tissue Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1232,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1233,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1234,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1235,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Tayside Tissue Bank,Illumina HiSeq,University of North Carolina,NO
1236,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
1237,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1238,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1239,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1240,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,St Joseph's Medical Center (MD),Illumina HiSeq,University of North Carolina,NO
1241,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Hartford Hospital,Illumina HiSeq,University of North Carolina,NO
1242,Liver Hepatocellular Carcinoma,Solid Tissue Normal,WGS,Alberta Health Services,Illumina HiSeq,Baylor College of Medicine,NO
1243,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1244,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
1245,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
1246,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1247,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1248,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
1249,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Tayside Tissue Bank,Illumina HiSeq,University of North Carolina,NO
1250,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1251,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1252,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1253,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,St Joseph's Medical Center (MD),Illumina HiSeq,Baylor College of Medicine,NO
1254,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1255,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1256,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1257,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1258,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1259,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1260,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1261,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,St Joseph's Medical Center (MD),Illumina HiSeq,University of North Carolina,NO
1262,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,Alberta Health Services,Illumina HiSeq,Baylor College of Medicine,NO
1263,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
1264,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1265,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1266,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Greenville Health System,Illumina HiSeq,University of North Carolina,NO
1267,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
1268,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1269,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1270,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1271,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1272,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1273,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
1274,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
1275,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
1276,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
1277,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1278,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
1279,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1280,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1281,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1282,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,St Joseph's Medical Center (MD),Illumina HiSeq,University of North Carolina,NO
1283,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1284,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1285,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1286,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,Alberta Health Services,Illumina HiSeq,Baylor College of Medicine,NO
1287,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Yale University,Illumina HiSeq,University of North Carolina,NO
1288,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1289,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1290,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1291,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1292,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1293,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1294,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1295,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Baylor College of Medicine,NO
1296,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1297,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1298,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Baylor College of Medicine,NO
1299,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1300,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Baylor College of Medicine,NO
1301,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1302,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1303,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Baylor College of Medicine,NO
1304,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
1305,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1306,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1307,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,Alberta Health Services,Illumina HiSeq,Baylor College of Medicine,NO
1308,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1309,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Tayside Tissue Bank,Illumina HiSeq,University of North Carolina,NO
1310,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
1311,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Baylor College of Medicine,NO
1312,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1313,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1314,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
1315,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1316,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
1317,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1318,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1319,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1320,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1321,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
1322,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1323,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1324,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1325,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1326,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1327,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
1328,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1329,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1330,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1331,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1332,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1333,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Baylor College of Medicine,NO
1334,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1335,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1336,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Kansas,Illumina HiSeq,University of North Carolina,NO
1337,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Utah,Illumina HiSeq,University of North Carolina,NO
1338,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1339,Liver Hepatocellular Carcinoma,Solid Tissue Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1340,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
1341,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1342,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1343,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1344,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1345,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1346,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1347,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1348,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
1349,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1350,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Hartford Hospital,Illumina HiSeq,University of North Carolina,NO
1351,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1352,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Utah,Illumina HiSeq,University of North Carolina,NO
1353,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1354,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
1355,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1356,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1357,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1358,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Yale University,Illumina HiSeq,University of North Carolina,NO
1359,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1360,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1361,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
1362,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1363,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1364,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1365,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1366,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1367,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1368,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1369,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
1370,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
1371,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
1372,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1373,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
1374,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Alberta Health Services,Illumina HiSeq,Baylor College of Medicine,NO
1375,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
1376,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1377,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
1378,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1379,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1380,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1381,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1382,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Hartford Hospital,Illumina HiSeq,University of North Carolina,NO
1383,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Alberta Health Services,Illumina HiSeq,Baylor College of Medicine,NO
1384,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1385,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1386,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1387,Liver Hepatocellular Carcinoma,Solid Tissue Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1388,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,Alberta Health Services,Illumina HiSeq,Baylor College of Medicine,NO
1389,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1390,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
1391,Liver Hepatocellular Carcinoma,Solid Tissue Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1392,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Alberta Health Services,Illumina HiSeq,Baylor College of Medicine,NO
1393,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1394,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1395,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
1396,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1397,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
1398,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Minnesota,Illumina HiSeq,University of North Carolina,NO
1399,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1400,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1401,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1402,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
1403,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1404,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1405,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1406,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
1407,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1408,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1409,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,University of North Carolina,NO
1410,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
1411,Liver Hepatocellular Carcinoma,Solid Tissue Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1412,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1413,Liver Hepatocellular Carcinoma,Solid Tissue Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1414,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1415,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,University of North Carolina,NO
1416,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Tayside Tissue Bank,Illumina HiSeq,University of North Carolina,NO
1417,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1418,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of California San Diego,Illumina HiSeq,University of North Carolina,NO
1419,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,University of North Carolina,NO
1420,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
1421,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,St Joseph's Medical Center (MD),Illumina HiSeq,Baylor College of Medicine,NO
1422,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1423,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,University of North Carolina,NO
1424,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Yale University,Illumina HiSeq,University of North Carolina,NO
1425,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1426,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
1427,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
1428,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1429,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
1430,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1431,Liver Hepatocellular Carcinoma,Solid Tissue Normal,WGS,University of Florida,Illumina HiSeq,Baylor College of Medicine,NO
1432,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1433,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
1434,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1435,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1436,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1437,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1438,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,University of Florida,Illumina HiSeq,Baylor College of Medicine,NO
1439,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Utah,Illumina HiSeq,University of North Carolina,NO
1440,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Alberta Health Services,Illumina HiSeq,Baylor College of Medicine,NO
1441,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1442,Liver Hepatocellular Carcinoma,Solid Tissue Normal,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
1443,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1444,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1445,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1446,Liver Hepatocellular Carcinoma,Solid Tissue Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1447,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1448,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1449,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1450,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1451,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
1452,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1453,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Baylor College of Medicine,NO
1454,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Baylor College of Medicine,NO
1455,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1456,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1457,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1458,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1459,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
1460,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1461,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
1462,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1463,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1464,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1465,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1466,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1467,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1468,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1469,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1470,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1471,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1472,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1473,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Baylor College of Medicine,NO
1474,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1475,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
1476,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1477,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1478,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1479,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1480,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1481,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1482,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1483,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
1484,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
1485,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
1486,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1487,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
1488,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Boston Medical Center,Illumina HiSeq,University of North Carolina,NO
1489,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Utah,Illumina HiSeq,University of North Carolina,NO
1490,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1491,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
1492,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1493,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
1494,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,University of Florida,Illumina HiSeq,University of North Carolina,NO
1495,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1496,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1497,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
1498,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1499,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
1500,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
1501,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1502,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1503,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,St Joseph's Medical Center (MD),Illumina HiSeq,Baylor College of Medicine,NO
1504,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,"Proteogenex, Inc",Illumina HiSeq,University of North Carolina,NO
1505,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
1506,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1507,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1508,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,University of North Carolina,NO
1509,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
1510,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Utah,Illumina HiSeq,University of North Carolina,NO
1511,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1512,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
1513,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1514,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1515,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1516,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
1517,Liver Hepatocellular Carcinoma,Solid Tissue Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1518,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
1519,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1520,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
1521,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Alberta Health Services,Illumina HiSeq,Baylor College of Medicine,NO
1522,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1523,Liver Hepatocellular Carcinoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
1524,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
1525,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
1526,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1527,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
1528,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1529,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,St. Joseph's Hospital Arizona,Illumina HiSeq,University of North Carolina,NO
1530,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1531,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
1532,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
1533,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1534,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
1535,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1536,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1537,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,University of North Carolina,NO
1538,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1539,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Duke University,Illumina HiSeq,University of North Carolina,NO
1540,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1541,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Utah,Illumina HiSeq,University of North Carolina,NO
1542,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,University of North Carolina,NO
1543,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1544,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1545,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1546,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,University of Minnesota,Illumina HiSeq,University of North Carolina,NO
1547,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1548,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
1549,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
1550,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1551,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1552,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1553,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,University of Minnesota,Illumina HiSeq,Baylor College of Medicine,NO
1554,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,University of North Carolina,NO
1555,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1556,Liver Hepatocellular Carcinoma,Solid Tissue Normal,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
1557,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
1558,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
1559,Liver Hepatocellular Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
1560,Liver Hepatocellular Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
1561,Liver Hepatocellular Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1562,Liver Hepatocellular Carcinoma,Blood Derived Normal,WGS,Alberta Health Services,Illumina HiSeq,Baylor College of Medicine,NO
1563,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
1564,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1565,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Emory University - Winship Cancer Inst.,Illumina HiSeq,University of North Carolina,NO
1566,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1567,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1568,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1569,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1570,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1571,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
1572,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1573,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
1574,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
1575,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1576,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
1577,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
1578,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1579,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1580,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
1581,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1582,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
1583,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1584,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1585,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Minnesota,Illumina HiSeq,University of North Carolina,NO
1586,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
1587,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
1588,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,"University Health Network, Toronto",Illumina HiSeq,Harvard Medical School,NO
1589,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
1590,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
1591,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
1592,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
1593,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
1594,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
1595,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
1596,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1597,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,"University Health Network, Toronto",Illumina HiSeq,Harvard Medical School,NO
1598,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
1599,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Vanderbilt University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
1600,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
1601,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1602,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1603,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
1604,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1605,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
1606,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Vanderbilt University,Illumina HiSeq,Baylor College of Medicine,NO
1607,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
1608,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,"University Health Network, Toronto",Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
1609,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
1610,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1611,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
1612,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
1613,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1614,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1615,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1616,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Minnesota,Illumina HiSeq,University of North Carolina,NO
1617,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Vanderbilt University,Illumina HiSeq,Baylor College of Medicine,NO
1618,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1619,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
1620,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Vanderbilt University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
1621,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1622,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1623,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1624,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1625,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
1626,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
1627,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1628,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
1629,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1630,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1631,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1632,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
1633,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1634,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
1635,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1636,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering Cancer Center,Illumina HiSeq,University of North Carolina,NO
1637,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
1638,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
1639,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
1640,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,"University Health Network, Toronto",Illumina HiSeq,Harvard Medical School,NO
1641,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
1642,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1643,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1644,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1645,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1646,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1647,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1648,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1649,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Vanderbilt University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
1650,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1651,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1652,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
1653,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1654,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1655,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1656,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
1657,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
1658,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,"University Health Network, Toronto",Illumina HiSeq,Harvard Medical School,NO
1659,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
1660,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
1661,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1662,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
1663,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,"University Health Network, Toronto",Illumina HiSeq,Harvard Medical School,NO
1664,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1665,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1666,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1667,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1668,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,"University Health Network, Toronto",Illumina HiSeq,Baylor College of Medicine,NO
1669,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1670,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Vanderbilt University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
1671,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1672,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Vanderbilt University,Illumina HiSeq,Baylor College of Medicine,NO
1673,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
1674,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
1675,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1676,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1677,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1678,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1679,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
1680,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
1681,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
1682,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1683,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1684,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1685,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1686,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1687,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1688,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1689,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1690,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1691,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
1692,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
1693,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1694,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,"University Health Network, Toronto",Illumina HiSeq,Harvard Medical School,NO
1695,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
1696,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1697,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1698,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Schleswig-Holstein,Illumina HiSeq,University of North Carolina,NO
1699,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1700,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1701,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Vanderbilt University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
1702,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1703,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1704,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
1705,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,ABS - IUPUI,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
1706,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1707,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
1708,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1709,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
1710,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1711,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Vanderbilt University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
1712,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
1713,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1714,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1715,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
1716,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1717,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1718,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
1719,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1720,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1721,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1722,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,"University Health Network, Toronto",Illumina HiSeq,Harvard Medical School,NO
1723,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
1724,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1725,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1726,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
1727,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1728,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1729,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1730,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
1731,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
1732,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
1733,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1734,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
1735,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
1736,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
1737,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1738,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
1739,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1740,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1741,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
1742,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,"University Health Network, Toronto",Illumina HiSeq,Harvard Medical School,NO
1743,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1744,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1745,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1746,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Michigan,Illumina HiSeq,Harvard Medical School,NO
1747,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1748,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1749,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1750,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
1751,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1752,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
1753,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1754,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1755,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1756,Head and Neck Squamous Cell Carcinoma,Metastatic,RNA-Seq,Hartford,Illumina HiSeq,University of North Carolina,NO
1757,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Vanderbilt University,Illumina HiSeq,Baylor College of Medicine,NO
1758,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
1759,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
1760,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1761,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1762,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
1763,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,"University Health Network, Toronto",Illumina HiSeq,Baylor College of Medicine,NO
1764,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1765,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1766,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
1767,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1768,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1769,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
1770,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
1771,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Vanderbilt University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
1772,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1773,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1774,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1775,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1776,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1777,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,St. University of Colorado Denver,Illumina HiSeq,University of North Carolina,NO
1778,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1779,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
1780,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,"University Health Network, Toronto",Illumina HiSeq,Harvard Medical School,NO
1781,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
1782,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Medical College of Georgia,Illumina HiSeq,University of North Carolina,NO
1783,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1784,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1785,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1786,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1787,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1788,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1789,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
1790,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
1791,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1792,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1793,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
1794,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1795,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1796,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1797,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1798,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
1799,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1800,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1801,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
1802,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1803,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1804,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1805,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1806,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
1807,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1808,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1809,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
1810,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Emory University - Winship Cancer Inst.,Illumina HiSeq,University of North Carolina,NO
1811,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
1812,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1813,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1814,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1815,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1816,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
1817,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1818,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
1819,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
1820,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
1821,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
1822,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1823,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
1824,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1825,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1826,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1827,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
1828,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1829,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
1830,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1831,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1832,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
1833,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1834,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
1835,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1836,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
1837,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
1838,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1839,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1840,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1841,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Emory University - Winship Cancer Inst.,Illumina HiSeq,University of North Carolina,NO
1842,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1843,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
1844,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
1845,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering Cancer Center,Illumina HiSeq,University of North Carolina,NO
1846,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1847,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1848,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1849,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Minnesota,Illumina HiSeq,University of North Carolina,NO
1850,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
1851,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
1852,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
1853,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1854,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
1855,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1856,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
1857,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1858,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1859,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1860,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1861,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1862,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
1863,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1864,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1865,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
1866,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Vanderbilt University,Illumina HiSeq,Baylor College of Medicine,NO
1867,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
1868,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
1869,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
1870,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1871,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
1872,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1873,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1874,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1875,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1876,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
1877,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
1878,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Medical College of Georgia,Illumina HiSeq,University of North Carolina,NO
1879,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,St. University of Colorado Denver,Illumina HiSeq,University of North Carolina,NO
1880,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1881,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1882,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
1883,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
1884,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
1885,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
1886,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1887,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1888,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1889,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1890,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Emory University - Winship Cancer Inst.,Illumina HiSeq,University of North Carolina,NO
1891,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
1892,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1893,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,"University Health Network, Toronto",Illumina HiSeq,Baylor College of Medicine,NO
1894,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
1895,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1896,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1897,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1898,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
1899,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
1900,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1901,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1902,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
1903,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
1904,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1905,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1906,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1907,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1908,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
1909,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1910,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1911,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
1912,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
1913,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1914,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1915,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1916,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
1917,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
1918,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1919,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1920,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1921,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
1922,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
1923,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
1924,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1925,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,"University Health Network, Toronto",Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
1926,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1927,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
1928,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
1929,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1930,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1931,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1932,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
1933,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1934,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1935,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
1936,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1937,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
1938,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Montefiore Medical Center,Illumina HiSeq,University of North Carolina,NO
1939,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
1940,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1941,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
1942,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1943,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
1944,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1945,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
1946,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1947,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1948,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Minnesota,Illumina HiSeq,University of North Carolina,NO
1949,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Medical College of Georgia,Illumina HiSeq,Baylor College of Medicine,NO
1950,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Medical College of Georgia,Illumina HiSeq,University of North Carolina,NO
1951,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1952,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
1953,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1954,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1955,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University Of Michigan,Illumina HiSeq,Harvard Medical School,NO
1956,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
1957,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
1958,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Emory University - Winship Cancer Inst.,Illumina HiSeq,University of North Carolina,NO
1959,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Michigan,Illumina HiSeq,Harvard Medical School,NO
1960,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
1961,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1962,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1963,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Montefiore Medical Center,Illumina HiSeq,University of North Carolina,NO
1964,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1965,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
1966,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,University of Schleswig-Holstein,Illumina HiSeq,University of North Carolina,NO
1967,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,"University Health Network, Toronto",Illumina HiSeq,Baylor College of Medicine,NO
1968,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
1969,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1970,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
1971,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
1972,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1973,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1974,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,"University Health Network, Toronto",Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
1975,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Vanderbilt University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
1976,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
1977,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1978,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1979,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Molecular Response,Illumina HiSeq,University of North Carolina,NO
1980,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
1981,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
1982,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1983,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Minnesota,Illumina HiSeq,University of North Carolina,NO
1984,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
1985,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
1986,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1987,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1988,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1989,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1990,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1991,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1992,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1993,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
1994,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
1995,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
1996,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Michigan,Illumina HiSeq,Baylor College of Medicine,NO
1997,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
1998,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
1999,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
2000,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2001,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
2002,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
2003,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Vanderbilt University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2004,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,"University Health Network, Toronto",Illumina HiSeq,Harvard Medical School,NO
2005,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
2006,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
2007,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2008,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
2009,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2010,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2011,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2012,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2013,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2014,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2015,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,"University Health Network, Toronto",Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2016,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,St. University of Colorado Denver,Illumina HiSeq,University of North Carolina,NO
2017,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
2018,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2019,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
2020,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2021,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
2022,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2023,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
2024,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2025,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2026,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
2027,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
2028,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2029,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
2030,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
2031,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2032,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2033,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2034,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2035,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2036,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
2037,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2038,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2039,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Vanderbilt University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2040,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
2041,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
2042,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2043,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2044,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
2045,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
2046,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Schleswig-Holstein,Illumina HiSeq,University of North Carolina,NO
2047,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Hartford,Illumina HiSeq,University of North Carolina,NO
2048,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
2049,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2050,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
2051,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Michigan,Illumina HiSeq,Baylor College of Medicine,NO
2052,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2053,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2054,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Hartford,Illumina HiSeq,University of North Carolina,NO
2055,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2056,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2057,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
2058,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
2059,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
2060,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2061,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2062,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
2063,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
2064,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
2065,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2066,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Minnesota,Illumina HiSeq,University of North Carolina,NO
2067,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
2068,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2069,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2070,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
2071,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2072,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Michigan,Illumina HiSeq,Harvard Medical School,NO
2073,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
2074,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
2075,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
2076,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2077,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
2078,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2079,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Medical College of Georgia,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2080,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2081,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
2082,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2083,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2084,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,"University Health Network, Toronto",Illumina HiSeq,Harvard Medical School,NO
2085,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
2086,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2087,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Michigan,Illumina HiSeq,Baylor College of Medicine,NO
2088,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
2089,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2090,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
2091,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2092,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Miami,Illumina HiSeq,MD Anderson - RPPA Core Facility (Proteomics),NO
2093,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2094,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Emory University - Winship Cancer Inst.,Illumina HiSeq,University of North Carolina,NO
2095,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2096,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
2097,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2098,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2099,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2100,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2101,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2102,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2103,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
2104,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
2105,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2106,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Vanderbilt University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2107,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2108,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
2109,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Vanderbilt University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2110,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2111,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
2112,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2113,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Vanderbilt University,Illumina HiSeq,Baylor College of Medicine,NO
2114,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Emory University - Winship Cancer Inst.,Illumina HiSeq,University of North Carolina,NO
2115,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2116,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2117,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Emory University - Winship Cancer Inst.,Illumina HiSeq,University of North Carolina,NO
2118,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
2119,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2120,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2121,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2122,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
2123,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2124,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
2125,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2126,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2127,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
2128,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2129,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
2130,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Molecular Response,Illumina HiSeq,University of North Carolina,NO
2131,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2132,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2133,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2134,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
2135,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2136,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2137,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
2138,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2139,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2140,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2141,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
2142,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2143,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,"University Health Network, Toronto",Illumina HiSeq,Harvard Medical School,NO
2144,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2145,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
2146,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
2147,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2148,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2149,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2150,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,"University Health Network, Toronto",Illumina HiSeq,Harvard Medical School,NO
2151,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2152,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2153,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2154,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2155,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2156,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
2157,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2158,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
2159,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
2160,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
2161,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
2162,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2163,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
2164,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2165,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2166,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
2167,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2168,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Emory University - Winship Cancer Inst.,Illumina HiSeq,University of North Carolina,NO
2169,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
2170,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
2171,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2172,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Vanderbilt University,Illumina HiSeq,Baylor College of Medicine,NO
2173,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2174,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
2175,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2176,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2177,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2178,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Emory University - Winship Cancer Inst.,Illumina HiSeq,University of North Carolina,NO
2179,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Emory University - Winship Cancer Inst.,Illumina HiSeq,University of North Carolina,NO
2180,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2181,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2182,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2183,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2184,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
2185,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2186,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2187,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2188,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,"University Health Network, Toronto",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2189,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2190,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2191,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
2192,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2193,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2194,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
2195,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
2196,Head and Neck Squamous Cell Carcinoma,Metastatic,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
2197,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2198,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2199,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
2200,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,"University Health Network, Toronto",Illumina HiSeq,Harvard Medical School,NO
2201,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2202,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
2203,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
2204,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2205,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2206,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2207,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2208,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2209,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2210,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2211,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,"University Health Network, Toronto",Illumina HiSeq,Harvard Medical School,NO
2212,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2213,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2214,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
2215,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
2216,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2217,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Montefiore Medical Center,Illumina HiSeq,University of North Carolina,NO
2218,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
2219,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Michigan,Illumina HiSeq,Harvard Medical School,NO
2220,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2221,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2222,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Emory University - Winship Cancer Inst.,Illumina HiSeq,University of North Carolina,NO
2223,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2224,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2225,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
2226,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2227,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2228,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2229,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
2230,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
2231,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2232,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
2233,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2234,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2235,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2236,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
2237,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2238,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Vanderbilt University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2239,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Michigan,Illumina HiSeq,Harvard Medical School,NO
2240,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
2241,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
2242,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2243,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2244,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2245,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,"University Health Network, Toronto",Illumina HiSeq,Harvard Medical School,NO
2246,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
2247,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Medical College of Georgia,Illumina HiSeq,Baylor College of Medicine,NO
2248,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2249,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2250,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,"University Health Network, Toronto",Illumina HiSeq,Harvard Medical School,NO
2251,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2252,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
2253,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2254,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2255,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
2256,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
2257,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2258,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,"University Health Network, Toronto",Illumina HiSeq,Harvard Medical School,NO
2259,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2260,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2261,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Vanderbilt University,Illumina HiSeq,Baylor College of Medicine,NO
2262,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
2263,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2264,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
2265,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2266,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2267,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2268,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
2269,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,St. University of Colorado Denver,Illumina HiSeq,University of North Carolina,NO
2270,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Vanderbilt University,Illumina HiSeq,Baylor College of Medicine,NO
2271,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
2272,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
2273,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2274,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Michigan,Illumina HiSeq,Baylor College of Medicine,NO
2275,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
2276,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
2277,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
2278,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,"University Health Network, Toronto",Illumina HiSeq,Harvard Medical School,NO
2279,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2280,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Emory University - Winship Cancer Inst.,Illumina HiSeq,University of North Carolina,NO
2281,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2282,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2283,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2284,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2285,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Hartford,Illumina HiSeq,University of North Carolina,NO
2286,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
2287,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
2288,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
2289,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2290,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Emory University - Winship Cancer Inst.,Illumina HiSeq,University of North Carolina,NO
2291,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Michigan,Illumina HiSeq,Harvard Medical School,NO
2292,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,"University Health Network, Toronto",Illumina HiSeq,Harvard Medical School,NO
2293,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
2294,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2295,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2296,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2297,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
2298,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
2299,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2300,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
2301,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2302,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2303,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
2304,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2305,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
2306,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
2307,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
2308,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
2309,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2310,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2311,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
2312,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
2313,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2314,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2315,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2316,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
2317,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2318,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2319,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2320,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
2321,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2322,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2323,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2324,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Medical College of Georgia,Illumina HiSeq,University of North Carolina,NO
2325,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
2326,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
2327,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2328,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2329,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Vanderbilt University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2330,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Vanderbilt University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2331,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2332,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2333,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2334,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
2335,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Medical College of Georgia,Illumina HiSeq,University of North Carolina,NO
2336,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
2337,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2338,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2339,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
2340,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Duke University,Illumina HiSeq,University of North Carolina,NO
2341,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2342,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2343,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2344,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
2345,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2346,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,"University Health Network, Toronto",Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2347,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
2348,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
2349,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
2350,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2351,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2352,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2353,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2354,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Vanderbilt University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2355,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Vanderbilt University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2356,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2357,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2358,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2359,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
2360,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
2361,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,"University Health Network, Toronto",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2362,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2363,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2364,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2365,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
2366,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
2367,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2368,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2369,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
2370,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Michigan,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2371,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Miami,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2372,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
2373,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2374,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2375,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Vanderbilt University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2376,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2377,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
2378,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2379,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2380,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2381,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Hartford,Illumina HiSeq,University of North Carolina,NO
2382,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2383,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2384,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Emory University - Winship Cancer Inst.,Illumina HiSeq,University of North Carolina,NO
2385,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2386,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2387,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2388,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2389,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2390,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
2391,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2392,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
2393,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2394,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Vanderbilt University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2395,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2396,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
2397,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2398,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Vanderbilt University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2399,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
2400,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2401,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Vanderbilt University,Illumina HiSeq,Baylor College of Medicine,NO
2402,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2403,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2404,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
2405,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
2406,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2407,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2408,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2409,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
2410,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2411,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2412,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2413,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
2414,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Medical College of Georgia,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2415,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
2416,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,ABS - IUPUI,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2417,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Michigan,Illumina HiSeq,Harvard Medical School,NO
2418,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
2419,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2420,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,University of North Carolina,NO
2421,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2422,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2423,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
2424,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
2425,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2426,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2427,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2428,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2429,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
2430,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2431,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Emory University - Winship Cancer Inst.,Illumina HiSeq,University of North Carolina,NO
2432,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2433,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2434,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
2435,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2436,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
2437,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2438,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2439,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2440,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2441,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
2442,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
2443,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2444,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2445,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2446,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2447,Head and Neck Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2448,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
2449,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2450,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
2451,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Vanderbilt University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2452,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Emory University - Winship Cancer Inst.,Illumina HiSeq,University of North Carolina,NO
2453,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2454,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2455,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2456,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2457,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
2458,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Vanderbilt University,Illumina HiSeq,University of North Carolina,NO
2459,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
2460,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2461,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2462,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
2463,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2464,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2465,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,"University Health Network, Toronto",Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2466,Head and Neck Squamous Cell Carcinoma,Primary Tumor,WGS,Vanderbilt University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2467,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
2468,Head and Neck Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
2469,Head and Neck Squamous Cell Carcinoma,Blood Derived Normal,WGS,Vanderbilt University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2470,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2471,Kidney Chromophobe,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
2472,Kidney Chromophobe,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2473,Kidney Chromophobe,Primary Tumor,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2474,Kidney Chromophobe,Primary Tumor,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2475,Kidney Chromophobe,Primary Tumor,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2476,Kidney Chromophobe,Primary Tumor,WGS,NCI Urologic Oncology Branch,Illumina HiSeq,Baylor College of Medicine,NO
2477,Kidney Chromophobe,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2478,Kidney Chromophobe,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
2479,Kidney Chromophobe,Primary Tumor,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2480,Kidney Chromophobe,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2481,Kidney Chromophobe,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2482,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2483,Kidney Chromophobe,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2484,Kidney Chromophobe,Primary Tumor,WGS,NCI Urologic Oncology Branch,Illumina HiSeq,Baylor College of Medicine,NO
2485,Kidney Chromophobe,Primary Tumor,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2486,Kidney Chromophobe,Solid Tissue Normal,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2487,Kidney Chromophobe,Primary Tumor,WGS,NCI Urologic Oncology Branch,Illumina HiSeq,Baylor College of Medicine,NO
2488,Kidney Chromophobe,Solid Tissue Normal,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2489,Kidney Chromophobe,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
2490,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2491,Kidney Chromophobe,Solid Tissue Normal,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2492,Kidney Chromophobe,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2493,Kidney Chromophobe,Solid Tissue Normal,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2494,Kidney Chromophobe,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2495,Kidney Chromophobe,Primary Tumor,WGS,NCI Urologic Oncology Branch,Illumina HiSeq,Baylor College of Medicine,NO
2496,Kidney Chromophobe,Solid Tissue Normal,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2497,Kidney Chromophobe,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
2498,Kidney Chromophobe,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2499,Kidney Chromophobe,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2500,Kidney Chromophobe,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2501,Kidney Chromophobe,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2502,Kidney Chromophobe,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
2503,Kidney Chromophobe,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2504,Kidney Chromophobe,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2505,Kidney Chromophobe,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2506,Kidney Chromophobe,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2507,Kidney Chromophobe,Solid Tissue Normal,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2508,Kidney Chromophobe,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2509,Kidney Chromophobe,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
2510,Kidney Chromophobe,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2511,Kidney Chromophobe,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
2512,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2513,Kidney Chromophobe,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2514,Kidney Chromophobe,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2515,Kidney Chromophobe,Solid Tissue Normal,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2516,Kidney Chromophobe,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2517,Kidney Chromophobe,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
2518,Kidney Chromophobe,Primary Tumor,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2519,Kidney Chromophobe,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2520,Kidney Chromophobe,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2521,Kidney Chromophobe,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
2522,Kidney Chromophobe,Blood Derived Normal,WGS,NCI Urologic Oncology Branch,Illumina HiSeq,Baylor College of Medicine,NO
2523,Kidney Chromophobe,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2524,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2525,Kidney Chromophobe,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2526,Kidney Chromophobe,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2527,Kidney Chromophobe,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2528,Kidney Chromophobe,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2529,Kidney Chromophobe,Solid Tissue Normal,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2530,Kidney Chromophobe,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2531,Kidney Chromophobe,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2532,Kidney Chromophobe,Blood Derived Normal,WGS,NCI Urologic Oncology Branch,Illumina HiSeq,Baylor College of Medicine,NO
2533,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2534,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2535,Kidney Chromophobe,Solid Tissue Normal,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2536,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2537,Kidney Chromophobe,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2538,Kidney Chromophobe,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2539,Kidney Chromophobe,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2540,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2541,Kidney Chromophobe,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2542,Kidney Chromophobe,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
2543,Kidney Chromophobe,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2544,Kidney Chromophobe,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
2545,Kidney Chromophobe,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2546,Kidney Chromophobe,Solid Tissue Normal,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2547,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2548,Kidney Chromophobe,Solid Tissue Normal,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2549,Kidney Chromophobe,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2550,Kidney Chromophobe,Blood Derived Normal,WGS,NCI Urologic Oncology Branch,Illumina HiSeq,Baylor College of Medicine,NO
2551,Kidney Chromophobe,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2552,Kidney Chromophobe,Primary Tumor,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2553,Kidney Chromophobe,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2554,Kidney Chromophobe,Solid Tissue Normal,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2555,Kidney Chromophobe,Primary Tumor,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2556,Kidney Chromophobe,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2557,Kidney Chromophobe,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2558,Kidney Chromophobe,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
2559,Kidney Chromophobe,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2560,Kidney Chromophobe,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2561,Kidney Chromophobe,Blood Derived Normal,WGS,NCI Urologic Oncology Branch,Illumina HiSeq,Baylor College of Medicine,NO
2562,Kidney Chromophobe,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2563,Kidney Chromophobe,Solid Tissue Normal,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2564,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2565,Kidney Chromophobe,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2566,Kidney Chromophobe,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2567,Kidney Chromophobe,Primary Tumor,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2568,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2569,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2570,Kidney Chromophobe,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
2571,Kidney Chromophobe,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2572,Kidney Chromophobe,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2573,Kidney Chromophobe,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2574,Kidney Chromophobe,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
2575,Kidney Chromophobe,Primary Tumor,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2576,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2577,Kidney Chromophobe,Primary Tumor,WGS,NCI Urologic Oncology Branch,Illumina HiSeq,Baylor College of Medicine,NO
2578,Kidney Chromophobe,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2579,Kidney Chromophobe,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2580,Kidney Chromophobe,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2581,Kidney Chromophobe,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2582,Kidney Chromophobe,Solid Tissue Normal,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2583,Kidney Chromophobe,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2584,Kidney Chromophobe,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2585,Kidney Chromophobe,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2586,Kidney Chromophobe,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2587,Kidney Chromophobe,Primary Tumor,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2588,Kidney Chromophobe,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2589,Kidney Chromophobe,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2590,Kidney Chromophobe,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
2591,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2592,Kidney Chromophobe,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2593,Kidney Chromophobe,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2594,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2595,Kidney Chromophobe,Primary Tumor,WGS,NCI Urologic Oncology Branch,Illumina HiSeq,Baylor College of Medicine,NO
2596,Kidney Chromophobe,Primary Tumor,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2597,Kidney Chromophobe,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2598,Kidney Chromophobe,Blood Derived Normal,WGS,NCI Urologic Oncology Branch,Illumina HiSeq,Baylor College of Medicine,NO
2599,Kidney Chromophobe,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2600,Kidney Chromophobe,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2601,Kidney Chromophobe,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2602,Kidney Chromophobe,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2603,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2604,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2605,Kidney Chromophobe,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2606,Kidney Chromophobe,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2607,Kidney Chromophobe,Solid Tissue Normal,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2608,Kidney Chromophobe,Blood Derived Normal,WGS,NCI Urologic Oncology Branch,Illumina HiSeq,Baylor College of Medicine,NO
2609,Kidney Chromophobe,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2610,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2611,Kidney Chromophobe,Blood Derived Normal,WGS,NCI Urologic Oncology Branch,Illumina HiSeq,Baylor College of Medicine,NO
2612,Kidney Chromophobe,Solid Tissue Normal,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2613,Kidney Chromophobe,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2614,Kidney Chromophobe,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2615,Kidney Chromophobe,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2616,Kidney Chromophobe,Primary Tumor,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2617,Kidney Chromophobe,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2618,Kidney Chromophobe,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2619,Kidney Chromophobe,Blood Derived Normal,WGS,NCI Urologic Oncology Branch,Illumina HiSeq,Baylor College of Medicine,NO
2620,Kidney Chromophobe,Primary Tumor,WGS,NCI Urologic Oncology Branch,Illumina HiSeq,Baylor College of Medicine,NO
2621,Kidney Chromophobe,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2622,Kidney Chromophobe,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2623,Kidney Chromophobe,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2624,Kidney Chromophobe,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2625,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2626,Kidney Chromophobe,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2627,Kidney Chromophobe,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2628,Kidney Chromophobe,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2629,Kidney Chromophobe,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2630,Kidney Chromophobe,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2631,Kidney Chromophobe,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2632,Kidney Chromophobe,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
2633,Kidney Chromophobe,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2634,Kidney Chromophobe,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2635,Kidney Chromophobe,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
2636,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2637,Kidney Chromophobe,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2638,Kidney Chromophobe,Primary Tumor,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2639,Kidney Chromophobe,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
2640,Kidney Chromophobe,Primary Tumor,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2641,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2642,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2643,Kidney Chromophobe,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
2644,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2645,Kidney Chromophobe,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
2646,Kidney Chromophobe,Primary Tumor,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
2647,Kidney Chromophobe,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2648,Kidney Chromophobe,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
2649,Kidney Chromophobe,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2650,Kidney Chromophobe,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
2651,Kidney Chromophobe,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
2652,Kidney Chromophobe,Primary Tumor,WGS,NCI Urologic Oncology Branch,Illumina HiSeq,Baylor College of Medicine,NO
2653,Kidney Chromophobe,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
2654,Kidney Chromophobe,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
2655,Kidney Chromophobe,Primary Tumor,WGS,NCI Urologic Oncology Branch,Illumina HiSeq,Baylor College of Medicine,NO
2656,Kidney Chromophobe,Blood Derived Normal,WGS,NCI Urologic Oncology Branch,Illumina HiSeq,Baylor College of Medicine,NO
2657,Kidney Chromophobe,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
2658,Kidney Chromophobe,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
2659,Kidney Chromophobe,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
2660,Kidney Chromophobe,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
2661,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2662,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2663,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2664,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2665,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
2666,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2667,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2668,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2669,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2670,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2671,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
2672,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2673,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2674,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
2675,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Peter MacCallum Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2676,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2677,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2678,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2679,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2680,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2681,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2682,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2683,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2684,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2685,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
2686,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2687,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2688,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2689,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2690,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Peter MacCallum Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2691,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2692,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2693,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2694,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2695,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2696,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2697,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
2698,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2699,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2700,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
2701,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2702,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
2703,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2704,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2705,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
2706,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
2707,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2708,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2709,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2710,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2711,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2712,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2713,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2714,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2715,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2716,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2717,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2718,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2719,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2720,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2721,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2722,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2723,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2724,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2725,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
2726,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2727,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2728,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2729,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2730,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2731,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2732,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2733,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2734,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2735,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2736,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2737,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2738,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2739,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2740,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2741,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2742,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2743,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2744,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2745,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2746,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
2747,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2748,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2749,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2750,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2751,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2752,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
2753,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
2754,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2755,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2756,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2757,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2758,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
2759,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2760,Stomach Adenocarcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
2761,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2762,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2763,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2764,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
2765,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2766,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2767,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2768,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2769,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2770,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2771,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2772,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
2773,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2774,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2775,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2776,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2777,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2778,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2779,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2780,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2781,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2782,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2783,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2784,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2785,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
2786,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
2787,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
2788,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2789,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2790,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2791,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2792,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2793,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2794,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2795,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2796,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2797,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2798,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2799,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2800,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2801,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2802,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2803,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2804,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
2805,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2806,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2807,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2808,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
2809,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
2810,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2811,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2812,Stomach Adenocarcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
2813,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2814,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2815,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2816,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2817,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2818,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2819,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2820,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
2821,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2822,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2823,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2824,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2825,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2826,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2827,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2828,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2829,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Peter MacCallum Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2830,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
2831,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2832,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
2833,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,University of Kansas Medical Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2834,Stomach Adenocarcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
2835,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
2836,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2837,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2838,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2839,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2840,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2841,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2842,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2843,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2844,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2845,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2846,Stomach Adenocarcinoma,Primary Tumor,WGS,Cureline,Illumina HiSeq,Harvard Medical School,NO
2847,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
2848,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2849,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2850,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2851,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2852,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2853,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2854,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2855,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2856,Stomach Adenocarcinoma,Primary Tumor,WGS,ILSBIO,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2857,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2858,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2859,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2860,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
2861,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2862,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2863,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2864,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
2865,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
2866,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2867,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2868,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2869,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2870,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
2871,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2872,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
2873,Stomach Adenocarcinoma,Blood Derived Normal,WGS,National Cancer Center Korea,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2874,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2875,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2876,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2877,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2878,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2879,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2880,Stomach Adenocarcinoma,Primary Tumor,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2881,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2882,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2883,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2884,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2885,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2886,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2887,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2888,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2889,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
2890,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2891,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2892,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2893,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
2894,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2895,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
2896,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2897,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2898,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2899,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2900,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2901,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2902,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2903,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
2904,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2905,Stomach Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2906,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2907,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2908,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2909,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2910,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2911,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2912,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2913,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2914,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2915,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2916,Stomach Adenocarcinoma,Primary Tumor,WGS,Cureline,Illumina HiSeq,Harvard Medical School,NO
2917,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2918,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2919,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2920,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2921,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
2922,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2923,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2924,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2925,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2926,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2927,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2928,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Peter MacCallum Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2929,Stomach Adenocarcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2930,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2931,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2932,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2933,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
2934,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2935,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2936,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2937,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2938,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2939,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2940,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2941,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2942,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2943,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2944,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2945,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2946,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2947,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2948,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2949,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2950,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2951,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2952,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2953,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2954,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2955,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
2956,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
2957,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2958,Stomach Adenocarcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
2959,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2960,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2961,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2962,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
2963,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2964,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2965,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
2966,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2967,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2968,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2969,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
2970,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2971,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2972,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
2973,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2974,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2975,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2976,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2977,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2978,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2979,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2980,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2981,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2982,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2983,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
2984,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2985,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2986,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
2987,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2988,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2989,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2990,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2991,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2992,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
2993,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
2994,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2995,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2996,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
2997,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
2998,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
2999,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3000,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3001,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3002,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3003,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3004,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3005,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3006,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3007,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3008,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3009,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3010,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3011,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3012,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,National Cancer Center Korea,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3013,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3014,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3015,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3016,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3017,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3018,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3019,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3020,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3021,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3022,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3023,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,UNC,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3024,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3025,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3026,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3027,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3028,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3029,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3030,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3031,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3032,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3033,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3034,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3035,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3036,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3037,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
3038,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3039,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3040,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3041,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3042,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3043,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3044,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Peter MacCallum Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3045,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3046,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3047,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3048,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3049,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3050,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3051,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3052,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3053,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3054,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3055,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3056,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3057,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
3058,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3059,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3060,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3061,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3062,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3063,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3064,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3065,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3066,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3067,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3068,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3069,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3070,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Cureline,Illumina HiSeq,Harvard Medical School,NO
3071,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3072,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3073,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3074,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3075,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3076,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3077,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3078,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3079,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3080,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3081,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3082,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3083,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3084,Stomach Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3085,Stomach Adenocarcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3086,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3087,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3088,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3089,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3090,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3091,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3092,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,ABS - IUPUI,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3093,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3094,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3095,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3096,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3097,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3098,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3099,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3100,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3101,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3102,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3103,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3104,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3105,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3106,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3107,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3108,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3109,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3110,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3111,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3112,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
3113,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3114,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3115,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3116,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3117,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3118,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3119,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3120,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3121,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3122,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3123,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3124,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3125,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3126,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3127,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3128,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3129,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3130,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3131,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3132,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3133,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3134,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3135,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3136,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3137,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3138,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3139,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3140,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3141,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3142,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3143,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3144,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3145,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3146,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3147,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3148,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3149,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3150,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3151,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Peter MacCallum Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3152,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3153,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3154,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3155,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Global Bioclinical-Moldova,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3156,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3157,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3158,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3159,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3160,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3161,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3162,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3163,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3164,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3165,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3166,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3167,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3168,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3169,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3170,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3171,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3172,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3173,Stomach Adenocarcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
3174,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,ABS - IUPUI,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3175,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3176,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3177,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3178,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3179,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3180,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3181,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3182,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3183,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3184,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3185,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3186,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3187,Stomach Adenocarcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
3188,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3189,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3190,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3191,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3192,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3193,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3194,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3195,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3196,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3197,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3198,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3199,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3200,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3201,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Cureline,Illumina HiSeq,Harvard Medical School,NO
3202,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3203,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3204,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3205,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
3206,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3207,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3208,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSBIO,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3209,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3210,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3211,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3212,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3213,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3214,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3215,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3216,Stomach Adenocarcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3217,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3218,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3219,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3220,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3221,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3222,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3223,Stomach Adenocarcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3224,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3225,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3226,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3227,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3228,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3229,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3230,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3231,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3232,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3233,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3234,Stomach Adenocarcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
3235,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3236,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3237,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3238,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3239,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3240,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3241,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3242,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3243,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3244,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3245,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3246,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3247,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3248,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3249,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3250,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3251,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3252,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3253,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3254,Stomach Adenocarcinoma,Blood Derived Normal,WGS,National Cancer Center Korea,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3255,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3256,Stomach Adenocarcinoma,Primary Tumor,WGS,Cureline,Illumina HiSeq,Harvard Medical School,NO
3257,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3258,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3259,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3260,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3261,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3262,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3263,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Peter MacCallum Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3264,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3265,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3266,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3267,Stomach Adenocarcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
3268,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3269,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3270,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3271,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3272,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3273,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3274,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3275,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3276,Stomach Adenocarcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3277,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3278,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3279,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3280,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3281,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3282,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3283,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3284,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3285,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3286,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3287,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3288,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3289,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3290,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3291,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3292,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3293,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3294,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3295,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3296,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3297,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3298,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3299,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3300,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3301,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3302,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3303,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3304,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3305,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3306,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3307,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3308,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3309,Stomach Adenocarcinoma,Primary Tumor,WGS,National Cancer Center Korea,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3310,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3311,Stomach Adenocarcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
3312,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3313,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3314,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3315,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3316,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3317,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Tayside Tissue Bank,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3318,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3319,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3320,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3321,Stomach Adenocarcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
3322,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3323,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3324,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3325,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3326,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3327,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3328,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3329,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3330,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3331,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3332,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3333,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3334,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3335,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3336,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3337,Stomach Adenocarcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
3338,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3339,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3340,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3341,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3342,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3343,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3344,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3345,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3346,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3347,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3348,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3349,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3350,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3351,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3352,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3353,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3354,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3355,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3356,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3357,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3358,Stomach Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3359,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3360,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3361,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3362,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3363,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3364,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3365,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3366,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3367,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3368,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3369,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3370,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3371,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3372,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3373,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3374,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3375,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3376,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3377,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3378,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3379,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3380,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3381,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3382,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3383,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3384,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3385,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3386,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3387,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3388,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3389,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3390,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3391,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3392,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Peter MacCallum Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3393,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3394,Stomach Adenocarcinoma,Primary Tumor,WGS,National Cancer Center Korea,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3395,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3396,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3397,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3398,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3399,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3400,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Peter MacCallum Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3401,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3402,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3403,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3404,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3405,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3406,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3407,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3408,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3409,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3410,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3411,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3412,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3413,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3414,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3415,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3416,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3417,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3418,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3419,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3420,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3421,Stomach Adenocarcinoma,Blood Derived Normal,WGS,National Cancer Center Korea,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3422,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3423,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3424,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3425,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3426,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3427,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3428,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3429,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3430,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3431,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3432,Stomach Adenocarcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
3433,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3434,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3435,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3436,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3437,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3438,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3439,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3440,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3441,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3442,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3443,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3444,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3445,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3446,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3447,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3448,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3449,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3450,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3451,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3452,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Peter MacCallum Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3453,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3454,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3455,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3456,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3457,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3458,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3459,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3460,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3461,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,University of Kansas Medical Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3462,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3463,Stomach Adenocarcinoma,Primary Tumor,WGS,National Cancer Center Korea,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3464,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3465,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3466,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3467,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3468,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3469,Stomach Adenocarcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
3470,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3471,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3472,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3473,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3474,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3475,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3476,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3477,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Peter MacCallum Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3478,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3479,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3480,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3481,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3482,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3483,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3484,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3485,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3486,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3487,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3488,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3489,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3490,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3491,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3492,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3493,Stomach Adenocarcinoma,Primary Tumor,WGS,National Cancer Center Korea,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3494,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3495,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3496,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3497,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3498,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3499,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3500,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3501,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Peter MacCallum Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3502,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3503,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3504,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3505,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3506,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3507,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3508,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3509,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3510,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3511,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3512,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3513,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3514,Stomach Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
3515,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3516,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3517,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3518,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3519,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3520,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3521,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3522,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3523,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3524,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3525,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3526,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3527,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3528,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3529,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3530,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3531,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3532,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3533,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3534,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3535,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3536,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3537,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3538,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3539,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3540,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3541,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Peter MacCallum Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3542,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3543,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3544,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3545,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3546,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3547,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3548,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3549,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3550,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3551,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3552,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3553,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3554,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3555,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3556,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3557,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3558,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3559,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3560,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3561,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3562,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3563,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3564,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3565,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
3566,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3567,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3568,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3569,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3570,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3571,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
3572,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3573,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3574,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3575,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3576,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3577,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3578,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
3579,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3580,Stomach Adenocarcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3581,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3582,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3583,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3584,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3585,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3586,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3587,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3588,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3589,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3590,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3591,Stomach Adenocarcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
3592,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3593,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3594,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3595,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3596,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3597,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3598,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3599,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3600,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3601,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3602,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3603,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3604,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3605,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3606,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3607,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3608,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3609,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3610,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3611,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3612,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3613,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3614,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3615,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3616,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3617,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3618,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3619,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3620,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3621,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3622,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3623,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3624,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3625,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3626,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3627,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3628,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3629,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3630,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3631,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3632,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3633,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3634,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3635,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3636,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3637,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3638,Stomach Adenocarcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
3639,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3640,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3641,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3642,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3643,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3644,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3645,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3646,Stomach Adenocarcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3647,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3648,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3649,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3650,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3651,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3652,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3653,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3654,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3655,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3656,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3657,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3658,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3659,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3660,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3661,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3662,Stomach Adenocarcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
3663,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3664,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3665,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3666,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3667,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3668,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3669,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3670,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3671,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3672,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3673,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3674,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3675,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3676,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3677,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3678,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3679,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3680,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3681,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3682,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3683,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3684,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3685,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3686,Stomach Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3687,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3688,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3689,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3690,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3691,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3692,Stomach Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
3693,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
3694,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3695,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3696,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
3697,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3698,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3699,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3700,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3701,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3702,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3703,Stomach Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3704,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3705,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3706,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3707,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Global Bioclinical-Moldova,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3708,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3709,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3710,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3711,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3712,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3713,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3714,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3715,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3716,Stomach Adenocarcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3717,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3718,Stomach Adenocarcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3719,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3720,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3721,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3722,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,"University Health Network, Toronto",Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3723,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3724,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3725,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3726,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3727,Stomach Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
3728,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3729,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3730,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3731,Stomach Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3732,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3733,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3734,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3735,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
3736,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3737,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3738,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Peter MacCallum Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3739,Stomach Adenocarcinoma,Solid Tissue Normal,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3740,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3741,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3742,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3743,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3744,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3745,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3746,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3747,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3748,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3749,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3750,Stomach Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
3751,Stomach Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3752,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3753,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina GA,Broad Institute of MIT and Harvard,NO
3754,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3755,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3756,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3757,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3758,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3759,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3760,Glioblastoma Multiforme,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3761,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3762,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3763,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3764,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3765,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3766,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3767,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3768,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3769,Glioblastoma Multiforme,Blood Derived Normal,WGS,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3770,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3771,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3772,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
3773,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3774,Glioblastoma Multiforme,Blood Derived Normal,WGS,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3775,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3776,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3777,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
3778,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina GA,Broad Institute of MIT and Harvard,NO
3779,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
3780,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3781,Glioblastoma Multiforme,Primary Tumor,WGS,University of Florida,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3782,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3783,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3784,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3785,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3786,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3787,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
3788,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3789,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3790,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3791,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3792,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3793,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3794,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3795,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3796,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3797,Glioblastoma Multiforme,Recurrent Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3798,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3799,Glioblastoma Multiforme,Primary Tumor,WGS,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3800,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
3801,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3802,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3803,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3804,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3805,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3806,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3807,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3808,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3809,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina GA,Broad Institute of MIT and Harvard,NO
3810,Glioblastoma Multiforme,Primary Tumor,WGS,Emory University,Illumina GA,Washington University School of Medicine,NO
3811,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
3812,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3813,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3814,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3815,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3816,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3817,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3818,Glioblastoma Multiforme,Recurrent Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3819,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3820,Glioblastoma Multiforme,Blood Derived Normal,WGS,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3821,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3822,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
3823,Glioblastoma Multiforme,Blood Derived Normal,WGS,Emory University,Illumina GA,Washington University School of Medicine,NO
3824,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3825,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3826,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3827,Glioblastoma Multiforme,Blood Derived Normal,WGS,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3828,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3829,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3830,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3831,Glioblastoma Multiforme,Recurrent Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3832,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina GA,Broad Institute of MIT and Harvard,NO
3833,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3834,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3835,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3836,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3837,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3838,Glioblastoma Multiforme,Recurrent Tumor,WGS,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3839,Glioblastoma Multiforme,Recurrent Tumor,WGS,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3840,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3841,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3842,Glioblastoma Multiforme,Recurrent Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3843,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3844,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3845,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3846,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina GA,Broad Institute of MIT and Harvard,NO
3847,Glioblastoma Multiforme,Primary Tumor,WGS,Toronto Western Hospital,Illumina GA,Washington University School of Medicine,NO
3848,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3849,Glioblastoma Multiforme,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3850,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3851,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3852,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3853,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
3854,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3855,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3856,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3857,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3858,Glioblastoma Multiforme,Blood Derived Normal,WGS,St. Joseph's Hospital (AZ),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3859,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3860,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3861,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3862,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3863,Glioblastoma Multiforme,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3864,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3865,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3866,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3867,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3868,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3869,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
3870,Glioblastoma Multiforme,Primary Tumor,WGS,Emory University,Illumina GA,Washington University School of Medicine,NO
3871,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3872,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3873,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3874,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3875,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina GA,Broad Institute of MIT and Harvard,NO
3876,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3877,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3878,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3879,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
3880,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3881,Glioblastoma Multiforme,Blood Derived Normal,WGS,Toronto Western Hospital,Illumina GA,Washington University School of Medicine,NO
3882,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3883,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3884,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3885,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3886,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3887,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3888,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
3889,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3890,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3891,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3892,Glioblastoma Multiforme,Blood Derived Normal,WGS,Emory University,Illumina GA,Washington University School of Medicine,NO
3893,Glioblastoma Multiforme,Primary Tumor,WGS,University of Florida,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3894,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3895,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3896,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3897,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3898,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3899,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3900,Glioblastoma Multiforme,Primary Tumor,WGS,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3901,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3902,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3903,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3904,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3905,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3906,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3907,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3908,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3909,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3910,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3911,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3912,Glioblastoma Multiforme,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3913,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3914,Glioblastoma Multiforme,Blood Derived Normal,WGS,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3915,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3916,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3917,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3918,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3919,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3920,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3921,Glioblastoma Multiforme,Primary Tumor,WGS,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3922,Glioblastoma Multiforme,Primary Tumor,WGS,Emory University,Illumina GA,Washington University School of Medicine,NO
3923,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3924,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3925,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3926,Glioblastoma Multiforme,Recurrent Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3927,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3928,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3929,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Toronto Western Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3930,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3931,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3932,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3933,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3934,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3935,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina GA,Broad Institute of MIT and Harvard,NO
3936,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3937,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3938,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina GA,Broad Institute of MIT and Harvard,NO
3939,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3940,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3941,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
3942,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3943,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3944,Glioblastoma Multiforme,Blood Derived Normal,WGS,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3945,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3946,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3947,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
3948,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3949,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3950,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3951,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3952,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3953,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina GA,Broad Institute of MIT and Harvard,NO
3954,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3955,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
3956,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
3957,Glioblastoma Multiforme,Primary Tumor,WGS,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3958,Glioblastoma Multiforme,Recurrent Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3959,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3960,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3961,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3962,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3963,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3964,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
3965,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Toronto Western Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3966,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3967,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3968,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3969,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Toronto Western Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3970,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3971,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3972,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3973,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3974,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3975,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3976,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3977,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
3978,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3979,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3980,Glioblastoma Multiforme,Blood Derived Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3981,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3982,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina GA,Broad Institute of MIT and Harvard,NO
3983,Glioblastoma Multiforme,Primary Tumor,WGS,Toronto Western Hospital,Illumina GA,Washington University School of Medicine,NO
3984,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3985,Glioblastoma Multiforme,Solid Tissue Normal,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
3986,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3987,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3988,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3989,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3990,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3991,Glioblastoma Multiforme,Blood Derived Normal,WGS,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3992,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3993,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3994,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3995,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3996,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3997,Glioblastoma Multiforme,Primary Tumor,WGS,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3998,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
3999,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4000,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4001,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4002,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4003,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
4004,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4005,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4006,Glioblastoma Multiforme,Recurrent Tumor,WGS,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4007,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4008,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4009,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
4010,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4011,Glioblastoma Multiforme,Blood Derived Normal,WGS,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4012,Glioblastoma Multiforme,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4013,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4014,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4015,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4016,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4017,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4018,Glioblastoma Multiforme,Blood Derived Normal,WGS,University of Florida,Illumina GA,Washington University School of Medicine,NO
4019,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4020,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4021,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
4022,Glioblastoma Multiforme,Blood Derived Normal,WGS,Toronto Western Hospital,Illumina GA,Washington University School of Medicine,NO
4023,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4024,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4025,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4026,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4027,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4028,Glioblastoma Multiforme,Blood Derived Normal,WGS,Emory University,Illumina GA,Washington University School of Medicine,NO
4029,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,LS 454,Baylor College of Medicine,NO
4030,Glioblastoma Multiforme,Primary Tumor,WGS,Emory University,Illumina GA,Washington University School of Medicine,NO
4031,Glioblastoma Multiforme,Primary Tumor,WGS,Emory University,Illumina GA,Washington University School of Medicine,NO
4032,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4033,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4034,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4035,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4036,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4037,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4038,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4039,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4040,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4041,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4042,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4043,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina GA,Broad Institute of MIT and Harvard,NO
4044,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina GA,Broad Institute of MIT and Harvard,NO
4045,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4046,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4047,Glioblastoma Multiforme,Blood Derived Normal,WGS,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4048,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4049,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4050,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4051,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4052,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4053,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4054,Glioblastoma Multiforme,Solid Tissue Normal,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
4055,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4056,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4057,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4058,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4059,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4060,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4061,Glioblastoma Multiforme,Blood Derived Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4062,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4063,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4064,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4065,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4066,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4067,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4068,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4069,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4070,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4071,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4072,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4073,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4074,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4075,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4076,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4077,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4078,Glioblastoma Multiforme,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4079,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4080,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4081,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4082,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4083,Glioblastoma Multiforme,Primary Tumor,WGS,Toronto Western Hospital,Illumina GA,Washington University School of Medicine,NO
4084,Glioblastoma Multiforme,Blood Derived Normal,WGS,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4085,Glioblastoma Multiforme,Blood Derived Normal,WGS,University of Florida,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4086,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4087,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4088,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4089,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4090,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4091,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4092,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4093,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4094,Glioblastoma Multiforme,Solid Tissue Normal,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
4095,Glioblastoma Multiforme,Blood Derived Normal,WGS,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4096,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4097,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4098,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Toronto Western Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4099,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina GA,Broad Institute of MIT and Harvard,NO
4100,Glioblastoma Multiforme,Primary Tumor,WGS,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4101,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4102,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4103,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4104,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4105,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
4106,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4107,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4108,Glioblastoma Multiforme,Primary Tumor,WGS,Emory University,Illumina GA,Washington University School of Medicine,NO
4109,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4110,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4111,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4112,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4113,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4114,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4115,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4116,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4117,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4118,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4119,Glioblastoma Multiforme,Primary Tumor,WGS,St. Joseph's Hospital (AZ),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4120,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4121,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4122,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4123,Glioblastoma Multiforme,Primary Tumor,WGS,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4124,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4125,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4126,Glioblastoma Multiforme,Blood Derived Normal,WGS,University of Florida,Illumina GA,Washington University School of Medicine,NO
4127,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4128,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4129,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina GA,Broad Institute of MIT and Harvard,NO
4130,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4131,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4132,Glioblastoma Multiforme,Blood Derived Normal,WGS,Toronto Western Hospital,Illumina GA,Washington University School of Medicine,NO
4133,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4134,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4135,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4136,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4137,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4138,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4139,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4140,Glioblastoma Multiforme,Primary Tumor,WGS,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4141,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4142,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4143,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4144,Glioblastoma Multiforme,Primary Tumor,WGS,Toronto Western Hospital,Illumina GA,Washington University School of Medicine,NO
4145,Glioblastoma Multiforme,Primary Tumor,WGS,University of Florida,Illumina GA,Washington University School of Medicine,NO
4146,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4147,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4148,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4149,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4150,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4151,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4152,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4153,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina GA,Broad Institute of MIT and Harvard,NO
4154,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4155,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4156,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4157,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4158,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4159,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4160,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4161,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4162,Glioblastoma Multiforme,Blood Derived Normal,WGS,Emory University,Illumina GA,Washington University School of Medicine,NO
4163,Glioblastoma Multiforme,Solid Tissue Normal,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
4164,Glioblastoma Multiforme,Primary Tumor,WGS,Emory University,Illumina GA,Washington University School of Medicine,NO
4165,Glioblastoma Multiforme,Primary Tumor,WGS,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4166,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4167,Glioblastoma Multiforme,Blood Derived Normal,WGS,Emory University,Illumina GA,Washington University School of Medicine,NO
4168,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4169,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4170,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
4171,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4172,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4173,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4174,Glioblastoma Multiforme,Primary Tumor,WGS,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4175,Glioblastoma Multiforme,Blood Derived Normal,WGS,Toronto Western Hospital,Illumina GA,Washington University School of Medicine,NO
4176,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4177,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4178,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4179,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4180,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4181,Glioblastoma Multiforme,Primary Tumor,WGS,Emory University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4182,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4183,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4184,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4185,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4186,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4187,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
4188,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4189,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4190,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4191,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4192,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4193,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4194,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
4195,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4196,Glioblastoma Multiforme,Blood Derived Normal,WGS,Emory University,Illumina GA,Washington University School of Medicine,NO
4197,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4198,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina GA,Broad Institute of MIT and Harvard,NO
4199,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4200,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4201,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4202,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4203,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4204,Glioblastoma Multiforme,Blood Derived Normal,WGS,Emory University,Illumina GA,Washington University School of Medicine,NO
4205,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4206,Glioblastoma Multiforme,Recurrent Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4207,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4208,Glioblastoma Multiforme,Blood Derived Normal,WGS,University of Florida,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4209,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4210,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4211,Glioblastoma Multiforme,Recurrent Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4212,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina GA,Broad Institute of MIT and Harvard,NO
4213,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4214,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4215,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4216,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4217,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4218,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4219,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4220,Glioblastoma Multiforme,Primary Tumor,WGS,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4221,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4222,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4223,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
4224,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4225,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4226,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
4227,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4228,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4229,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4230,Glioblastoma Multiforme,Primary Tumor,WGS,University of Florida,Illumina GA,Washington University School of Medicine,NO
4231,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4232,Glioblastoma Multiforme,Blood Derived Normal,WGS,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4233,Glioblastoma Multiforme,Solid Tissue Normal,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
4234,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina GA,Broad Institute of MIT and Harvard,NO
4235,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4236,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4237,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4238,Glioblastoma Multiforme,Primary Tumor,WGS,Emory University,Illumina GA,Washington University School of Medicine,NO
4239,Glioblastoma Multiforme,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4240,Glioblastoma Multiforme,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina GA,Washington University School of Medicine,NO
4241,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4242,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4243,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4244,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4245,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4246,Glioblastoma Multiforme,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
4247,Glioblastoma Multiforme,Blood Derived Normal,WGS,Emory University,Illumina GA,Washington University School of Medicine,NO
4248,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
4249,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4250,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4251,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4252,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4253,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4254,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4255,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
4256,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4257,Colon Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
4258,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4259,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4260,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4261,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4262,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4263,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4264,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
4265,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4266,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
4267,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4268,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4269,Colon Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
4270,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4271,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4272,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4273,Colon Adenocarcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
4274,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4275,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4276,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4277,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
4278,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4279,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
4280,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
4281,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
4282,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
4283,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4284,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4285,Colon Adenocarcinoma,Primary Tumor,WGS,BLN - Baylor,Illumina HiSeq,Baylor College of Medicine,NO
4286,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4287,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
4288,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
4289,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4290,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4291,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4292,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
4293,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4294,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
4295,Colon Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
4296,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4297,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4298,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4299,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
4300,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
4301,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4302,Colon Adenocarcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
4303,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
4304,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4305,Colon Adenocarcinoma,Blood Derived Normal,WGS,BLN - Baylor,Illumina HiSeq,Baylor College of Medicine,NO
4306,Colon Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
4307,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4308,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4309,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
4310,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4311,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4312,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
4313,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
4314,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4315,Colon Adenocarcinoma,Metastatic,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
4316,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4317,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4318,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4319,Colon Adenocarcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
4320,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4321,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
4322,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4323,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4324,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
4325,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4326,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
4327,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4328,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4329,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
4330,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4331,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4332,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
4333,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4334,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
4335,Colon Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
4336,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
4337,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Albert Einstein Medical Center,Illumina HiSeq,University of North Carolina,NO
4338,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
4339,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4340,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4341,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
4342,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4343,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
4344,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4345,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Kansas,Illumina HiSeq,University of North Carolina,NO
4346,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4347,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4348,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
4349,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4350,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4351,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4352,Colon Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
4353,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4354,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
4355,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
4356,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4357,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4358,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
4359,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
4360,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4361,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4362,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4363,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4364,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4365,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4366,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
4367,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4368,Colon Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
4369,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4370,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4371,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4372,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4373,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
4374,Colon Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
4375,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
4376,Colon Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
4377,Colon Adenocarcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
4378,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
4379,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4380,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
4381,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4382,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4383,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4384,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4385,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4386,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4387,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
4388,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4389,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4390,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
4391,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4392,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
4393,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4394,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4395,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4396,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4397,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4398,Colon Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
4399,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
4400,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4401,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
4402,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4403,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4404,Colon Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
4405,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
4406,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4407,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
4408,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4409,Colon Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
4410,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4411,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4412,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4413,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
4414,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4415,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4416,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4417,Colon Adenocarcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Baylor College of Medicine,NO
4418,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4419,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4420,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
4421,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4422,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
4423,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4424,Colon Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
4425,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4426,Colon Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
4427,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4428,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
4429,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
4430,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
4431,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4432,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
4433,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4434,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4435,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
4436,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
4437,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
4438,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
4439,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4440,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
4441,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4442,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
4443,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4444,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4445,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
4446,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4447,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4448,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
4449,Colon Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
4450,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4451,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4452,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4453,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
4454,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4455,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4456,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
4457,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4458,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
4459,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4460,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4461,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
4462,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4463,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
4464,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4465,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4466,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4467,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
4468,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4469,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4470,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4471,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Molecular Response,Illumina HiSeq,University of North Carolina,NO
4472,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
4473,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
4474,Colon Adenocarcinoma,Primary Tumor,WGS,Harvard,Illumina HiSeq,Harvard Medical School,NO
4475,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4476,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
4477,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
4478,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
4479,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4480,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
4481,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4482,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4483,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4484,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4485,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4486,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4487,Colon Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
4488,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
4489,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
4490,Colon Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
4491,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4492,Colon Adenocarcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
4493,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4494,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4495,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4496,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4497,Colon Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
4498,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
4499,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
4500,Colon Adenocarcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Baylor College of Medicine,NO
4501,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4502,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4503,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
4504,Colon Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
4505,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4506,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
4507,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4508,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
4509,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4510,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4511,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
4512,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4513,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4514,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4515,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
4516,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4517,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4518,Colon Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
4519,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4520,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4521,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4522,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
4523,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4524,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4525,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
4526,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
4527,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4528,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
4529,Colon Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
4530,Colon Adenocarcinoma,Primary Tumor,WGS,BLN - Baylor,Illumina HiSeq,Baylor College of Medicine,NO
4531,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4532,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4533,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
4534,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4535,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina GA,University of North Carolina,NO
4536,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
4537,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
4538,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
4539,Colon Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
4540,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
4541,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4542,Colon Adenocarcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Baylor College of Medicine,NO
4543,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
4544,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
4545,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4546,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4547,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
4548,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
4549,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4550,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4551,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4552,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4553,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4554,Colon Adenocarcinoma,Primary Tumor,WGS,BLN - Baylor,Illumina HiSeq,Baylor College of Medicine,NO
4555,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
4556,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
4557,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
4558,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4559,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4560,Colon Adenocarcinoma,Primary Tumor,WGS,Candler,Illumina HiSeq,Baylor College of Medicine,NO
4561,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4562,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
4563,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4564,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
4565,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina GA,University of North Carolina,NO
4566,Colon Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
4567,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
4568,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4569,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4570,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4571,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4572,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4573,Colon Adenocarcinoma,Primary Tumor,WGS,BLN - Baylor,Illumina HiSeq,Baylor College of Medicine,NO
4574,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
4575,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4576,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4577,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
4578,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
4579,Colon Adenocarcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
4580,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4581,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4582,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
4583,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4584,Colon Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
4585,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4586,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
4587,Colon Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
4588,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4589,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4590,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
4591,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4592,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4593,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4594,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4595,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4596,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
4597,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4598,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4599,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4600,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4601,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
4602,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
4603,Colon Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
4604,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
4605,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
4606,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4607,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4608,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4609,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
4610,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4611,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4612,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
4613,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4614,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
4615,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4616,Colon Adenocarcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
4617,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4618,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4619,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4620,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4621,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4622,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4623,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4624,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4625,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
4626,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4627,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina GA,Harvard Medical School,NO
4628,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4629,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
4630,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4631,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4632,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4633,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4634,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
4635,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4636,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4637,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4638,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4639,Colon Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
4640,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
4641,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
4642,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4643,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4644,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4645,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4646,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
4647,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4648,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4649,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4650,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4651,Colon Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
4652,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
4653,Colon Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
4654,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4655,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4656,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4657,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Northwestern University,Illumina HiSeq,University of North Carolina,NO
4658,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4659,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4660,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
4661,Colon Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
4662,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4663,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4664,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4665,Colon Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
4666,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4667,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4668,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina GA,University of North Carolina,NO
4669,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
4670,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
4671,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4672,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4673,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
4674,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
4675,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4676,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4677,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4678,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4679,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4680,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
4681,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4682,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4683,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4684,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4685,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
4686,Colon Adenocarcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
4687,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4688,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4689,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4690,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4691,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4692,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4693,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
4694,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
4695,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4696,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4697,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4698,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4699,Colon Adenocarcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
4700,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4701,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4702,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4703,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4704,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4705,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
4706,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4707,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
4708,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
4709,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4710,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4711,Colon Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
4712,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
4713,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4714,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4715,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4716,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4717,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
4718,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4719,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4720,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
4721,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4722,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4723,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
4724,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4725,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4726,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
4727,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
4728,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4729,Colon Adenocarcinoma,Blood Derived Normal,WGS,Candler,Illumina HiSeq,Baylor College of Medicine,NO
4730,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
4731,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4732,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
4733,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4734,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4735,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
4736,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
4737,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4738,Colon Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
4739,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
4740,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4741,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4742,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4743,Colon Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
4744,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4745,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4746,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4747,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4748,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4749,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
4750,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4751,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
4752,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4753,Colon Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
4754,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4755,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4756,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4757,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4758,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4759,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina GA,Harvard Medical School,NO
4760,Colon Adenocarcinoma,Blood Derived Normal,WGS,BLN - Baylor,Illumina HiSeq,Baylor College of Medicine,NO
4761,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4762,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
4763,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4764,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
4765,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
4766,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
4767,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
4768,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4769,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4770,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4771,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina GA,Harvard Medical School,NO
4772,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
4773,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4774,Colon Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
4775,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
4776,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
4777,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4778,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4779,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4780,Colon Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
4781,Colon Adenocarcinoma,Blood Derived Normal,WGS,Harvard,Illumina HiSeq,Harvard Medical School,NO
4782,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4783,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4784,Colon Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
4785,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
4786,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4787,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4788,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4789,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina GA,University of North Carolina,NO
4790,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4791,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4792,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
4793,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
4794,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
4795,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4796,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
4797,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4798,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4799,Colon Adenocarcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
4800,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4801,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4802,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4803,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4804,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4805,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina GA,Harvard Medical School,NO
4806,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4807,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4808,Colon Adenocarcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
4809,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4810,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4811,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4812,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4813,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4814,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4815,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4816,Colon Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
4817,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4818,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
4819,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4820,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4821,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4822,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4823,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
4824,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4825,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4826,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4827,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4828,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4829,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
4830,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4831,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4832,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
4833,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4834,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4835,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4836,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
4837,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4838,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4839,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
4840,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4841,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4842,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
4843,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4844,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
4845,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
4846,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
4847,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4848,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
4849,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4850,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina GA,Harvard Medical School,NO
4851,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
4852,Colon Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
4853,Colon Adenocarcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
4854,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4855,Colon Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
4856,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4857,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4858,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4859,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
4860,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
4861,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4862,Colon Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
4863,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4864,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
4865,Colon Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
4866,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
4867,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4868,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4869,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
4870,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4871,Colon Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
4872,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4873,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4874,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4875,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
4876,Colon Adenocarcinoma,Blood Derived Normal,WGS,BLN - Baylor,Illumina HiSeq,Baylor College of Medicine,NO
4877,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
4878,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
4879,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4880,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4881,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina GA,Harvard Medical School,NO
4882,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4883,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
4884,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4885,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina GA,University of North Carolina,NO
4886,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
4887,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
4888,Colon Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
4889,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4890,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,St Joseph's Medical Center (MD),Illumina HiSeq,University of North Carolina,NO
4891,Colon Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
4892,Colon Adenocarcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
4893,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4894,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
4895,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4896,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
4897,Colon Adenocarcinoma,Blood Derived Normal,WGS,Candler,Illumina HiSeq,Baylor College of Medicine,NO
4898,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4899,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
4900,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4901,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4902,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4903,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4904,Colon Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
4905,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4906,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4907,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
4908,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4909,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4910,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4911,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4912,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4913,Colon Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
4914,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4915,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4916,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4917,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4918,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4919,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
4920,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4921,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4922,Colon Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
4923,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4924,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
4925,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4926,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4927,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
4928,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
4929,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4930,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4931,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4932,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4933,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
4934,Colon Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
4935,Colon Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
4936,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4937,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4938,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4939,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
4940,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
4941,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4942,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4943,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4944,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4945,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4946,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4947,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4948,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
4949,Colon Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
4950,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina GA,Harvard Medical School,NO
4951,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4952,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
4953,Colon Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
4954,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4955,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4956,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4957,Colon Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
4958,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4959,Colon Adenocarcinoma,Blood Derived Normal,WGS,BLN - Baylor,Illumina HiSeq,Baylor College of Medicine,NO
4960,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4961,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
4962,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4963,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
4964,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4965,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4966,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4967,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4968,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4969,Colon Adenocarcinoma,Primary Tumor,WGS,Candler,Illumina HiSeq,Baylor College of Medicine,NO
4970,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
4971,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4972,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4973,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
4974,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4975,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4976,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4977,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
4978,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4979,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4980,Colon Adenocarcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
4981,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4982,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4983,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
4984,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
4985,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
4986,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
4987,Colon Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
4988,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4989,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
4990,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
4991,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4992,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
4993,Colon Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
4994,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4995,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
4996,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Mary Bird Perkins Cancer Center - Our Lady of the Lake,Illumina HiSeq,University of North Carolina,NO
4997,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
4998,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
4999,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5000,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5001,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5002,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
5003,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
5004,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
5005,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5006,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
5007,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5008,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5009,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
5010,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5011,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5012,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5013,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5014,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
5015,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5016,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
5017,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
5018,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5019,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5020,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
5021,Colon Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
5022,Colon Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
5023,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
5024,Colon Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5025,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5026,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
5027,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
5028,Colon Adenocarcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
5029,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
5030,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5031,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5032,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
5033,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina GA,University of North Carolina,NO
5034,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5035,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5036,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
5037,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5038,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5039,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
5040,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
5041,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
5042,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
5043,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
5044,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5045,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5046,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
5047,Colon Adenocarcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
5048,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5049,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5050,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5051,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
5052,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5053,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5054,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5055,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
5056,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5057,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
5058,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina GA,University of North Carolina,NO
5059,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
5060,Colon Adenocarcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
5061,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5062,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5063,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
5064,Colon Adenocarcinoma,Recurrent Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
5065,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
5066,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5067,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5068,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
5069,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
5070,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
5071,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5072,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
5073,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
5074,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5075,Colon Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
5076,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
5077,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
5078,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5079,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5080,Colon Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5081,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5082,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
5083,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5084,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
5085,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5086,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5087,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5088,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5089,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5090,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5091,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
5092,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5093,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
5094,Colon Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
5095,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5096,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
5097,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
5098,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
5099,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
5100,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
5101,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,St Joseph's Medical Center (MD),Illumina HiSeq,University of North Carolina,NO
5102,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5103,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina GA,Harvard Medical School,NO
5104,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5105,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
5106,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5107,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5108,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
5109,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
5110,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
5111,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5112,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5113,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5114,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
5115,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
5116,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
5117,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina GA,Harvard Medical School,NO
5118,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
5119,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
5120,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5121,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
5122,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Duke University,Illumina HiSeq,University of North Carolina,NO
5123,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
5124,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5125,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
5126,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5127,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
5128,Colon Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
5129,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5130,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
5131,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5132,Colon Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
5133,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5134,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5135,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5136,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5137,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5138,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
5139,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
5140,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5141,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5142,Colon Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
5143,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5144,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5145,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5146,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5147,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
5148,Colon Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
5149,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
5150,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
5151,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5152,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
5153,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5154,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
5155,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5156,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
5157,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
5158,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
5159,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5160,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
5161,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
5162,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
5163,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5164,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
5165,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5166,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5167,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5168,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
5169,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5170,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5171,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
5172,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
5173,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5174,Colon Adenocarcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
5175,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
5176,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
5177,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
5178,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5179,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
5180,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
5181,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
5182,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
5183,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
5184,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5185,Colon Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
5186,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina GA,University of North Carolina,NO
5187,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
5188,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5189,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
5190,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
5191,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
5192,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5193,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
5194,Colon Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
5195,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
5196,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5197,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5198,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
5199,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5200,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
5201,Colon Adenocarcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
5202,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
5203,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5204,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5205,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
5206,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5207,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5208,Colon Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
5209,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5210,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
5211,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5212,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5213,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5214,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
5215,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5216,Colon Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
5217,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5218,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5219,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5220,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
5221,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
5222,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5223,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
5224,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
5225,Colon Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
5226,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
5227,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina GA,Harvard Medical School,NO
5228,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
5229,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
5230,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
5231,Colon Adenocarcinoma,Blood Derived Normal,WGS,BLN - Baylor,Illumina HiSeq,Baylor College of Medicine,NO
5232,Colon Adenocarcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Baylor College of Medicine,NO
5233,Colon Adenocarcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
5234,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5235,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5236,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5237,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5238,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5239,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5240,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
5241,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
5242,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
5243,Colon Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
5244,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
5245,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
5246,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5247,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5248,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5249,Colon Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5250,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
5251,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5252,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5253,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5254,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
5255,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5256,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5257,Colon Adenocarcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
5258,Colon Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
5259,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
5260,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
5261,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
5262,Colon Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
5263,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5264,Colon Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
5265,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5266,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
5267,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5268,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5269,Thyroid Carcinoma,Blood Derived Normal,WGS,University of North Carolina,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5270,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5271,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5272,Thyroid Carcinoma,Blood Derived Normal,WGS,University of North Carolina,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5273,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,Harvard Medical School,NO
5274,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5275,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5276,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5277,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5278,Thyroid Carcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
5279,Thyroid Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
5280,Thyroid Carcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
5281,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5282,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5283,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5284,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5285,Thyroid Carcinoma,Metastatic,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5286,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5287,Thyroid Carcinoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5288,Thyroid Carcinoma,Primary Tumor,WGS,MD Anderson,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5289,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5290,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5291,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
5292,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5293,Thyroid Carcinoma,Solid Tissue Normal,WGS,University Health Network,Illumina HiSeq,Harvard Medical School,NO
5294,Thyroid Carcinoma,Solid Tissue Normal,WGS,University Health Network,Illumina HiSeq,Harvard Medical School,NO
5295,Thyroid Carcinoma,Blood Derived Normal,WGS,Ohio State University,Illumina HiSeq,Harvard Medical School,NO
5296,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5297,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5298,Thyroid Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5299,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5300,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5301,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5302,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5303,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
5304,Thyroid Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5305,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
5306,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
5307,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
5308,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5309,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5310,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5311,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5312,Thyroid Carcinoma,Blood Derived Normal,WGS,Ohio State University,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5313,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5314,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5315,Thyroid Carcinoma,Primary Tumor,WGS,Ohio State University,Illumina HiSeq,Harvard Medical School,NO
5316,Thyroid Carcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
5317,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Ohio State University,Illumina HiSeq,University of North Carolina,NO
5318,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5319,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5320,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5321,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5322,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5323,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5324,Thyroid Carcinoma,Primary Tumor,WGS,MD Anderson,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5325,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5326,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
5327,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5328,Thyroid Carcinoma,Blood Derived Normal,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
5329,Thyroid Carcinoma,Primary Tumor,WGS,MD Anderson,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5330,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5331,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5332,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5333,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5334,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5335,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
5336,Thyroid Carcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5337,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Ohio State University,Illumina HiSeq,University of North Carolina,NO
5338,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
5339,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5340,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5341,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5342,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5343,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5344,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
5345,Thyroid Carcinoma,Blood Derived Normal,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
5346,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5347,Thyroid Carcinoma,Primary Tumor,WGS,Ohio State University,Illumina HiSeq,Harvard Medical School,NO
5348,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5349,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
5350,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5351,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,Harvard Medical School,NO
5352,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5353,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5354,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
5355,Thyroid Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
5356,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5357,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5358,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5359,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5360,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5361,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
5362,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5363,Thyroid Carcinoma,Solid Tissue Normal,WGS,MD Anderson,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5364,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5365,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
5366,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
5367,Thyroid Carcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
5368,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5369,Thyroid Carcinoma,Primary Tumor,WGS,University of North Carolina,Illumina HiSeq,Harvard Medical School,NO
5370,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5371,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5372,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
5373,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
5374,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5375,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
5376,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5377,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5378,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5379,Thyroid Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
5380,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5381,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5382,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5383,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5384,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5385,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5386,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5387,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5388,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5389,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5390,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5391,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5392,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
5393,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5394,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5395,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5396,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5397,Thyroid Carcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
5398,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5399,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Ohio State University,Illumina HiSeq,University of North Carolina,NO
5400,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
5401,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5402,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
5403,Thyroid Carcinoma,Primary Tumor,WGS,Ohio State University,Illumina HiSeq,Harvard Medical School,NO
5404,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5405,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5406,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
5407,Thyroid Carcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
5408,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
5409,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5410,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
5411,Thyroid Carcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5412,Thyroid Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
5413,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5414,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,MD Anderson - RPPA Core Facility (Proteomics),NO
5415,Thyroid Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5416,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5417,Thyroid Carcinoma,Blood Derived Normal,WGS,Ohio State University,Illumina HiSeq,Harvard Medical School,NO
5418,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5419,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5420,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5421,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5422,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Ohio State University,Illumina HiSeq,University of North Carolina,NO
5423,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5424,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5425,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5426,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5427,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5428,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5429,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
5430,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
5431,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5432,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5433,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5434,Thyroid Carcinoma,Metastatic,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
5435,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
5436,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5437,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
5438,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5439,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5440,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5441,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5442,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5443,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5444,Thyroid Carcinoma,Blood Derived Normal,WGS,Ohio State University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5445,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5446,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5447,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5448,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5449,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5450,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5451,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5452,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,Harvard Medical School,NO
5453,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5454,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Ohio State University,Illumina HiSeq,University of North Carolina,NO
5455,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5456,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
5457,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5458,Thyroid Carcinoma,Solid Tissue Normal,WGS,University Health Network,Illumina HiSeq,Harvard Medical School,NO
5459,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
5460,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5461,Thyroid Carcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5462,Thyroid Carcinoma,Primary Tumor,WGS,MD Anderson,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5463,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5464,Thyroid Carcinoma,Blood Derived Normal,WGS,Ohio State University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5465,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5466,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
5467,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5468,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5469,Thyroid Carcinoma,Primary Tumor,WGS,University of North Carolina,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5470,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5471,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5472,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5473,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5474,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5475,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,Harvard Medical School,NO
5476,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
5477,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5478,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5479,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5480,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5481,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5482,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
5483,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
5484,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5485,Thyroid Carcinoma,Blood Derived Normal,WGS,Ohio State University,Illumina HiSeq,Harvard Medical School,NO
5486,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5487,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
5488,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5489,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
5490,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5491,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5492,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5493,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5494,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5495,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5496,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
5497,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5498,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5499,Thyroid Carcinoma,Blood Derived Normal,WGS,ABS - IUPUI,Illumina HiSeq,Harvard Medical School,NO
5500,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5501,Thyroid Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5502,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5503,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,Harvard Medical School,NO
5504,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5505,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
5506,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5507,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5508,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Medical College of Georgia,Illumina HiSeq,University of North Carolina,NO
5509,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5510,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5511,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5512,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5513,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5514,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5515,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5516,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5517,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5518,Thyroid Carcinoma,Blood Derived Normal,WGS,Ohio State University,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5519,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5520,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5521,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5522,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5523,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5524,Thyroid Carcinoma,Solid Tissue Normal,WGS,MD Anderson,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5525,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5526,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5527,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5528,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5529,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Ohio State University,Illumina HiSeq,University of North Carolina,NO
5530,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5531,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5532,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5533,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5534,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5535,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
5536,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5537,Thyroid Carcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5538,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5539,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5540,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5541,Thyroid Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
5542,Thyroid Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5543,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5544,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5545,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5546,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5547,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5548,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5549,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5550,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5551,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
5552,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5553,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5554,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5555,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5556,Thyroid Carcinoma,Primary Tumor,WGS,MD Anderson,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5557,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5558,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5559,Thyroid Carcinoma,Solid Tissue Normal,WGS,MD Anderson,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5560,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5561,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5562,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
5563,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5564,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5565,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5566,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5567,Thyroid Carcinoma,Solid Tissue Normal,WGS,Medical College of Georgia,Illumina HiSeq,Harvard Medical School,NO
5568,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
5569,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Medical College of Georgia,Illumina HiSeq,University of North Carolina,NO
5570,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5571,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5572,Thyroid Carcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5573,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5574,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5575,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
5576,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5577,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5578,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
5579,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5580,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5581,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5582,Thyroid Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5583,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5584,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5585,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5586,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5587,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5588,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5589,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5590,Thyroid Carcinoma,Solid Tissue Normal,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5591,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
5592,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
5593,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5594,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5595,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5596,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5597,Thyroid Carcinoma,Blood Derived Normal,WGS,University of North Carolina,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5598,Thyroid Carcinoma,Blood Derived Normal,WGS,Ohio State University,Illumina HiSeq,Harvard Medical School,NO
5599,Thyroid Carcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5600,Thyroid Carcinoma,Blood Derived Normal,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5601,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5602,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5603,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
5604,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
5605,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5606,Thyroid Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
5607,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5608,Thyroid Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
5609,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5610,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5611,Thyroid Carcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
5612,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5613,Thyroid Carcinoma,Metastatic,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
5614,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5615,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5616,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5617,Thyroid Carcinoma,Primary Tumor,WGS,ABS - IUPUI,Illumina HiSeq,Harvard Medical School,NO
5618,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5619,Thyroid Carcinoma,Solid Tissue Normal,WGS,University Health Network,Illumina HiSeq,Harvard Medical School,NO
5620,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5621,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
5622,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5623,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5624,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5625,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5626,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5627,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5628,Thyroid Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5629,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5630,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5631,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5632,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5633,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5634,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5635,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5636,Thyroid Carcinoma,Metastatic,WGS,Mayo Clinic,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5637,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5638,Thyroid Carcinoma,Solid Tissue Normal,WGS,MD Anderson,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5639,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5640,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5641,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5642,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5643,Thyroid Carcinoma,Primary Tumor,WGS,Ohio State University,Illumina HiSeq,Harvard Medical School,NO
5644,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5645,Thyroid Carcinoma,Blood Derived Normal,WGS,National Institutes of Health,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5646,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5647,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5648,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5649,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5650,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5651,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5652,Thyroid Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5653,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5654,Thyroid Carcinoma,Primary Tumor,WGS,University of North Carolina,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5655,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5656,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5657,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5658,Thyroid Carcinoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5659,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5660,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5661,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5662,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5663,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Ohio State University,Illumina HiSeq,University of North Carolina,NO
5664,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5665,Thyroid Carcinoma,Primary Tumor,WGS,Ohio State University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5666,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5667,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Ohio State University,Illumina HiSeq,University of North Carolina,NO
5668,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5669,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
5670,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Ohio State University,Illumina HiSeq,University of North Carolina,NO
5671,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5672,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5673,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5674,Thyroid Carcinoma,Blood Derived Normal,WGS,Ohio State University,Illumina HiSeq,Harvard Medical School,NO
5675,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
5676,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5677,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
5678,Thyroid Carcinoma,Blood Derived Normal,WGS,Medical College of Georgia,Illumina HiSeq,Harvard Medical School,NO
5679,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Ohio State University,Illumina HiSeq,University of North Carolina,NO
5680,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5681,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5682,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5683,Thyroid Carcinoma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
5684,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5685,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
5686,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5687,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5688,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5689,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5690,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5691,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5692,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5693,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5694,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5695,Thyroid Carcinoma,Solid Tissue Normal,WGS,University Health Network,Illumina HiSeq,Harvard Medical School,NO
5696,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5697,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5698,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5699,Thyroid Carcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5700,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Ohio State University,Illumina HiSeq,University of North Carolina,NO
5701,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5702,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5703,Thyroid Carcinoma,Blood Derived Normal,WGS,Ohio State University,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5704,Thyroid Carcinoma,Blood Derived Normal,WGS,Ohio State University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5705,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
5706,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5707,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
5708,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
5709,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5710,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
5711,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5712,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5713,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5714,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5715,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5716,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5717,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,Harvard Medical School,NO
5718,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5719,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5720,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
5721,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5722,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5723,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5724,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5725,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5726,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5727,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5728,Thyroid Carcinoma,Blood Derived Normal,WGS,Ohio State University,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5729,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
5730,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,Harvard Medical School,NO
5731,Thyroid Carcinoma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
5732,Thyroid Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
5733,Thyroid Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5734,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
5735,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
5736,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5737,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5738,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5739,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5740,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5741,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5742,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5743,Thyroid Carcinoma,Primary Tumor,WGS,Medical College of Georgia,Illumina HiSeq,Harvard Medical School,NO
5744,Thyroid Carcinoma,Blood Derived Normal,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5745,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5746,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5747,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
5748,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5749,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
5750,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
5751,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5752,Thyroid Carcinoma,Solid Tissue Normal,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
5753,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5754,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,Harvard Medical School,NO
5755,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
5756,Thyroid Carcinoma,Primary Tumor,WGS,Ohio State University,Illumina HiSeq,Harvard Medical School,NO
5757,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5758,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5759,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5760,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5761,Thyroid Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
5762,Thyroid Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
5763,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5764,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5765,Thyroid Carcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
5766,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5767,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5768,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,Medical College of Georgia,Illumina HiSeq,University of North Carolina,NO
5769,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
5770,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5771,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5772,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5773,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5774,Thyroid Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
5775,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5776,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5777,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5778,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
5779,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5780,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5781,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5782,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5783,Thyroid Carcinoma,Primary Tumor,WGS,University of North Carolina,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5784,Thyroid Carcinoma,Primary Tumor,WGS,Ohio State University,Illumina HiSeq,Harvard Medical School,NO
5785,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5786,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5787,Thyroid Carcinoma,Blood Derived Normal,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5788,Thyroid Carcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5789,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5790,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5791,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5792,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5793,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,Harvard Medical School,NO
5794,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5795,Thyroid Carcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5796,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5797,Thyroid Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
5798,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5799,Thyroid Carcinoma,Blood Derived Normal,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
5800,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5801,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5802,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5803,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5804,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5805,Thyroid Carcinoma,Primary Tumor,WGS,Ohio State University,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5806,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5807,Thyroid Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
5808,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5809,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5810,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5811,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5812,Thyroid Carcinoma,Metastatic,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5813,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5814,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5815,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5816,Thyroid Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5817,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5818,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5819,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5820,Thyroid Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5821,Thyroid Carcinoma,Metastatic,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
5822,Thyroid Carcinoma,Blood Derived Normal,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5823,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5824,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5825,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
5826,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5827,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5828,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5829,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5830,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5831,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5832,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5833,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5834,Thyroid Carcinoma,Blood Derived Normal,WGS,University of North Carolina,Illumina HiSeq,Harvard Medical School,NO
5835,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5836,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5837,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5838,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5839,Thyroid Carcinoma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
5840,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5841,Thyroid Carcinoma,Blood Derived Normal,WGS,Ohio State University,Illumina HiSeq,Harvard Medical School,NO
5842,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5843,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5844,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5845,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5846,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5847,Thyroid Carcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5848,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5849,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5850,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5851,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5852,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5853,Thyroid Carcinoma,Metastatic,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5854,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5855,Thyroid Carcinoma,Solid Tissue Normal,WGS,MD Anderson,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5856,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
5857,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,University of North Carolina,NO
5858,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
5859,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5860,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5861,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5862,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
5863,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
5864,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5865,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5866,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5867,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
5868,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5869,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5870,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
5871,Thyroid Carcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5872,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5873,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5874,Thyroid Carcinoma,Primary Tumor,WGS,Medical College of Georgia,Illumina HiSeq,Harvard Medical School,NO
5875,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5876,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5877,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5878,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5879,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5880,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,Harvard Medical School,NO
5881,Thyroid Carcinoma,Primary Tumor,WGS,MD Anderson,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5882,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
5883,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,MD Anderson - RPPA Core Facility (Proteomics),NO
5884,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5885,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5886,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
5887,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5888,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5889,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5890,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5891,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5892,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Medical College of Georgia,Illumina HiSeq,University of North Carolina,NO
5893,Thyroid Carcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5894,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5895,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5896,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5897,Thyroid Carcinoma,Solid Tissue Normal,WGS,MD Anderson,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5898,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5899,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5900,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5901,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5902,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5903,Thyroid Carcinoma,Primary Tumor,WGS,Ohio State University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5904,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5905,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
5906,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5907,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5908,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
5909,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5910,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5911,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5912,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5913,Thyroid Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
5914,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5915,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5916,Thyroid Carcinoma,Blood Derived Normal,WGS,University of North Carolina,Illumina HiSeq,Harvard Medical School,NO
5917,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
5918,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5919,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5920,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5921,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5922,Thyroid Carcinoma,Solid Tissue Normal,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
5923,Thyroid Carcinoma,Primary Tumor,WGS,Ohio State University,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5924,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5925,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5926,Thyroid Carcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5927,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Ohio State University,Illumina HiSeq,University of North Carolina,NO
5928,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5929,Thyroid Carcinoma,Blood Derived Normal,WGS,Ohio State University,Illumina HiSeq,Harvard Medical School,NO
5930,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5931,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5932,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5933,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
5934,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5935,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5936,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5937,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5938,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
5939,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5940,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5941,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5942,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5943,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5944,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5945,Thyroid Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
5946,Thyroid Carcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5947,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5948,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5949,Thyroid Carcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5950,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5951,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5952,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5953,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5954,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5955,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
5956,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5957,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5958,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Mary Bird Perkins Cancer Center - Our Lady of the Lake,Illumina HiSeq,University of North Carolina,NO
5959,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5960,Thyroid Carcinoma,Primary Tumor,WGS,Ohio State University,Illumina HiSeq,MD Anderson - RPPA Core Facility (Proteomics),NO
5961,Thyroid Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
5962,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
5963,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Ohio State University,Illumina HiSeq,University of North Carolina,NO
5964,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
5965,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
5966,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
5967,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
5968,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5969,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5970,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
5971,Thyroid Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
5972,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5973,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
5974,Thyroid Carcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5975,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
5976,Thyroid Carcinoma,Primary Tumor,WGS,MD Anderson,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5977,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5978,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5979,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5980,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5981,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5982,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5983,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
5984,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5985,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5986,Thyroid Carcinoma,Blood Derived Normal,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
5987,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
5988,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
5989,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5990,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5991,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5992,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
5993,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5994,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5995,Thyroid Carcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
5996,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
5997,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
5998,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
5999,Thyroid Carcinoma,Primary Tumor,WGS,Ohio State University,Illumina HiSeq,Harvard Medical School,NO
6000,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
6001,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6002,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
6003,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
6004,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
6005,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6006,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6007,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
6008,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
6009,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,Harvard Medical School,NO
6010,Thyroid Carcinoma,Blood Derived Normal,WGS,Medical College of Georgia,Illumina HiSeq,Harvard Medical School,NO
6011,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
6012,Thyroid Carcinoma,Metastatic,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
6013,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
6014,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
6015,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6016,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6017,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
6018,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6019,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
6020,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6021,Thyroid Carcinoma,Primary Tumor,WGS,Ohio State University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6022,Thyroid Carcinoma,Primary Tumor,WGS,MD Anderson,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6023,Thyroid Carcinoma,Primary Tumor,WGS,MD Anderson,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6024,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
6025,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,Harvard Medical School,NO
6026,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
6027,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
6028,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6029,Thyroid Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
6030,Thyroid Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
6031,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6032,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
6033,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
6034,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
6035,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
6036,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
6037,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
6038,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,Harvard Medical School,NO
6039,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,Harvard Medical School,NO
6040,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
6041,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6042,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
6043,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
6044,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6045,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
6046,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6047,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
6048,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
6049,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6050,Thyroid Carcinoma,Primary Tumor,WGS,Ohio State University,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
6051,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
6052,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6053,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
6054,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
6055,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
6056,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
6057,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6058,Thyroid Carcinoma,Blood Derived Normal,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6059,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
6060,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
6061,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6062,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6063,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
6064,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
6065,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
6066,Thyroid Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6067,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6068,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Ohio State University,Illumina HiSeq,University of North Carolina,NO
6069,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
6070,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
6071,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6072,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
6073,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
6074,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6075,Thyroid Carcinoma,Solid Tissue Normal,WGS,MD Anderson,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6076,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
6077,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6078,Thyroid Carcinoma,Primary Tumor,WGS,National Institutes of Health,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6079,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
6080,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
6081,Thyroid Carcinoma,Solid Tissue Normal,WGS,University Health Network,Illumina HiSeq,Harvard Medical School,NO
6082,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
6083,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6084,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6085,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6086,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
6087,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
6088,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6089,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6090,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
6091,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
6092,Thyroid Carcinoma,Primary Tumor,WGS,Ohio State University,Illumina HiSeq,Harvard Medical School,NO
6093,Thyroid Carcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
6094,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Ohio State University,Illumina HiSeq,University of North Carolina,NO
6095,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
6096,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6097,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,Harvard Medical School,NO
6098,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
6099,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
6100,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6101,Thyroid Carcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
6102,Thyroid Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6103,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
6104,Thyroid Carcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6105,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
6106,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6107,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
6108,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
6109,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6110,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
6111,Thyroid Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
6112,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
6113,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6114,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
6115,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6116,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6117,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
6118,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6119,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6120,Thyroid Carcinoma,Metastatic,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
6121,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
6122,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
6123,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6124,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6125,Thyroid Carcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6126,Thyroid Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
6127,Thyroid Carcinoma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
6128,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
6129,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
6130,Thyroid Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6131,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6132,Thyroid Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
6133,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6134,Thyroid Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
6135,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6136,Thyroid Carcinoma,Primary Tumor,RNA-Seq,Ohio State University,Illumina HiSeq,University of North Carolina,NO
6137,Thyroid Carcinoma,Blood Derived Normal,WGS,Ohio State University,Illumina HiSeq,Harvard Medical School,NO
6138,Thyroid Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
6139,Thyroid Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6140,Thyroid Carcinoma,Primary Tumor,WGS,University of North Carolina,Illumina HiSeq,Harvard Medical School,NO
6141,Thyroid Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
6142,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
6143,Thyroid Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
6144,Thyroid Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6145,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
6146,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,Cleveland Clinic,Illumina HiSeq,Baylor College of Medicine,NO
6147,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6148,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
6149,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
6150,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6151,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
6152,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6153,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
6154,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
6155,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University Hospital Erlangen,Illumina HiSeq,University of North Carolina,NO
6156,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,ABS - IUPUI,Illumina HiSeq,Baylor College of Medicine,NO
6157,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6158,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
6159,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6160,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
6161,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6162,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6163,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6164,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6165,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
6166,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
6167,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6168,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
6169,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6170,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University Hospital Erlangen,Illumina HiSeq,University of North Carolina,NO
6171,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
6172,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
6173,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
6174,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
6175,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6176,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
6177,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6178,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
6179,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6180,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Gundersen Lutheran,Illumina HiSeq,University of North Carolina,NO
6181,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,BLN - Baylor,Illumina HiSeq,Baylor College of Medicine,NO
6182,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6183,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Greenville Health System,Illumina HiSeq,University of North Carolina,NO
6184,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
6185,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
6186,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
6187,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of Oklahoma HSC,Illumina HiSeq,University of North Carolina,NO
6188,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
6189,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Baylor College of Medicine,NO
6190,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
6191,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6192,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
6193,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6194,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6195,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6196,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6197,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
6198,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6199,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6200,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
6201,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6202,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
6203,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
6204,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6205,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
6206,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6207,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
6208,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
6209,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
6210,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6211,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6212,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,Fox Chase,Illumina HiSeq,Baylor College of Medicine,NO
6213,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
6214,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
6215,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
6216,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
6217,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
6218,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
6219,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,Fox Chase,Illumina HiSeq,Baylor College of Medicine,NO
6220,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,CHI-Penrose Colorado,Illumina HiSeq,University of North Carolina,NO
6221,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Baylor College of Medicine,NO
6222,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
6223,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6224,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
6225,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
6226,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Baylor College of Medicine,NO
6227,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6228,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6229,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
6230,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6231,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Baylor College of Medicine,NO
6232,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
6233,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
6234,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6235,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
6236,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6237,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Baylor College of Medicine,NO
6238,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6239,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
6240,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
6241,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
6242,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University Hospital Erlangen,Illumina HiSeq,University of North Carolina,NO
6243,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Baylor College of Medicine,NO
6244,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6245,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,Fox Chase,Illumina HiSeq,Baylor College of Medicine,NO
6246,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
6247,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6248,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Hartford,Illumina HiSeq,University of North Carolina,NO
6249,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
6250,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,BLN - Baylor,Illumina HiSeq,Baylor College of Medicine,NO
6251,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6252,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University Hospital Erlangen,Illumina HiSeq,University of North Carolina,NO
6253,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Gundersen Lutheran,Illumina HiSeq,University of North Carolina,NO
6254,Kidney Renal Papillary Cell Carcinoma,Additional - New Primary,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
6255,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
6256,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6257,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
6258,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6259,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
6260,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University Hospital Erlangen,Illumina HiSeq,University of North Carolina,NO
6261,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of Kansas,Illumina HiSeq,University of North Carolina,NO
6262,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
6263,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
6264,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6265,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
6266,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
6267,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6268,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6269,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
6270,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
6271,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
6272,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6273,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6274,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,Fox Chase,Illumina HiSeq,Baylor College of Medicine,NO
6275,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
6276,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
6277,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
6278,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
6279,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,Fox Chase,Illumina HiSeq,Baylor College of Medicine,NO
6280,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,BLN - Baylor,Illumina HiSeq,Baylor College of Medicine,NO
6281,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
6282,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
6283,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
6284,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
6285,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Hartford,Illumina HiSeq,University of North Carolina,NO
6286,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,Fox Chase,Illumina HiSeq,Baylor College of Medicine,NO
6287,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6288,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
6289,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6290,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
6291,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
6292,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,Fox Chase,Illumina HiSeq,Baylor College of Medicine,NO
6293,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
6294,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6295,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
6296,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6297,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
6298,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
6299,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
6300,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
6301,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,BLN - Baylor,Illumina HiSeq,Baylor College of Medicine,NO
6302,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6303,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,ABS - IUPUI,Illumina HiSeq,Baylor College of Medicine,NO
6304,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of Kansas,Illumina HiSeq,University of North Carolina,NO
6305,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Baylor College of Medicine,NO
6306,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6307,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6308,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
6309,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
6310,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
6311,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6312,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,Fox Chase,Illumina HiSeq,Baylor College of Medicine,NO
6313,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
6314,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
6315,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6316,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6317,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
6318,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6319,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Mary Bird Perkins Cancer Center - Our Lady of the Lake,Illumina HiSeq,University of North Carolina,NO
6320,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Baylor College of Medicine,NO
6321,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6322,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,BLN - Baylor,Illumina HiSeq,Baylor College of Medicine,NO
6323,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,Fox Chase,Illumina HiSeq,Baylor College of Medicine,NO
6324,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
6325,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6326,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
6327,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University Hospital Erlangen,Illumina HiSeq,University of North Carolina,NO
6328,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
6329,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6330,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6331,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Mary Bird Perkins Cancer Center - Our Lady of the Lake,Illumina HiSeq,University of North Carolina,NO
6332,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
6333,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Baylor College of Medicine,NO
6334,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
6335,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
6336,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
6337,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
6338,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
6339,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6340,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University Hospital Erlangen,Illumina HiSeq,University of North Carolina,NO
6341,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,Fox Chase,Illumina HiSeq,Baylor College of Medicine,NO
6342,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
6343,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
6344,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,ABS - IUPUI,Illumina HiSeq,Baylor College of Medicine,NO
6345,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University Hospital Erlangen,Illumina HiSeq,University of North Carolina,NO
6346,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
6347,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6348,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,BLN - Baylor,Illumina HiSeq,Baylor College of Medicine,NO
6349,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
6350,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
6351,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
6352,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
6353,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,CHI-Penrose Colorado,Illumina HiSeq,University of North Carolina,NO
6354,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6355,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Saint Mary's Health Care,Illumina HiSeq,University of North Carolina,NO
6356,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
6357,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
6358,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
6359,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
6360,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
6361,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6362,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
6363,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6364,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
6365,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,Cleveland Clinic,Illumina HiSeq,Baylor College of Medicine,NO
6366,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
6367,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Baylor College of Medicine,NO
6368,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6369,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
6370,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6371,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
6372,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
6373,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
6374,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Baylor College of Medicine,NO
6375,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6376,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,Fox Chase,Illumina HiSeq,Baylor College of Medicine,NO
6377,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
6378,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6379,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
6380,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6381,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6382,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
6383,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6384,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
6385,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
6386,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
6387,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
6388,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
6389,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6390,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
6391,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,St Joseph's Medical Center (MD),Illumina HiSeq,University of North Carolina,NO
6392,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Medical College of Georgia,Illumina HiSeq,University of North Carolina,NO
6393,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6394,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
6395,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6396,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
6397,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
6398,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
6399,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
6400,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
6401,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6402,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
6403,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
6404,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6405,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6406,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
6407,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,BLN - Baylor,Illumina HiSeq,Baylor College of Medicine,NO
6408,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6409,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,ABS - IUPUI,Illumina HiSeq,Baylor College of Medicine,NO
6410,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University Hospital Erlangen,Illumina HiSeq,University of North Carolina,NO
6411,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
6412,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
6413,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6414,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
6415,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
6416,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
6417,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6418,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6419,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
6420,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University Hospital Erlangen,Illumina HiSeq,University of North Carolina,NO
6421,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6422,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6423,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,Cleveland Clinic,Illumina HiSeq,Baylor College of Medicine,NO
6424,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6425,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6426,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6427,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
6428,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6429,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
6430,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
6431,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6432,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6433,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
6434,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
6435,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
6436,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
6437,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6438,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6439,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University Hospital Erlangen,Illumina HiSeq,University of North Carolina,NO
6440,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
6441,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
6442,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6443,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6444,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
6445,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
6446,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
6447,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6448,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
6449,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,BLN - Baylor,Illumina HiSeq,Baylor College of Medicine,NO
6450,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6451,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6452,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
6453,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6454,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
6455,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Hartford,Illumina HiSeq,University of North Carolina,NO
6456,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6457,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
6458,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
6459,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
6460,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6461,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
6462,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
6463,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
6464,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University Hospital Erlangen,Illumina HiSeq,University of North Carolina,NO
6465,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6466,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
6467,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
6468,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
6469,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,Fox Chase,Illumina HiSeq,Baylor College of Medicine,NO
6470,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
6471,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
6472,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6473,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,BLN - Baylor,Illumina HiSeq,Baylor College of Medicine,NO
6474,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
6475,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,Cleveland Clinic,Illumina HiSeq,Baylor College of Medicine,NO
6476,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6477,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6478,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6479,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6480,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
6481,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6482,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
6483,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University Hospital Erlangen,Illumina HiSeq,University of North Carolina,NO
6484,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University Hospital Erlangen,Illumina HiSeq,University of North Carolina,NO
6485,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
6486,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6487,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Mary Bird Perkins Cancer Center - Our Lady of the Lake,Illumina HiSeq,University of North Carolina,NO
6488,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6489,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
6490,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
6491,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
6492,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
6493,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
6494,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University Hospital Erlangen,Illumina HiSeq,University of North Carolina,NO
6495,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6496,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
6497,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6498,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
6499,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
6500,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
6501,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6502,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
6503,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6504,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
6505,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
6506,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University Hospital Erlangen,Illumina HiSeq,University of North Carolina,NO
6507,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,CHI-Penrose Colorado,Illumina HiSeq,University of North Carolina,NO
6508,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
6509,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6510,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
6511,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6512,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Baylor College of Medicine,NO
6513,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
6514,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
6515,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
6516,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6517,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
6518,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
6519,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
6520,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
6521,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
6522,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
6523,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
6524,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University Hospital Erlangen,Illumina HiSeq,University of North Carolina,NO
6525,Kidney Renal Papillary Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
6526,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6527,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
6528,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6529,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6530,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
6531,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
6532,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
6533,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6534,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
6535,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
6536,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
6537,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6538,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,BLN - Baylor,Illumina HiSeq,Baylor College of Medicine,NO
6539,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6540,Kidney Renal Papillary Cell Carcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
6541,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6542,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
6543,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Baylor College of Medicine,NO
6544,Kidney Renal Papillary Cell Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
6545,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Emory,Illumina HiSeq,University of North Carolina,NO
6546,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,St Joseph's Medical Center (MD),Illumina HiSeq,University of North Carolina,NO
6547,Lung Adenocarcinoma,Blood Derived Normal,WGS,Cureline,Illumina HiSeq,Harvard Medical School,NO
6548,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
6549,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6550,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6551,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
6552,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
6553,Lung Adenocarcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6554,Lung Adenocarcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
6555,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6556,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
6557,Lung Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6558,Lung Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
6559,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6560,Lung Adenocarcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
6561,Lung Adenocarcinoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
6562,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
6563,Lung Adenocarcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6564,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6565,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
6566,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
6567,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6568,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
6569,Lung Adenocarcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
6570,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6571,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
6572,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - St. Louis,Illumina HiSeq,University of North Carolina,NO
6573,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
6574,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
6575,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
6576,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
6577,Lung Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6578,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6579,Lung Adenocarcinoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6580,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6581,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Alabama,Illumina HiSeq,University of North Carolina,NO
6582,Lung Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
6583,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6584,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6585,Lung Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
6586,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
6587,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6588,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
6589,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6590,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6591,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Rush University,Illumina HiSeq,University of North Carolina,NO
6592,Lung Adenocarcinoma,Primary Tumor,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Harvard Medical School,NO
6593,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
6594,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6595,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
6596,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
6597,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6598,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6599,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6600,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6601,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6602,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6603,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,St Joseph's Medical Center (MD),Illumina HiSeq,University of North Carolina,NO
6604,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6605,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
6606,Lung Adenocarcinoma,Primary Tumor,WGS,ABS - IUPUI,Illumina HiSeq,Harvard Medical School,NO
6607,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
6608,Lung Adenocarcinoma,Primary Tumor,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6609,Lung Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
6610,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6611,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
6612,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6613,Lung Adenocarcinoma,Primary Tumor,WGS,St Joseph's Medical Center (MD),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6614,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6615,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
6616,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
6617,Lung Adenocarcinoma,Primary Tumor,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Harvard Medical School,NO
6618,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
6619,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6620,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
6621,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,St Joseph's Medical Center (MD),Illumina HiSeq,University of North Carolina,NO
6622,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6623,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6624,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6625,Lung Adenocarcinoma,Primary Tumor,WGS,ABS - IUPUI,Illumina HiSeq,Harvard Medical School,NO
6626,Lung Adenocarcinoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6627,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Emory,Illumina HiSeq,University of North Carolina,NO
6628,Lung Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
6629,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
6630,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6631,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6632,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
6633,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
6634,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
6635,Lung Adenocarcinoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6636,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
6637,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
6638,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
6639,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6640,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR)/Ottawa,Illumina HiSeq,University of North Carolina,NO
6641,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6642,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
6643,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
6644,Lung Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6645,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
6646,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6647,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6648,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
6649,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
6650,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
6651,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6652,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
6653,Lung Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
6654,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
6655,Lung Adenocarcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
6656,Lung Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
6657,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
6658,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6659,Lung Adenocarcinoma,Primary Tumor,WGS,Fox Chase,Illumina HiSeq,Harvard Medical School,NO
6660,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
6661,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6662,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6663,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6664,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6665,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6666,Lung Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
6667,Lung Adenocarcinoma,Primary Tumor,WGS,ABS - IUPUI,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6668,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6669,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6670,Lung Adenocarcinoma,Blood Derived Normal,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Harvard Medical School,NO
6671,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
6672,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6673,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6674,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
6675,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6676,Lung Adenocarcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
6677,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
6678,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
6679,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
6680,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
6681,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6682,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
6683,Lung Adenocarcinoma,Blood Derived Normal,WGS,Prince Charles Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6684,Lung Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
6685,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6686,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
6687,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
6688,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
6689,Lung Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6690,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6691,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
6692,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6693,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6694,Lung Adenocarcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
6695,Lung Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6696,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
6697,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
6698,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
6699,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6700,Lung Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
6701,Lung Adenocarcinoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6702,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
6703,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Alabama,Illumina HiSeq,University of North Carolina,NO
6704,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
6705,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6706,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6707,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6708,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
6709,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6710,Lung Adenocarcinoma,Solid Tissue Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
6711,Lung Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
6712,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
6713,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
6714,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6715,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6716,Lung Adenocarcinoma,Blood Derived Normal,WGS,St Joseph's Medical Center (MD),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6717,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6718,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6719,Lung Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
6720,Lung Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6721,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
6722,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
6723,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
6724,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
6725,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6726,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
6727,Lung Adenocarcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
6728,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6729,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6730,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6731,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6732,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6733,Lung Adenocarcinoma,Primary Tumor,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Harvard Medical School,NO
6734,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6735,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6736,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6737,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6738,Lung Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
6739,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6740,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Emory,Illumina HiSeq,University of North Carolina,NO
6741,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
6742,Lung Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6743,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6744,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
6745,Lung Adenocarcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
6746,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
6747,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Emory,Illumina HiSeq,University of North Carolina,NO
6748,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
6749,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
6750,Lung Adenocarcinoma,Primary Tumor,WGS,Prince Charles Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6751,Lung Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
6752,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
6753,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6754,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6755,Lung Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
6756,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6757,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6758,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,St Joseph's Medical Center (MD),Illumina HiSeq,University of North Carolina,NO
6759,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
6760,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6761,Lung Adenocarcinoma,Primary Tumor,WGS,Prince Charles Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6762,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
6763,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
6764,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6765,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
6766,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
6767,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
6768,Lung Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6769,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Rush University,Illumina HiSeq,University of North Carolina,NO
6770,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
6771,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
6772,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
6773,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
6774,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6775,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
6776,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6777,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
6778,Lung Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
6779,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6780,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6781,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
6782,Lung Adenocarcinoma,Primary Tumor,WGS,St Joseph's Medical Center (MD),Illumina HiSeq,Harvard Medical School,NO
6783,Lung Adenocarcinoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina GA,Broad Institute of MIT and Harvard,NO
6784,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
6785,Lung Adenocarcinoma,Blood Derived Normal,WGS,Washington University - NYU,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6786,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
6787,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6788,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
6789,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6790,Lung Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6791,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
6792,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6793,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
6794,Lung Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
6795,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6796,Lung Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
6797,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6798,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
6799,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6800,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6801,Lung Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
6802,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
6803,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6804,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
6805,Lung Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
6806,Lung Adenocarcinoma,Solid Tissue Normal,WGS,UNC,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6807,Lung Adenocarcinoma,Blood Derived Normal,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Harvard Medical School,NO
6808,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
6809,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
6810,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
6811,Lung Adenocarcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
6812,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Gundersen Lutheran Health System,Illumina HiSeq,University of North Carolina,NO
6813,Lung Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
6814,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6815,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
6816,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
6817,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6818,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6819,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
6820,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
6821,Lung Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
6822,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6823,Lung Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
6824,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
6825,Lung Adenocarcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
6826,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Rush University,Illumina HiSeq,University of North Carolina,NO
6827,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6828,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
6829,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6830,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
6831,Lung Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
6832,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6833,Lung Adenocarcinoma,Primary Tumor,WGS,Prince Charles Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6834,Lung Adenocarcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
6835,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
6836,Lung Adenocarcinoma,Primary Tumor,WGS,Fox Chase,Illumina HiSeq,Harvard Medical School,NO
6837,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
6838,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6839,Lung Adenocarcinoma,Solid Tissue Normal,WGS,ABS - IUPUI,Illumina HiSeq,Harvard Medical School,NO
6840,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
6841,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6842,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6843,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6844,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6845,Lung Adenocarcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
6846,Lung Adenocarcinoma,Blood Derived Normal,WGS,Prince Charles Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6847,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6848,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6849,Lung Adenocarcinoma,Blood Derived Normal,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6850,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6851,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
6852,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6853,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6854,Lung Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
6855,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6856,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6857,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6858,Lung Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
6859,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6860,Lung Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6861,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6862,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6863,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
6864,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
6865,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
6866,Lung Adenocarcinoma,Primary Tumor,WGS,Washington University - NYU,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6867,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
6868,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6869,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6870,Lung Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
6871,Lung Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
6872,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
6873,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6874,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6875,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6876,Lung Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
6877,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6878,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6879,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
6880,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
6881,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6882,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6883,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6884,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
6885,Lung Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
6886,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6887,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6888,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
6889,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
6890,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6891,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6892,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,CHI-Penrose Colorado,Illumina HiSeq,University of North Carolina,NO
6893,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6894,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6895,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6896,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
6897,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
6898,Lung Adenocarcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
6899,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
6900,Lung Adenocarcinoma,Primary Tumor,WGS,ABS - IUPUI,Illumina HiSeq,Harvard Medical School,NO
6901,Lung Adenocarcinoma,Blood Derived Normal,WGS,ABS - IUPUI,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6902,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6903,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
6904,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
6905,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
6906,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6907,Lung Adenocarcinoma,Primary Tumor,WGS,Prince Charles Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6908,Lung Adenocarcinoma,Blood Derived Normal,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Harvard Medical School,NO
6909,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
6910,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
6911,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR)/Ottawa,Illumina HiSeq,University of North Carolina,NO
6912,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6913,Lung Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
6914,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6915,Lung Adenocarcinoma,Blood Derived Normal,WGS,Fox Chase,Illumina HiSeq,Harvard Medical School,NO
6916,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6917,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
6918,Lung Adenocarcinoma,Blood Derived Normal,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Harvard Medical School,NO
6919,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
6920,Lung Adenocarcinoma,Primary Tumor,WGS,St Joseph's Medical Center (MD),Illumina GA,Broad Institute of MIT and Harvard,NO
6921,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
6922,Lung Adenocarcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
6923,Lung Adenocarcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
6924,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Albert Einstein Medical Center,Illumina HiSeq,University of North Carolina,NO
6925,Lung Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6926,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
6927,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6928,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
6929,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
6930,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - St. Louis,Illumina HiSeq,University of North Carolina,NO
6931,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6932,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
6933,Lung Adenocarcinoma,Blood Derived Normal,WGS,Prince Charles Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6934,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
6935,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6936,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6937,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6938,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6939,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6940,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6941,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
6942,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6943,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
6944,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
6945,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
6946,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
6947,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
6948,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
6949,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
6950,Lung Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6951,Lung Adenocarcinoma,Blood Derived Normal,WGS,St Joseph's Medical Center (MD),Illumina HiSeq,Harvard Medical School,NO
6952,Lung Adenocarcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
6953,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
6954,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
6955,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Rush University,Illumina HiSeq,University of North Carolina,NO
6956,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6957,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
6958,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
6959,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6960,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
6961,Lung Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
6962,Lung Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6963,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6964,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
6965,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
6966,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6967,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
6968,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6969,Lung Adenocarcinoma,Blood Derived Normal,WGS,Fox Chase,Illumina HiSeq,Harvard Medical School,NO
6970,Lung Adenocarcinoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina GA,Broad Institute of MIT and Harvard,NO
6971,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6972,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6973,Lung Adenocarcinoma,Blood Derived Normal,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Harvard Medical School,NO
6974,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
6975,Lung Adenocarcinoma,Blood Derived Normal,WGS,St Joseph's Medical Center (MD),Illumina HiSeq,Harvard Medical School,NO
6976,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6977,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
6978,Lung Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
6979,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
6980,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
6981,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
6982,Lung Adenocarcinoma,Primary Tumor,WGS,Fox Chase,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6983,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Alabama,Illumina HiSeq,University of North Carolina,NO
6984,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
6985,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6986,Lung Adenocarcinoma,Blood Derived Normal,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Harvard Medical School,NO
6987,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
6988,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
6989,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
6990,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
6991,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
6992,Lung Adenocarcinoma,Solid Tissue Normal,WGS,ABS - IUPUI,Illumina HiSeq,Harvard Medical School,NO
6993,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
6994,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
6995,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
6996,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
6997,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
6998,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
6999,Lung Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
7000,Lung Adenocarcinoma,Primary Tumor,WGS,St Joseph's Medical Center (MD),Illumina HiSeq,Harvard Medical School,NO
7001,Lung Adenocarcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7002,Lung Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7003,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7004,Lung Adenocarcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
7005,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7006,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
7007,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7008,Lung Adenocarcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
7009,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
7010,Lung Adenocarcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
7011,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7012,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7013,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7014,Lung Adenocarcinoma,Primary Tumor,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Harvard Medical School,NO
7015,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7016,Lung Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7017,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7018,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,St Joseph's Medical Center (MD),Illumina HiSeq,University of North Carolina,NO
7019,Lung Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
7020,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7021,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7022,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
7023,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
7024,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7025,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7026,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
7027,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7028,Lung Adenocarcinoma,Solid Tissue Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
7029,Lung Adenocarcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
7030,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
7031,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7032,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,St Joseph's Medical Center (MD),Illumina HiSeq,University of North Carolina,NO
7033,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
7034,Lung Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
7035,Lung Adenocarcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
7036,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7037,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7038,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7039,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7040,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - St. Louis,Illumina HiSeq,University of North Carolina,NO
7041,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7042,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - St. Louis,Illumina HiSeq,University of North Carolina,NO
7043,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7044,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7045,Lung Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina GA,Broad Institute of MIT and Harvard,NO
7046,Lung Adenocarcinoma,Blood Derived Normal,WGS,Fox Chase,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7047,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7048,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7049,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7050,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7051,Lung Adenocarcinoma,Primary Tumor,WGS,St Joseph's Medical Center (MD),Illumina HiSeq,Harvard Medical School,NO
7052,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7053,Lung Adenocarcinoma,Primary Tumor,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Harvard Medical School,NO
7054,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Mary Bird Perkins Cancer Center - Our Lady of the Lake,Illumina HiSeq,University of North Carolina,NO
7055,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7056,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7057,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7058,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7059,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
7060,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7061,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
7062,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7063,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7064,Lung Adenocarcinoma,Recurrent Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7065,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7066,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7067,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7068,Lung Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina GA,Broad Institute of MIT and Harvard,NO
7069,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7070,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7071,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
7072,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7073,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7074,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
7075,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7076,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7077,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7078,Lung Adenocarcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7079,Lung Adenocarcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7080,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
7081,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7082,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7083,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Rush University,Illumina HiSeq,University of North Carolina,NO
7084,Lung Adenocarcinoma,Primary Tumor,WGS,ABS - IUPUI,Illumina HiSeq,Harvard Medical School,NO
7085,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
7086,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
7087,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
7088,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
7089,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7090,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,St Joseph's Medical Center (MD),Illumina HiSeq,University of North Carolina,NO
7091,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7092,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7093,Lung Adenocarcinoma,Blood Derived Normal,WGS,St Joseph's Medical Center (MD),Illumina HiSeq,Harvard Medical School,NO
7094,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
7095,Lung Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
7096,Lung Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7097,Lung Adenocarcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7098,Lung Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
7099,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
7100,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7101,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
7102,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7103,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7104,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7105,Lung Adenocarcinoma,Blood Derived Normal,WGS,St Joseph's Medical Center (MD),Illumina GA,Broad Institute of MIT and Harvard,NO
7106,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7107,Lung Adenocarcinoma,Blood Derived Normal,WGS,Fox Chase,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7108,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7109,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7110,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7111,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
7112,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
7113,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
7114,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7115,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
7116,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7117,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
7118,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,St Joseph's Medical Center (MD),Illumina HiSeq,University of North Carolina,NO
7119,Lung Adenocarcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
7120,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7121,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7122,Lung Adenocarcinoma,Primary Tumor,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7123,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7124,Lung Adenocarcinoma,Blood Derived Normal,WGS,Fox Chase,Illumina HiSeq,Harvard Medical School,NO
7125,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7126,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7127,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7128,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7129,Lung Adenocarcinoma,Primary Tumor,WGS,Fox Chase,Illumina HiSeq,Harvard Medical School,NO
7130,Lung Adenocarcinoma,Recurrent Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7131,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
7132,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
7133,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7134,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7135,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7136,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7137,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7138,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7139,Lung Adenocarcinoma,Blood Derived Normal,WGS,Cureline,Illumina HiSeq,Harvard Medical School,NO
7140,Lung Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
7141,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7142,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
7143,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
7144,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
7145,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7146,Lung Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7147,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7148,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Emory,Illumina HiSeq,University of North Carolina,NO
7149,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7150,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7151,Lung Adenocarcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7152,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7153,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
7154,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7155,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - St. Louis,Illumina HiSeq,University of North Carolina,NO
7156,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7157,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
7158,Lung Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
7159,Lung Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7160,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
7161,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7162,Lung Adenocarcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
7163,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7164,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7165,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
7166,Lung Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
7167,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Emory,Illumina HiSeq,University of North Carolina,NO
7168,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7169,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
7170,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7171,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7172,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
7173,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
7174,Lung Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7175,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
7176,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7177,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7178,Lung Adenocarcinoma,Primary Tumor,WGS,St Joseph's Medical Center (MD),Illumina GA,Broad Institute of MIT and Harvard,NO
7179,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7180,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7181,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7182,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
7183,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7184,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7185,Lung Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
7186,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7187,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
7188,Lung Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
7189,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
7190,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7191,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7192,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7193,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7194,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
7195,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
7196,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7197,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7198,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
7199,Lung Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7200,Lung Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7201,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
7202,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7203,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
7204,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7205,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7206,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Emory,Illumina HiSeq,University of North Carolina,NO
7207,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7208,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7209,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7210,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7211,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7212,Lung Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7213,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
7214,Lung Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7215,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7216,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7217,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
7218,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
7219,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Emory,Illumina HiSeq,University of North Carolina,NO
7220,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
7221,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7222,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7223,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7224,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7225,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7226,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
7227,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7228,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7229,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
7230,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
7231,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7232,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7233,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7234,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7235,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
7236,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7237,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
7238,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7239,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Rush University,Illumina HiSeq,University of North Carolina,NO
7240,Lung Adenocarcinoma,Blood Derived Normal,WGS,St Joseph's Medical Center (MD),Illumina GA,Broad Institute of MIT and Harvard,NO
7241,Lung Adenocarcinoma,Blood Derived Normal,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Harvard Medical School,NO
7242,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Rush University,Illumina HiSeq,University of North Carolina,NO
7243,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7244,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
7245,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7246,Lung Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
7247,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Emory,Illumina HiSeq,University of North Carolina,NO
7248,Lung Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7249,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7250,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
7251,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,St Joseph's Medical Center (MD),Illumina HiSeq,University of North Carolina,NO
7252,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7253,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
7254,Lung Adenocarcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7255,Lung Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
7256,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7257,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
7258,Lung Adenocarcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
7259,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
7260,Lung Adenocarcinoma,Primary Tumor,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7261,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
7262,Lung Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7263,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
7264,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7265,Lung Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
7266,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7267,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7268,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
7269,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Alabama,Illumina HiSeq,University of North Carolina,NO
7270,Lung Adenocarcinoma,Primary Tumor,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Harvard Medical School,NO
7271,Lung Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7272,Lung Adenocarcinoma,Solid Tissue Normal,WGS,ABS - IUPUI,Illumina HiSeq,Harvard Medical School,NO
7273,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7274,Lung Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7275,Lung Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7276,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7277,Lung Adenocarcinoma,Primary Tumor,WGS,Prince Charles Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7278,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
7279,Lung Adenocarcinoma,Primary Tumor,WGS,Cureline,Illumina HiSeq,Harvard Medical School,NO
7280,Lung Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
7281,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7282,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR)/Ottawa,Illumina HiSeq,University of North Carolina,NO
7283,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
7284,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7285,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7286,Lung Adenocarcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
7287,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
7288,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7289,Lung Adenocarcinoma,Blood Derived Normal,WGS,Fox Chase,Illumina HiSeq,Harvard Medical School,NO
7290,Lung Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7291,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7292,Lung Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
7293,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
7294,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7295,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7296,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7297,Lung Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
7298,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7299,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7300,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7301,Lung Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7302,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7303,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7304,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
7305,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
7306,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7307,Lung Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina GA,Broad Institute of MIT and Harvard,NO
7308,Lung Adenocarcinoma,Solid Tissue Normal,WGS,ABS - IUPUI,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7309,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7310,Lung Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
7311,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7312,Lung Adenocarcinoma,Solid Tissue Normal,WGS,UNC,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7313,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7314,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
7315,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7316,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7317,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Rush University,Illumina HiSeq,University of North Carolina,NO
7318,Lung Adenocarcinoma,Primary Tumor,WGS,ABS - IUPUI,Illumina HiSeq,Harvard Medical School,NO
7319,Lung Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina GA,Broad Institute of MIT and Harvard,NO
7320,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7321,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
7322,Lung Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7323,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7324,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7325,Lung Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7326,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
7327,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
7328,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
7329,Lung Adenocarcinoma,Blood Derived Normal,WGS,Fox Chase,Illumina HiSeq,Harvard Medical School,NO
7330,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7331,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7332,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7333,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
7334,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
7335,Lung Adenocarcinoma,Primary Tumor,WGS,Fox Chase,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7336,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7337,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7338,Lung Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7339,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7340,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7341,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7342,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
7343,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
7344,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
7345,Lung Adenocarcinoma,Blood Derived Normal,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7346,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7347,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - CALGB,Illumina HiSeq,University of North Carolina,NO
7348,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
7349,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Emory,Illumina HiSeq,University of North Carolina,NO
7350,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
7351,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7352,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7353,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7354,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
7355,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
7356,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7357,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7358,Lung Adenocarcinoma,Primary Tumor,WGS,Fox Chase,Illumina HiSeq,Harvard Medical School,NO
7359,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
7360,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
7361,Lung Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
7362,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7363,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7364,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7365,Lung Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
7366,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7367,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7368,Lung Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7369,Lung Adenocarcinoma,Solid Tissue Normal,WGS,ABS - IUPUI,Illumina HiSeq,Harvard Medical School,NO
7370,Lung Adenocarcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
7371,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7372,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7373,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7374,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7375,Lung Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
7376,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7377,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7378,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7379,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7380,Lung Adenocarcinoma,Blood Derived Normal,WGS,Fox Chase,Illumina HiSeq,Harvard Medical School,NO
7381,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7382,Lung Adenocarcinoma,Blood Derived Normal,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7383,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7384,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
7385,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
7386,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7387,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7388,Lung Adenocarcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
7389,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7390,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7391,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7392,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
7393,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7394,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7395,Lung Adenocarcinoma,Solid Tissue Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
7396,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
7397,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7398,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
7399,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7400,Lung Adenocarcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7401,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
7402,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
7403,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7404,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7405,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7406,Lung Adenocarcinoma,Primary Tumor,WGS,Fox Chase,Illumina HiSeq,Harvard Medical School,NO
7407,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
7408,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7409,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7410,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7411,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7412,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7413,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
7414,Lung Adenocarcinoma,Solid Tissue Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
7415,Lung Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7416,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7417,Lung Adenocarcinoma,Blood Derived Normal,WGS,Prince Charles Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7418,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
7419,Lung Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
7420,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
7421,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7422,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7423,Lung Adenocarcinoma,Primary Tumor,WGS,ABS - IUPUI,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7424,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7425,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7426,Lung Adenocarcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Harvard Medical School,NO
7427,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7428,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7429,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7430,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7431,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7432,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7433,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7434,Lung Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina GA,Broad Institute of MIT and Harvard,NO
7435,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - St. Louis,Illumina HiSeq,University of North Carolina,NO
7436,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7437,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7438,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
7439,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7440,Lung Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
7441,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
7442,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7443,Lung Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
7444,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7445,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7446,Lung Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7447,Lung Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina GA,Broad Institute of MIT and Harvard,NO
7448,Lung Adenocarcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
7449,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
7450,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Emory,Illumina HiSeq,University of North Carolina,NO
7451,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7452,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7453,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
7454,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7455,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7456,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7457,Lung Adenocarcinoma,Primary Tumor,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Harvard Medical School,NO
7458,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7459,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Alabama,Illumina HiSeq,University of North Carolina,NO
7460,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7461,Lung Adenocarcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
7462,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7463,Lung Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
7464,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7465,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - St. Louis,Illumina HiSeq,University of North Carolina,NO
7466,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7467,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Emory,Illumina HiSeq,University of North Carolina,NO
7468,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7469,Lung Adenocarcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
7470,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7471,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Rush University,Illumina HiSeq,University of North Carolina,NO
7472,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Gundersen Lutheran Health System,Illumina HiSeq,University of North Carolina,NO
7473,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7474,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7475,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7476,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7477,Lung Adenocarcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
7478,Lung Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7479,Lung Adenocarcinoma,Solid Tissue Normal,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
7480,Lung Adenocarcinoma,Primary Tumor,WGS,Fox Chase,Illumina HiSeq,Harvard Medical School,NO
7481,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7482,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - Alabama,Illumina HiSeq,University of North Carolina,NO
7483,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7484,Lung Adenocarcinoma,Blood Derived Normal,WGS,ABS - IUPUI,Illumina HiSeq,Harvard Medical School,NO
7485,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7486,Lung Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
7487,Lung Adenocarcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
7488,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7489,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7490,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
7491,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
7492,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7493,Lung Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7494,Lung Adenocarcinoma,Primary Tumor,WGS,Cureline,Illumina HiSeq,Harvard Medical School,NO
7495,Lung Adenocarcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
7496,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7497,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
7498,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7499,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Princess Margaret Hospital (Canada),Illumina HiSeq,University of North Carolina,NO
7500,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7501,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7502,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7503,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
7504,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7505,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Alabama,Illumina HiSeq,University of North Carolina,NO
7506,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7507,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7508,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7509,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7510,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7511,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7512,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7513,Lung Squamous Cell Carcinoma,Blood Derived Normal,WGS,Fox Chase Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7514,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Princess Margaret Hospital (Canada),Illumina HiSeq,University of North Carolina,NO
7515,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Princess Margaret Hospital (Canada),Illumina HiSeq,University of North Carolina,NO
7516,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7517,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7518,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7519,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7520,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7521,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
7522,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7523,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
7524,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7525,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7526,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
7527,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7528,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7529,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7530,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,University of North Carolina,NO
7531,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
7532,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Princess Margaret Hospital (Canada),Illumina HiSeq,University of North Carolina,NO
7533,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7534,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Albert Einstein Medical Center,Illumina HiSeq,University of North Carolina,NO
7535,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7536,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7537,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Fox Chase Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7538,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7539,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7540,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,University of North Carolina,NO
7541,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
7542,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7543,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7544,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Princess Margaret Hospital (Canada),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7545,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7546,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7547,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7548,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
7549,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7550,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7551,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
7552,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7553,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
7554,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7555,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - CHUV,Illumina HiSeq,University of North Carolina,NO
7556,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,University of North Carolina,NO
7557,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7558,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7559,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7560,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7561,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - CHUV,Illumina HiSeq,University of North Carolina,NO
7562,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7563,Lung Squamous Cell Carcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7564,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
7565,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Princess Margaret Hospital (Canada),Illumina HiSeq,University of North Carolina,NO
7566,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Alabama,Illumina HiSeq,University of North Carolina,NO
7567,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7568,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,University of North Carolina,NO
7569,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7570,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
7571,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7572,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
7573,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Emory,Illumina HiSeq,University of North Carolina,NO
7574,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Fox Chase Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7575,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7576,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
7577,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7578,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7579,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,University of Miami,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7580,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7581,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Princess Margaret Hospital (Canada),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7582,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,University of North Carolina,NO
7583,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7584,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7585,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7586,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7587,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,St Joseph's Medical Center (MD),Illumina HiSeq,University of North Carolina,NO
7588,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
7589,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7590,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
7591,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7592,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7593,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - CHUV,Illumina HiSeq,University of North Carolina,NO
7594,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
7595,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7596,Lung Squamous Cell Carcinoma,Blood Derived Normal,WGS,Washington University - Cleveland Clinic,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7597,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Washington University - Cleveland Clinic,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7598,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Prince Charles Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7599,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7600,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7601,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7602,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7603,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7604,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7605,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7606,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - CALGB,Illumina HiSeq,University of North Carolina,NO
7607,Lung Squamous Cell Carcinoma,Blood Derived Normal,WGS,Fox Chase Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7608,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7609,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7610,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Princess Margaret Hospital (Canada),Illumina HiSeq,University of North Carolina,NO
7611,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7612,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7613,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7614,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7615,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7616,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7617,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7618,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Emory,Illumina HiSeq,University of North Carolina,NO
7619,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7620,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
7621,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7622,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - CHUV,Illumina HiSeq,University of North Carolina,NO
7623,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
7624,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7625,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7626,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
7627,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7628,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
7629,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7630,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
7631,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7632,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
7633,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7634,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7635,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
7636,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Princess Margaret Hospital (Canada),Illumina HiSeq,University of North Carolina,NO
7637,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
7638,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7639,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7640,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Gundersen Lutheran Health System,Illumina HiSeq,University of North Carolina,NO
7641,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
7642,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7643,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7644,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Emory,Illumina HiSeq,University of North Carolina,NO
7645,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7646,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7647,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
7648,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7649,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7650,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7651,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7652,Lung Squamous Cell Carcinoma,Blood Derived Normal,WGS,Washington University - Cleveland Clinic,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7653,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7654,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
7655,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Rush University,Illumina HiSeq,University of North Carolina,NO
7656,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7657,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Fox Chase Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7658,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7659,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7660,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
7661,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7662,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - CHUV,Illumina HiSeq,University of North Carolina,NO
7663,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
7664,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7665,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7666,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7667,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
7668,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7669,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7670,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7671,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
7672,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7673,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - St. Louis,Illumina HiSeq,University of North Carolina,NO
7674,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Alabama,Illumina HiSeq,University of North Carolina,NO
7675,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7676,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
7677,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,ABS - IUPUI,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7678,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Princess Margaret Hospital (Canada),Illumina HiSeq,University of North Carolina,NO
7679,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7680,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Princess Margaret Hospital (Canada),Illumina HiSeq,University of North Carolina,NO
7681,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7682,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7683,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7684,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Fox Chase Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7685,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Princess Margaret Hospital (Canada),Illumina HiSeq,University of North Carolina,NO
7686,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7687,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7688,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - CHUV,Illumina HiSeq,University of North Carolina,NO
7689,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7690,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7691,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Princess Margaret Hospital (Canada),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7692,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7693,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,University of North Carolina,NO
7694,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7695,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7696,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7697,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7698,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7699,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7700,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
7701,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Alabama,Illumina HiSeq,University of North Carolina,NO
7702,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7703,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7704,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7705,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7706,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7707,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7708,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7709,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7710,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Princess Margaret Hospital (Canada),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7711,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
7712,Lung Squamous Cell Carcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7713,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Alabama,Illumina HiSeq,University of North Carolina,NO
7714,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
7715,Lung Squamous Cell Carcinoma,Blood Derived Normal,WGS,Washington University - Emory,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7716,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7717,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7718,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7719,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
7720,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7721,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7722,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7723,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Alabama,Illumina HiSeq,University of North Carolina,NO
7724,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7725,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7726,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7727,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7728,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7729,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7730,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7731,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7732,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7733,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
7734,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7735,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Princess Margaret Hospital (Canada),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7736,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
7737,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
7738,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7739,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7740,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
7741,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Washington University - NYU,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7742,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7743,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7744,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
7745,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7746,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7747,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7748,Lung Squamous Cell Carcinoma,Blood Derived Normal,WGS,Cureline,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7749,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7750,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
7751,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
7752,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7753,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7754,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7755,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7756,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7757,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,St Joseph's Medical Center (MD),Illumina HiSeq,University of North Carolina,NO
7758,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7759,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7760,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7761,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7762,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7763,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Washington University - St. Louis,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7764,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
7765,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
7766,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,University of North Carolina,NO
7767,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7768,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7769,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Minnesota,Illumina HiSeq,University of North Carolina,NO
7770,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7771,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - CHUV,Illumina HiSeq,University of North Carolina,NO
7772,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7773,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
7774,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7775,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7776,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
7777,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7778,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,University of North Carolina,NO
7779,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Alabama,Illumina HiSeq,University of North Carolina,NO
7780,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7781,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7782,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7783,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7784,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
7785,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7786,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7787,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
7788,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
7789,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7790,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
7791,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7792,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7793,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7794,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7795,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7796,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7797,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7798,Lung Squamous Cell Carcinoma,Blood Derived Normal,WGS,Washington University - Alabama,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7799,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7800,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7801,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7802,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7803,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7804,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7805,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
7806,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7807,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7808,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
7809,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7810,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7811,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7812,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7813,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7814,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - St. Louis,Illumina HiSeq,University of North Carolina,NO
7815,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7816,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Princess Margaret Hospital (Canada),Illumina HiSeq,University of North Carolina,NO
7817,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7818,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7819,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Princess Margaret Hospital (Canada),Illumina HiSeq,University of North Carolina,NO
7820,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7821,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
7822,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7823,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Rush University,Illumina HiSeq,University of North Carolina,NO
7824,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7825,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
7826,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
7827,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7828,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7829,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7830,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Emory,Illumina HiSeq,University of North Carolina,NO
7831,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7832,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,St Joseph's Medical Center (MD),Illumina HiSeq,University of North Carolina,NO
7833,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7834,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7835,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7836,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
7837,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7838,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7839,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Gundersen Lutheran Health System,Illumina HiSeq,University of North Carolina,NO
7840,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7841,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
7842,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
7843,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - CHUV,Illumina HiSeq,University of North Carolina,NO
7844,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Johns Hopkins,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7845,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7846,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7847,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7848,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7849,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7850,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Emory,Illumina HiSeq,University of North Carolina,NO
7851,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
7852,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7853,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7854,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
7855,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7856,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7857,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7858,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
7859,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7860,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7861,Lung Squamous Cell Carcinoma,Blood Derived Normal,WGS,Washington University - St. Louis,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7862,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
7863,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - CHUV,Illumina HiSeq,University of North Carolina,NO
7864,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Washington University - St. Louis,Illumina HiSeq,University of North Carolina,NO
7865,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7866,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Kansas,Illumina HiSeq,University of North Carolina,NO
7867,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7868,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
7869,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7870,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7871,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7872,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
7873,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7874,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7875,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7876,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
7877,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7878,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7879,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7880,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Emory,Illumina HiSeq,University of North Carolina,NO
7881,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7882,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7883,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7884,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7885,Lung Squamous Cell Carcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7886,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Princess Margaret Hospital (Canada),Illumina HiSeq,University of North Carolina,NO
7887,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
7888,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7889,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
7890,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
7891,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
7892,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7893,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
7894,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Alabama,Illumina HiSeq,University of North Carolina,NO
7895,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
7896,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7897,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7898,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7899,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7900,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Alabama,Illumina HiSeq,University of North Carolina,NO
7901,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - St. Louis,Illumina HiSeq,University of North Carolina,NO
7902,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7903,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
7904,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7905,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
7906,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7907,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7908,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7909,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - CHUV,Illumina HiSeq,University of North Carolina,NO
7910,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7911,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
7912,Lung Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7913,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
7914,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - CHUV,Illumina HiSeq,University of North Carolina,NO
7915,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,University of North Carolina,NO
7916,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7917,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7918,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7919,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Rush University,Illumina HiSeq,University of North Carolina,NO
7920,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
7921,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7922,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7923,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7924,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7925,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7926,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7927,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
7928,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7929,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7930,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7931,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7932,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - St. Louis,Illumina HiSeq,University of North Carolina,NO
7933,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7934,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Fox Chase Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7935,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7936,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7937,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - CHUV,Illumina HiSeq,University of North Carolina,NO
7938,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7939,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
7940,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7941,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7942,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7943,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7944,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7945,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7946,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7947,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
7948,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7949,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,St Joseph's Medical Center (MD),Illumina HiSeq,University of North Carolina,NO
7950,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7951,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
7952,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Fox Chase Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7953,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7954,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
7955,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Fox Chase Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7956,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - St. Louis,Illumina HiSeq,University of North Carolina,NO
7957,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,University of North Carolina,NO
7958,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7959,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7960,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
7961,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
7962,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7963,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,University of North Carolina,NO
7964,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7965,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7966,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7967,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7968,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7969,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7970,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
7971,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7972,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Princess Margaret Hospital (Canada),Illumina HiSeq,University of North Carolina,NO
7973,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7974,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
7975,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7976,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7977,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7978,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7979,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Washington University - Cleveland Clinic,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7980,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR)/Ottawa,Illumina HiSeq,University of North Carolina,NO
7981,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
7982,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
7983,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7984,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7985,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Emory,Illumina HiSeq,University of North Carolina,NO
7986,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Princess Margaret Hospital (Canada),Illumina HiSeq,Broad Institute of MIT and Harvard,NO
7987,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
7988,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
7989,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
7990,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
7991,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
7992,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7993,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7994,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
7995,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
7996,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
7997,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
7998,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Alabama,Illumina HiSeq,University of North Carolina,NO
7999,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - CHUV,Illumina HiSeq,University of North Carolina,NO
8000,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
8001,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8002,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8003,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8004,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
8005,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
8006,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
8007,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
8008,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8009,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8010,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Prince Charles Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8011,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
8012,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,University of North Carolina,NO
8013,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8014,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
8015,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
8016,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Emory,Illumina HiSeq,University of North Carolina,NO
8017,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
8018,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Thoraxklinik at University Hospital Heidelberg,Illumina HiSeq,University of North Carolina,NO
8019,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
8020,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
8021,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Princess Margaret Hospital (Canada),Illumina HiSeq,University of North Carolina,NO
8022,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8023,Lung Squamous Cell Carcinoma,Blood Derived Normal,WGS,Washington University - NYU,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8024,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
8025,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8026,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8027,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
8028,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
8029,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
8030,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8031,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
8032,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Alabama,Illumina HiSeq,University of North Carolina,NO
8033,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8034,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
8035,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Cureline,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8036,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8037,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8038,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
8039,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8040,Lung Squamous Cell Carcinoma,Blood Derived Normal,WGS,Prince Charles Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8041,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
8042,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
8043,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
8044,Lung Squamous Cell Carcinoma,Blood Derived Normal,WGS,Prince Charles Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8045,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8046,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8047,Lung Squamous Cell Carcinoma,Blood Derived Normal,WGS,ABS - IUPUI,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8048,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8049,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
8050,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
8051,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8052,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8053,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
8054,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,University of North Carolina,NO
8055,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
8056,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
8057,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
8058,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,University of North Carolina,NO
8059,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
8060,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,St Joseph's Medical Center (MD),Illumina HiSeq,University of North Carolina,NO
8061,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
8062,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Princess Margaret Hospital (Canada),Illumina HiSeq,University of North Carolina,NO
8063,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Alabama,Illumina HiSeq,University of North Carolina,NO
8064,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
8065,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Princess Margaret Hospital (Canada),Illumina HiSeq,University of North Carolina,NO
8066,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - CHUV,Illumina HiSeq,University of North Carolina,NO
8067,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Washington University - Alabama,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8068,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8069,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
8070,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
8071,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - CALGB,Illumina HiSeq,University of North Carolina,NO
8072,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8073,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
8074,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - CALGB,Illumina HiSeq,University of North Carolina,NO
8075,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - CALGB,Illumina HiSeq,University of North Carolina,NO
8076,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
8077,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
8078,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8079,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
8080,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8081,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
8082,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
8083,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8084,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8085,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
8086,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8087,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,St Joseph's Medical Center (MD),Illumina HiSeq,University of North Carolina,NO
8088,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8089,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
8090,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8091,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,University of North Carolina,NO
8092,Lung Squamous Cell Carcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8093,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8094,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
8095,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8096,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8097,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8098,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Washington University - Emory,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8099,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8100,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
8101,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8102,Lung Squamous Cell Carcinoma,Blood Derived Normal,WGS,University of Miami,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8103,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,University of North Carolina,NO
8104,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - CALGB,Illumina HiSeq,University of North Carolina,NO
8105,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8106,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Rush University,Illumina HiSeq,University of North Carolina,NO
8107,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
8108,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
8109,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8110,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Rush University,Illumina HiSeq,University of North Carolina,NO
8111,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
8112,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Princess Margaret Hospital (Canada),Illumina HiSeq,University of North Carolina,NO
8113,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
8114,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
8115,Lung Squamous Cell Carcinoma,Solid Tissue Normal,WGS,Fox Chase Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8116,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,University of North Carolina,NO
8117,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8118,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,University of North Carolina,NO
8119,Lung Squamous Cell Carcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8120,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
8121,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8122,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
8123,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
8124,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - CALGB,Illumina HiSeq,University of North Carolina,NO
8125,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Alabama,Illumina HiSeq,University of North Carolina,NO
8126,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8127,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8128,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
8129,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8130,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
8131,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
8132,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,St Joseph's Medical Center (MD),Illumina HiSeq,University of North Carolina,NO
8133,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
8134,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
8135,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
8136,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
8137,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
8138,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
8139,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
8140,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase Cancer Center,Illumina HiSeq,University of North Carolina,NO
8141,Lung Squamous Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Prince Charles Hospital,Illumina HiSeq,University of North Carolina,NO
8142,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Alabama,Illumina HiSeq,University of North Carolina,NO
8143,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - Emory,Illumina HiSeq,University of North Carolina,NO
8144,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - CHUV,Illumina HiSeq,University of North Carolina,NO
8145,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8146,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8147,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Washington University - CHUV,Illumina HiSeq,University of North Carolina,NO
8148,Lung Squamous Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8149,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8150,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8151,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8152,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8153,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8154,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8155,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8156,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8157,Kidney Renal Clear Cell Carcinoma,Blood Derived Normal,WGS,Fox Chase,Illumina HiSeq,Baylor College of Medicine,NO
8158,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8159,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8160,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8161,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
8162,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8163,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8164,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
8165,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8166,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8167,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8168,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8169,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
8170,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8171,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8172,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8173,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
8174,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8175,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8176,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8177,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8178,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
8179,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8180,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8181,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8182,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8183,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
8184,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8185,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
8186,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8187,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
8188,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8189,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8190,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
8191,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8192,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
8193,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8194,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8195,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8196,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8197,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8198,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
8199,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8200,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8201,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8202,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8203,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8204,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8205,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8206,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8207,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
8208,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8209,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8210,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8211,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8212,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,St Joseph's Medical Center (MD),Illumina HiSeq,University of North Carolina,NO
8213,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8214,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8215,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
8216,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
8217,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8218,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8219,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8220,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
8221,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8222,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
8223,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8224,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
8225,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8226,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8227,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8228,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8229,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
8230,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8231,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8232,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8233,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8234,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8235,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8236,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8237,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8238,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8239,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8240,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8241,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8242,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8243,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8244,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8245,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
8246,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8247,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8248,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8249,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8250,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8251,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8252,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8253,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8254,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8255,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8256,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8257,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8258,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8259,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8260,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8261,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8262,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
8263,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8264,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8265,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8266,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8267,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8268,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8269,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8270,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8271,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8272,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8273,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8274,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8275,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8276,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8277,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8278,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8279,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8280,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8281,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
8282,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8283,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8284,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8285,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8286,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8287,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8288,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8289,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8290,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8291,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8292,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8293,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8294,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8295,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8296,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8297,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
8298,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8299,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8300,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8301,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
8302,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8303,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8304,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8305,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8306,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8307,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8308,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8309,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8310,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8311,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8312,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8313,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8314,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8315,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
8316,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8317,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8318,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8319,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
8320,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8321,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8322,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8323,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8324,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8325,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8326,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
8327,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8328,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8329,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8330,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8331,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
8332,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8333,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8334,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8335,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8336,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8337,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8338,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8339,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8340,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8341,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8342,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8343,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
8344,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8345,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8346,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8347,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8348,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8349,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8350,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8351,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8352,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8353,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8354,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8355,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8356,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8357,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8358,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
8359,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8360,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8361,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8362,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8363,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8364,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8365,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
8366,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8367,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8368,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8369,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8370,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8371,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8372,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8373,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8374,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8375,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8376,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
8377,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8378,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8379,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8380,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,NCI Urologic Oncology Branch,Illumina HiSeq,Baylor College of Medicine,NO
8381,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8382,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8383,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
8384,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
8385,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8386,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8387,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8388,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8389,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
8390,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8391,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8392,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8393,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8394,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
8395,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
8396,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8397,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8398,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8399,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8400,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8401,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8402,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
8403,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8404,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8405,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8406,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8407,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8408,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8409,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
8410,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8411,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8412,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8413,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8414,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8415,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8416,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8417,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8418,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8419,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8420,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8421,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8422,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8423,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8424,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
8425,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8426,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8427,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8428,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
8429,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8430,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8431,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8432,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
8433,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8434,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8435,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8436,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8437,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8438,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8439,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8440,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8441,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
8442,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8443,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8444,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8445,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8446,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8447,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8448,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8449,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8450,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8451,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8452,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8453,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8454,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8455,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8456,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8457,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8458,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8459,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8460,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8461,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8462,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8463,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8464,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8465,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
8466,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8467,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8468,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
8469,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8470,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8471,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8472,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
8473,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8474,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8475,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
8476,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8477,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8478,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8479,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8480,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8481,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8482,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,CHI-Penrose Colorado,Illumina HiSeq,University of North Carolina,NO
8483,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8484,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8485,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8486,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8487,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8488,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8489,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8490,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8491,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8492,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8493,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8494,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8495,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8496,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8497,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
8498,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8499,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8500,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8501,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8502,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8503,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
8504,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8505,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8506,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Molecular Response,Illumina HiSeq,University of North Carolina,NO
8507,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8508,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
8509,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8510,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8511,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8512,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8513,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8514,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8515,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8516,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8517,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8518,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8519,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8520,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8521,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8522,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
8523,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8524,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8525,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
8526,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8527,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8528,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
8529,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8530,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
8531,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8532,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8533,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8534,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8535,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8536,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8537,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8538,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8539,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
8540,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
8541,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8542,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8543,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8544,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8545,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8546,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8547,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8548,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8549,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8550,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8551,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8552,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8553,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8554,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
8555,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8556,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8557,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
8558,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8559,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8560,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
8561,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8562,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8563,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
8564,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8565,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8566,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
8567,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8568,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8569,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8570,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8571,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8572,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8573,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8574,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8575,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8576,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
8577,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8578,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
8579,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
8580,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8581,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8582,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8583,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8584,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8585,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8586,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8587,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8588,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8589,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8590,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8591,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8592,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8593,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8594,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8595,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8596,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8597,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8598,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8599,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8600,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8601,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8602,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8603,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8604,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8605,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8606,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8607,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8608,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8609,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8610,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8611,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8612,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8613,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8614,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8615,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8616,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8617,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8618,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8619,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8620,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8621,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8622,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8623,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8624,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8625,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8626,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8627,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8628,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8629,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8630,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8631,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8632,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8633,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8634,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8635,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8636,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8637,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8638,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8639,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8640,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8641,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8642,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8643,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8644,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8645,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8646,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8647,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8648,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
8649,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8650,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8651,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8652,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8653,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8654,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8655,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8656,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8657,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8658,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8659,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8660,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Oklahoma HSC,Illumina HiSeq,University of North Carolina,NO
8661,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8662,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8663,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8664,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8665,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8666,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
8667,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8668,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8669,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
8670,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8671,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8672,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8673,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8674,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8675,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8676,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8677,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8678,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
8679,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8680,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8681,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8682,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8683,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8684,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8685,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8686,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
8687,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8688,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8689,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8690,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8691,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8692,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8693,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8694,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
8695,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8696,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8697,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8698,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8699,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8700,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8701,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8702,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8703,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8704,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8705,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8706,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,St Joseph's Medical Center (MD),Illumina HiSeq,University of North Carolina,NO
8707,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
8708,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8709,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8710,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8711,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8712,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8713,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
8714,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8715,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8716,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8717,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8718,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8719,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8720,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8721,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8722,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8723,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8724,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8725,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8726,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8727,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8728,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8729,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8730,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
8731,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8732,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8733,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8734,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8735,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
8736,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8737,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8738,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8739,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8740,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8741,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8742,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8743,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8744,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8745,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8746,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8747,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8748,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8749,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8750,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8751,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8752,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8753,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8754,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8755,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
8756,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8757,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8758,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8759,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8760,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8761,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8762,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8763,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8764,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8765,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
8766,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8767,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8768,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8769,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8770,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8771,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8772,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8773,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8774,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8775,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8776,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8777,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8778,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8779,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8780,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8781,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8782,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8783,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8784,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
8785,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8786,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8787,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8788,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8789,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8790,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,Harvard,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8791,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8792,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8793,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Baylor College of Medicine,NO
8794,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8795,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8796,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8797,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,Harvard,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8798,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8799,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8800,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8801,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8802,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8803,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
8804,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8805,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8806,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8807,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,CHI-Penrose Colorado,Illumina HiSeq,University of North Carolina,NO
8808,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8809,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8810,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8811,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8812,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8813,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
8814,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8815,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8816,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8817,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8818,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8819,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8820,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8821,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8822,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8823,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8824,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8825,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8826,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8827,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8828,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8829,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8830,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8831,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8832,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8833,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8834,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8835,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8836,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8837,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8838,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
8839,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8840,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8841,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8842,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8843,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8844,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
8845,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
8846,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
8847,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8848,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8849,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8850,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8851,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8852,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8853,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8854,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Baylor College of Medicine,NO
8855,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8856,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
8857,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8858,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8859,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8860,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8861,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8862,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8863,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8864,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8865,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8866,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8867,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
8868,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8869,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8870,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8871,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8872,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
8873,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8874,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8875,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
8876,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8877,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8878,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8879,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8880,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8881,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8882,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8883,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8884,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8885,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8886,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8887,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8888,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8889,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8890,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8891,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8892,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8893,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8894,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
8895,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8896,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8897,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8898,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8899,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8900,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8901,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8902,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8903,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8904,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8905,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8906,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
8907,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8908,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
8909,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8910,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8911,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8912,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,Fox Chase,Illumina HiSeq,Baylor College of Medicine,NO
8913,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8914,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8915,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8916,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8917,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8918,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
8919,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8920,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8921,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8922,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8923,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8924,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8925,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8926,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8927,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
8928,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8929,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
8930,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8931,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8932,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8933,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8934,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8935,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8936,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8937,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8938,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8939,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8940,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
8941,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8942,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8943,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8944,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8945,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8946,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8947,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8948,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8949,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8950,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
8951,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8952,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
8953,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8954,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8955,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8956,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
8957,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8958,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8959,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8960,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8961,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8962,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8963,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
8964,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8965,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
8966,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8967,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8968,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8969,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Baylor College of Medicine,NO
8970,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
8971,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8972,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8973,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8974,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8975,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8976,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8977,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
8978,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8979,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
8980,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8981,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8982,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
8983,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
8984,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8985,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
8986,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8987,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
8988,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8989,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8990,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
8991,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
8992,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
8993,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8994,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8995,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8996,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
8997,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8998,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
8999,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9000,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9001,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
9002,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9003,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
9004,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9005,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9006,Kidney Renal Clear Cell Carcinoma,Blood Derived Normal,WGS,Fox Chase,Illumina HiSeq,Baylor College of Medicine,NO
9007,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9008,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9009,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,CHI-Penrose Colorado,Illumina HiSeq,University of North Carolina,NO
9010,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9011,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9012,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
9013,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9014,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9015,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9016,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
9017,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
9018,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
9019,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9020,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9021,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9022,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
9023,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
9024,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9025,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
9026,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9027,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9028,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
9029,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9030,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,CHI-Penrose Colorado,Illumina HiSeq,University of North Carolina,NO
9031,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9032,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
9033,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
9034,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
9035,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9036,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
9037,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9038,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9039,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
9040,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9041,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9042,Kidney Renal Clear Cell Carcinoma,Blood Derived Normal,WGS,Fox Chase,Illumina HiSeq,Baylor College of Medicine,NO
9043,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
9044,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9045,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9046,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9047,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9048,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9049,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
9050,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
9051,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9052,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9053,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9054,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9055,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9056,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9057,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
9058,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9059,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9060,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9061,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9062,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9063,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9064,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
9065,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
9066,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
9067,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9068,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9069,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
9070,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9071,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
9072,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
9073,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9074,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9075,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9076,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9077,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9078,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9079,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9080,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9081,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9082,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
9083,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9084,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9085,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9086,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9087,Kidney Renal Clear Cell Carcinoma,Blood Derived Normal,WGS,NCI Urologic Oncology Branch,Illumina HiSeq,Baylor College of Medicine,NO
9088,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9089,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
9090,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9091,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9092,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9093,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9094,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9095,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9096,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
9097,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9098,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9099,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
9100,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
9101,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9102,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9103,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9104,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9105,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9106,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
9107,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9108,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9109,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9110,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9111,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
9112,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9113,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,Fox Chase,Illumina HiSeq,Baylor College of Medicine,NO
9114,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9115,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,Fox Chase,Illumina HiSeq,Baylor College of Medicine,NO
9116,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
9117,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
9118,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9119,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9120,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mary Bird Perkins Cancer Center - Our Lady of the Lake,Illumina HiSeq,University of North Carolina,NO
9121,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9122,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9123,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9124,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
9125,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9126,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9127,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
9128,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9129,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
9130,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9131,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9132,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9133,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9134,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9135,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9136,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9137,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9138,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9139,Kidney Renal Clear Cell Carcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
9140,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9141,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
9142,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9143,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9144,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9145,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9146,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9147,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9148,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9149,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9150,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9151,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
9152,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9153,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
9154,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9155,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
9156,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
9157,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9158,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9159,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9160,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9161,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9162,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9163,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9164,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
9165,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9166,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9167,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9168,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9169,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
9170,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
9171,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
9172,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9173,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
9174,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9175,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9176,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
9177,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9178,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9179,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9180,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9181,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9182,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9183,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9184,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9185,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9186,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
9187,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9188,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9189,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
9190,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9191,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9192,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9193,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
9194,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9195,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9196,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9197,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9198,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
9199,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9200,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
9201,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9202,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9203,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9204,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9205,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9206,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
9207,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9208,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9209,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9210,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9211,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
9212,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9213,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
9214,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9215,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9216,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9217,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
9218,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9219,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9220,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9221,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
9222,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
9223,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9224,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9225,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9226,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
9227,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9228,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
9229,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
9230,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9231,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9232,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9233,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
9234,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9235,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9236,Kidney Renal Clear Cell Carcinoma,Additional - New Primary,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
9237,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
9238,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9239,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9240,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9241,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9242,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9243,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
9244,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9245,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9246,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9247,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,MSKCC,Illumina HiSeq,Baylor College of Medicine,NO
9248,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9249,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9250,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9251,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
9252,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
9253,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
9254,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9255,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
9256,Kidney Renal Clear Cell Carcinoma,Primary Tumor,WGS,Harvard,Illumina HiSeq,Baylor College of Medicine,NO
9257,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9258,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9259,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9260,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
9261,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9262,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
9263,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9264,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
9265,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9266,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9267,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
9268,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,WGS,MD Anderson Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
9269,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9270,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9271,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9272,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9273,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9274,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
9275,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
9276,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
9277,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
9278,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9279,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9280,Kidney Renal Clear Cell Carcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9281,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9282,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
9283,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
9284,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9285,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
9286,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9287,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9288,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
9289,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
9290,Kidney Renal Clear Cell Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9291,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
9292,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Harvard Medical School,NO
9293,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9294,Brain Lower Grade Glioma,Recurrent Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9295,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western - St Joes,Illumina HiSeq,Harvard Medical School,NO
9296,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western - St Joes,Illumina HiSeq,Harvard Medical School,NO
9297,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9298,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,University of North Carolina,NO
9299,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9300,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
9301,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9302,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Thomas Jefferson University,Illumina HiSeq,Harvard Medical School,NO
9303,Brain Lower Grade Glioma,Blood Derived Normal,WGS,University of Sao Paulo,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9304,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9305,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9306,Brain Lower Grade Glioma,Primary Tumor,WGS,University of Sao Paulo,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9307,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9308,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9309,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,University of North Carolina,NO
9310,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
9311,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9312,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9313,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9314,Brain Lower Grade Glioma,Recurrent Tumor,RNA-Seq,The University of New South Wales,Illumina HiSeq,University of North Carolina,NO
9315,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
9316,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9317,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9318,Brain Lower Grade Glioma,Recurrent Tumor,WGS,University of Sao Paulo,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9319,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9320,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9321,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9322,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Hartford,Illumina HiSeq,University of North Carolina,NO
9323,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9324,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9325,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9326,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9327,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9328,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western - St Joes,Illumina HiSeq,Harvard Medical School,NO
9329,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9330,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,The University of New South Wales,Illumina HiSeq,University of North Carolina,NO
9331,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9332,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9333,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9334,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western - St Joes,Illumina HiSeq,Harvard Medical School,NO
9335,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,The University of New South Wales,Illumina HiSeq,University of North Carolina,NO
9336,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9337,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,The University of New South Wales,Illumina HiSeq,University of North Carolina,NO
9338,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9339,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9340,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9341,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9342,Brain Lower Grade Glioma,Recurrent Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9343,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9344,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9345,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Fondazione-Besta,Illumina HiSeq,University of North Carolina,NO
9346,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9347,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western - St Joes,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9348,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9349,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
9350,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9351,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9352,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,University of North Carolina,NO
9353,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
9354,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9355,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
9356,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9357,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,University of North Carolina,NO
9358,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,The University of New South Wales,Illumina HiSeq,University of North Carolina,NO
9359,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9360,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9361,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,University of North Carolina,NO
9362,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western - St Joes,Illumina HiSeq,Harvard Medical School,NO
9363,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9364,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9365,Brain Lower Grade Glioma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Harvard Medical School,NO
9366,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9367,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9368,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
9369,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9370,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9371,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9372,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9373,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9374,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9375,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9376,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Thomas Jefferson University,Illumina HiSeq,Harvard Medical School,NO
9377,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9378,Brain Lower Grade Glioma,Primary Tumor,WGS,University of Florida,Illumina HiSeq,Harvard Medical School,NO
9379,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
9380,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Northwestern University,Illumina HiSeq,University of North Carolina,NO
9381,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9382,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9383,Brain Lower Grade Glioma,Recurrent Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9384,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
9385,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9386,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9387,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western - St Joes,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9388,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9389,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9390,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9391,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9392,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9393,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9394,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
9395,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9396,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Thomas Jefferson University,Illumina HiSeq,Harvard Medical School,NO
9397,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Kansas,Illumina HiSeq,University of North Carolina,NO
9398,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9399,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9400,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Thomas Jefferson University,Illumina HiSeq,Harvard Medical School,NO
9401,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9402,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,University of North Carolina,NO
9403,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9404,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9405,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9406,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,University of North Carolina,NO
9407,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9408,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9409,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9410,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
9411,Brain Lower Grade Glioma,Recurrent Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9412,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Fondazione-Besta,Illumina HiSeq,University of North Carolina,NO
9413,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9414,Brain Lower Grade Glioma,Primary Tumor,WGS,Thomas Jefferson University,Illumina HiSeq,Harvard Medical School,NO
9415,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9416,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9417,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9418,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9419,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western,Illumina HiSeq,Harvard Medical School,NO
9420,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western - St Joes,Illumina HiSeq,Harvard Medical School,NO
9421,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
9422,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9423,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9424,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9425,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
9426,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9427,Brain Lower Grade Glioma,Recurrent Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9428,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9429,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western - St Joes,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9430,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9431,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9432,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9433,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western - St Joes,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9434,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9435,Brain Lower Grade Glioma,Recurrent Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9436,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western - St Joes,Illumina HiSeq,Harvard Medical School,NO
9437,Brain Lower Grade Glioma,Recurrent Tumor,WGS,The University of New South Wales,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9438,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Fondazione-Besta,Illumina HiSeq,University of North Carolina,NO
9439,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Huntsman Cancer Institute,Illumina HiSeq,University of North Carolina,NO
9440,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9441,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9442,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9443,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9444,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9445,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9446,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9447,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Fondazione-Besta,Illumina HiSeq,University of North Carolina,NO
9448,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
9449,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9450,Brain Lower Grade Glioma,Recurrent Tumor,WGS,University of Florida,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9451,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9452,Brain Lower Grade Glioma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Harvard Medical School,NO
9453,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western,Illumina HiSeq,Harvard Medical School,NO
9454,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9455,Brain Lower Grade Glioma,Recurrent Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9456,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9457,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9458,Brain Lower Grade Glioma,Primary Tumor,WGS,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9459,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9460,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9461,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9462,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9463,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9464,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9465,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,University of North Carolina,NO
9466,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9467,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9468,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9469,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9470,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9471,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9472,Brain Lower Grade Glioma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9473,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9474,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9475,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9476,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9477,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9478,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9479,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9480,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Huntsman Cancer Institute,Illumina HiSeq,University of North Carolina,NO
9481,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9482,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Greenville Health System,Illumina HiSeq,University of North Carolina,NO
9483,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9484,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9485,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9486,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9487,Brain Lower Grade Glioma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9488,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9489,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9490,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
9491,Brain Lower Grade Glioma,Recurrent Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9492,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9493,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Northwestern University,Illumina HiSeq,University of North Carolina,NO
9494,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9495,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9496,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9497,Brain Lower Grade Glioma,Recurrent Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9498,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9499,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,University of North Carolina,NO
9500,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9501,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western - St Joes,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9502,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9503,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9504,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9505,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western - St Joes,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9506,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9507,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western,Illumina HiSeq,Harvard Medical School,NO
9508,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9509,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9510,Brain Lower Grade Glioma,Primary Tumor,WGS,Thomas Jefferson University,Illumina HiSeq,Harvard Medical School,NO
9511,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
9512,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9513,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9514,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9515,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9516,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9517,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9518,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9519,Brain Lower Grade Glioma,Recurrent Tumor,WGS,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9520,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9521,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9522,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9523,Brain Lower Grade Glioma,Recurrent Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9524,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9525,Brain Lower Grade Glioma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
9526,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,University of North Carolina,NO
9527,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9528,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western,Illumina HiSeq,Harvard Medical School,NO
9529,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9530,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9531,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9532,Brain Lower Grade Glioma,Primary Tumor,WGS,Thomas Jefferson University,Illumina HiSeq,Harvard Medical School,NO
9533,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9534,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9535,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
9536,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
9537,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western - St Joes,Illumina HiSeq,Harvard Medical School,NO
9538,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9539,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9540,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9541,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9542,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9543,Brain Lower Grade Glioma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9544,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9545,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,The University of New South Wales,Illumina HiSeq,University of North Carolina,NO
9546,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Fondazione-Besta,Illumina HiSeq,University of North Carolina,NO
9547,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9548,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,The University of New South Wales,Illumina HiSeq,University of North Carolina,NO
9549,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9550,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9551,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9552,Brain Lower Grade Glioma,Recurrent Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9553,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9554,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9555,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9556,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,The University of New South Wales,Illumina HiSeq,University of North Carolina,NO
9557,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9558,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9559,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9560,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9561,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,University of North Carolina,NO
9562,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Harvard Medical School,NO
9563,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9564,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,University of North Carolina,NO
9565,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9566,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9567,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9568,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9569,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9570,Brain Lower Grade Glioma,Recurrent Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9571,Brain Lower Grade Glioma,Recurrent Tumor,WGS,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9572,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9573,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,University of North Carolina,NO
9574,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9575,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,The University of New South Wales,Illumina HiSeq,University of North Carolina,NO
9576,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9577,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,University of North Carolina,NO
9578,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9579,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9580,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9581,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9582,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
9583,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9584,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9585,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9586,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9587,Brain Lower Grade Glioma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
9588,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9589,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9590,Brain Lower Grade Glioma,Recurrent Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9591,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9592,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9593,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9594,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9595,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,The University of New South Wales,Illumina HiSeq,University of North Carolina,NO
9596,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western - St Joes,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9597,Brain Lower Grade Glioma,Recurrent Tumor,WGS,University of Sao Paulo,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9598,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9599,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Fondazione-Besta,Illumina HiSeq,University of North Carolina,NO
9600,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9601,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9602,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9603,Brain Lower Grade Glioma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9604,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9605,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,University of North Carolina,NO
9606,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9607,Brain Lower Grade Glioma,Recurrent Tumor,WGS,University of Sao Paulo,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9608,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9609,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9610,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9611,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9612,Brain Lower Grade Glioma,Primary Tumor,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
9613,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9614,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9615,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9616,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9617,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9618,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9619,Brain Lower Grade Glioma,Recurrent Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9620,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
9621,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9622,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9623,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9624,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
9625,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9626,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9627,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9628,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9629,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9630,Brain Lower Grade Glioma,Primary Tumor,WGS,University of Florida,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9631,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9632,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
9633,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9634,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Huntsman Cancer Institute,Illumina HiSeq,University of North Carolina,NO
9635,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9636,Brain Lower Grade Glioma,Primary Tumor,WGS,Thomas Jefferson University,Illumina HiSeq,Harvard Medical School,NO
9637,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9638,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9639,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9640,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9641,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9642,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
9643,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9644,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,University of North Carolina,NO
9645,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,University of North Carolina,NO
9646,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western,Illumina HiSeq,Harvard Medical School,NO
9647,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9648,Brain Lower Grade Glioma,Primary Tumor,WGS,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9649,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9650,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9651,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Huntsman Cancer Institute,Illumina HiSeq,University of North Carolina,NO
9652,Brain Lower Grade Glioma,Recurrent Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9653,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9654,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Fondazione-Besta,Illumina HiSeq,University of North Carolina,NO
9655,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9656,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9657,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9658,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western - St Joes,Illumina HiSeq,Harvard Medical School,NO
9659,Brain Lower Grade Glioma,Primary Tumor,WGS,Thomas Jefferson University,Illumina HiSeq,Harvard Medical School,NO
9660,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Fondazione-Besta,Illumina HiSeq,University of North Carolina,NO
9661,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9662,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,The University of New South Wales,Illumina HiSeq,University of North Carolina,NO
9663,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
9664,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9665,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9666,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9667,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Thomas Jefferson University,Illumina HiSeq,Harvard Medical School,NO
9668,Brain Lower Grade Glioma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9669,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9670,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9671,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Fondazione-Besta,Illumina HiSeq,University of North Carolina,NO
9672,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9673,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Fondazione-Besta,Illumina HiSeq,University of North Carolina,NO
9674,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9675,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9676,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9677,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western - St Joes,Illumina HiSeq,Harvard Medical School,NO
9678,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Harvard Medical School,NO
9679,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9680,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9681,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9682,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9683,Brain Lower Grade Glioma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9684,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9685,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western - St Joes,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9686,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9687,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western - St Joes,Illumina HiSeq,Harvard Medical School,NO
9688,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
9689,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9690,Brain Lower Grade Glioma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9691,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9692,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9693,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western,Illumina HiSeq,Harvard Medical School,NO
9694,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9695,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9696,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Fondazione-Besta,Illumina HiSeq,University of North Carolina,NO
9697,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9698,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,University of North Carolina,NO
9699,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9700,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9701,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9702,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
9703,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9704,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,The University of New South Wales,Illumina HiSeq,University of North Carolina,NO
9705,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western,Illumina HiSeq,Harvard Medical School,NO
9706,Brain Lower Grade Glioma,Recurrent Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9707,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9708,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9709,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9710,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
9711,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9712,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9713,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9714,Brain Lower Grade Glioma,Blood Derived Normal,WGS,University of Florida,Illumina HiSeq,Harvard Medical School,NO
9715,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,The University of New South Wales,Illumina HiSeq,University of North Carolina,NO
9716,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9717,Brain Lower Grade Glioma,Recurrent Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9718,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9719,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9720,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9721,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western - St Joes,Illumina HiSeq,Harvard Medical School,NO
9722,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
9723,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9724,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9725,Brain Lower Grade Glioma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Harvard Medical School,NO
9726,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western,Illumina HiSeq,Harvard Medical School,NO
9727,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9728,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9729,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9730,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9731,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9732,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9733,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9734,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western,Illumina HiSeq,Harvard Medical School,NO
9735,Brain Lower Grade Glioma,Primary Tumor,WGS,The University of New South Wales,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9736,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9737,Brain Lower Grade Glioma,Primary Tumor,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Harvard Medical School,NO
9738,Brain Lower Grade Glioma,Blood Derived Normal,WGS,University of Sao Paulo,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9739,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9740,Brain Lower Grade Glioma,Blood Derived Normal,WGS,The University of New South Wales,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9741,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9742,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9743,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
9744,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9745,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9746,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9747,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9748,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9749,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9750,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
9751,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9752,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,University of North Carolina,NO
9753,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9754,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,The University of New South Wales,Illumina HiSeq,University of North Carolina,NO
9755,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9756,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9757,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
9758,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9759,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9760,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9761,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9762,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9763,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9764,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9765,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9766,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9767,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9768,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Huntsman Cancer Institute,Illumina HiSeq,University of North Carolina,NO
9769,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9770,Brain Lower Grade Glioma,Primary Tumor,WGS,University of Sao Paulo,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9771,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9772,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9773,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9774,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9775,Brain Lower Grade Glioma,Recurrent Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9776,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
9777,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9778,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9779,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Huntsman Cancer Institute,Illumina HiSeq,University of North Carolina,NO
9780,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9781,Brain Lower Grade Glioma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
9782,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9783,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Fondazione-Besta,Illumina HiSeq,University of North Carolina,NO
9784,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Huntsman Cancer Institute,Illumina HiSeq,University of North Carolina,NO
9785,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9786,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
9787,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9788,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
9789,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9790,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9791,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9792,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9793,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9794,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9795,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9796,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Fondazione-Besta,Illumina HiSeq,University of North Carolina,NO
9797,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9798,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9799,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9800,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,University of North Carolina,NO
9801,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9802,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9803,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Fondazione-Besta,Illumina HiSeq,University of North Carolina,NO
9804,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
9805,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9806,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9807,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,The University of New South Wales,Illumina HiSeq,University of North Carolina,NO
9808,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9809,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9810,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western,Illumina HiSeq,Harvard Medical School,NO
9811,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9812,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Thomas Jefferson University,Illumina HiSeq,Harvard Medical School,NO
9813,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9814,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Fondazione-Besta,Illumina HiSeq,University of North Carolina,NO
9815,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9816,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9817,Brain Lower Grade Glioma,Primary Tumor,WGS,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9818,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9819,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9820,Brain Lower Grade Glioma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
9821,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9822,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9823,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
9824,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9825,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,University of North Carolina,NO
9826,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
9827,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western - St Joes,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9828,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9829,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9830,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9831,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9832,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9833,Brain Lower Grade Glioma,Recurrent Tumor,WGS,University of Sao Paulo,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9834,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9835,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9836,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9837,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9838,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9839,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9840,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Fondazione-Besta,Illumina HiSeq,University of North Carolina,NO
9841,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,The University of New South Wales,Illumina HiSeq,University of North Carolina,NO
9842,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9843,Brain Lower Grade Glioma,Primary Tumor,WGS,University of Sao Paulo,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9844,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9845,Brain Lower Grade Glioma,Recurrent Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
9846,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9847,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western,Illumina HiSeq,Harvard Medical School,NO
9848,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,University of North Carolina,NO
9849,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9850,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9851,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9852,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9853,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9854,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9855,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western - St Joes,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9856,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9857,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9858,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,University of North Carolina,NO
9859,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western,Illumina HiSeq,Harvard Medical School,NO
9860,Brain Lower Grade Glioma,Recurrent Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
9861,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,University of North Carolina,NO
9862,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9863,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9864,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9865,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9866,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9867,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9868,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9869,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Mayo Clinic - Rochester,Illumina HiSeq,Harvard Medical School,NO
9870,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9871,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9872,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9873,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9874,Brain Lower Grade Glioma,Recurrent Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9875,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Fondazione-Besta,Illumina HiSeq,University of North Carolina,NO
9876,Brain Lower Grade Glioma,Blood Derived Normal,WGS,University of Sao Paulo,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9877,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Fondazione-Besta,Illumina HiSeq,University of North Carolina,NO
9878,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9879,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9880,Brain Lower Grade Glioma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
9881,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9882,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9883,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9884,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,University of North Carolina,NO
9885,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western - St Joes,Illumina HiSeq,Harvard Medical School,NO
9886,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
9887,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9888,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Fondazione-Besta,Illumina HiSeq,University of North Carolina,NO
9889,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9890,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9891,Brain Lower Grade Glioma,Primary Tumor,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
9892,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9893,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9894,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9895,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
9896,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9897,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,University of North Carolina,NO
9898,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
9899,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9900,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9901,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9902,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9903,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9904,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9905,Brain Lower Grade Glioma,Recurrent Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
9906,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9907,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9908,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9909,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9910,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9911,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,University of North Carolina,NO
9912,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Hartford,Illumina HiSeq,University of North Carolina,NO
9913,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9914,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9915,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,University of North Carolina,NO
9916,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9917,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western,Illumina HiSeq,Harvard Medical School,NO
9918,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9919,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
9920,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9921,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western,Illumina HiSeq,Harvard Medical School,NO
9922,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9923,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9924,Brain Lower Grade Glioma,Primary Tumor,WGS,Duke,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9925,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9926,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9927,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
9928,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9929,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9930,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9931,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9932,Brain Lower Grade Glioma,Primary Tumor,WGS,Duke,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9933,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9934,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9935,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9936,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,University of North Carolina,NO
9937,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9938,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9939,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9940,Brain Lower Grade Glioma,Primary Tumor,WGS,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9941,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9942,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,The University of New South Wales,Illumina HiSeq,University of North Carolina,NO
9943,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
9944,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9945,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
9946,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9947,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9948,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Huntsman Cancer Institute,Illumina HiSeq,University of North Carolina,NO
9949,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9950,Brain Lower Grade Glioma,Primary Tumor,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
9951,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9952,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9953,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9954,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9955,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
9956,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
9957,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9958,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,University of North Carolina,NO
9959,Brain Lower Grade Glioma,Primary Tumor,WGS,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9960,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9961,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9962,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9963,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,The University of New South Wales,Illumina HiSeq,University of North Carolina,NO
9964,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western - St Joes,Illumina HiSeq,Harvard Medical School,NO
9965,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
9966,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9967,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9968,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,The University of New South Wales,Illumina HiSeq,University of North Carolina,NO
9969,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9970,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
9971,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9972,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9973,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9974,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Thomas Jefferson University,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9975,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9976,Brain Lower Grade Glioma,Recurrent Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
9977,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9978,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9979,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
9980,Brain Lower Grade Glioma,Recurrent Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
9981,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9982,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,University of North Carolina,NO
9983,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9984,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Fondazione-Besta,Illumina HiSeq,University of North Carolina,NO
9985,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9986,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9987,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9988,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western - St Joes,Illumina HiSeq,Harvard Medical School,NO
9989,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,University of North Carolina,NO
9990,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,University of North Carolina,NO
9991,Brain Lower Grade Glioma,Blood Derived Normal,WGS,University of Florida,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
9992,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9993,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
9994,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
9995,Brain Lower Grade Glioma,Primary Tumor,WGS,Thomas Jefferson University,Illumina HiSeq,Harvard Medical School,NO
9996,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
9997,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
9998,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
9999,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
10000,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western,Illumina HiSeq,University of North Carolina,NO
10001,Brain Lower Grade Glioma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
10002,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,The University of New South Wales,Illumina HiSeq,University of North Carolina,NO
10003,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10004,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
10005,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Thomas Jefferson University,Illumina HiSeq,University of North Carolina,NO
10006,Brain Lower Grade Glioma,Primary Tumor,WGS,Henry Ford Hospital,Illumina HiSeq,Harvard Medical School,NO
10007,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
10008,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,University of Florida,Illumina HiSeq,University of North Carolina,NO
10009,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
10010,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
10011,Brain Lower Grade Glioma,Primary Tumor,WGS,Case Western - St Joes,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10012,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
10013,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western - St Joes,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10014,Brain Lower Grade Glioma,Recurrent Tumor,RNA-Seq,University of Florida,Illumina HiSeq,University of North Carolina,NO
10015,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Fondazione-Besta,Illumina HiSeq,University of North Carolina,NO
10016,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
10017,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Case Western - St Joes,Illumina HiSeq,University of North Carolina,NO
10018,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
10019,Brain Lower Grade Glioma,Blood Derived Normal,WGS,Case Western - St Joes,Illumina HiSeq,Harvard Medical School,NO
10020,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Henry Ford Hospital,Illumina HiSeq,University of North Carolina,NO
10021,Brain Lower Grade Glioma,Primary Tumor,RNA-Seq,Dept of Neurosurgery at University of Heidelberg,Illumina HiSeq,University of North Carolina,NO
10022,Brain Lower Grade Glioma,Primary Tumor,WGS,UNC,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10023,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10024,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10025,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10026,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10027,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10028,Skin Cutaneous Melanoma,Metastatic,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10029,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Greenville Health System,Illumina HiSeq,University of North Carolina,NO
10030,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10031,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10032,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Cureline,Illumina HiSeq,Harvard Medical School,NO
10033,Skin Cutaneous Melanoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
10034,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10035,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Roswell,Illumina HiSeq,University of North Carolina,NO
10036,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10037,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
10038,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Yale,Illumina HiSeq,University of North Carolina,NO
10039,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10040,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10041,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10042,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10043,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
10044,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10045,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10046,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10047,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
10048,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Yale,Illumina HiSeq,University of North Carolina,NO
10049,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10050,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10051,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10052,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10053,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Yale,Illumina HiSeq,Harvard Medical School,NO
10054,Skin Cutaneous Melanoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10055,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10056,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10057,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
10058,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10059,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10060,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10061,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10062,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10063,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10064,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10065,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10066,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10067,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10068,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10069,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10070,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Roswell,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10071,Skin Cutaneous Melanoma,Additional Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10072,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10073,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10074,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10075,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10076,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10077,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10078,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10079,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
10080,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Yale,Illumina HiSeq,University of North Carolina,NO
10081,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10082,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10083,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10084,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10085,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10086,Skin Cutaneous Melanoma,Metastatic,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10087,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
10088,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Cureline,Illumina HiSeq,Harvard Medical School,NO
10089,Skin Cutaneous Melanoma,Metastatic,WGS,Yale,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10090,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10091,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10092,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10093,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
10094,Skin Cutaneous Melanoma,Metastatic,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10095,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10096,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10097,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
10098,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
10099,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,University of North Carolina,NO
10100,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10101,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10102,Skin Cutaneous Melanoma,Metastatic,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
10103,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10104,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10105,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10106,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10107,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10108,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10109,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10110,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10111,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10112,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10113,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10114,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10115,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10116,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
10117,Skin Cutaneous Melanoma,Metastatic,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
10118,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10119,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10120,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10121,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10122,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Puerto Rico,Illumina HiSeq,University of North Carolina,NO
10123,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10124,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10125,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Yale,Illumina HiSeq,University of North Carolina,NO
10126,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10127,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Roswell,Illumina HiSeq,University of North Carolina,NO
10128,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10129,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10130,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10131,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10132,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10133,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Roswell,Illumina HiSeq,University of North Carolina,NO
10134,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
10135,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10136,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10137,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Yale,Illumina HiSeq,Harvard Medical School,NO
10138,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Roswell,Illumina HiSeq,University of North Carolina,NO
10139,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10140,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Yale,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10141,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Yale,Illumina HiSeq,University of North Carolina,NO
10142,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10143,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
10144,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10145,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10146,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Roswell,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10147,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10148,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10149,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10150,Skin Cutaneous Melanoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10151,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10152,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10153,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Greenville Health System,Illumina HiSeq,University of North Carolina,NO
10154,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
10155,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10156,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Hartford Hospital,Illumina HiSeq,University of North Carolina,NO
10157,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10158,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10159,Skin Cutaneous Melanoma,Metastatic,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
10160,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10161,Skin Cutaneous Melanoma,Metastatic,WGS,MD Anderson,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10162,Skin Cutaneous Melanoma,Metastatic,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
10163,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Yale,Illumina HiSeq,Harvard Medical School,NO
10164,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10165,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10166,Skin Cutaneous Melanoma,Primary Tumor,WGS,Cureline,Illumina HiSeq,Harvard Medical School,NO
10167,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10168,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10169,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10170,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10171,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10172,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
10173,Skin Cutaneous Melanoma,Metastatic,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
10174,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Saint Mary's Health Care,Illumina HiSeq,University of North Carolina,NO
10175,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10176,Skin Cutaneous Melanoma,Metastatic,WGS,Yale,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10177,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
10178,Skin Cutaneous Melanoma,Metastatic,WGS,Roswell,Illumina HiSeq,Harvard Medical School,NO
10179,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10180,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10181,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10182,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10183,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10184,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10185,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,University of North Carolina,NO
10186,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10187,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10188,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10189,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10190,Skin Cutaneous Melanoma,Metastatic,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10191,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10192,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Greenville Health System,Illumina HiSeq,University of North Carolina,NO
10193,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10194,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10195,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Cureline,Illumina HiSeq,Harvard Medical School,NO
10196,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10197,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10198,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10199,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10200,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10201,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10202,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
10203,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10204,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10205,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
10206,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10207,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10208,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10209,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10210,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10211,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10212,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10213,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
10214,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10215,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10216,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10217,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10218,Skin Cutaneous Melanoma,Metastatic,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
10219,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10220,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10221,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10222,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10223,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10224,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10225,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Roswell,Illumina HiSeq,University of North Carolina,NO
10226,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10227,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10228,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10229,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,ABS - IUPUI,Illumina HiSeq,Harvard Medical School,NO
10230,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
10231,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10232,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10233,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Yale,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10234,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10235,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10236,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10237,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
10238,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10239,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10240,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10241,Skin Cutaneous Melanoma,Metastatic,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10242,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10243,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10244,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
10245,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
10246,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10247,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10248,Skin Cutaneous Melanoma,Metastatic,WGS,Yale,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10249,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10250,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10251,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Cureline,Illumina HiSeq,Harvard Medical School,NO
10252,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10253,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10254,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10255,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10256,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
10257,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
10258,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10259,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10260,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Roswell,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10261,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10262,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Yale,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10263,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10264,Skin Cutaneous Melanoma,Metastatic,WGS,Roswell,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10265,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10266,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10267,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10268,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10269,Skin Cutaneous Melanoma,Metastatic,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10270,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Roswell,Illumina HiSeq,University of North Carolina,NO
10271,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,University of North Carolina,NO
10272,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10273,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10274,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10275,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10276,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10277,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Roswell,Illumina HiSeq,University of North Carolina,NO
10278,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10279,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10280,Skin Cutaneous Melanoma,Metastatic,WGS,Yale,Illumina HiSeq,Harvard Medical School,NO
10281,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Yale,Illumina HiSeq,University of North Carolina,NO
10282,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
10283,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10284,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
10285,Skin Cutaneous Melanoma,Metastatic,WGS,Greater Poland Cancer Center,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10286,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10287,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Roswell,Illumina HiSeq,University of North Carolina,NO
10288,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Yale,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10289,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Roswell,Illumina HiSeq,University of North Carolina,NO
10290,Skin Cutaneous Melanoma,Metastatic,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
10291,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10292,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10293,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10294,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10295,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
10296,Skin Cutaneous Melanoma,Metastatic,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10297,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10298,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10299,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10300,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Yale,Illumina HiSeq,University of North Carolina,NO
10301,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10302,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Roswell,Illumina HiSeq,University of North Carolina,NO
10303,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10304,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10305,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10306,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Yale,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10307,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
10308,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10309,Skin Cutaneous Melanoma,Metastatic,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10310,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10311,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10312,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Yale,Illumina HiSeq,University of North Carolina,NO
10313,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10314,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
10315,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10316,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10317,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
10318,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10319,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10320,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10321,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10322,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10323,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10324,Skin Cutaneous Melanoma,Metastatic,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Harvard Medical School,NO
10325,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Roswell,Illumina HiSeq,University of North Carolina,NO
10326,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10327,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10328,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10329,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10330,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
10331,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
10332,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
10333,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
10334,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10335,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10336,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10337,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10338,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10339,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
10340,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10341,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
10342,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10343,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
10344,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10345,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10346,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10347,Skin Cutaneous Melanoma,Primary Tumor,WGS,Cureline,Illumina HiSeq,Harvard Medical School,NO
10348,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10349,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10350,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Yale,Illumina HiSeq,University of North Carolina,NO
10351,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10352,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,IDI-IRCCS,Illumina HiSeq,University of North Carolina,NO
10353,Skin Cutaneous Melanoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10354,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10355,Skin Cutaneous Melanoma,Metastatic,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
10356,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Yale,Illumina HiSeq,University of North Carolina,NO
10357,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10358,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Yale,Illumina HiSeq,University of North Carolina,NO
10359,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10360,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10361,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10362,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10363,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10364,Skin Cutaneous Melanoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
10365,Skin Cutaneous Melanoma,Metastatic,WGS,Yale,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10366,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10367,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
10368,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Yale,Illumina HiSeq,Harvard Medical School,NO
10369,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10370,Skin Cutaneous Melanoma,Metastatic,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10371,Skin Cutaneous Melanoma,Metastatic,WGS,MD Anderson,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10372,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
10373,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10374,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10375,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10376,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10377,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10378,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Emory University,Illumina HiSeq,University of North Carolina,NO
10379,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Roswell,Illumina HiSeq,University of North Carolina,NO
10380,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,IDI-IRCCS,Illumina HiSeq,University of North Carolina,NO
10381,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10382,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10383,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
10384,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10385,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10386,Skin Cutaneous Melanoma,Primary Tumor,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10387,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10388,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10389,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10390,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10391,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
10392,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10393,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
10394,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10395,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Yale,Illumina HiSeq,University of North Carolina,NO
10396,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Roswell,Illumina HiSeq,University of North Carolina,NO
10397,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10398,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10399,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Roswell,Illumina HiSeq,University of North Carolina,NO
10400,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10401,Skin Cutaneous Melanoma,Metastatic,WGS,Roswell,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10402,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10403,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
10404,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10405,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10406,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10407,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10408,Skin Cutaneous Melanoma,Metastatic,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
10409,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
10410,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10411,Skin Cutaneous Melanoma,Metastatic,WGS,Roswell,Illumina HiSeq,Harvard Medical School,NO
10412,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
10413,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10414,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10415,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10416,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10417,Skin Cutaneous Melanoma,Metastatic,WGS,Yale,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10418,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10419,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10420,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Yale,Illumina HiSeq,University of North Carolina,NO
10421,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10422,Skin Cutaneous Melanoma,Primary Tumor,WGS,Cureline,Illumina HiSeq,Harvard Medical School,NO
10423,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10424,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Puerto Rico,Illumina HiSeq,University of North Carolina,NO
10425,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10426,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10427,Skin Cutaneous Melanoma,Metastatic,WGS,Yale,Illumina HiSeq,Harvard Medical School,NO
10428,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10429,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10430,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10431,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10432,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10433,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10434,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10435,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10436,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10437,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10438,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10439,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Roswell,Illumina HiSeq,University of North Carolina,NO
10440,Skin Cutaneous Melanoma,Metastatic,WGS,Yale,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10441,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10442,Skin Cutaneous Melanoma,Primary Tumor,WGS,Cureline,Illumina HiSeq,Harvard Medical School,NO
10443,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10444,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Yale,Illumina HiSeq,University of North Carolina,NO
10445,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10446,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10447,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10448,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10449,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10450,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
10451,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10452,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Roswell,Illumina HiSeq,Harvard Medical School,NO
10453,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10454,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10455,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Roswell,Illumina HiSeq,University of North Carolina,NO
10456,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10457,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10458,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10459,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,University of North Carolina,NO
10460,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
10461,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10462,Skin Cutaneous Melanoma,Primary Tumor,WGS,ABS - IUPUI,Illumina HiSeq,Harvard Medical School,NO
10463,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
10464,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Roswell,Illumina HiSeq,University of North Carolina,NO
10465,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10466,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10467,Skin Cutaneous Melanoma,Metastatic,WGS,Yale,Illumina HiSeq,Harvard Medical School,NO
10468,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Yale,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10469,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10470,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10471,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10472,Skin Cutaneous Melanoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10473,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10474,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10475,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10476,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,University of North Carolina,NO
10477,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10478,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10479,Skin Cutaneous Melanoma,Metastatic,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10480,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
10481,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10482,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10483,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10484,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10485,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10486,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
10487,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10488,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10489,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10490,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10491,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10492,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10493,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10494,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10495,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10496,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10497,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10498,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10499,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10500,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10501,Skin Cutaneous Melanoma,Metastatic,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
10502,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10503,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10504,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Yale,Illumina HiSeq,University of North Carolina,NO
10505,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10506,Skin Cutaneous Melanoma,Metastatic,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10507,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10508,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10509,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10510,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10511,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10512,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10513,Skin Cutaneous Melanoma,Metastatic,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10514,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Yale,Illumina HiSeq,University of North Carolina,NO
10515,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Yale,Illumina HiSeq,University of North Carolina,NO
10516,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
10517,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
10518,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10519,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10520,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10521,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10522,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Roswell,Illumina HiSeq,University of North Carolina,NO
10523,Skin Cutaneous Melanoma,Solid Tissue Normal,RNA-Seq,Roswell,Illumina HiSeq,University of North Carolina,NO
10524,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10525,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10526,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
10527,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10528,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10529,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10530,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
10531,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
10532,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Yale,Illumina HiSeq,University of North Carolina,NO
10533,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10534,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10535,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10536,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10537,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
10538,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10539,Skin Cutaneous Melanoma,Metastatic,WGS,Yale,Illumina HiSeq,Harvard Medical School,NO
10540,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10541,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10542,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Roswell,Illumina HiSeq,University of North Carolina,NO
10543,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10544,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10545,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10546,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10547,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10548,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10549,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
10550,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10551,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10552,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
10553,Skin Cutaneous Melanoma,Metastatic,WGS,Yale,Illumina HiSeq,Harvard Medical School,NO
10554,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Yale,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10555,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10556,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10557,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,IDI-IRCCS,Illumina HiSeq,University of North Carolina,NO
10558,Skin Cutaneous Melanoma,Metastatic,WGS,Yale,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10559,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
10560,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10561,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10562,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10563,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10564,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10565,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10566,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10567,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Yale,Illumina HiSeq,University of North Carolina,NO
10568,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10569,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Emory University,Illumina HiSeq,University of North Carolina,NO
10570,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10571,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10572,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10573,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10574,Skin Cutaneous Melanoma,Metastatic,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10575,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10576,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10577,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
10578,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Yale,Illumina HiSeq,Harvard Medical School,NO
10579,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Roswell,Illumina HiSeq,University of North Carolina,NO
10580,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
10581,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10582,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10583,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10584,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10585,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10586,Skin Cutaneous Melanoma,Metastatic,WGS,Yale,Illumina HiSeq,Harvard Medical School,NO
10587,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10588,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10589,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10590,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Harvard Medical School,NO
10591,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10592,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10593,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Roswell,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10594,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Cureline,Illumina HiSeq,Harvard Medical School,NO
10595,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10596,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10597,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10598,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
10599,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Yale,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10600,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10601,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
10602,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10603,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10604,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10605,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10606,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
10607,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10608,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10609,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10610,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10611,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
10612,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
10613,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10614,Skin Cutaneous Melanoma,Metastatic,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
10615,Skin Cutaneous Melanoma,Metastatic,WGS,Roswell,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10616,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10617,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10618,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10619,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10620,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10621,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Harvard Medical School,NO
10622,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
10623,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Yale,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10624,Skin Cutaneous Melanoma,Metastatic,WGS,MD Anderson,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10625,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10626,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10627,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
10628,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10629,Skin Cutaneous Melanoma,Metastatic,WGS,Yale,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10630,Skin Cutaneous Melanoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
10631,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10632,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
10633,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10634,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10635,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10636,Skin Cutaneous Melanoma,Primary Tumor,WGS,Cureline,Illumina HiSeq,Harvard Medical School,NO
10637,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10638,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10639,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10640,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10641,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10642,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10643,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10644,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
10645,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
10646,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10647,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10648,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
10649,Skin Cutaneous Melanoma,Metastatic,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
10650,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Yale,Illumina HiSeq,University of North Carolina,NO
10651,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10652,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Roswell,Illumina HiSeq,Harvard Medical School,NO
10653,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10654,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10655,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Yale,Illumina HiSeq,Harvard Medical School,NO
10656,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
10657,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10658,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
10659,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10660,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10661,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10662,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10663,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
10664,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Yale,Illumina HiSeq,University of North Carolina,NO
10665,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10666,Skin Cutaneous Melanoma,Metastatic,WGS,Yale,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10667,Skin Cutaneous Melanoma,Primary Tumor,WGS,Roswell,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10668,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
10669,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
10670,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10671,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
10672,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
10673,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Yale,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10674,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10675,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10676,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10677,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10678,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10679,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10680,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10681,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10682,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10683,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10684,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10685,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10686,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10687,Skin Cutaneous Melanoma,Metastatic,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10688,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10689,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10690,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10691,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10692,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10693,Skin Cutaneous Melanoma,Metastatic,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
10694,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10695,Skin Cutaneous Melanoma,Metastatic,WGS,Yale,Illumina HiSeq,Harvard Medical School,NO
10696,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10697,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10698,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10699,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10700,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10701,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10702,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10703,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10704,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10705,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10706,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
10707,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10708,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10709,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
10710,Skin Cutaneous Melanoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10711,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10712,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10713,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
10714,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10715,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10716,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
10717,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10718,Skin Cutaneous Melanoma,Metastatic,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10719,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10720,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Yale,Illumina HiSeq,University of North Carolina,NO
10721,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10722,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10723,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
10724,Skin Cutaneous Melanoma,Metastatic,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10725,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10726,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10727,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10728,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10729,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
10730,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
10731,Skin Cutaneous Melanoma,Metastatic,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
10732,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10733,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10734,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
10735,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10736,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10737,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10738,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Yale,Illumina HiSeq,Harvard Medical School,NO
10739,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10740,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10741,Skin Cutaneous Melanoma,Metastatic,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10742,Skin Cutaneous Melanoma,Metastatic,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10743,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Yale,Illumina HiSeq,University of North Carolina,NO
10744,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10745,Skin Cutaneous Melanoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10746,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10747,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10748,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10749,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10750,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10751,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,University of Puerto Rico,Illumina HiSeq,University of North Carolina,NO
10752,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10753,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
10754,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10755,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10756,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10757,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10758,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10759,Skin Cutaneous Melanoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10760,Skin Cutaneous Melanoma,Metastatic,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10761,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10762,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10763,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10764,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10765,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10766,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10767,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Roswell,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10768,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10769,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10770,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10771,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10772,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10773,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10774,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
10775,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
10776,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10777,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10778,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10779,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10780,Skin Cutaneous Melanoma,Metastatic,WGS,Roswell,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10781,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
10782,Skin Cutaneous Melanoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10783,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10784,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10785,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10786,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
10787,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10788,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10789,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10790,Skin Cutaneous Melanoma,Metastatic,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Harvard Medical School,NO
10791,Skin Cutaneous Melanoma,Metastatic,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
10792,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10793,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10794,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
10795,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10796,Skin Cutaneous Melanoma,Metastatic,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10797,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10798,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Essen,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10799,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Harvard Medical School,NO
10800,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
10801,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10802,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10803,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
10804,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10805,Skin Cutaneous Melanoma,Metastatic,WGS,Yale,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10806,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
10807,Skin Cutaneous Melanoma,Metastatic,WGS,University of Sydney,Illumina HiSeq,Harvard Medical School,NO
10808,Skin Cutaneous Melanoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
10809,Skin Cutaneous Melanoma,Metastatic,WGS,Greater Poland Cancer Center,Illumina HiSeq,Harvard Medical School,NO
10810,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10811,Skin Cutaneous Melanoma,Metastatic,WGS,Essen,Illumina HiSeq,Harvard Medical School,NO
10812,Skin Cutaneous Melanoma,Metastatic,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
10813,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,University of Sydney,Illumina HiSeq,University of North Carolina,NO
10814,Skin Cutaneous Melanoma,Metastatic,RNA-Seq,Essen,Illumina HiSeq,University of North Carolina,NO
10815,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10816,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
10817,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10818,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10819,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10820,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10821,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
10822,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10823,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10824,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10825,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10826,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10827,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10828,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10829,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10830,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10831,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10832,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
10833,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10834,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10835,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10836,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10837,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10838,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10839,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10840,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10841,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10842,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10843,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10844,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10845,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10846,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10847,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
10848,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10849,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10850,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10851,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10852,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10853,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10854,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10855,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10856,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10857,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10858,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10859,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10860,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10861,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10862,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10863,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10864,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10865,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10866,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10867,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10868,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10869,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10870,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
10871,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10872,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
10873,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10874,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina HiSeq,Johns Hopkins / University of Southern California,NO
10875,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10876,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10877,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10878,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10879,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10880,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10881,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10882,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10883,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10884,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10885,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10886,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
10887,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10888,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10889,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10890,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10891,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10892,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10893,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10894,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10895,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10896,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10897,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10898,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
10899,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10900,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10901,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
10902,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
10903,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10904,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10905,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10906,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10907,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
10908,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
10909,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10910,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10911,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10912,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
10913,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10914,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10915,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10916,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10917,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10918,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10919,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10920,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10921,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
10922,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10923,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10924,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10925,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10926,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10927,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10928,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10929,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10930,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10931,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10932,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10933,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
10934,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10935,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10936,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10937,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10938,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10939,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10940,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10941,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10942,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
10943,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10944,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10945,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10946,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10947,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10948,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10949,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
10950,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10951,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10952,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10953,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10954,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
10955,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10956,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10957,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10958,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10959,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10960,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10961,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
10962,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10963,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
10964,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10965,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10966,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10967,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
10968,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10969,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10970,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10971,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10972,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10973,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10974,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
10975,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10976,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10977,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10978,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10979,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10980,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10981,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10982,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10983,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10984,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10985,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10986,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10987,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10988,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10989,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10990,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10991,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10992,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10993,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10994,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10995,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10996,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10997,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
10998,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
10999,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11000,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11001,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11002,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11003,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11004,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
11005,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11006,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11007,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11008,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11009,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11010,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11011,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11012,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11013,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11014,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11015,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11016,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11017,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11018,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11019,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11020,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11021,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11022,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11023,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11024,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11025,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11026,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11027,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11028,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11029,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11030,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11031,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11032,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11033,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11034,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11035,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11036,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11037,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11038,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11039,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11040,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11041,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11042,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11043,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
11044,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11045,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11046,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11047,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11048,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11049,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11050,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
11051,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11052,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11053,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11054,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11055,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11056,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11057,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11058,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11059,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11060,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
11061,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11062,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11063,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11064,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
11065,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11066,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11067,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
11068,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11069,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11070,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11071,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11072,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11073,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11074,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11075,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11076,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11077,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11078,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11079,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11080,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina HiSeq,Johns Hopkins / University of Southern California,NO
11081,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
11082,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11083,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11084,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11085,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11086,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11087,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11088,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11089,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11090,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11091,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11092,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11093,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11094,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11095,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11096,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11097,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11098,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11099,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11100,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11101,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11102,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
11103,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11104,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11105,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11106,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11107,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11108,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11109,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11110,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11111,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11112,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11113,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11114,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11115,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11116,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
11117,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11118,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11119,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11120,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11121,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11122,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11123,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11124,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
11125,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11126,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11127,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11128,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11129,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11130,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11131,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11132,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11133,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11134,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11135,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11136,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11137,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
11138,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
11139,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11140,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
11141,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11142,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11143,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,WGS,Washington University,Illumina GA,Johns Hopkins / University of Southern California,NO
11144,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11145,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11146,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11147,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11148,Acute Myeloid Leukemia,Primary Blood Derived Cancer - Peripheral Blood,RNA-Seq,Washington University,Illumina GA,Canada's Michael Smith Genome Sciences Centre,NO
11149,Acute Myeloid Leukemia,Solid Tissue Normal,WGS,Washington University,Illumina GA,Washington University School of Medicine,NO
11150,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11151,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
11152,Breast Invasive Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
11153,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11154,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11155,Breast Invasive Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
11156,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11157,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11158,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11159,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11160,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11161,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11162,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11163,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
11164,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
11165,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11166,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11167,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
11168,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,University of North Carolina,NO
11169,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11170,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
11171,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11172,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Not available,Illumina HiSeq,Washington University School of Medicine,NO
11173,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11174,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Cureline,Illumina HiSeq,Washington University School of Medicine,NO
11175,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
11176,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11177,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11178,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Columbia University,Illumina HiSeq,University of North Carolina,NO
11179,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11180,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11181,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
11182,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Mayo,Illumina HiSeq,Harvard Medical School,NO
11183,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11184,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Mayo,Illumina HiSeq,Washington University School of Medicine,NO
11185,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11186,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11187,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11188,Breast Invasive Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
11189,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11190,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11191,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11192,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11193,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
11194,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11195,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11196,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11197,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Miami,Illumina HiSeq,Washington University School of Medicine,NO
11198,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11199,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11200,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
11201,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11202,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
11203,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
11204,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11205,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11206,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
11207,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11208,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11209,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11210,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11211,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11212,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11213,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11214,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11215,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
11216,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
11217,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11218,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11219,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11220,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11221,Breast Invasive Carcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Washington University School of Medicine,NO
11222,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
11223,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11224,Breast Invasive Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
11225,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Institute of Human Virology Nigeria,Illumina HiSeq,University of North Carolina,NO
11226,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11227,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11228,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11229,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11230,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11231,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11232,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11233,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
11234,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11235,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11236,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
11237,Breast Invasive Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
11238,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
11239,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,YES
11240,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11241,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11242,Breast Invasive Carcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Washington University School of Medicine,NO
11243,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11244,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11245,Breast Invasive Carcinoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11246,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11247,Breast Invasive Carcinoma,Metastatic,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11248,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11249,Breast Invasive Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
11250,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Albert Einstein Medical Center,Illumina HiSeq,University of North Carolina,NO
11251,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
11252,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
11253,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11254,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
11255,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11256,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11257,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Cureline,Illumina HiSeq,Washington University School of Medicine,NO
11258,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11259,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11260,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11261,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11262,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11263,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11264,Breast Invasive Carcinoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Washington University School of Medicine,NO
11265,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11266,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11267,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11268,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11269,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11270,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11271,Breast Invasive Carcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Washington University School of Medicine,NO
11272,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11273,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
11274,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11275,Breast Invasive Carcinoma,Primary Tumor,WGS,Indivumed,Illumina MiSeq,Washington University School of Medicine,NO
11276,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
11277,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
11278,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11279,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11280,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11281,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11282,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11283,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
11284,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11285,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11286,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11287,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
11288,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Washington University School of Medicine,NO
11289,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
11290,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11291,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11292,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11293,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11294,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11295,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Mayo,Illumina HiSeq,Washington University School of Medicine,NO
11296,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
11297,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11298,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11299,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11300,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11301,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11302,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Miami,Illumina HiSeq,Washington University School of Medicine,NO
11303,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11304,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11305,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11306,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11307,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
11308,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11309,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11310,Breast Invasive Carcinoma,Blood Derived Normal,WGS,University of Miami,Illumina HiSeq,Washington University School of Medicine,NO
11311,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11312,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11313,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11314,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11315,Breast Invasive Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
11316,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,University of North Carolina,NO
11317,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11318,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11319,Breast Invasive Carcinoma,Primary Tumor,WGS,ABS - IUPUI,Illumina HiSeq,Washington University School of Medicine,NO
11320,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11321,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11322,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11323,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11324,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11325,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11326,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11327,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
11328,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11329,Breast Invasive Carcinoma,Primary Tumor,WGS,Mayo,Illumina HiSeq,Washington University School of Medicine,NO
11330,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11331,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11332,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11333,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11334,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11335,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11336,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
11337,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11338,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
11339,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11340,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11341,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11342,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11343,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
11344,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
11345,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11346,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11347,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11348,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11349,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Washington University School of Medicine,NO
11350,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11351,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
11352,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11353,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11354,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11355,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11356,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11357,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11358,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
11359,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11360,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11361,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11362,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
11363,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11364,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11365,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11366,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11367,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
11368,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11369,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
11370,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11371,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11372,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
11373,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
11374,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11375,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11376,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Columbia University,Illumina HiSeq,University of North Carolina,NO
11377,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11378,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11379,Breast Invasive Carcinoma,Primary Tumor,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
11380,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
11381,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11382,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11383,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11384,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11385,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11386,Breast Invasive Carcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Washington University School of Medicine,NO
11387,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
11388,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11389,Breast Invasive Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
11390,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11391,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Miami,Illumina HiSeq,Washington University School of Medicine,NO
11392,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
11393,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
11394,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
11395,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11396,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11397,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
11398,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11399,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11400,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11401,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11402,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11403,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11404,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11405,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
11406,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11407,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Gundersen Lutheran Health System,Illumina HiSeq,University of North Carolina,NO
11408,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11409,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,John Wayne Cancer Center,Illumina HiSeq,University of North Carolina,NO
11410,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11411,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
11412,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11413,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11414,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11415,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11416,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11417,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11418,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11419,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11420,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11421,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11422,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11423,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11424,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11425,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11426,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11427,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11428,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
11429,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11430,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11431,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
11432,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
11433,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11434,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,University of North Carolina,NO
11435,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11436,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11437,Breast Invasive Carcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Washington University School of Medicine,NO
11438,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11439,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11440,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11441,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11442,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
11443,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
11444,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
11445,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11446,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11447,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11448,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11449,Breast Invasive Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
11450,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
11451,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11452,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11453,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11454,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11455,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
11456,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11457,Breast Invasive Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Washington University School of Medicine,NO
11458,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
11459,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11460,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11461,Breast Invasive Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
11462,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11463,Breast Invasive Carcinoma,Primary Tumor,WGS,Cureline,Illumina HiSeq,Washington University School of Medicine,NO
11464,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11465,Breast Invasive Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
11466,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11467,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11468,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11469,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
11470,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11471,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
11472,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11473,Breast Invasive Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
11474,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Columbia University,Illumina HiSeq,University of North Carolina,NO
11475,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11476,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11477,Breast Invasive Carcinoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Washington University School of Medicine,NO
11478,Breast Invasive Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
11479,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11480,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11481,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11482,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11483,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11484,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,University of North Carolina,NO
11485,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11486,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11487,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11488,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Washington University School of Medicine,NO
11489,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11490,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11491,Breast Invasive Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Washington University School of Medicine,NO
11492,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11493,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11494,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11495,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
11496,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11497,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
11498,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11499,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
11500,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
11501,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11502,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11503,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11504,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11505,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Institute of Human Virology Nigeria,Illumina HiSeq,University of North Carolina,NO
11506,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Albert Einstein Medical Center,Illumina HiSeq,University of North Carolina,NO
11507,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11508,Breast Invasive Carcinoma,Primary Tumor,WGS,Cureline,Illumina HiSeq,Washington University School of Medicine,NO
11509,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11510,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11511,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11512,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11513,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11514,Breast Invasive Carcinoma,Primary Tumor,WGS,Mayo,Illumina HiSeq,Washington University School of Medicine,NO
11515,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
11516,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11517,Breast Invasive Carcinoma,Primary Tumor,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
11518,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11519,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11520,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11521,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11522,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11523,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11524,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11525,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11526,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
11527,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mary Bird Perkins Cancer Center - Our Lady of the Lake,Illumina HiSeq,University of North Carolina,NO
11528,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11529,Breast Invasive Carcinoma,Primary Tumor,WGS,Mayo,Illumina HiSeq,Harvard Medical School,NO
11530,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11531,Breast Invasive Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
11532,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11533,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11534,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11535,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
11536,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11537,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11538,Breast Invasive Carcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Washington University School of Medicine,NO
11539,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ABS - Research Metrics Pakistan,Illumina HiSeq,University of North Carolina,NO
11540,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11541,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11542,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11543,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
11544,Breast Invasive Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
11545,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
11546,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
11547,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11548,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11549,Breast Invasive Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Washington University School of Medicine,NO
11550,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11551,Breast Invasive Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Washington University School of Medicine,NO
11552,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11553,Breast Invasive Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Washington University School of Medicine,NO
11554,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
11555,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11556,Breast Invasive Carcinoma,Blood Derived Normal,WGS,University of Miami,Illumina HiSeq,Washington University School of Medicine,NO
11557,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11558,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11559,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11560,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11561,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11562,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11563,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11564,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11565,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11566,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11567,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11568,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
11569,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11570,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
11571,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11572,Breast Invasive Carcinoma,Primary Tumor,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
11573,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11574,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11575,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11576,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11577,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11578,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11579,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11580,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
11581,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Mayo,Illumina HiSeq,Washington University School of Medicine,NO
11582,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11583,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11584,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11585,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
11586,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11587,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11588,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11589,Breast Invasive Carcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
11590,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11591,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11592,Breast Invasive Carcinoma,Solid Tissue Normal,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
11593,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11594,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11595,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11596,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11597,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11598,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11599,Breast Invasive Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
11600,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11601,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
11602,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11603,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11604,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
11605,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11606,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11607,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11608,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11609,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11610,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11611,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11612,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11613,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11614,Breast Invasive Carcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
11615,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11616,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11617,Breast Invasive Carcinoma,Blood Derived Normal,WGS,University of Miami,Illumina HiSeq,Washington University School of Medicine,NO
11618,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11619,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
11620,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11621,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11622,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11623,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11624,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11625,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11626,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
11627,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Washington University School of Medicine,NO
11628,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11629,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11630,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11631,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11632,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11633,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11634,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
11635,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11636,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11637,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11638,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
11639,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11640,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11641,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11642,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11643,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11644,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11645,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11646,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
11647,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
11648,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11649,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
11650,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
11651,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11652,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
11653,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11654,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11655,Breast Invasive Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
11656,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11657,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11658,Breast Invasive Carcinoma,Solid Tissue Normal,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
11659,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Hartford Hospital,Illumina HiSeq,University of North Carolina,NO
11660,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11661,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
11662,Breast Invasive Carcinoma,Metastatic,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
11663,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
11664,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11665,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
11666,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11667,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11668,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11669,Breast Invasive Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
11670,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11671,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
11672,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
11673,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11674,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11675,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11676,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11677,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11678,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11679,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11680,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11681,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11682,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11683,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11684,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11685,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11686,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11687,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
11688,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
11689,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11690,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
11691,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11692,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11693,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11694,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
11695,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11696,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
11697,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11698,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,YES
11699,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11700,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11701,Breast Invasive Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
11702,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11703,Breast Invasive Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
11704,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11705,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11706,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
11707,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11708,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greenville Health System,Illumina HiSeq,University of North Carolina,NO
11709,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11710,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11711,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11712,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11713,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11714,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11715,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11716,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
11717,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11718,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11719,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11720,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11721,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Hartford Hospital,Illumina HiSeq,University of North Carolina,NO
11722,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
11723,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11724,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11725,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
11726,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11727,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
11728,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11729,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11730,Breast Invasive Carcinoma,Primary Tumor,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
11731,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11732,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11733,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11734,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
11735,Breast Invasive Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
11736,Breast Invasive Carcinoma,Blood Derived Normal,WGS,University of Miami,Illumina HiSeq,Washington University School of Medicine,NO
11737,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11738,Breast Invasive Carcinoma,Primary Tumor,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
11739,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11740,Breast Invasive Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
11741,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11742,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
11743,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11744,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11745,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11746,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11747,Breast Invasive Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Washington University School of Medicine,NO
11748,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11749,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11750,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
11751,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Miami,Illumina HiSeq,Washington University School of Medicine,NO
11752,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11753,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11754,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11755,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
11756,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11757,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11758,Breast Invasive Carcinoma,Primary Tumor,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
11759,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11760,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
11761,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11762,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11763,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11764,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11765,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Kansas,Illumina HiSeq,University of North Carolina,NO
11766,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11767,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11768,Breast Invasive Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
11769,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11770,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11771,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11772,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11773,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11774,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11775,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11776,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11777,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11778,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11779,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Hartford Hospital,Illumina HiSeq,University of North Carolina,NO
11780,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,
11781,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11782,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11783,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11784,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11785,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Albert Einstein Medical Center,Illumina HiSeq,University of North Carolina,NO
11786,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11787,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11788,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11789,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11790,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11791,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
11792,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11793,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11794,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
11795,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11796,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11797,Breast Invasive Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Washington University School of Medicine,NO
11798,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11799,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11800,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11801,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11802,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11803,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
11804,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
11805,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11806,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11807,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11808,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11809,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
11810,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,University of North Carolina,NO
11811,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11812,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11813,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11814,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11815,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11816,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11817,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11818,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11819,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11820,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11821,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
11822,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11823,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11824,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11825,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11826,Breast Invasive Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
11827,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11828,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11829,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11830,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11831,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11832,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
11833,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11834,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11835,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
11836,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11837,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11838,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11839,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
11840,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11841,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
11842,Breast Invasive Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
11843,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11844,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11845,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11846,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11847,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11848,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
11849,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11850,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11851,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Washington University School of Medicine,NO
11852,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
11853,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11854,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11855,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11856,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11857,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
11858,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11859,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
11860,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11861,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Washington University School of Medicine,NO
11862,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Mayo,Illumina HiSeq,Washington University School of Medicine,NO
11863,Breast Invasive Carcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,Washington University School of Medicine,NO
11864,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
11865,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11866,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11867,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Kansas,Illumina HiSeq,University of North Carolina,NO
11868,Breast Invasive Carcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Washington University School of Medicine,NO
11869,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11870,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
11871,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11872,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11873,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11874,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
11875,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11876,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11877,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
11878,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11879,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11880,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11881,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11882,Breast Invasive Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
11883,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Washington University School of Medicine,NO
11884,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11885,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Albert Einstein Medical Center,Illumina HiSeq,University of North Carolina,NO
11886,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11887,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
11888,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11889,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11890,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11891,Breast Invasive Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
11892,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11893,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11894,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11895,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
11896,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11897,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11898,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
11899,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11900,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
11901,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,University of North Carolina,NO
11902,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11903,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11904,Breast Invasive Carcinoma,Primary Tumor,WGS,Mayo,Illumina HiSeq,Washington University School of Medicine,NO
11905,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11906,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11907,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11908,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11909,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11910,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
11911,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11912,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
11913,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11914,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11915,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
11916,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11917,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11918,Breast Invasive Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
11919,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11920,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11921,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11922,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
11923,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11924,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11925,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11926,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11927,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11928,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11929,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
11930,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11931,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11932,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11933,Breast Invasive Carcinoma,Primary Tumor,WGS,MD Anderson,Illumina HiSeq,Washington University School of Medicine,NO
11934,Breast Invasive Carcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Washington University School of Medicine,NO
11935,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11936,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11937,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11938,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11939,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11940,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11941,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11942,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11943,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
11944,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11945,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11946,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11947,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
11948,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11949,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11950,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11951,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11952,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11953,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
11954,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
11955,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11956,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11957,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11958,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11959,Breast Invasive Carcinoma,Primary Tumor,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
11960,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11961,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11962,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11963,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11964,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11965,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11966,Breast Invasive Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Washington University School of Medicine,NO
11967,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11968,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11969,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
11970,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
11971,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Medical College of Georgia,Illumina HiSeq,University of North Carolina,NO
11972,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Columbia University,Illumina HiSeq,University of North Carolina,NO
11973,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11974,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
11975,Breast Invasive Carcinoma,Blood Derived Normal,WGS,University of Miami,Illumina HiSeq,Washington University School of Medicine,NO
11976,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,University of North Carolina,NO
11977,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
11978,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11979,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
11980,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,YES
11981,Breast Invasive Carcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
11982,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
11983,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11984,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
11985,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Miami,Illumina HiSeq,Washington University School of Medicine,NO
11986,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
11987,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11988,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
11989,Breast Invasive Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
11990,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,YES
11991,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11992,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
11993,Breast Invasive Carcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
11994,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11995,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
11996,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
11997,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
11998,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
11999,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
12000,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12001,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12002,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12003,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12004,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
12005,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12006,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12007,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12008,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12009,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12010,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12011,Breast Invasive Carcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Washington University School of Medicine,NO
12012,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Washington University School of Medicine,NO
12013,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12014,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
12015,Breast Invasive Carcinoma,Metastatic,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
12016,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12017,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
12018,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ABS - Research Metrics Pakistan,Illumina HiSeq,University of North Carolina,NO
12019,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12020,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12021,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12022,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12023,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12024,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12025,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
12026,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12027,Breast Invasive Carcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Washington University School of Medicine,NO
12028,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12029,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
12030,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Albert Einstein Medical Center,Illumina HiSeq,University of North Carolina,NO
12031,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12032,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12033,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12034,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12035,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mount Sinai School of Medicine,Illumina HiSeq,University of North Carolina,NO
12036,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
12037,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12038,Breast Invasive Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
12039,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
12040,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
12041,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
12042,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12043,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12044,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12045,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12046,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12047,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12048,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12049,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12050,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12051,Breast Invasive Carcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Washington University School of Medicine,NO
12052,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12053,Breast Invasive Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
12054,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
12055,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
12056,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12057,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12058,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
12059,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12060,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12061,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12062,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12063,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12064,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12065,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12066,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12067,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
12068,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12069,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Albert Einstein Medical Center,Illumina HiSeq,University of North Carolina,NO
12070,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12071,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,University of North Carolina,NO
12072,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12073,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12074,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12075,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12076,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
12077,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12078,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12079,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Hartford Hospital,Illumina HiSeq,University of North Carolina,NO
12080,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
12081,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12082,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,YES
12083,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12084,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12085,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12086,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12087,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12088,Breast Invasive Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
12089,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12090,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12091,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
12092,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12093,Breast Invasive Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
12094,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12095,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
12096,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12097,Breast Invasive Carcinoma,Primary Tumor,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
12098,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12099,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12100,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
12101,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12102,Breast Invasive Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
12103,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12104,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12105,Breast Invasive Carcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
12106,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12107,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12108,Breast Invasive Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
12109,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
12110,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
12111,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12112,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Albert Einstein Medical Center,Illumina HiSeq,University of North Carolina,NO
12113,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12114,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,YES
12115,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12116,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12117,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12118,Breast Invasive Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
12119,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
12120,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12121,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12122,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12123,Breast Invasive Carcinoma,Solid Tissue Normal,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
12124,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Holy Cross,Illumina HiSeq,University of North Carolina,NO
12125,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12126,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
12127,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12128,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12129,Breast Invasive Carcinoma,Primary Tumor,WGS,Mayo,Illumina HiSeq,Washington University School of Medicine,NO
12130,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
12131,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
12132,Breast Invasive Carcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
12133,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12134,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
12135,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12136,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12137,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12138,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12139,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12140,Breast Invasive Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
12141,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12142,Breast Invasive Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,YES
12143,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12144,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12145,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12146,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12147,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12148,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
12149,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12150,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,University of North Carolina,NO
12151,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Hartford Hospital,Illumina HiSeq,University of North Carolina,NO
12152,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
12153,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
12154,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12155,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12156,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12157,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12158,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Washington University School of Medicine,NO
12159,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
12160,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
12161,Breast Invasive Carcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Washington University School of Medicine,NO
12162,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Washington University School of Medicine,NO
12163,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12164,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
12165,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
12166,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12167,Breast Invasive Carcinoma,Primary Tumor,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
12168,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12169,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12170,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
12171,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12172,Breast Invasive Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
12173,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
12174,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12175,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
12176,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12177,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
12178,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12179,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12180,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12181,Breast Invasive Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
12182,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12183,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12184,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12185,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
12186,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12187,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Albert Einstein Medical Center,Illumina HiSeq,University of North Carolina,NO
12188,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12189,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,University of North Carolina,NO
12190,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12191,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
12192,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
12193,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
12194,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12195,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12196,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
12197,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12198,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12199,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12200,Breast Invasive Carcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
12201,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12202,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12203,Breast Invasive Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
12204,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12205,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Washington University School of Medicine,NO
12206,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12207,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12208,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12209,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12210,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12211,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12212,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12213,Breast Invasive Carcinoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina HiSeq,Washington University School of Medicine,NO
12214,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
12215,Breast Invasive Carcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
12216,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12217,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12218,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12219,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12220,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12221,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
12222,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
12223,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12224,Breast Invasive Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
12225,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
12226,Breast Invasive Carcinoma,Primary Tumor,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
12227,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12228,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Minnesota,Illumina HiSeq,University of North Carolina,NO
12229,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
12230,Breast Invasive Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
12231,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
12232,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12233,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12234,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Cureline,Illumina HiSeq,Washington University School of Medicine,NO
12235,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12236,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,YES
12237,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12238,Breast Invasive Carcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
12239,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
12240,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12241,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
12242,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
12243,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12244,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12245,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12246,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12247,Breast Invasive Carcinoma,Primary Tumor,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
12248,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12249,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12250,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12251,Breast Invasive Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
12252,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
12253,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12254,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12255,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,YES
12256,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
12257,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12258,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12259,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12260,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Washington University School of Medicine,NO
12261,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12262,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
12263,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12264,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12265,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12266,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12267,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12268,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12269,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12270,Breast Invasive Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Washington University School of Medicine,NO
12271,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12272,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
12273,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12274,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12275,Breast Invasive Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
12276,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12277,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12278,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
12279,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
12280,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12281,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12282,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
12283,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12284,Breast Invasive Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
12285,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12286,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12287,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12288,Breast Invasive Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
12289,Breast Invasive Carcinoma,Solid Tissue Normal,WGS,ABS - IUPUI,Illumina HiSeq,Washington University School of Medicine,NO
12290,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
12291,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
12292,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12293,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12294,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12295,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12296,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
12297,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
12298,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
12299,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12300,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12301,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12302,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12303,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
12304,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12305,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12306,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12307,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12308,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12309,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12310,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12311,Breast Invasive Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
12312,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12313,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12314,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
12315,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12316,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12317,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
12318,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12319,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12320,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12321,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12322,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12323,Breast Invasive Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
12324,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12325,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12326,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12327,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
12328,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12329,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12330,Breast Invasive Carcinoma,Primary Tumor,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
12331,Breast Invasive Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
12332,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
12333,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12334,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12335,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12336,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
12337,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12338,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12339,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12340,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12341,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
12342,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12343,Breast Invasive Carcinoma,Primary Tumor,WGS,Walter Reed,Illumina HiSeq,Harvard Medical School,NO
12344,Breast Invasive Carcinoma,Primary Tumor,WGS,Cureline,Illumina HiSeq,Washington University School of Medicine,NO
12345,Breast Invasive Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
12346,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12347,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12348,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12349,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
12350,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
12351,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
12352,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12353,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12354,Breast Invasive Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
12355,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
12356,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,University of North Carolina,NO
12357,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12358,Breast Invasive Carcinoma,Primary Tumor,WGS,UCSF,Illumina HiSeq,Washington University School of Medicine,NO
12359,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12360,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12361,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12362,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
12363,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
12364,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
12365,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
12366,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12367,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12368,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12369,Breast Invasive Carcinoma,Metastatic,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
12370,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12371,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12372,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12373,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
12374,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12375,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12376,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
12377,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12378,Breast Invasive Carcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Washington University School of Medicine,NO
12379,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12380,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12381,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12382,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12383,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12384,Breast Invasive Carcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
12385,Breast Invasive Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
12386,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
12387,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12388,Breast Invasive Carcinoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12389,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
12390,Breast Invasive Carcinoma,Metastatic,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12391,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12392,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12393,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
12394,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
12395,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12396,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12397,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Albert Einstein Medical Center,Illumina HiSeq,University of North Carolina,NO
12398,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
12399,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12400,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Institute of Human Virology Nigeria,Illumina HiSeq,University of North Carolina,NO
12401,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12402,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12403,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
12404,Breast Invasive Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
12405,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12406,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
12407,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12408,Breast Invasive Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
12409,Breast Invasive Carcinoma,Metastatic,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12410,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
12411,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12412,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12413,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12414,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12415,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12416,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
12417,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12418,Breast Invasive Carcinoma,Primary Tumor,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
12419,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12420,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12421,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12422,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12423,Breast Invasive Carcinoma,Primary Tumor,WGS,Not available,Illumina HiSeq,Washington University School of Medicine,NO
12424,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12425,Breast Invasive Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
12426,Breast Invasive Carcinoma,Solid Tissue Normal,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
12427,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12428,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12429,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12430,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12431,Breast Invasive Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
12432,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12433,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12434,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12435,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
12436,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12437,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
12438,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12439,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12440,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12441,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12442,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
12443,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12444,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
12445,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12446,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12447,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12448,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12449,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
12450,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12451,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12452,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12453,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12454,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Institute of Human Virology Nigeria,Illumina HiSeq,University of North Carolina,NO
12455,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12456,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
12457,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12458,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12459,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
12460,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12461,Breast Invasive Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,YES
12462,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12463,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12464,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12465,Breast Invasive Carcinoma,Blood Derived Normal,WGS,UCSF,Illumina HiSeq,Washington University School of Medicine,NO
12466,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12467,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Miami,Illumina HiSeq,Washington University School of Medicine,NO
12468,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12469,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12470,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12471,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12472,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
12473,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12474,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12475,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12476,Breast Invasive Carcinoma,Metastatic,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12477,Breast Invasive Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
12478,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
12479,Breast Invasive Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Washington University School of Medicine,NO
12480,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12481,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12482,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12483,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12484,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12485,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,"Proteogenex, Inc",Illumina HiSeq,University of North Carolina,NO
12486,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
12487,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
12488,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12489,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
12490,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,University of North Carolina,NO
12491,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12492,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
12493,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12494,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
12495,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12496,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
12497,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12498,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12499,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12500,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12501,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Walter Reed,Illumina HiSeq,Harvard Medical School,NO
12502,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12503,Breast Invasive Carcinoma,Primary Tumor,WGS,Cureline,Illumina HiSeq,Washington University School of Medicine,NO
12504,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12505,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12506,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
12507,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
12508,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12509,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12510,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12511,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12512,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12513,Breast Invasive Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
12514,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12515,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
12516,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
12517,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
12518,Breast Invasive Carcinoma,Primary Tumor,WGS,Mayo,Illumina HiSeq,Washington University School of Medicine,NO
12519,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12520,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12521,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12522,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12523,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12524,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
12525,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12526,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Mayo,Illumina HiSeq,Washington University School of Medicine,NO
12527,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12528,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12529,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12530,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
12531,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12532,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
12533,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12534,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12535,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Albert Einstein Medical Center,Illumina HiSeq,University of North Carolina,NO
12536,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12537,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12538,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
12539,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
12540,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
12541,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12542,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
12543,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Cureline,Illumina HiSeq,Washington University School of Medicine,NO
12544,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12545,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12546,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Washington University School of Medicine,NO
12547,Breast Invasive Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
12548,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12549,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,John Wayne Cancer Center,Illumina HiSeq,University of North Carolina,NO
12550,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
12551,Breast Invasive Carcinoma,Primary Tumor,WGS,MD Anderson,Illumina HiSeq,Washington University School of Medicine,NO
12552,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12553,Breast Invasive Carcinoma,Primary Tumor,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
12554,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12555,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12556,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12557,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
12558,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
12559,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
12560,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
12561,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
12562,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12563,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12564,Breast Invasive Carcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
12565,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
12566,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12567,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
12568,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12569,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
12570,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12571,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12572,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
12573,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12574,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12575,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12576,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12577,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12578,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
12579,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Washington University School of Medicine,NO
12580,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
12581,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12582,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12583,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12584,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
12585,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12586,Breast Invasive Carcinoma,Blood Derived Normal,WGS,University of Miami,Illumina HiSeq,Washington University School of Medicine,NO
12587,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12588,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12589,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12590,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12591,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
12592,Breast Invasive Carcinoma,Primary Tumor,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
12593,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,University of North Carolina,NO
12594,Breast Invasive Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
12595,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12596,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12597,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,University of North Carolina,NO
12598,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12599,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12600,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12601,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12602,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12603,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
12604,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12605,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12606,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12607,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
12608,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
12609,Breast Invasive Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
12610,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12611,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12612,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12613,Breast Invasive Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
12614,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12615,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12616,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
12617,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12618,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
12619,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12620,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
12621,Breast Invasive Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
12622,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12623,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12624,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
12625,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
12626,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
12627,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12628,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12629,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
12630,Breast Invasive Carcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Washington University School of Medicine,NO
12631,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Mayo,Illumina HiSeq,University of North Carolina,NO
12632,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
12633,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
12634,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12635,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
12636,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12637,Breast Invasive Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
12638,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
12639,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
12640,Breast Invasive Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12641,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
12642,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Walter Reed,Illumina HiSeq,University of North Carolina,NO
12643,Breast Invasive Carcinoma,Primary Tumor,WGS,Walter Reed,Illumina HiSeq,Washington University School of Medicine,NO
12644,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12645,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
12646,Breast Invasive Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12647,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
12648,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
12649,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12650,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
12651,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
12652,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
12653,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
12654,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
12655,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
12656,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
12657,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University Health Network,Illumina HiSeq,Washington University School of Medicine,NO
12658,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina GA,University of North Carolina,NO
12659,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
12660,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12661,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12662,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
12663,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
12664,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
12665,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
12666,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
12667,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
12668,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
12669,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
12670,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
12671,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
12672,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
12673,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
12674,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,University of North Carolina,NO
12675,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
12676,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
12677,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina GA,University of North Carolina,NO
12678,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
12679,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
12680,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
12681,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
12682,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
12683,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Washington University School of Medicine,NO
12684,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12685,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
12686,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12687,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina GA,University of North Carolina,NO
12688,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
12689,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
12690,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12691,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12692,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
12693,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
12694,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
12695,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
12696,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12697,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12698,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12699,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
12700,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
12701,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
12702,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12703,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12704,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
12705,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
12706,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
12707,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
12708,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12709,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12710,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12711,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
12712,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
12713,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
12714,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
12715,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
12716,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
12717,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12718,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
12719,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
12720,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12721,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
12722,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
12723,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
12724,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12725,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
12726,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
12727,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12728,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12729,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
12730,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12731,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
12732,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12733,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Montefiore Medical Center,Illumina HiSeq,University of North Carolina,NO
12734,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
12735,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
12736,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12737,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
12738,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
12739,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
12740,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12741,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
12742,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina GA,University of North Carolina,NO
12743,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
12744,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12745,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12746,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,University of Hawaii - Normal Study,Illumina HiSeq,University of North Carolina,NO
12747,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
12748,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
12749,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina GA,University of North Carolina,NO
12750,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12751,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Washington University School of Medicine,NO
12752,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
12753,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
12754,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina GA,University of North Carolina,NO
12755,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
12756,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
12757,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
12758,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
12759,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
12760,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
12761,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
12762,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
12763,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
12764,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
12765,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Washington University School of Medicine,NO
12766,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina GA,University of North Carolina,NO
12767,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
12768,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
12769,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
12770,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
12771,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
12772,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Washington University,Illumina HiSeq,Harvard Medical School,NO
12773,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
12774,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
12775,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12776,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12777,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
12778,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
12779,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
12780,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
12781,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
12782,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
12783,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
12784,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
12785,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12786,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12787,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
12788,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
12789,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
12790,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
12791,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12792,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
12793,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
12794,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
12795,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12796,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
12797,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12798,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
12799,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12800,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
12801,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
12802,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
12803,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
12804,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
12805,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
12806,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina GA,University of North Carolina,NO
12807,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
12808,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Montefiore Medical Center,Illumina HiSeq,University of North Carolina,NO
12809,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Washington University,Illumina HiSeq,Harvard Medical School,NO
12810,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
12811,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
12812,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
12813,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12814,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12815,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
12816,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12817,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
12818,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
12819,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina GA,University of North Carolina,NO
12820,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
12821,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
12822,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Conosrtium,Illumina GA,University of North Carolina,NO
12823,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
12824,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
12825,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
12826,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina GA,University of North Carolina,NO
12827,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
12828,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12829,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
12830,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina GA,University of North Carolina,NO
12831,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
12832,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
12833,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
12834,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
12835,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
12836,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
12837,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
12838,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
12839,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
12840,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12841,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Hawaii,Illumina HiSeq,Washington University School of Medicine,NO
12842,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12843,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Harvard Medical School,NO
12844,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
12845,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12846,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
12847,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Hawaii,Illumina HiSeq,Washington University School of Medicine,NO
12848,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
12849,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
12850,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
12851,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Washington University School of Medicine,NO
12852,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
12853,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
12854,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
12855,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,University of Hawaii - Normal Study,Illumina GA,University of North Carolina,NO
12856,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
12857,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12858,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
12859,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
12860,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,University of Hawaii - Normal Study,Illumina HiSeq,University of North Carolina,NO
12861,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
12862,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,University of Hawaii - Normal Study,Illumina HiSeq,University of North Carolina,NO
12863,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
12864,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,University of North Carolina,NO
12865,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
12866,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12867,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Washington University School of Medicine,NO
12868,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12869,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
12870,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
12871,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12872,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
12873,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of North Carolina,Illumina HiSeq,Washington University School of Medicine,NO
12874,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
12875,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
12876,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina GA,University of North Carolina,NO
12877,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Montefiore Medical Center,Illumina HiSeq,University of North Carolina,NO
12878,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12879,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
12880,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
12881,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,University of North Carolina,NO
12882,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Washington University,Illumina HiSeq,Harvard Medical School,NO
12883,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
12884,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12885,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
12886,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
12887,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12888,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
12889,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
12890,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
12891,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
12892,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
12893,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
12894,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12895,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
12896,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina GA,University of North Carolina,NO
12897,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
12898,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
12899,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
12900,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Albert Einstein Medical Center,Illumina HiSeq,University of North Carolina,NO
12901,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
12902,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12903,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12904,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
12905,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12906,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,British Columbia Cancer Agency,Illumina HiSeq,University of North Carolina,NO
12907,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
12908,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
12909,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12910,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12911,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
12912,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
12913,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
12914,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
12915,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
12916,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
12917,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
12918,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
12919,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
12920,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Washington University School of Medicine,NO
12921,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
12922,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12923,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
12924,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
12925,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
12926,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina GA,University of North Carolina,NO
12927,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
12928,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina GA,University of North Carolina,NO
12929,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Hawaii,Illumina HiSeq,Washington University School of Medicine,NO
12930,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
12931,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
12932,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
12933,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of North Carolina,Illumina HiSeq,Washington University School of Medicine,NO
12934,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12935,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
12936,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12937,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
12938,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
12939,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
12940,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
12941,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
12942,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
12943,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12944,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
12945,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
12946,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
12947,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
12948,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
12949,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
12950,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12951,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
12952,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12953,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,University of North Carolina,NO
12954,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12955,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
12956,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,University of North Carolina,NO
12957,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Harvard Medical School,NO
12958,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
12959,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12960,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
12961,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Harvard Medical School,NO
12962,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
12963,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
12964,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
12965,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
12966,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12967,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
12968,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
12969,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
12970,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12971,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
12972,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
12973,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
12974,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
12975,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
12976,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina GA,University of North Carolina,NO
12977,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
12978,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina GA,University of North Carolina,NO
12979,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
12980,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
12981,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
12982,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
12983,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12984,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Washington University School of Medicine,NO
12985,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
12986,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
12987,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12988,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
12989,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
12990,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Hawaii,Illumina HiSeq,Washington University School of Medicine,NO
12991,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
12992,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
12993,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
12994,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
12995,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
12996,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
12997,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
12998,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina GA,University of North Carolina,NO
12999,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13000,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13001,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13002,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13003,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
13004,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13005,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina GA,University of North Carolina,NO
13006,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
13007,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13008,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
13009,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13010,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13011,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13012,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13013,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13014,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
13015,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13016,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13017,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13018,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13019,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13020,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13021,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13022,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13023,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13024,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13025,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13026,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13027,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina GA,University of North Carolina,NO
13028,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13029,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13030,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Harvard Medical School,NO
13031,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13032,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13033,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
13034,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13035,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
13036,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
13037,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13038,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
13039,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
13040,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13041,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13042,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
13043,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13044,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina GA,University of North Carolina,NO
13045,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
13046,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13047,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13048,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13049,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
13050,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
13051,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
13052,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Kansas Medical Center,Illumina HiSeq,University of North Carolina,NO
13053,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13054,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13055,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,University of Hawaii - Normal Study,Illumina HiSeq,University of North Carolina,NO
13056,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13057,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
13058,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
13059,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13060,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13061,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
13062,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13063,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
13064,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Harvard Medical School,NO
13065,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
13066,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13067,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina GA,University of North Carolina,NO
13068,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13069,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13070,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,British Columbia Cancer Agency,Illumina HiSeq,University of North Carolina,NO
13071,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13072,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
13073,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Hawaii,Illumina HiSeq,Washington University School of Medicine,NO
13074,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13075,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13076,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13077,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13078,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13079,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13080,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
13081,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13082,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13083,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Hawaii,Illumina HiSeq,Washington University School of Medicine,NO
13084,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13085,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
13086,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13087,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
13088,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13089,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13090,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13091,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina GA,University of North Carolina,NO
13092,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13093,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13094,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13095,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13096,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
13097,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13098,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina GA,University of North Carolina,NO
13099,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
13100,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
13101,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
13102,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13103,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13104,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina GA,University of North Carolina,NO
13105,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
13106,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13107,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
13108,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13109,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13110,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13111,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
13112,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina GA,University of North Carolina,NO
13113,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13114,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
13115,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13116,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13117,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13118,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13119,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13120,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13121,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13122,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13123,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
13124,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
13125,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13126,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Montefiore Medical Center,Illumina HiSeq,University of North Carolina,NO
13127,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13128,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13129,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina GA,University of North Carolina,NO
13130,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13131,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Hawaii,Illumina HiSeq,Washington University School of Medicine,NO
13132,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
13133,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13134,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
13135,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13136,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13137,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13138,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13139,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13140,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13141,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13142,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13143,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13144,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
13145,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
13146,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13147,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13148,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
13149,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
13150,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13151,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13152,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13153,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13154,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,University of Hawaii - Normal Study,Illumina HiSeq,University of North Carolina,NO
13155,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13156,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13157,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13158,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13159,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13160,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13161,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13162,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13163,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
13164,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13165,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
13166,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
13167,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13168,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Washington University School of Medicine,NO
13169,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina GA,University of North Carolina,NO
13170,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13171,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
13172,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
13173,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,University of North Carolina,NO
13174,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
13175,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
13176,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13177,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina HiSeq,University of North Carolina,NO
13178,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
13179,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13180,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13181,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
13182,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13183,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina GA,University of North Carolina,NO
13184,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
13185,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
13186,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13187,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13188,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13189,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13190,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13191,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
13192,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13193,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
13194,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13195,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13196,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,University of Hawaii - Normal Study,Illumina HiSeq,University of North Carolina,NO
13197,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13198,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13199,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13200,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13201,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
13202,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
13203,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13204,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13205,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13206,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13207,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13208,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
13209,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13210,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13211,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13212,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13213,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Hawaii,Illumina HiSeq,Washington University School of Medicine,NO
13214,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13215,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Hawaii,Illumina HiSeq,Washington University School of Medicine,NO
13216,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
13217,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13218,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13219,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
13220,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Holy Cross,Illumina HiSeq,University of North Carolina,NO
13221,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina GA,University of North Carolina,NO
13222,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13223,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13224,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
13225,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13226,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
13227,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of North Carolina,Illumina HiSeq,Washington University School of Medicine,NO
13228,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Washington University School of Medicine,NO
13229,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13230,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
13231,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
13232,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
13233,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13234,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
13235,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13236,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13237,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13238,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13239,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13240,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13241,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13242,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13243,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13244,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13245,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13246,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13247,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13248,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13249,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13250,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13251,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,International Genomics Conosrtium,Illumina HiSeq,Washington University School of Medicine,NO
13252,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
13253,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13254,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13255,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
13256,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13257,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
13258,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
13259,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13260,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
13261,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13262,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13263,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13264,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University Health Network,Illumina HiSeq,Washington University School of Medicine,NO
13265,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13266,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13267,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
13268,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
13269,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13270,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13271,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13272,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
13273,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
13274,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13275,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina GA,University of North Carolina,NO
13276,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13277,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
13278,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
13279,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13280,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
13281,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
13282,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
13283,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13284,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13285,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Washington University School of Medicine,NO
13286,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13287,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13288,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13289,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13290,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13291,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina GA,University of North Carolina,NO
13292,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Washington University School of Medicine,NO
13293,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Hawaii,Illumina HiSeq,Washington University School of Medicine,NO
13294,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13295,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
13296,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13297,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,University of North Carolina,NO
13298,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13299,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13300,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13301,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
13302,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13303,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
13304,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
13305,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13306,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
13307,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
13308,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina GA,University of North Carolina,NO
13309,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13310,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13311,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13312,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13313,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13314,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
13315,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
13316,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
13317,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
13318,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,University of North Carolina,NO
13319,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of North Carolina,Illumina HiSeq,Harvard Medical School,NO
13320,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
13321,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13322,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13323,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,University of Hawaii - Normal Study,Illumina HiSeq,University of North Carolina,NO
13324,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13325,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13326,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13327,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
13328,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
13329,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13330,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
13331,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13332,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13333,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13334,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13335,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13336,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
13337,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13338,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13339,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
13340,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13341,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Montefiore Medical Center,Illumina HiSeq,University of North Carolina,NO
13342,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13343,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
13344,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13345,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13346,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13347,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina GA,University of North Carolina,NO
13348,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13349,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13350,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
13351,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,British Columbia Cancer Agency,Illumina HiSeq,University of North Carolina,NO
13352,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13353,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13354,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13355,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13356,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13357,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13358,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13359,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13360,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13361,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13362,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
13363,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13364,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina GA,University of North Carolina,NO
13365,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13366,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13367,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Medical College of Georgia,Illumina HiSeq,University of North Carolina,NO
13368,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13369,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13370,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13371,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
13372,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13373,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13374,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13375,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
13376,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina GA,University of North Carolina,NO
13377,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13378,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
13379,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13380,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13381,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13382,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
13383,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13384,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13385,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13386,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13387,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13388,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13389,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Washington University School of Medicine,NO
13390,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
13391,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13392,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13393,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13394,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13395,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13396,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina GA,University of North Carolina,NO
13397,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13398,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
13399,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13400,Uterine Corpus Endometrial Carcinoma,Recurrent Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
13401,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
13402,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13403,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13404,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
13405,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina GA,University of North Carolina,NO
13406,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
13407,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
13408,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina GA,University of North Carolina,NO
13409,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
13410,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13411,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13412,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Hawaii,Illumina HiSeq,Washington University School of Medicine,NO
13413,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
13414,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13415,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
13416,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13417,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13418,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
13419,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
13420,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13421,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13422,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13423,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
13424,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13425,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13426,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13427,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Washington University School of Medicine,NO
13428,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13429,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina GA,University of North Carolina,NO
13430,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13431,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13432,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13433,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Washington University School of Medicine,NO
13434,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
13435,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13436,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13437,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13438,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13439,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
13440,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
13441,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13442,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Washington University School of Medicine,NO
13443,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13444,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13445,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13446,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13447,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13448,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13449,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
13450,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
13451,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
13452,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13453,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13454,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13455,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13456,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13457,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13458,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
13459,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
13460,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13461,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13462,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13463,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,British Columbia Cancer Agency,Illumina HiSeq,University of North Carolina,NO
13464,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13465,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina GA,University of North Carolina,NO
13466,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Harvard Medical School,NO
13467,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MD Anderson,Illumina HiSeq,Washington University School of Medicine,NO
13468,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13469,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Miami,Illumina HiSeq,University of North Carolina,NO
13470,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13471,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
13472,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13473,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13474,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina HiSeq,University of North Carolina,NO
13475,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Washington University School of Medicine,NO
13476,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13477,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13478,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13479,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13480,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13481,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13482,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Washington University School of Medicine,NO
13483,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
13484,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13485,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13486,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13487,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina GA,University of North Carolina,NO
13488,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13489,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13490,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13491,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
13492,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13493,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina GA,University of North Carolina,NO
13494,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
13495,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
13496,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13497,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
13498,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
13499,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13500,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
13501,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
13502,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
13503,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
13504,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Harvard Medical School,NO
13505,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13506,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
13507,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina GA,University of North Carolina,NO
13508,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13509,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13510,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13511,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Washington University School of Medicine,NO
13512,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Washington University School of Medicine,NO
13513,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13514,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
13515,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
13516,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
13517,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13518,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
13519,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13520,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13521,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13522,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13523,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13524,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of North Carolina,Illumina HiSeq,Harvard Medical School,NO
13525,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
13526,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13527,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Washington University School of Medicine,NO
13528,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13529,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13530,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13531,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Molecular Response,Illumina HiSeq,University of North Carolina,NO
13532,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13533,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
13534,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
13535,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
13536,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13537,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13538,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13539,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13540,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13541,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,International Genomics Conosrtium,Illumina HiSeq,Washington University School of Medicine,NO
13542,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
13543,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13544,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13545,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Washington University School of Medicine,NO
13546,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
13547,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina GA,University of North Carolina,NO
13548,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13549,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13550,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13551,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13552,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Hawaii,Illumina HiSeq,Washington University School of Medicine,NO
13553,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
13554,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
13555,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13556,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13557,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13558,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13559,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13560,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13561,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13562,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
13563,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
13564,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
13565,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
13566,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
13567,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13568,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13569,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13570,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13571,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13572,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13573,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13574,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13575,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13576,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13577,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of North Carolina,Illumina HiSeq,Washington University School of Medicine,NO
13578,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13579,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
13580,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
13581,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
13582,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13583,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13584,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13585,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
13586,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13587,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13588,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13589,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13590,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
13591,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
13592,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13593,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13594,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
13595,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13596,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
13597,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Washington University School of Medicine,NO
13598,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13599,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13600,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13601,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13602,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13603,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13604,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Washington University School of Medicine,NO
13605,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13606,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
13607,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13608,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13609,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13610,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13611,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13612,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13613,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13614,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13615,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13616,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
13617,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13618,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
13619,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13620,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13621,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
13622,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13623,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13624,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13625,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13626,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13627,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13628,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
13629,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Washington University School of Medicine,NO
13630,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13631,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13632,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
13633,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13634,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13635,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13636,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
13637,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,University of Hawaii - Normal Study,Illumina HiSeq,University of North Carolina,NO
13638,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13639,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
13640,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina GA,University of North Carolina,NO
13641,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Washington University School of Medicine,NO
13642,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
13643,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Washington University,Illumina HiSeq,Harvard Medical School,NO
13644,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,University of North Carolina,NO
13645,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
13646,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina GA,University of North Carolina,NO
13647,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,WGS,MD Anderson,Illumina HiSeq,Washington University School of Medicine,NO
13648,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
13649,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13650,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13651,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13652,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Montefiore Medical Center,Illumina HiSeq,University of North Carolina,NO
13653,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13654,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
13655,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13656,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13657,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13658,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13659,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13660,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13661,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13662,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13663,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13664,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13665,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,British Columbia Cancer Agency,Illumina HiSeq,University of North Carolina,NO
13666,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13667,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
13668,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
13669,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13670,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13671,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13672,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Washington University School of Medicine,NO
13673,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13674,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13675,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
13676,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13677,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13678,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13679,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13680,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13681,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13682,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Albert Einstein Medical Center,Illumina HiSeq,University of North Carolina,NO
13683,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina GA,University of North Carolina,NO
13684,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
13685,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13686,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13687,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
13688,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13689,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13690,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
13691,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Harvard Medical School,NO
13692,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13693,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
13694,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13695,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
13696,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13697,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13698,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
13699,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13700,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13701,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13702,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13703,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina GA,University of North Carolina,NO
13704,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
13705,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13706,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13707,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
13708,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
13709,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
13710,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13711,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13712,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13713,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13714,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13715,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13716,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13717,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13718,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13719,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13720,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13721,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13722,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,MD Anderson,Illumina GA,University of North Carolina,NO
13723,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13724,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13725,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13726,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13727,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
13728,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13729,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13730,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13731,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina GA,University of North Carolina,NO
13732,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
13733,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13734,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
13735,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
13736,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
13737,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina GA,University of North Carolina,NO
13738,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13739,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13740,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13741,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
13742,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13743,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13744,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
13745,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13746,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
13747,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Washington University School of Medicine,NO
13748,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13749,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Harvard Medical School,NO
13750,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
13751,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13752,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13753,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13754,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
13755,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
13756,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina GA,University of North Carolina,NO
13757,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,University of Hawaii - Normal Study,Illumina HiSeq,University of North Carolina,NO
13758,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
13759,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13760,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
13761,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13762,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
13763,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
13764,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13765,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13766,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13767,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,University of Hawaii - Normal Study,Illumina HiSeq,University of North Carolina,NO
13768,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13769,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
13770,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13771,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13772,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
13773,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13774,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13775,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13776,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Hawaii,Illumina HiSeq,Harvard Medical School,NO
13777,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13778,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13779,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13780,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13781,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13782,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13783,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13784,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
13785,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13786,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
13787,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
13788,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13789,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13790,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13791,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13792,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
13793,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina GA,University of North Carolina,NO
13794,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
13795,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
13796,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13797,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13798,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Washington University School of Medicine,NO
13799,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Washington University School of Medicine,NO
13800,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13801,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Harvard Medical School,NO
13802,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
13803,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13804,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
13805,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13806,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13807,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina GA,University of North Carolina,NO
13808,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
13809,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
13810,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Washington University School of Medicine,NO
13811,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Washington University,Illumina HiSeq,Harvard Medical School,NO
13812,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
13813,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13814,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13815,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
13816,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
13817,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina GA,University of North Carolina,NO
13818,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13819,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13820,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13821,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13822,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
13823,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Washington University School of Medicine,NO
13824,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13825,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Washington University School of Medicine,NO
13826,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina GA,University of North Carolina,NO
13827,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13828,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13829,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
13830,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
13831,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13832,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13833,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13834,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13835,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13836,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Washington University School of Medicine,NO
13837,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
13838,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
13839,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13840,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13841,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13842,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Washington University School of Medicine,NO
13843,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13844,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13845,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina GA,University of North Carolina,NO
13846,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13847,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13848,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
13849,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13850,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13851,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,MSKCC,Illumina HiSeq,Harvard Medical School,NO
13852,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13853,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13854,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
13855,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
13856,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13857,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Montefiore Medical Center,Illumina HiSeq,University of North Carolina,NO
13858,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina GA,University of North Carolina,NO
13859,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13860,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13861,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Washington University,Illumina HiSeq,Harvard Medical School,NO
13862,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13863,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13864,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13865,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Harvard Medical School,NO
13866,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina GA,University of North Carolina,NO
13867,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13868,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Harvard Medical School,NO
13869,Uterine Corpus Endometrial Carcinoma,Solid Tissue Normal,RNA-Seq,University of Hawaii - Normal Study,Illumina HiSeq,University of North Carolina,NO
13870,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13871,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina HiSeq,University of North Carolina,NO
13872,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina GA,University of North Carolina,NO
13873,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13874,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina GA,University of North Carolina,NO
13875,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
13876,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Duke,Illumina GA,University of North Carolina,NO
13877,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
13878,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
13879,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina GA,University of North Carolina,NO
13880,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Mayo Clinic,Illumina HiSeq,Washington University School of Medicine,NO
13881,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina GA,University of North Carolina,NO
13882,Uterine Corpus Endometrial Carcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Washington University School of Medicine,NO
13883,Uterine Corpus Endometrial Carcinoma,Primary Tumor,WGS,Duke,Illumina HiSeq,Harvard Medical School,NO
13884,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Conosrtium,Illumina HiSeq,University of North Carolina,NO
13885,Uterine Corpus Endometrial Carcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina GA,University of North Carolina,NO
13886,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
13887,Prostate Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
13888,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
13889,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
13890,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13891,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
13892,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
13893,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
13894,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
13895,Prostate Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
13896,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
13897,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
13898,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
13899,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
13900,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
13901,Prostate Adenocarcinoma,Primary Tumor,WGS,Fox Chase,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
13902,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
13903,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
13904,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
13905,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
13906,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
13907,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Institute for Medical Research,Illumina HiSeq,University of North Carolina,NO
13908,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
13909,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
13910,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
13911,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
13912,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
13913,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
13914,Prostate Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
13915,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
13916,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
13917,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
13918,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Arizona,Illumina HiSeq,University of North Carolina,NO
13919,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
13920,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
13921,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
13922,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
13923,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
13924,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
13925,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering Cancer Center,Illumina HiSeq,University of North Carolina,NO
13926,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
13927,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
13928,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
13929,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
13930,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13931,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
13932,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
13933,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
13934,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
13935,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
13936,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
13937,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
13938,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
13939,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
13940,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
13941,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
13942,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
13943,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
13944,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Cornell Medical College,Illumina HiSeq,University of North Carolina,NO
13945,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13946,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Fox Chase,Illumina HiSeq,Harvard Medical School,NO
13947,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
13948,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering Cancer Center,Illumina HiSeq,University of North Carolina,NO
13949,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
13950,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
13951,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Harvard Beth Israel,Illumina HiSeq,University of North Carolina,NO
13952,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
13953,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
13954,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
13955,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
13956,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
13957,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
13958,Prostate Adenocarcinoma,Primary Tumor,WGS,Fox Chase,Illumina HiSeq,Harvard Medical School,NO
13959,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
13960,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
13961,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,YES
13962,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
13963,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,University of North Carolina,NO
13964,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Kansas,Illumina HiSeq,University of North Carolina,NO
13965,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
13966,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
13967,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
13968,Prostate Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
13969,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13970,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
13971,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
13972,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
13973,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
13974,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
13975,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Kansas,Illumina HiSeq,University of North Carolina,NO
13976,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
13977,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
13978,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
13979,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University Medical Center Hamburg-Eppendorf,Illumina HiSeq,University of North Carolina,NO
13980,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13981,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
13982,Prostate Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
13983,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
13984,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
13985,Prostate Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
13986,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
13987,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering Cancer Center,Illumina HiSeq,University of North Carolina,NO
13988,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
13989,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Cornell Medical College,Illumina HiSeq,University of North Carolina,NO
13990,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
13991,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University Medical Center Hamburg-Eppendorf,Illumina HiSeq,University of North Carolina,NO
13992,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
13993,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Cornell Medical College,Illumina HiSeq,University of North Carolina,NO
13994,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
13995,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
13996,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
13997,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
13998,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
13999,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14000,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14001,Prostate Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
14002,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14003,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14004,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14005,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Cornell Medical College,Illumina HiSeq,University of North Carolina,NO
14006,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14007,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14008,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14009,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14010,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14011,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14012,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14013,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14014,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14015,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14016,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14017,Prostate Adenocarcinoma,Primary Tumor,WGS,Fox Chase,Illumina HiSeq,Harvard Medical School,NO
14018,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14019,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14020,Prostate Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
14021,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14022,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University Medical Center Hamburg-Eppendorf,Illumina HiSeq,University of North Carolina,NO
14023,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14024,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14025,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Melbourne Health,Illumina HiSeq,University of North Carolina,NO
14026,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14027,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14028,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14029,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14030,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14031,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14032,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14033,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14034,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14035,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14036,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
14037,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14038,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14039,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14040,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
14041,Prostate Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
14042,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14043,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
14044,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,YES
14045,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Institute for Medical Research,Illumina HiSeq,University of North Carolina,NO
14046,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14047,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14048,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14049,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14050,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14051,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14052,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
14053,Prostate Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
14054,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14055,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
14056,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14057,Prostate Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
14058,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14059,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14060,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,University of North Carolina,NO
14061,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University Medical Center Hamburg-Eppendorf,Illumina HiSeq,University of North Carolina,NO
14062,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14063,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14064,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14065,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14066,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14067,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14068,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14069,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
14070,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14071,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14072,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,University of North Carolina,NO
14073,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14074,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14075,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14076,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14077,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14078,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14079,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
14080,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14081,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14082,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14083,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14084,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14085,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14086,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14087,Prostate Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
14088,Prostate Adenocarcinoma,Metastatic,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14089,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Kansas,Illumina HiSeq,University of North Carolina,NO
14090,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14091,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14092,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14093,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering Cancer Center,Illumina HiSeq,University of North Carolina,NO
14094,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14095,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14096,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14097,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14098,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14099,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14100,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University Medical Center Hamburg-Eppendorf,Illumina HiSeq,University of North Carolina,NO
14101,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Fox Chase,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14102,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14103,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University Medical Center Hamburg-Eppendorf,Illumina HiSeq,University of North Carolina,NO
14104,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
14105,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14106,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
14107,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University Medical Center Hamburg-Eppendorf,Illumina HiSeq,University of North Carolina,NO
14108,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14109,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14110,Prostate Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14111,Prostate Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14112,Prostate Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14113,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14114,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14115,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14116,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14117,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14118,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14119,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14120,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14121,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14122,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14123,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
14124,Prostate Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
14125,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14126,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14127,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14128,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14129,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Cornell Medical College,Illumina HiSeq,University of North Carolina,NO
14130,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
14131,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
14132,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14133,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14134,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14135,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14136,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering Cancer Center,Illumina HiSeq,University of North Carolina,NO
14137,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14138,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
14139,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14140,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14141,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14142,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14143,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14144,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Cornell Medical College,Illumina HiSeq,University of North Carolina,NO
14145,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14146,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14147,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14148,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14149,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14150,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14151,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
14152,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Cornell Medical College,Illumina HiSeq,University of North Carolina,NO
14153,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14154,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
14155,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
14156,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14157,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14158,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Melbourne Health,Illumina HiSeq,University of North Carolina,NO
14159,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14160,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14161,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14162,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Maine Medical Center,Illumina HiSeq,University of North Carolina,NO
14163,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14164,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14165,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14166,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Fox Chase,Illumina HiSeq,Harvard Medical School,NO
14167,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14168,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14169,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14170,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14171,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
14172,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14173,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14174,Prostate Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14175,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Harvard Beth Israel,Illumina HiSeq,University of North Carolina,NO
14176,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14177,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University Medical Center Hamburg-Eppendorf,Illumina HiSeq,University of North Carolina,NO
14178,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14179,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14180,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14181,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14182,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14183,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Melbourne Health,Illumina HiSeq,University of North Carolina,NO
14184,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14185,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14186,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14187,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14188,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14189,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14190,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14191,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University Medical Center Hamburg-Eppendorf,Illumina HiSeq,University of North Carolina,NO
14192,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14193,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14194,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14195,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14196,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14197,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14198,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14199,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14200,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14201,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14202,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14203,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14204,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14205,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14206,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14207,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14208,Prostate Adenocarcinoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14209,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14210,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14211,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14212,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14213,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14214,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14215,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14216,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14217,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14218,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
14219,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University Medical Center Hamburg-Eppendorf,Illumina HiSeq,University of North Carolina,NO
14220,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14221,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
14222,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,YES
14223,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14224,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14225,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
14226,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14227,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14228,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14229,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14230,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14231,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,University of North Carolina,NO
14232,Prostate Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14233,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14234,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14235,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14236,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University Medical Center Hamburg-Eppendorf,Illumina HiSeq,University of North Carolina,NO
14237,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14238,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14239,Prostate Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14240,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14241,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14242,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14243,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14244,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,YES
14245,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14246,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14247,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14248,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14249,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14250,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14251,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14252,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14253,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14254,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14255,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Melbourne Health,Illumina HiSeq,University of North Carolina,NO
14256,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14257,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14258,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
14259,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14260,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14261,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14262,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14263,Prostate Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14264,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14265,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,YES
14266,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
14267,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14268,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14269,Prostate Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14270,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14271,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University Medical Center Hamburg-Eppendorf,Illumina HiSeq,University of North Carolina,NO
14272,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14273,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
14274,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14275,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
14276,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14277,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14278,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14279,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14280,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14281,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering Cancer Center,Illumina HiSeq,University of North Carolina,NO
14282,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14283,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14284,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14285,Prostate Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
14286,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
14287,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14288,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14289,Prostate Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14290,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14291,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Kansas,Illumina HiSeq,University of North Carolina,NO
14292,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14293,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14294,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14295,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14296,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14297,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14298,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University Medical Center Hamburg-Eppendorf,Illumina HiSeq,University of North Carolina,NO
14299,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14300,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14301,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
14302,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14303,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Global Bioclinical-Moldova,Illumina HiSeq,University of North Carolina,NO
14304,Prostate Adenocarcinoma,Primary Tumor,WGS,Fox Chase,Illumina HiSeq,Harvard Medical School,NO
14305,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14306,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14307,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14308,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,University of North Carolina,NO
14309,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14310,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14311,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14312,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14313,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14314,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14315,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14316,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14317,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14318,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14319,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14320,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14321,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14322,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Melbourne Health,Illumina HiSeq,University of North Carolina,NO
14323,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14324,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14325,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14326,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14327,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14328,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14329,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14330,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14331,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14332,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
14333,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14334,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Harvard Beth Israel,Illumina HiSeq,University of North Carolina,NO
14335,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14336,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14337,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14338,Prostate Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
14339,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14340,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14341,Prostate Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
14342,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14343,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14344,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
14345,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14346,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14347,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14348,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University Medical Center Hamburg-Eppendorf,Illumina HiSeq,University of North Carolina,NO
14349,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14350,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14351,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University Medical Center Hamburg-Eppendorf,Illumina HiSeq,University of North Carolina,NO
14352,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14353,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,University of North Carolina,NO
14354,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,University of North Carolina,NO
14355,Prostate Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14356,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14357,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14358,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14359,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14360,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14361,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14362,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14363,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14364,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14365,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University Medical Center Hamburg-Eppendorf,Illumina HiSeq,University of North Carolina,NO
14366,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
14367,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14368,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14369,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
14370,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14371,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14372,Prostate Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
14373,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14374,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Maine Medical Center,Illumina HiSeq,University of North Carolina,NO
14375,Prostate Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
14376,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Kansas,Illumina HiSeq,University of North Carolina,NO
14377,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14378,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14379,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14380,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14381,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14382,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14383,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,YES
14384,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
14385,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Cornell Medical College,Illumina HiSeq,University of North Carolina,NO
14386,Prostate Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
14387,Prostate Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14388,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14389,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Melbourne Health,Illumina HiSeq,University of North Carolina,NO
14390,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14391,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14392,Prostate Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
14393,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14394,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14395,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14396,Prostate Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14397,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14398,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
14399,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14400,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14401,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14402,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14403,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Harvard Beth Israel,Illumina HiSeq,University of North Carolina,NO
14404,Prostate Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
14405,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14406,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14407,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14408,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14409,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
14410,Prostate Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14411,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Melbourne Health,Illumina HiSeq,University of North Carolina,NO
14412,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14413,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering Cancer Center,Illumina HiSeq,University of North Carolina,NO
14414,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14415,Prostate Adenocarcinoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
14416,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14417,Prostate Adenocarcinoma,Primary Tumor,WGS,Fox Chase,Illumina HiSeq,Harvard Medical School,NO
14418,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14419,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
14420,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
14421,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14422,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14423,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Cornell Medical College,Illumina HiSeq,University of North Carolina,NO
14424,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14425,Prostate Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14426,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14427,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14428,Prostate Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14429,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,University of North Carolina,NO
14430,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14431,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14432,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
14433,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14434,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14435,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14436,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14437,Prostate Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
14438,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
14439,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14440,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14441,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14442,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14443,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14444,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
14445,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14446,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14447,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
14448,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14449,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14450,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14451,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Wake Forest University,Illumina HiSeq,University of North Carolina,NO
14452,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14453,Prostate Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14454,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14455,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14456,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14457,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14458,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
14459,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
14460,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14461,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14462,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14463,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14464,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14465,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14466,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
14467,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14468,Prostate Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
14469,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14470,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
14471,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14472,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Kansas,Illumina HiSeq,University of North Carolina,NO
14473,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14474,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14475,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
14476,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14477,Prostate Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
14478,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14479,Prostate Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14480,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14481,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University Medical Center Hamburg-Eppendorf,Illumina HiSeq,University of North Carolina,NO
14482,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Fox Chase,Illumina HiSeq,Harvard Medical School,NO
14483,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Arizona,Illumina HiSeq,University of North Carolina,NO
14484,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14485,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14486,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
14487,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Harvard Beth Israel,Illumina HiSeq,University of North Carolina,NO
14488,Prostate Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14489,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14490,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14491,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14492,Prostate Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14493,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14494,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14495,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14496,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,University of North Carolina,NO
14497,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14498,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14499,Prostate Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
14500,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14501,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14502,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14503,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14504,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14505,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14506,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14507,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14508,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
14509,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14510,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
14511,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14512,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14513,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14514,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering Cancer Center,Illumina HiSeq,University of North Carolina,NO
14515,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14516,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14517,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14518,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14519,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14520,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14521,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14522,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14523,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14524,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14525,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14526,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14527,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14528,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14529,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14530,Prostate Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
14531,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14532,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14533,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
14534,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14535,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14536,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14537,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14538,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14539,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14540,Prostate Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
14541,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
14542,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14543,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Global BioClinical - Georgia,Illumina HiSeq,University of North Carolina,NO
14544,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14545,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14546,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14547,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
14548,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14549,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14550,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14551,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14552,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14553,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14554,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14555,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14556,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14557,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14558,Prostate Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
14559,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
14560,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14561,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14562,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14563,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14564,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14565,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
14566,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14567,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14568,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14569,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14570,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14571,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14572,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14573,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14574,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14575,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14576,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
14577,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14578,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Melbourne Health,Illumina HiSeq,University of North Carolina,NO
14579,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
14580,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14581,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14582,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14583,Prostate Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14584,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14585,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering Cancer Center,Illumina HiSeq,University of North Carolina,NO
14586,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14587,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
14588,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14589,Prostate Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14590,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14591,Prostate Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14592,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14593,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14594,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Fox Chase,Illumina HiSeq,Harvard Medical School,NO
14595,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14596,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14597,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14598,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14599,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14600,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14601,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14602,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,NCI Urologic Oncology Branch,Illumina HiSeq,University of North Carolina,NO
14603,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,"Proteogenex, Inc",Illumina HiSeq,University of North Carolina,NO
14604,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14605,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14606,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14607,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14608,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14609,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14610,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,University of North Carolina,NO
14611,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Stanford University,Illumina HiSeq,University of North Carolina,NO
14612,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14613,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14614,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14615,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14616,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14617,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14618,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14619,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14620,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University Medical Center Hamburg-Eppendorf,Illumina HiSeq,University of North Carolina,NO
14621,Prostate Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Harvard Medical School,NO
14622,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University Medical Center Hamburg-Eppendorf,Illumina HiSeq,University of North Carolina,NO
14623,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14624,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14625,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14626,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
14627,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14628,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14629,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14630,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14631,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
14632,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14633,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14634,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14635,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14636,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14637,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14638,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,University of North Carolina,NO
14639,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14640,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14641,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14642,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14643,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14644,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14645,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14646,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University Medical Center Hamburg-Eppendorf,Illumina HiSeq,University of North Carolina,NO
14647,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14648,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14649,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,University of North Carolina,NO
14650,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14651,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
14652,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University Medical Center Hamburg-Eppendorf,Illumina HiSeq,University of North Carolina,NO
14653,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering Cancer Center,Illumina HiSeq,University of North Carolina,NO
14654,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,University of North Carolina,NO
14655,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University Medical Center Hamburg-Eppendorf,Illumina HiSeq,University of North Carolina,NO
14656,Prostate Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14657,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Kansas,Illumina HiSeq,University of North Carolina,NO
14658,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14659,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14660,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14661,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14662,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14663,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14664,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14665,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14666,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14667,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14668,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
14669,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14670,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
14671,Prostate Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14672,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14673,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14674,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14675,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University Medical Center Hamburg-Eppendorf,Illumina HiSeq,University of North Carolina,NO
14676,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14677,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14678,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14679,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14680,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14681,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14682,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14683,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14684,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14685,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14686,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14687,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14688,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14689,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14690,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14691,Prostate Adenocarcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14692,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14693,Prostate Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14694,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14695,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14696,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Melbourne Health,Illumina HiSeq,University of North Carolina,NO
14697,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,YES
14698,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
14699,Prostate Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14700,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14701,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University Medical Center Hamburg-Eppendorf,Illumina HiSeq,University of North Carolina,NO
14702,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,YES
14703,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14704,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
14705,Prostate Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
14706,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14707,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14708,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,PROCURE Biobank,Illumina HiSeq,University of North Carolina,NO
14709,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
14710,Prostate Adenocarcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14711,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,Cornell Medical College,Illumina HiSeq,University of North Carolina,NO
14712,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14713,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14714,Prostate Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14715,Prostate Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14716,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
14717,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
14718,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - Cleveland Clinic,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14719,Bladder Urothelial Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14720,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - Cleveland Clinic,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14721,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
14722,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
14723,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14724,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Puerto Rico,Illumina HiSeq,University of North Carolina,NO
14725,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14726,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14727,Bladder Urothelial Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14728,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
14729,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
14730,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14731,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
14732,Bladder Urothelial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14733,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - UT Southwestern Medical Center at Dallas,Illumina HiSeq,University of North Carolina,NO
14734,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
14735,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14736,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
14737,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
14738,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
14739,Bladder Urothelial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14740,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
14741,Bladder Urothelial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14742,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
14743,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
14744,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14745,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
14746,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14747,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Cornell Medical College,Illumina HiSeq,University of North Carolina,NO
14748,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
14749,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
14750,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14751,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
14752,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
14753,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
14754,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
14755,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14756,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
14757,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
14758,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - UT Southwestern Medical Center at Dallas,Illumina HiSeq,University of North Carolina,NO
14759,Bladder Urothelial Carcinoma,Primary Tumor,WGS,MD Anderson,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14760,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
14761,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14762,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14763,Bladder Urothelial Carcinoma,Primary Tumor,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
14764,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
14765,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
14766,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14767,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Cornell Medical College,Illumina HiSeq,University of North Carolina,NO
14768,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14769,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
14770,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
14771,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14772,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
14773,Bladder Urothelial Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14774,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
14775,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14776,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
14777,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,ABS - IUPUI,Illumina HiSeq,Harvard Medical School,NO
14778,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
14779,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14780,Bladder Urothelial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14781,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14782,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
14783,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Medical College of Georgia,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14784,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
14785,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
14786,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
14787,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14788,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14789,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - Cleveland Clinic,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14790,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
14791,Bladder Urothelial Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14792,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14793,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
14794,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
14795,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,ABS - IUPUI,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14796,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
14797,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
14798,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
14799,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
14800,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - University Of Chicago,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14801,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
14802,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14803,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14804,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14805,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14806,Bladder Urothelial Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14807,Bladder Urothelial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14808,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
14809,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
14810,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14811,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
14812,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
14813,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
14814,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
14815,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
14816,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14817,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
14818,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
14819,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
14820,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14821,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - Cleveland Clinic,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14822,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Colorado Denver,Illumina HiSeq,University of North Carolina,NO
14823,Bladder Urothelial Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14824,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14825,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
14826,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
14827,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
14828,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
14829,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14830,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
14831,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
14832,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14833,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
14834,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
14835,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
14836,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
14837,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
14838,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14839,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
14840,Bladder Urothelial Carcinoma,Solid Tissue Normal,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
14841,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - University of Miami,Illumina HiSeq,Harvard Medical School,NO
14842,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - UT Southwestern Medical Center at Dallas,Illumina HiSeq,University of North Carolina,NO
14843,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,CHI-Penrose Colorado,Illumina HiSeq,University of North Carolina,NO
14844,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
14845,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14846,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
14847,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - UT Southwestern Medical Center at Dallas,Illumina HiSeq,University of North Carolina,NO
14848,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Medical College of Georgia,Illumina HiSeq,Harvard Medical School,NO
14849,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
14850,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14851,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
14852,Bladder Urothelial Carcinoma,Solid Tissue Normal,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14853,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
14854,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - University Of Chicago,Illumina HiSeq,Harvard Medical School,NO
14855,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14856,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
14857,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
14858,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14859,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14860,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14861,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - Cleveland Clinic,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14862,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,ABS - IUPUI,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14863,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
14864,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Medical College of Georgia,Illumina HiSeq,University of North Carolina,NO
14865,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
14866,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
14867,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
14868,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14869,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
14870,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
14871,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - University Of Chicago,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14872,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
14873,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
14874,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
14875,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
14876,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
14877,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
14878,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14879,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
14880,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
14881,Bladder Urothelial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14882,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
14883,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
14884,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Colorado Denver,Illumina HiSeq,University of North Carolina,NO
14885,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
14886,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14887,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14888,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14889,Bladder Urothelial Carcinoma,Solid Tissue Normal,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
14890,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
14891,Bladder Urothelial Carcinoma,Primary Tumor,WGS,ABS - IUPUI,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14892,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
14893,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
14894,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14895,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14896,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
14897,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
14898,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
14899,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14900,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
14901,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
14902,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
14903,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Cornell Medical College,Illumina HiSeq,University of North Carolina,NO
14904,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
14905,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
14906,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
14907,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14908,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14909,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
14910,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
14911,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
14912,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14913,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
14914,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14915,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
14916,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14917,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
14918,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
14919,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14920,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14921,Bladder Urothelial Carcinoma,Primary Tumor,WGS,MD Anderson,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14922,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
14923,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
14924,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
14925,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
14926,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14927,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14928,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
14929,Bladder Urothelial Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
14930,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - Cleveland Clinic,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14931,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
14932,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14933,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14934,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14935,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14936,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
14937,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
14938,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - Cleveland Clinic,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14939,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14940,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14941,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
14942,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Cornell Medical College,Illumina HiSeq,University of North Carolina,NO
14943,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
14944,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
14945,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - University Of Chicago,Illumina HiSeq,Harvard Medical School,NO
14946,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
14947,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
14948,Bladder Urothelial Carcinoma,Primary Tumor,WGS,MD Anderson,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14949,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
14950,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,ABS - IUPUI,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14951,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
14952,Bladder Urothelial Carcinoma,Primary Tumor,WGS,ABS - Lahey Clinic,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14953,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
14954,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
14955,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University of Miami,Illumina HiSeq,University of North Carolina,NO
14956,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
14957,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
14958,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
14959,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
14960,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14961,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
14962,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
14963,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - University of Miami,Illumina HiSeq,Harvard Medical School,NO
14964,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
14965,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,ABS - Lahey Clinic,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14966,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
14967,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
14968,Bladder Urothelial Carcinoma,Primary Tumor,WGS,ABS - IUPUI,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14969,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
14970,Bladder Urothelial Carcinoma,Primary Tumor,WGS,ABS - IUPUI,Illumina HiSeq,Harvard Medical School,NO
14971,Bladder Urothelial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14972,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,ABS - Lahey Clinic,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14973,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14974,Bladder Urothelial Carcinoma,Solid Tissue Normal,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
14975,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
14976,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
14977,Bladder Urothelial Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
14978,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
14979,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
14980,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14981,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - University Of Chicago,Illumina HiSeq,Harvard Medical School,NO
14982,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Medical College of Georgia,Illumina HiSeq,Harvard Medical School,NO
14983,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
14984,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
14985,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
14986,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
14987,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
14988,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
14989,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
14990,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
14991,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
14992,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14993,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
14994,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Harvard Medical School,NO
14995,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
14996,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
14997,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
14998,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
14999,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15000,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15001,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15002,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15003,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15004,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15005,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
15006,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
15007,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15008,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15009,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
15010,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15011,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15012,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
15013,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15014,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15015,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University of Miami,Illumina HiSeq,University of North Carolina,NO
15016,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15017,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
15018,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15019,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
15020,Bladder Urothelial Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
15021,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
15022,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
15023,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
15024,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15025,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15026,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
15027,Bladder Urothelial Carcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
15028,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
15029,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
15030,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15031,Bladder Urothelial Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15032,Bladder Urothelial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15033,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15034,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
15035,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,ABS - IUPUI,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15036,Bladder Urothelial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
15037,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
15038,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - UT Southwestern Medical Center at Dallas,Illumina HiSeq,University of North Carolina,NO
15039,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
15040,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
15041,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
15042,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15043,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15044,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15045,Bladder Urothelial Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15046,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
15047,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15048,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
15049,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15050,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15051,Bladder Urothelial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15052,Bladder Urothelial Carcinoma,Solid Tissue Normal,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
15053,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15054,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
15055,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15056,Bladder Urothelial Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
15057,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - University Of Chicago,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15058,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
15059,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15060,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - University of Miami,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15061,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15062,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - Cleveland Clinic,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15063,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15064,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
15065,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
15066,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
15067,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15068,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,ABS - IUPUI,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15069,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15070,Bladder Urothelial Carcinoma,Primary Tumor,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
15071,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
15072,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
15073,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15074,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15075,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15076,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - UT Southwestern Medical Center at Dallas,Illumina HiSeq,University of North Carolina,NO
15077,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15078,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
15079,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
15080,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
15081,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15082,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
15083,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15084,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
15085,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - Cleveland Clinic,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15086,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15087,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15088,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
15089,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
15090,Bladder Urothelial Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15091,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - University Of Chicago,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15092,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
15093,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
15094,Bladder Urothelial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
15095,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - Cleveland Clinic,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15096,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15097,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15098,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15099,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15100,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,ABS - IUPUI,Illumina HiSeq,Harvard Medical School,NO
15101,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15102,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Harvard Medical School,NO
15103,Bladder Urothelial Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15104,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15105,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
15106,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Cornell Medical College,Illumina HiSeq,University of North Carolina,NO
15107,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
15108,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15109,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
15110,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15111,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
15112,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15113,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University Hospital Erlangen,Illumina HiSeq,University of North Carolina,NO
15114,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
15115,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
15116,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15117,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
15118,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15119,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15120,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15121,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15122,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
15123,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
15124,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
15125,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15126,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15127,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
15128,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15129,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - UT Southwestern Medical Center at Dallas,Illumina HiSeq,University of North Carolina,NO
15130,Bladder Urothelial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
15131,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15132,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15133,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15134,Bladder Urothelial Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15135,Bladder Urothelial Carcinoma,Primary Tumor,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
15136,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - University of Miami,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15137,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15138,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
15139,Bladder Urothelial Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15140,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15141,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15142,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
15143,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
15144,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
15145,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Gundersen Lutheran Health System,Illumina HiSeq,University of North Carolina,NO
15146,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15147,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
15148,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15149,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15150,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15151,Bladder Urothelial Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15152,Bladder Urothelial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
15153,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
15154,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - UT Southwestern Medical Center at Dallas,Illumina HiSeq,University of North Carolina,NO
15155,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
15156,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - Cleveland Clinic,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15157,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
15158,Bladder Urothelial Carcinoma,Primary Tumor,WGS,ABS - IUPUI,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15159,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15160,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
15161,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15162,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - UT Southwestern Medical Center at Dallas,Illumina HiSeq,University of North Carolina,NO
15163,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15164,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
15165,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15166,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
15167,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15168,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15169,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
15170,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15171,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
15172,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
15173,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15174,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
15175,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15176,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15177,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
15178,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15179,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
15180,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
15181,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15182,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15183,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15184,Bladder Urothelial Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
15185,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15186,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
15187,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
15188,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15189,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
15190,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - RPPA Core Facility (Proteomics),NO
15191,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
15192,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
15193,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15194,Bladder Urothelial Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15195,Bladder Urothelial Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
15196,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15197,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
15198,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,ABS - Lahey Clinic,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15199,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15200,Bladder Urothelial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
15201,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
15202,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15203,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
15204,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Minnesota,Illumina HiSeq,University of North Carolina,NO
15205,Bladder Urothelial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15206,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
15207,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
15208,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15209,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15210,Bladder Urothelial Carcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
15211,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15212,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15213,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15214,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15215,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
15216,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15217,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15218,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15219,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
15220,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
15221,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15222,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
15223,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
15224,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15225,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
15226,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15227,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15228,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
15229,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
15230,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15231,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
15232,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15233,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15234,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
15235,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
15236,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15237,Bladder Urothelial Carcinoma,Primary Tumor,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
15238,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15239,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - University Of Chicago,Illumina HiSeq,Harvard Medical School,NO
15240,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University Hospital Erlangen,Illumina HiSeq,University of North Carolina,NO
15241,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15242,Bladder Urothelial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
15243,Bladder Urothelial Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15244,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
15245,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
15246,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,YES
15247,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
15248,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - University Of Chicago,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15249,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
15250,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - Cleveland Clinic,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15251,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15252,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
15253,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
15254,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15255,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
15256,Bladder Urothelial Carcinoma,Primary Tumor,WGS,ABS - Lahey Clinic,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15257,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15258,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
15259,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15260,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Gundersen Lutheran Health System,Illumina HiSeq,University of North Carolina,NO
15261,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
15262,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15263,Bladder Urothelial Carcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
15264,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15265,Bladder Urothelial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15266,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15267,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15268,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
15269,Bladder Urothelial Carcinoma,Solid Tissue Normal,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
15270,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15271,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
15272,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Medical College of Georgia,Illumina HiSeq,University of North Carolina,NO
15273,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
15274,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,ABS - IUPUI,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15275,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
15276,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15277,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15278,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15279,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15280,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
15281,Bladder Urothelial Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
15282,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15283,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
15284,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15285,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
15286,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15287,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15288,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
15289,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15290,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
15291,Bladder Urothelial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15292,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15293,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15294,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15295,Bladder Urothelial Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
15296,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
15297,Bladder Urothelial Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15298,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Cornell Medical College,Illumina HiSeq,University of North Carolina,NO
15299,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
15300,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
15301,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
15302,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15303,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
15304,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15305,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
15306,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
15307,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
15308,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15309,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15310,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15311,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15312,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15313,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
15314,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
15315,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15316,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15317,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15318,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15319,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - RPPA Core Facility (Proteomics),NO
15320,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15321,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15322,Bladder Urothelial Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15323,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
15324,Bladder Urothelial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
15325,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
15326,Bladder Urothelial Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15327,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15328,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
15329,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
15330,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - Cleveland Clinic,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15331,Bladder Urothelial Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15332,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15333,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15334,Bladder Urothelial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15335,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15336,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
15337,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
15338,Bladder Urothelial Carcinoma,Primary Tumor,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
15339,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
15340,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15341,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15342,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15343,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15344,Bladder Urothelial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
15345,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
15346,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15347,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15348,Bladder Urothelial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15349,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
15350,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
15351,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - Cleveland Clinic,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15352,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15353,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15354,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15355,Bladder Urothelial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Harvard Medical School,NO
15356,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
15357,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - Cleveland Clinic,Illumina HiSeq,University of North Carolina,NO
15358,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15359,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - UT Southwestern Medical Center at Dallas,Illumina HiSeq,University of North Carolina,NO
15360,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
15361,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,Harvard Medical School,NO
15362,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Medical College of Georgia,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15363,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15364,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15365,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
15366,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ILSBIO,Illumina HiSeq,University of North Carolina,NO
15367,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15368,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
15369,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15370,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15371,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
15372,Bladder Urothelial Carcinoma,Primary Tumor,WGS,UNC,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15373,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
15374,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15375,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15376,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
15377,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15378,Bladder Urothelial Carcinoma,Primary Tumor,WGS,ABS - IUPUI,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15379,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
15380,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15381,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
15382,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
15383,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15384,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - University Of Chicago,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15385,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
15386,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
15387,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
15388,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15389,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15390,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
15391,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15392,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
15393,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
15394,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15395,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15396,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15397,Bladder Urothelial Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15398,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - UT Southwestern Medical Center at Dallas,Illumina HiSeq,University of North Carolina,NO
15399,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
15400,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,MD Anderson,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15401,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
15402,Bladder Urothelial Carcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15403,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Sheffield,Illumina HiSeq,University of North Carolina,NO
15404,Bladder Urothelial Carcinoma,Solid Tissue Normal,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
15405,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15406,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15407,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
15408,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15409,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Arizona,Illumina HiSeq,University of North Carolina,NO
15410,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Puerto Rico,Illumina HiSeq,University of North Carolina,NO
15411,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15412,Bladder Urothelial Carcinoma,Primary Tumor,WGS,MD Anderson,Illumina HiSeq,Harvard Medical School,NO
15413,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
15414,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15415,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Harvard Medical School,NO
15416,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Harvard Medical School,NO
15417,Bladder Urothelial Carcinoma,Primary Tumor,WGS,BLN - University Of Chicago,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15418,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15419,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15420,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
15421,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,UNC,Illumina HiSeq,Harvard Medical School,NO
15422,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
15423,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of California San Francisco,Illumina HiSeq,University of North Carolina,NO
15424,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Hartford Hospital,Illumina HiSeq,University of North Carolina,NO
15425,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
15426,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,ABS - Lahey Clinic,Illumina HiSeq,University of North Carolina,NO
15427,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
15428,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15429,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15430,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
15431,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
15432,Bladder Urothelial Carcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15433,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15434,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
15435,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,University of Pittsburgh,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15436,Bladder Urothelial Carcinoma,Primary Tumor,WGS,University of Pittsburgh,Illumina HiSeq,Broad Institute of MIT and Harvard,NO
15437,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15438,Bladder Urothelial Carcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15439,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15440,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
15441,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15442,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
15443,Bladder Urothelial Carcinoma,Primary Tumor,RNA-Seq,BLN - University Of Chicago,Illumina HiSeq,University of North Carolina,NO
15444,Bladder Urothelial Carcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
15445,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15446,Sarcoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
15447,Sarcoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15448,Sarcoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
15449,Sarcoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
15450,Sarcoma,Primary Tumor,RNA-Seq,University of Kansas,Illumina HiSeq,University of North Carolina,NO
15451,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15452,Sarcoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
15453,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15454,Sarcoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15455,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15456,Sarcoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
15457,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15458,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15459,Sarcoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
15460,Sarcoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
15461,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15462,Sarcoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
15463,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15464,Sarcoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Washington University School of Medicine,NO
15465,Sarcoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
15466,Sarcoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Washington University School of Medicine,NO
15467,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15468,Sarcoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
15469,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15470,Sarcoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
15471,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15472,Sarcoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Washington University School of Medicine,NO
15473,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15474,Sarcoma,Primary Tumor,RNA-Seq,University of Iowa,Illumina HiSeq,University of North Carolina,NO
15475,Sarcoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15476,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15477,Sarcoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15478,Sarcoma,Primary Tumor,WGS,University of North Carolina,Illumina HiSeq,Washington University School of Medicine,NO
15479,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15480,Sarcoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
15481,Sarcoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
15482,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15483,Sarcoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
15484,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15485,Sarcoma,Primary Tumor,RNA-Seq,Washington University St. Louis,Illumina HiSeq,University of North Carolina,NO
15486,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15487,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15488,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15489,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15490,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15491,Sarcoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,Washington University School of Medicine,NO
15492,Sarcoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15493,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15494,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15495,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15496,Sarcoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
15497,Sarcoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Washington University School of Medicine,NO
15498,Sarcoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15499,Sarcoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15500,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15501,Sarcoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
15502,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15503,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15504,Sarcoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
15505,Sarcoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15506,Sarcoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
15507,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15508,Sarcoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
15509,Sarcoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
15510,Sarcoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15511,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15512,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15513,Sarcoma,Recurrent Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15514,Sarcoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15515,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15516,Sarcoma,Blood Derived Normal,WGS,University of Pittsburgh,HiSeq X Ten,Washington University School of Medicine,NO
15517,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15518,Sarcoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
15519,Sarcoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15520,Sarcoma,Primary Tumor,RNA-Seq,Vanderbilt,Illumina HiSeq,University of North Carolina,NO
15521,Sarcoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15522,Sarcoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
15523,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15524,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15525,Sarcoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15526,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15527,Sarcoma,Primary Tumor,RNA-Seq,Brigham and Women's Hospital,Illumina HiSeq,University of North Carolina,NO
15528,Sarcoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
15529,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15530,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15531,Sarcoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15532,Sarcoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
15533,Sarcoma,Primary Tumor,RNA-Seq,University of Iowa,Illumina HiSeq,University of North Carolina,NO
15534,Sarcoma,Primary Tumor,RNA-Seq,University of Iowa,Illumina HiSeq,University of North Carolina,NO
15535,Sarcoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15536,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15537,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15538,Sarcoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Washington University School of Medicine,NO
15539,Sarcoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15540,Sarcoma,Primary Tumor,RNA-Seq,University of Iowa,Illumina HiSeq,University of North Carolina,NO
15541,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15542,Sarcoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
15543,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15544,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15545,Sarcoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15546,Sarcoma,Blood Derived Normal,WGS,University of North Carolina,Illumina HiSeq,Washington University School of Medicine,NO
15547,Sarcoma,Primary Tumor,RNA-Seq,University of Iowa,Illumina HiSeq,University of North Carolina,NO
15548,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15549,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15550,Sarcoma,Primary Tumor,RNA-Seq,Brigham and Women's Hospital,Illumina HiSeq,University of North Carolina,NO
15551,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15552,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15553,Sarcoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15554,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15555,Sarcoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15556,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15557,Sarcoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
15558,Sarcoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Washington University School of Medicine,NO
15559,Sarcoma,Primary Tumor,RNA-Seq,University of Iowa,Illumina HiSeq,University of North Carolina,NO
15560,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15561,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15562,Sarcoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
15563,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15564,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15565,Sarcoma,Recurrent Tumor,RNA-Seq,Vanderbilt,Illumina HiSeq,University of North Carolina,NO
15566,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15567,Sarcoma,Primary Tumor,RNA-Seq,University of Minnesota,Illumina HiSeq,University of North Carolina,NO
15568,Sarcoma,Primary Tumor,RNA-Seq,"University of California, Davis",Illumina HiSeq,University of North Carolina,NO
15569,Sarcoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
15570,Sarcoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15571,Sarcoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15572,Sarcoma,Primary Tumor,RNA-Seq,University of Minnesota,Illumina HiSeq,University of North Carolina,NO
15573,Sarcoma,Primary Tumor,WGS,University of Pittsburgh,HiSeq X Ten,Washington University School of Medicine,NO
15574,Sarcoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Washington University School of Medicine,NO
15575,Sarcoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15576,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15577,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15578,Sarcoma,Primary Tumor,RNA-Seq,Brigham and Women's Hospital,Illumina HiSeq,University of North Carolina,NO
15579,Sarcoma,Solid Tissue Normal,WGS,Memorial Sloan Kettering,HiSeq X Ten,Washington University School of Medicine,NO
15580,Sarcoma,Primary Tumor,RNA-Seq,Cleveland Clinic Foundation,Illumina HiSeq,University of North Carolina,NO
15581,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15582,Sarcoma,Primary Tumor,RNA-Seq,Cleveland Clinic Foundation,Illumina HiSeq,University of North Carolina,NO
15583,Sarcoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
15584,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15585,Sarcoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
15586,Sarcoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15587,Sarcoma,Primary Tumor,RNA-Seq,Washington University St. Louis,Illumina HiSeq,University of North Carolina,NO
15588,Sarcoma,Primary Tumor,RNA-Seq,University of Iowa,Illumina HiSeq,University of North Carolina,NO
15589,Sarcoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
15590,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15591,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15592,Sarcoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
15593,Sarcoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
15594,Sarcoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
15595,Sarcoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15596,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15597,Sarcoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
15598,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15599,Sarcoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina HiSeq,Washington University School of Medicine,NO
15600,Sarcoma,Blood Derived Normal,WGS,University of North Carolina,Illumina HiSeq,Washington University School of Medicine,NO
15601,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15602,Sarcoma,Primary Tumor,RNA-Seq,University of Iowa,Illumina HiSeq,University of North Carolina,NO
15603,Sarcoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
15604,Sarcoma,Primary Tumor,RNA-Seq,Brigham and Women's Hospital,Illumina HiSeq,University of North Carolina,NO
15605,Sarcoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15606,Sarcoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
15607,Sarcoma,Primary Tumor,WGS,ABS - IUPUI,Illumina HiSeq,Washington University School of Medicine,NO
15608,Sarcoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina HiSeq,Washington University School of Medicine,NO
15609,Sarcoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Washington University School of Medicine,NO
15610,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15611,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15612,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15613,Sarcoma,Primary Tumor,RNA-Seq,Vanderbilt,Illumina HiSeq,University of North Carolina,NO
15614,Sarcoma,Primary Tumor,RNA-Seq,Hartford Hospital,Illumina HiSeq,University of North Carolina,NO
15615,Sarcoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15616,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15617,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15618,Sarcoma,Blood Derived Normal,WGS,ABS - IUPUI,Illumina HiSeq,Washington University School of Medicine,NO
15619,Sarcoma,Solid Tissue Normal,WGS,Montefiore Medical Center,HiSeq X Ten,Washington University School of Medicine,NO
15620,Sarcoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
15621,Sarcoma,Primary Tumor,WGS,Memorial Sloan Kettering,HiSeq X Ten,Washington University School of Medicine,NO
15622,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15623,Sarcoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
15624,Sarcoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
15625,Sarcoma,Primary Tumor,WGS,University of Kansas,HiSeq X Ten,Washington University School of Medicine,NO
15626,Sarcoma,Primary Tumor,RNA-Seq,Brigham and Women's Hospital,Illumina HiSeq,University of North Carolina,NO
15627,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15628,Sarcoma,Primary Tumor,WGS,University of Washington,HiSeq X Ten,Washington University School of Medicine,NO
15629,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15630,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15631,Sarcoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
15632,Sarcoma,Primary Tumor,RNA-Seq,University of Texas MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
15633,Sarcoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15634,Sarcoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15635,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15636,Sarcoma,Primary Tumor,RNA-Seq,Hartford Hospital,Illumina HiSeq,University of North Carolina,NO
15637,Sarcoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15638,Sarcoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,Washington University School of Medicine,NO
15639,Sarcoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15640,Sarcoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15641,Sarcoma,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,University of North Carolina,NO
15642,Sarcoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,Washington University School of Medicine,NO
15643,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15644,Sarcoma,Primary Tumor,RNA-Seq,University of Iowa,Illumina HiSeq,University of North Carolina,NO
15645,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15646,Sarcoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
15647,Sarcoma,Primary Tumor,RNA-Seq,Mount Sinai School of Medicine,Illumina HiSeq,University of North Carolina,NO
15648,Sarcoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
15649,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15650,Sarcoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15651,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15652,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15653,Sarcoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Washington University School of Medicine,NO
15654,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15655,Sarcoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Washington University School of Medicine,NO
15656,Sarcoma,Primary Tumor,RNA-Seq,University of Texas MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
15657,Sarcoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15658,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15659,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15660,Sarcoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15661,Sarcoma,Primary Tumor,RNA-Seq,University of Washington,Illumina HiSeq,University of North Carolina,NO
15662,Sarcoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15663,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15664,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15665,Sarcoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
15666,Sarcoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
15667,Sarcoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
15668,Sarcoma,Primary Tumor,RNA-Seq,University of Minnesota,Illumina HiSeq,University of North Carolina,NO
15669,Sarcoma,Primary Tumor,RNA-Seq,Brigham and Women's Hospital,Illumina HiSeq,University of North Carolina,NO
15670,Sarcoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15671,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15672,Sarcoma,Primary Tumor,WGS,Memorial Sloan Kettering,HiSeq X Ten,Washington University School of Medicine,NO
15673,Sarcoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
15674,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15675,Sarcoma,Blood Derived Normal,WGS,ABS - IUPUI,Illumina HiSeq,Washington University School of Medicine,NO
15676,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15677,Sarcoma,Primary Tumor,RNA-Seq,Mount Sinai School of Medicine,Illumina HiSeq,University of North Carolina,NO
15678,Sarcoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15679,Sarcoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
15680,Sarcoma,Primary Tumor,WGS,University of Texas MD Anderson Cancer Center,Illumina HiSeq,Washington University School of Medicine,NO
15681,Sarcoma,Primary Tumor,RNA-Seq,Maine Medical Center,Illumina HiSeq,University of North Carolina,NO
15682,Sarcoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,Washington University School of Medicine,NO
15683,Sarcoma,Blood Derived Normal,WGS,University of Washington,HiSeq X Ten,Washington University School of Medicine,NO
15684,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15685,Sarcoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
15686,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15687,Sarcoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
15688,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15689,Sarcoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15690,Sarcoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15691,Sarcoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15692,Sarcoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15693,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15694,Sarcoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
15695,Sarcoma,Primary Tumor,RNA-Seq,Washington University St. Louis,Illumina HiSeq,University of North Carolina,NO
15696,Sarcoma,Primary Tumor,RNA-Seq,University of Minnesota,Illumina HiSeq,University of North Carolina,NO
15697,Sarcoma,Primary Tumor,RNA-Seq,Vanderbilt,Illumina HiSeq,University of North Carolina,NO
15698,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15699,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15700,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15701,Sarcoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
15702,Sarcoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
15703,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15704,Sarcoma,Primary Tumor,RNA-Seq,Washington University St. Louis,Illumina HiSeq,University of North Carolina,NO
15705,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15706,Sarcoma,Blood Derived Normal,WGS,University of Kansas,HiSeq X Ten,Washington University School of Medicine,NO
15707,Sarcoma,Primary Tumor,RNA-Seq,University of Texas MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
15708,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15709,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15710,Sarcoma,Primary Tumor,WGS,ABS - IUPUI,Illumina HiSeq,Washington University School of Medicine,NO
15711,Sarcoma,Primary Tumor,RNA-Seq,Brigham and Women's Hospital,Illumina HiSeq,University of North Carolina,NO
15712,Sarcoma,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,University of North Carolina,NO
15713,Sarcoma,Primary Tumor,RNA-Seq,Brigham and Women's Hospital,Illumina HiSeq,University of North Carolina,NO
15714,Sarcoma,Primary Tumor,RNA-Seq,University of Iowa,Illumina HiSeq,University of North Carolina,NO
15715,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15716,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15717,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15718,Sarcoma,Metastatic,RNA-Seq,Washington University St. Louis,Illumina HiSeq,University of North Carolina,NO
15719,Sarcoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
15720,Sarcoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
15721,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15722,Sarcoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
15723,Sarcoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
15724,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15725,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15726,Sarcoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
15727,Sarcoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
15728,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15729,Sarcoma,Primary Tumor,RNA-Seq,University of Iowa,Illumina HiSeq,University of North Carolina,NO
15730,Sarcoma,Primary Tumor,RNA-Seq,Washington University St. Louis,Illumina HiSeq,University of North Carolina,NO
15731,Sarcoma,Primary Tumor,RNA-Seq,Montefiore Medical Center,Illumina HiSeq,University of North Carolina,NO
15732,Sarcoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
15733,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15734,Sarcoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15735,Sarcoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15736,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15737,Sarcoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
15738,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15739,Sarcoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
15740,Sarcoma,Solid Tissue Normal,WGS,University of Texas MD Anderson Cancer Center,Illumina HiSeq,Washington University School of Medicine,NO
15741,Sarcoma,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,University of North Carolina,NO
15742,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15743,Sarcoma,Recurrent Tumor,WGS,University of Pittsburgh,HiSeq X Ten,Washington University School of Medicine,NO
15744,Sarcoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15745,Sarcoma,Primary Tumor,RNA-Seq,Fox Chase,Illumina HiSeq,University of North Carolina,NO
15746,Sarcoma,Primary Tumor,RNA-Seq,"University of California, Davis",Illumina HiSeq,University of North Carolina,NO
15747,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15748,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15749,Sarcoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15750,Sarcoma,Primary Tumor,WGS,Montefiore Medical Center,HiSeq X Ten,Washington University School of Medicine,NO
15751,Sarcoma,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,University of North Carolina,NO
15752,Sarcoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15753,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15754,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15755,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15756,Sarcoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15757,Sarcoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
15758,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15759,Sarcoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
15760,Sarcoma,Primary Tumor,RNA-Seq,University of Minnesota,Illumina HiSeq,University of North Carolina,NO
15761,Sarcoma,Primary Tumor,RNA-Seq,University of New Mexico,Illumina HiSeq,University of North Carolina,NO
15762,Sarcoma,Primary Tumor,WGS,University of North Carolina,Illumina HiSeq,Washington University School of Medicine,NO
15763,Sarcoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
15764,Sarcoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
15765,Sarcoma,Primary Tumor,RNA-Seq,Mount Sinai School of Medicine,Illumina HiSeq,University of North Carolina,NO
15766,Sarcoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
15767,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15768,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15769,Sarcoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
15770,Sarcoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15771,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15772,Sarcoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15773,Sarcoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15774,Sarcoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
15775,Sarcoma,Primary Tumor,RNA-Seq,Cleveland Clinic Foundation,Illumina HiSeq,University of North Carolina,NO
15776,Sarcoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
15777,Sarcoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
15778,Sarcoma,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,University of North Carolina,NO
15779,Sarcoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
15780,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15781,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15782,Sarcoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
15783,Sarcoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
15784,Sarcoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15785,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15786,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15787,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15788,Sarcoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
15789,Sarcoma,Recurrent Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15790,Sarcoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
15791,Sarcoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,Washington University School of Medicine,NO
15792,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15793,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
15794,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15795,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina GA,Harvard Medical School,NO
15796,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15797,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
15798,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15799,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
15800,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15801,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15802,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15803,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
15804,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
15805,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
15806,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15807,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15808,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
15809,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
15810,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15811,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
15812,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
15813,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
15814,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15815,Rectum Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
15816,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15817,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
15818,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15819,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
15820,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
15821,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15822,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15823,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15824,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
15825,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15826,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
15827,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
15828,Rectum Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
15829,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15830,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
15831,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15832,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15833,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15834,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
15835,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15836,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15837,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15838,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15839,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15840,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15841,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15842,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15843,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
15844,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15845,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15846,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15847,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15848,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15849,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
15850,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15851,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
15852,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
15853,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15854,Rectum Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
15855,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15856,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15857,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15858,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15859,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15860,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15861,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
15862,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
15863,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15864,Rectum Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15865,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina GA,Harvard Medical School,NO
15866,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15867,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
15868,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
15869,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
15870,Rectum Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
15871,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
15872,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15873,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15874,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
15875,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina GA,Harvard Medical School,NO
15876,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
15877,Rectum Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
15878,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
15879,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15880,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15881,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
15882,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15883,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15884,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
15885,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15886,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
15887,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15888,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
15889,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15890,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15891,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15892,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15893,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15894,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15895,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
15896,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
15897,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
15898,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15899,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15900,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15901,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15902,Rectum Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,Baylor College of Medicine,NO
15903,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
15904,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
15905,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15906,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
15907,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15908,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15909,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15910,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
15911,Rectum Adenocarcinoma,Primary Tumor,WGS,Greater Poland Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
15912,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15913,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15914,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15915,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
15916,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
15917,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15918,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15919,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
15920,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
15921,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
15922,Rectum Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15923,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15924,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
15925,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
15926,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15927,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15928,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
15929,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15930,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
15931,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
15932,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
15933,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15934,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
15935,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15936,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15937,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15938,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15939,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15940,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
15941,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15942,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15943,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15944,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
15945,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
15946,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15947,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
15948,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
15949,Rectum Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
15950,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15951,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
15952,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15953,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
15954,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15955,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15956,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15957,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15958,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15959,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15960,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
15961,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina GA,Harvard Medical School,NO
15962,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
15963,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15964,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina GA,Harvard Medical School,NO
15965,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15966,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15967,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15968,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
15969,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15970,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15971,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
15972,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15973,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15974,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
15975,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
15976,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina GA,Harvard Medical School,NO
15977,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15978,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15979,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15980,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15981,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15982,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15983,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
15984,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
15985,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15986,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Greater Poland Cancer Center,Illumina HiSeq,Baylor College of Medicine,NO
15987,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15988,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
15989,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
15990,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
15991,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
15992,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
15993,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15994,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
15995,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
15996,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15997,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15998,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
15999,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16000,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
16001,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16002,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
16003,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16004,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
16005,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
16006,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16007,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
16008,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16009,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
16010,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
16011,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16012,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16013,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16014,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,Baylor College of Medicine,NO
16015,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
16016,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16017,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Harvard,Illumina HiSeq,University of North Carolina,NO
16018,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16019,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16020,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
16021,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16022,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
16023,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16024,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16025,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
16026,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16027,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16028,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16029,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16030,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16031,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16032,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
16033,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16034,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16035,Rectum Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
16036,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16037,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16038,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16039,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
16040,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16041,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16042,Rectum Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
16043,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16044,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16045,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
16046,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
16047,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16048,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina GA,Harvard Medical School,NO
16049,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16050,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16051,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16052,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
16053,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16054,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
16055,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
16056,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16057,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
16058,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16059,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16060,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16061,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16062,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
16063,Rectum Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
16064,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16065,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16066,Rectum Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
16067,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16068,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16069,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
16070,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16071,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
16072,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina GA,Harvard Medical School,NO
16073,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16074,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
16075,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16076,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16077,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16078,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
16079,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16080,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
16081,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
16082,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16083,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
16084,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16085,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16086,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16087,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16088,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16089,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
16090,Rectum Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
16091,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina GA,Harvard Medical School,NO
16092,Rectum Adenocarcinoma,Solid Tissue Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16093,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16094,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16095,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16096,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16097,Rectum Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
16098,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16099,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16100,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16101,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16102,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
16103,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16104,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
16105,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16106,Rectum Adenocarcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
16107,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16108,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16109,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
16110,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16111,Rectum Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
16112,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
16113,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16114,Rectum Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
16115,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16116,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
16117,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
16118,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
16119,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
16120,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina GA,University of North Carolina,NO
16121,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
16122,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16123,Rectum Adenocarcinoma,Recurrent Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
16124,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
16125,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
16126,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16127,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
16128,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16129,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16130,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16131,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16132,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
16133,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
16134,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16135,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
16136,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16137,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16138,Rectum Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
16139,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16140,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina GA,Harvard Medical School,NO
16141,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16142,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
16143,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16144,Rectum Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
16145,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16146,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16147,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Greater Poland Cancer Center,Illumina HiSeq,University of North Carolina,NO
16148,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
16149,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina HiSeq,University of North Carolina,NO
16150,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
16151,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16152,Rectum Adenocarcinoma,Solid Tissue Normal,WGS,Christiana Healthcare,Illumina HiSeq,Harvard Medical School,NO
16153,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16154,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16155,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
16156,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16157,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16158,Rectum Adenocarcinoma,Primary Tumor,WGS,Indivumed,Illumina HiSeq,Baylor College of Medicine,NO
16159,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16160,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16161,Rectum Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,Baylor College of Medicine,NO
16162,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16163,Rectum Adenocarcinoma,Blood Derived Normal,WGS,Indivumed,Illumina HiSeq,Harvard Medical School,NO
16164,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Indivumed,Illumina GA,University of North Carolina,NO
16165,Rectum Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16166,Esophageal Carcinoma,Primary Tumor,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16167,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Duke University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16168,Esophageal Carcinoma,Solid Tissue Normal,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16169,Esophageal Carcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16170,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16171,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16172,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16173,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16174,Esophageal Carcinoma,Primary Tumor,WGS,University of Michigan,HiSeq X Ten,Washington University School of Medicine,NO
16175,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16176,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16177,Esophageal Carcinoma,Primary Tumor,WGS,Asterand,HiSeq X Ten,Washington University School of Medicine,NO
16178,Esophageal Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16179,Esophageal Carcinoma,Solid Tissue Normal,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16180,Esophageal Carcinoma,Blood Derived Normal,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16181,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,HiSeq X Ten,Washington University School of Medicine,NO
16182,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16183,Esophageal Carcinoma,Solid Tissue Normal,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16184,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16185,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16186,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,HiSeq X Ten,Washington University School of Medicine,NO
16187,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16188,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16189,Esophageal Carcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16190,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16191,Esophageal Carcinoma,Solid Tissue Normal,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16192,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16193,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16194,Esophageal Carcinoma,Primary Tumor,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16195,Esophageal Carcinoma,Metastatic,RNA-Seq,Duke University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16196,Esophageal Carcinoma,Solid Tissue Normal,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16197,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16198,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16199,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,HiSeq X Ten,Washington University School of Medicine,NO
16200,Esophageal Carcinoma,Solid Tissue Normal,WGS,University of Michigan,HiSeq X Ten,Washington University School of Medicine,NO
16201,Esophageal Carcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16202,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16203,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16204,Esophageal Carcinoma,Solid Tissue Normal,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16205,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16206,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16207,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16208,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16209,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16210,Esophageal Carcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16211,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16212,Esophageal Carcinoma,Solid Tissue Normal,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16213,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16214,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16215,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16216,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Duke University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16217,Esophageal Carcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16218,Esophageal Carcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16219,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16220,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16221,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16222,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16223,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Duke University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16224,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16225,Esophageal Carcinoma,Primary Tumor,WGS,University of Michigan,HiSeq X Ten,Washington University School of Medicine,NO
16226,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16227,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16228,Esophageal Carcinoma,Blood Derived Normal,WGS,Duke University,HiSeq X Ten,Washington University School of Medicine,NO
16229,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16230,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16231,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16232,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16233,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16234,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16235,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16236,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16237,Esophageal Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16238,Esophageal Carcinoma,Solid Tissue Normal,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16239,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16240,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16241,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,HiSeq X Ten,Washington University School of Medicine,NO
16242,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16243,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16244,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16245,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16246,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16247,Esophageal Carcinoma,Solid Tissue Normal,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16248,Esophageal Carcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16249,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16250,Esophageal Carcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16251,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16252,Esophageal Carcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16253,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Duke University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16254,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16255,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16256,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16257,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16258,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16259,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,HiSeq X Ten,Washington University School of Medicine,NO
16260,Esophageal Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16261,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16262,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16263,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16264,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16265,Esophageal Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16266,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16267,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16268,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16269,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16270,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16271,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Duke University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16272,Esophageal Carcinoma,Blood Derived Normal,WGS,Christiana Care,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16273,Esophageal Carcinoma,Solid Tissue Normal,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16274,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16275,Esophageal Carcinoma,Solid Tissue Normal,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16276,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16277,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16278,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16279,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16280,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,HiSeq X Ten,Washington University School of Medicine,NO
16281,Esophageal Carcinoma,Primary Tumor,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16282,Esophageal Carcinoma,Primary Tumor,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16283,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16284,Esophageal Carcinoma,Solid Tissue Normal,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16285,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16286,Esophageal Carcinoma,Solid Tissue Normal,WGS,University of Michigan,HiSeq X Ten,Washington University School of Medicine,NO
16287,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16288,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,HiSeq X Ten,Washington University School of Medicine,NO
16289,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16290,Esophageal Carcinoma,Blood Derived Normal,WGS,Christiana Care,HiSeq X Ten,Washington University School of Medicine,NO
16291,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,HiSeq X Ten,Washington University School of Medicine,NO
16292,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16293,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16294,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16295,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16296,Esophageal Carcinoma,Blood Derived Normal,WGS,Asterand,HiSeq X Ten,Washington University School of Medicine,NO
16297,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16298,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16299,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16300,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16301,Esophageal Carcinoma,Primary Tumor,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16302,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16303,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16304,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16305,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16306,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16307,Esophageal Carcinoma,Primary Tumor,WGS,University of Michigan,HiSeq X Ten,Washington University School of Medicine,NO
16308,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16309,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16310,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16311,Esophageal Carcinoma,Solid Tissue Normal,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16312,Esophageal Carcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16313,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16314,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16315,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16316,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16317,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16318,Esophageal Carcinoma,Solid Tissue Normal,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16319,Esophageal Carcinoma,Solid Tissue Normal,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16320,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16321,Esophageal Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16322,Esophageal Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16323,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16324,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16325,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16326,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16327,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16328,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16329,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16330,Esophageal Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16331,Esophageal Carcinoma,Solid Tissue Normal,WGS,University of Michigan,HiSeq X Ten,Washington University School of Medicine,NO
16332,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16333,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16334,Esophageal Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16335,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16336,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16337,Esophageal Carcinoma,Solid Tissue Normal,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16338,Esophageal Carcinoma,Solid Tissue Normal,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16339,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,HiSeq X Ten,Washington University School of Medicine,NO
16340,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16341,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16342,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16343,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Peter MacCallum Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16344,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16345,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16346,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16347,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16348,Esophageal Carcinoma,Primary Tumor,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16349,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16350,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16351,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16352,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16353,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16354,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16355,Esophageal Carcinoma,Primary Tumor,WGS,Asterand,HiSeq X Ten,Washington University School of Medicine,NO
16356,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16357,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16358,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Christiana Care,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16359,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,HiSeq X Ten,Washington University School of Medicine,NO
16360,Esophageal Carcinoma,Solid Tissue Normal,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16361,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16362,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16363,Esophageal Carcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16364,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16365,Esophageal Carcinoma,Solid Tissue Normal,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16366,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16367,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16368,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Christiana Care,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16369,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,HiSeq X Ten,Washington University School of Medicine,NO
16370,Esophageal Carcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16371,Esophageal Carcinoma,Primary Tumor,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16372,Esophageal Carcinoma,Solid Tissue Normal,WGS,University of Michigan,HiSeq X Ten,Washington University School of Medicine,NO
16373,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16374,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16375,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16376,Esophageal Carcinoma,Blood Derived Normal,WGS,University Health Network,HiSeq X Ten,Washington University School of Medicine,NO
16377,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16378,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16379,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16380,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16381,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16382,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16383,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16384,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16385,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16386,Esophageal Carcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16387,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16388,Esophageal Carcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16389,Esophageal Carcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16390,Esophageal Carcinoma,Primary Tumor,WGS,Christiana Care,HiSeq X Ten,Washington University School of Medicine,NO
16391,Esophageal Carcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16392,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16393,Esophageal Carcinoma,Primary Tumor,WGS,Duke University,HiSeq X Ten,Washington University School of Medicine,NO
16394,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16395,Esophageal Carcinoma,Primary Tumor,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16396,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16397,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16398,Esophageal Carcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16399,Esophageal Carcinoma,Primary Tumor,WGS,Christiana Care,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16400,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16401,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16402,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16403,Esophageal Carcinoma,Solid Tissue Normal,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16404,Esophageal Carcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16405,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,HiSeq X Ten,Washington University School of Medicine,NO
16406,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16407,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16408,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16409,Esophageal Carcinoma,Solid Tissue Normal,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16410,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16411,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16412,Esophageal Carcinoma,Blood Derived Normal,WGS,Asterand,HiSeq X Ten,Washington University School of Medicine,NO
16413,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16414,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16415,Esophageal Carcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16416,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16417,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16418,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16419,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16420,Esophageal Carcinoma,Solid Tissue Normal,RNA-Seq,Duke University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16421,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16422,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16423,Esophageal Carcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16424,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16425,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16426,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16427,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Duke University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16428,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16429,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16430,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16431,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16432,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16433,Esophageal Carcinoma,Solid Tissue Normal,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16434,Esophageal Carcinoma,Solid Tissue Normal,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16435,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16436,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16437,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16438,Esophageal Carcinoma,Primary Tumor,WGS,University of Michigan,HiSeq X Ten,Washington University School of Medicine,NO
16439,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16440,Esophageal Carcinoma,Primary Tumor,WGS,University of Michigan,HiSeq X Ten,Washington University School of Medicine,NO
16441,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16442,Esophageal Carcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16443,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16444,Esophageal Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16445,Esophageal Carcinoma,Primary Tumor,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16446,Esophageal Carcinoma,Primary Tumor,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16447,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16448,Esophageal Carcinoma,Metastatic,WGS,Duke University,HiSeq X Ten,Washington University School of Medicine,NO
16449,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16450,Esophageal Carcinoma,Primary Tumor,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16451,Esophageal Carcinoma,Solid Tissue Normal,WGS,University of Michigan,HiSeq X Ten,Washington University School of Medicine,NO
16452,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16453,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16454,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16455,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16456,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,HiSeq X Ten,Washington University School of Medicine,NO
16457,Esophageal Carcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16458,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16459,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,HiSeq X Ten,Washington University School of Medicine,NO
16460,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16461,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,HiSeq X Ten,Washington University School of Medicine,NO
16462,Esophageal Carcinoma,Solid Tissue Normal,WGS,University of Michigan,HiSeq X Ten,Washington University School of Medicine,NO
16463,Esophageal Carcinoma,Primary Tumor,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16464,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16465,Esophageal Carcinoma,Solid Tissue Normal,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16466,Esophageal Carcinoma,Primary Tumor,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16467,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16468,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16469,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16470,Esophageal Carcinoma,Primary Tumor,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16471,Esophageal Carcinoma,Primary Tumor,RNA-Seq,St. Joseph's Hospital Arizona,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16472,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Tayside Tissue Bank,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16473,Esophageal Carcinoma,Solid Tissue Normal,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16474,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16475,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16476,Esophageal Carcinoma,Primary Tumor,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16477,Esophageal Carcinoma,Solid Tissue Normal,RNA-Seq,Duke University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16478,Esophageal Carcinoma,Blood Derived Normal,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16479,Esophageal Carcinoma,Solid Tissue Normal,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16480,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16481,Esophageal Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16482,Esophageal Carcinoma,Primary Tumor,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16483,Esophageal Carcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16484,Esophageal Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16485,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16486,Esophageal Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16487,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16488,Esophageal Carcinoma,Primary Tumor,WGS,University of Michigan,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16489,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16490,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16491,Esophageal Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16492,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16493,Esophageal Carcinoma,Solid Tissue Normal,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16494,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16495,Esophageal Carcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16496,Esophageal Carcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16497,Esophageal Carcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16498,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16499,Esophageal Carcinoma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16500,Esophageal Carcinoma,Primary Tumor,WGS,ILSbio,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16501,Esophageal Carcinoma,Primary Tumor,WGS,University Health Network,HiSeq X Ten,Washington University School of Medicine,NO
16502,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16503,Esophageal Carcinoma,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16504,Esophageal Carcinoma,Primary Tumor,WGS,University of Michigan,HiSeq X Ten,Washington University School of Medicine,NO
16505,Esophageal Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,Canada's Michael Smith Genome Sciences Centre,NO
16506,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
16507,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16508,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
16509,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Harvard Medical School,NO
16510,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,NCI HRE Branch,Illumina HiSeq,University of North Carolina,NO
16511,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16512,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16513,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16514,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16515,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
16516,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Medical College of Wisconsin,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16517,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,University of North Carolina,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16518,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16519,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
16520,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Medical College of Wisconsin,Illumina HiSeq,Washington University School of Medicine,NO
16521,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
16522,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,NCI HRE Branch,Illumina HiSeq,University of North Carolina,NO
16523,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Harvard Medical School,NO
16524,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,University of North Carolina,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16525,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16526,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16527,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
16528,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
16529,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,NCI HRE Branch,Illumina HiSeq,University of North Carolina,NO
16530,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16531,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,NCI HRE Branch,Illumina HiSeq,University of North Carolina,NO
16532,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
16533,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16534,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Medical College of Wisconsin,Illumina HiSeq,Washington University School of Medicine,NO
16535,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Alabama,Illumina HiSeq,University of North Carolina,NO
16536,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Oklahoma HSC,Illumina HiSeq,University of North Carolina,NO
16537,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16538,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Washington University,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16539,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,MD Anderson - RPPA Core Facility (Proteomics),NO
16540,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Medical College of Wisconsin,Illumina HiSeq,Harvard Medical School,NO
16541,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16542,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,NCI HRE Branch,Illumina HiSeq,University of North Carolina,NO
16543,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Oklahoma HSC,Illumina HiSeq,University of North Carolina,NO
16544,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Medical College of Wisconsin,Illumina HiSeq,Washington University School of Medicine,NO
16545,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
16546,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
16547,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16548,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
16549,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16550,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16551,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16552,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16553,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Oklahoma HSC,Illumina HiSeq,University of North Carolina,NO
16554,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16555,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16556,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16557,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16558,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16559,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Montefiore Medical Center,Illumina HiSeq,University of North Carolina,NO
16560,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16561,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Medical College of Wisconsin,Illumina HiSeq,Harvard Medical School,NO
16562,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16563,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16564,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Medical College of Wisconsin,Illumina HiSeq,Washington University School of Medicine,NO
16565,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16566,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16567,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16568,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Washington,Illumina HiSeq,University of North Carolina,NO
16569,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
16570,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16571,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
16572,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16573,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Oklahoma HSC,Illumina HiSeq,University of North Carolina,NO
16574,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16575,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16576,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Oklahoma HSC,Illumina HiSeq,University of North Carolina,NO
16577,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16578,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Washington University,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16579,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16580,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16581,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Medical College of Wisconsin,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16582,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16583,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Medical College of Wisconsin,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16584,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16585,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Solid Tissue Normal,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16586,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16587,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Christiana Healthcare,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16588,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16589,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16590,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,MD Anderson - RPPA Core Facility (Proteomics),NO
16591,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16592,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16593,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,NCI HRE Branch,Illumina HiSeq,University of North Carolina,NO
16594,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16595,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16596,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Medical College of Wisconsin,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16597,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Medical College of Wisconsin,Illumina HiSeq,Washington University School of Medicine,NO
16598,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Medical College of Wisconsin,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16599,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16600,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16601,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
16602,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Washington University,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16603,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Medical College of Wisconsin,Illumina HiSeq,Washington University School of Medicine,NO
16604,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16605,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16606,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Medical College of Wisconsin,Illumina HiSeq,Washington University School of Medicine,NO
16607,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16608,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16609,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16610,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16611,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
16612,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16613,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16614,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16615,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
16616,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16617,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Medical College of Wisconsin,Illumina HiSeq,Washington University School of Medicine,NO
16618,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
16619,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Washington University School of Medicine,NO
16620,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Minnesota,Illumina HiSeq,University of North Carolina,NO
16621,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16622,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
16623,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
16624,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
16625,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16626,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16627,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16628,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16629,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16630,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
16631,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina HiSeq,University of North Carolina,NO
16632,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16633,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Medical College of Wisconsin,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16634,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Oklahoma HSC,Illumina HiSeq,University of North Carolina,NO
16635,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Washington University School of Medicine,NO
16636,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Harvard Medical School,NO
16637,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
16638,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Medical College of Wisconsin,Illumina HiSeq,Washington University School of Medicine,NO
16639,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
16640,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16641,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Oklahoma HSC,Illumina HiSeq,University of North Carolina,NO
16642,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
16643,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Oklahoma HSC,Illumina HiSeq,University of North Carolina,NO
16644,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16645,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16646,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Solid Tissue Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16647,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16648,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Washington University School of Medicine,NO
16649,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
16650,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Metastatic,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
16651,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16652,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
16653,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Montefiore Medical Center,Illumina HiSeq,University of North Carolina,NO
16654,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
16655,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16656,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16657,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16658,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16659,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
16660,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16661,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
16662,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16663,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16664,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16665,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Montefiore Medical Center,Illumina HiSeq,University of North Carolina,NO
16666,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Medical College of Wisconsin,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16667,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16668,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16669,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16670,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16671,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16672,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,University of North Carolina,NO
16673,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16674,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
16675,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
16676,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Harvard Medical School,NO
16677,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16678,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16679,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
16680,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
16681,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Medical College of Wisconsin,Illumina HiSeq,Washington University School of Medicine,NO
16682,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
16683,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,NCI HRE Branch,Illumina HiSeq,University of North Carolina,NO
16684,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
16685,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,CHI-Penrose Colorado,Illumina HiSeq,University of North Carolina,NO
16686,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16687,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16688,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16689,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Washington University School of Medicine,NO
16690,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16691,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
16692,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16693,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16694,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Ontario Institute for Cancer Research,Illumina HiSeq,Washington University School of Medicine,NO
16695,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Cedars Sinai,Illumina HiSeq,Washington University School of Medicine,NO
16696,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
16697,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Washington University School of Medicine,NO
16698,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
16699,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Oklahoma HSC,Illumina HiSeq,University of North Carolina,NO
16700,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16701,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
16702,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Medical College of Wisconsin,Illumina HiSeq,Washington University School of Medicine,NO
16703,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16704,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
16705,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,NCI HRE Branch,Illumina HiSeq,University of North Carolina,NO
16706,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16707,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Medical College of Wisconsin,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16708,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
16709,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
16710,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Medical College of Wisconsin,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16711,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Medical College of Wisconsin,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16712,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16713,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
16714,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16715,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
16716,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16717,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16718,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,University of North Carolina,NO
16719,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
16720,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Roswell Park,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16721,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Medical College of Wisconsin,Illumina HiSeq,Washington University School of Medicine,NO
16722,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16723,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Ontario Institute for Cancer Research,Illumina HiSeq,Washington University School of Medicine,NO
16724,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16725,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,University of North Carolina,Illumina HiSeq,Washington University School of Medicine,NO
16726,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Montefiore Medical Center,Illumina HiSeq,University of North Carolina,NO
16727,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
16728,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
16729,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
16730,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16731,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Washington University School of Medicine,NO
16732,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Christiana Healthcare,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16733,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16734,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16735,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16736,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16737,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Oklahoma HSC,Illumina HiSeq,University of North Carolina,NO
16738,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16739,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16740,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
16741,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
16742,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16743,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Medical College of Wisconsin,Illumina HiSeq,Washington University School of Medicine,NO
16744,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
16745,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16746,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
16747,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16748,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
16749,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
16750,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16751,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16752,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Hawaii,Illumina HiSeq,University of North Carolina,NO
16753,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16754,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,University of North Carolina,Illumina HiSeq,Washington University School of Medicine,NO
16755,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16756,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16757,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
16758,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16759,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Washington University School of Medicine,NO
16760,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16761,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16762,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16763,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16764,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16765,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16766,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16767,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16768,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16769,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
16770,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16771,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16772,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16773,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16774,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,NCI HRE Branch,Illumina HiSeq,University of North Carolina,NO
16775,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16776,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Oklahoma HSC,Illumina HiSeq,University of North Carolina,NO
16777,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Washington,Illumina HiSeq,University of North Carolina,NO
16778,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16779,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16780,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
16781,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16782,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16783,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16784,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16785,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
16786,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16787,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16788,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16789,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16790,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16791,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Harvard Medical School,NO
16792,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Metastatic,RNA-Seq,University of Washington,Illumina HiSeq,University of North Carolina,NO
16793,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16794,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16795,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16796,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16797,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16798,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16799,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Kansas,Illumina HiSeq,University of North Carolina,NO
16800,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,NCI HRE Branch,Illumina HiSeq,University of North Carolina,NO
16801,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
16802,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16803,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,ILSBIO,Illumina HiSeq,University of North Carolina,NO
16804,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Washington University,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16805,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16806,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16807,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16808,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16809,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16810,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
16811,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,NCI HRE Branch,Illumina HiSeq,University of North Carolina,NO
16812,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Medical College of Wisconsin,Illumina HiSeq,Washington University School of Medicine,NO
16813,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16814,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16815,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16816,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16817,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Medical College of Wisconsin,Illumina HiSeq,Washington University School of Medicine,NO
16818,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16819,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
16820,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16821,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,NCI HRE Branch,Illumina HiSeq,University of North Carolina,NO
16822,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16823,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Minnesota,Illumina HiSeq,University of North Carolina,NO
16824,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16825,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16826,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16827,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Medical College of Wisconsin,Illumina HiSeq,Washington University School of Medicine,NO
16828,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16829,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Medical College of Wisconsin,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16830,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16831,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
16832,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16833,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
16834,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Cedars Sinai,Illumina HiSeq,Washington University School of Medicine,NO
16835,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16836,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16837,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16838,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Medical College of Wisconsin,Illumina HiSeq,Washington University School of Medicine,NO
16839,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Washington,Illumina HiSeq,University of North Carolina,NO
16840,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16841,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Medical College of Wisconsin,Illumina HiSeq,Washington University School of Medicine,NO
16842,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16843,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16844,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16845,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16846,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Washington University,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16847,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16848,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16849,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Washington University School of Medicine,NO
16850,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,"Proteogenex, Inc",Illumina HiSeq,University of North Carolina,NO
16851,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
16852,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16853,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Medical College of Wisconsin,Illumina HiSeq,Harvard Medical School,NO
16854,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
16855,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
16856,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Minnesota,Illumina HiSeq,University of North Carolina,NO
16857,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Harvard Medical School,NO
16858,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Medical College of Wisconsin,Illumina HiSeq,Washington University School of Medicine,NO
16859,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Harvard Medical School,NO
16860,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
16861,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
16862,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Medical College of Wisconsin,Illumina HiSeq,Harvard Medical School,NO
16863,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
16864,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16865,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Medical College of Wisconsin,Illumina HiSeq,Washington University School of Medicine,NO
16866,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Medical College of Wisconsin,Illumina HiSeq,Washington University School of Medicine,NO
16867,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16868,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16869,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16870,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16871,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16872,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,NCI HRE Branch,Illumina HiSeq,University of North Carolina,NO
16873,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Medical College of Wisconsin,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16874,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16875,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
16876,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16877,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
16878,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16879,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16880,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16881,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
16882,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
16883,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16884,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16885,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Gynecologic Oncology Group,Illumina HiSeq,Harvard Medical School,NO
16886,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16887,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - RPPA Core Facility (Proteomics),NO
16888,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
16889,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16890,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
16891,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16892,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16893,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research,Illumina HiSeq,University of North Carolina,NO
16894,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,NCI HRE Branch,Illumina HiSeq,University of North Carolina,NO
16895,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16896,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16897,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
16898,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16899,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16900,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16901,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Medical College of Wisconsin,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16902,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Washington University School of Medicine,NO
16903,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16904,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
16905,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16906,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,NCI HRE Branch,Illumina HiSeq,University of North Carolina,NO
16907,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16908,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16909,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of New Mexico,Illumina HiSeq,University of North Carolina,NO
16910,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16911,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16912,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,University of North Carolina,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16913,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Institute of Human Virology Nigeria,Illumina HiSeq,University of North Carolina,NO
16914,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16915,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16916,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16917,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
16918,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
16919,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Medical College of Wisconsin,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16920,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Roswell Park,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16921,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16922,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16923,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
16924,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - RPPA Core Facility (Proteomics),NO
16925,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16926,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Memorial Sloan Kettering,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16927,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Medical College of Wisconsin,Illumina HiSeq,Washington University School of Medicine,NO
16928,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16929,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16930,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Washington University,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16931,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,International Genomics Consortium,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16932,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16933,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Montefiore Medical Center,Illumina HiSeq,University of North Carolina,NO
16934,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
16935,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16936,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16937,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16938,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
16939,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16940,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,NCI HRE Branch,Illumina HiSeq,University of North Carolina,NO
16941,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Medical College of Wisconsin,Illumina HiSeq,Washington University School of Medicine,NO
16942,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
16943,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16944,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,University of North Carolina,NO
16945,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,University of North Carolina,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16946,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
16947,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,University of North Carolina,NO
16948,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Gynecologic Oncology Group,Illumina HiSeq,University of North Carolina,NO
16949,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Gynecologic Oncology Group,Illumina HiSeq,Washington University School of Medicine,NO
16950,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,WGS,Medical College of Wisconsin,Illumina HiSeq,Washington University School of Medicine,NO
16951,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16952,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,University of Washington,Illumina HiSeq,University of North Carolina,NO
16953,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16954,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Blood Derived Normal,WGS,Asterand,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
16955,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
16956,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
16957,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Fundacio Clinic per a la Recerca Biomedica,Illumina HiSeq,University of North Carolina,NO
16958,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Blood Derived Normal,WGS,SingHealth,Illumina HiSeq,Baylor College of Medicine,NO
16959,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,University of Nebraska Medical Center (UNMC),Illumina HiSeq,University of North Carolina,NO
16960,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
16961,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
16962,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,University of North Carolina,NO
16963,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Fundacio Clinic per a la Recerca Biomedica,Illumina HiSeq,University of North Carolina,NO
16964,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,SingHealth,Illumina HiSeq,University of North Carolina,NO
16965,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Fundacio Clinic per a la Recerca Biomedica,Illumina HiSeq,University of North Carolina,NO
16966,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16967,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
16968,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,WGS,SingHealth,Illumina HiSeq,Baylor College of Medicine,NO
16969,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16970,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
16971,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Blood Derived Normal,WGS,SingHealth,Illumina HiSeq,Baylor College of Medicine,NO
16972,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,SingHealth,Illumina HiSeq,University of North Carolina,NO
16973,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,SingHealth,Illumina HiSeq,University of North Carolina,NO
16974,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,WGS,SingHealth,Illumina HiSeq,Baylor College of Medicine,NO
16975,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16976,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,SingHealth,Illumina HiSeq,University of North Carolina,NO
16977,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,University of North Carolina,NO
16978,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,WGS,SingHealth,Illumina HiSeq,Baylor College of Medicine,NO
16979,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Fundacio Clinic per a la Recerca Biomedica,Illumina HiSeq,University of North Carolina,NO
16980,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,University of North Carolina,NO
16981,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Global BioClinical - Georgia,Illumina HiSeq,University of North Carolina,NO
16982,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,University of Nebraska Medical Center (UNMC),Illumina HiSeq,University of North Carolina,NO
16983,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16984,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,SingHealth,Illumina HiSeq,University of North Carolina,NO
16985,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16986,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Blood Derived Normal,WGS,SingHealth,Illumina HiSeq,Baylor College of Medicine,NO
16987,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Fundacio Clinic per a la Recerca Biomedica,Illumina HiSeq,University of North Carolina,NO
16988,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,University of Nebraska Medical Center (UNMC),Illumina HiSeq,University of North Carolina,NO
16989,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,WGS,SingHealth,Illumina HiSeq,Baylor College of Medicine,NO
16990,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,University of Nebraska Medical Center (UNMC),Illumina HiSeq,University of North Carolina,NO
16991,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,SingHealth,Illumina HiSeq,University of North Carolina,NO
16992,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Blood Derived Normal,WGS,SingHealth,Illumina HiSeq,Baylor College of Medicine,NO
16993,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,WGS,SingHealth,Illumina HiSeq,Baylor College of Medicine,NO
16994,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Blood Derived Normal,WGS,SingHealth,Illumina HiSeq,Baylor College of Medicine,NO
16995,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
16996,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16997,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,WGS,SingHealth,Illumina HiSeq,Baylor College of Medicine,NO
16998,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
16999,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Fundacio Clinic per a la Recerca Biomedica,Illumina HiSeq,University of North Carolina,NO
17000,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Fundacio Clinic per a la Recerca Biomedica,Illumina HiSeq,University of North Carolina,NO
17001,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Fundacio Clinic per a la Recerca Biomedica,Illumina HiSeq,University of North Carolina,NO
17002,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,SingHealth,Illumina HiSeq,University of North Carolina,NO
17003,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
17004,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Blood Derived Normal,WGS,SingHealth,Illumina HiSeq,Baylor College of Medicine,NO
17005,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
17006,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,SingHealth,Illumina HiSeq,University of North Carolina,NO
17007,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,SingHealth,Illumina HiSeq,University of North Carolina,NO
17008,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
17009,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
17010,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,University of Nebraska Medical Center (UNMC),Illumina HiSeq,University of North Carolina,NO
17011,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Fundacio Clinic per a la Recerca Biomedica,Illumina HiSeq,University of North Carolina,NO
17012,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,SingHealth,Illumina HiSeq,University of North Carolina,NO
17013,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,University of Nebraska Medical Center (UNMC),Illumina HiSeq,University of North Carolina,NO
17014,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,SingHealth,Illumina HiSeq,University of North Carolina,NO
17015,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Fundacio Clinic per a la Recerca Biomedica,Illumina HiSeq,University of North Carolina,NO
17016,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,WGS,SingHealth,Illumina HiSeq,Baylor College of Medicine,NO
17017,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Blood Derived Normal,WGS,SingHealth,Illumina HiSeq,Baylor College of Medicine,NO
17018,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
17019,Uveal Melanoma,Primary Tumor,RNA-Seq,The Ohio State University,Illumina HiSeq,University of North Carolina,NO
17020,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17021,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17022,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17023,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17024,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17025,Uveal Melanoma,Primary Tumor,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17026,Uveal Melanoma,Primary Tumor,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17027,Uveal Melanoma,Primary Tumor,WGS,Cleveland Clinic Foundation,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17028,Uveal Melanoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
17029,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17030,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17031,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17032,Uveal Melanoma,Blood Derived Normal,WGS,Cleveland Clinic Foundation,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17033,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17034,Uveal Melanoma,Blood Derived Normal,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17035,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17036,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17037,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17038,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17039,Uveal Melanoma,Blood Derived Normal,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17040,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17041,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17042,Uveal Melanoma,Blood Derived Normal,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17043,Uveal Melanoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
17044,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17045,Uveal Melanoma,Primary Tumor,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17046,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17047,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17048,Uveal Melanoma,Primary Tumor,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17049,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17050,Uveal Melanoma,Primary Tumor,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17051,Uveal Melanoma,Primary Tumor,RNA-Seq,The Ohio State University,Illumina HiSeq,University of North Carolina,NO
17052,Uveal Melanoma,Primary Tumor,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17053,Uveal Melanoma,Blood Derived Normal,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17054,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17055,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17056,Uveal Melanoma,Primary Tumor,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17057,Uveal Melanoma,Primary Tumor,WGS,Wills Eye Institute,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17058,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17059,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17060,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17061,Uveal Melanoma,Primary Tumor,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17062,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17063,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17064,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17065,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17066,Uveal Melanoma,Blood Derived Normal,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17067,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17068,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17069,Uveal Melanoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
17070,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17071,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17072,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17073,Uveal Melanoma,Primary Tumor,RNA-Seq,Wills Eye Institute,Illumina HiSeq,University of North Carolina,NO
17074,Uveal Melanoma,Primary Tumor,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17075,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17076,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17077,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17078,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17079,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17080,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17081,Uveal Melanoma,Primary Tumor,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17082,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17083,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17084,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17085,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17086,Uveal Melanoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
17087,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17088,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17089,Uveal Melanoma,Primary Tumor,RNA-Seq,The Ohio State University,Illumina HiSeq,University of North Carolina,NO
17090,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17091,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17092,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17093,Uveal Melanoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
17094,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17095,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17096,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17097,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17098,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17099,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17100,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17101,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17102,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17103,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17104,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17105,Uveal Melanoma,Blood Derived Normal,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17106,Uveal Melanoma,Primary Tumor,WGS,Cleveland Clinic Foundation,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17107,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17108,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17109,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17110,Uveal Melanoma,Blood Derived Normal,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - RPPA Core Facility (Proteomics),NO
17111,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17112,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17113,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17114,Uveal Melanoma,Primary Tumor,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17115,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17116,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17117,Uveal Melanoma,Blood Derived Normal,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17118,Uveal Melanoma,Primary Tumor,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17119,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17120,Uveal Melanoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
17121,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17122,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17123,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17124,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17125,Uveal Melanoma,Primary Tumor,RNA-Seq,The Ohio State University,Illumina HiSeq,University of North Carolina,NO
17126,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17127,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17128,Uveal Melanoma,Blood Derived Normal,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17129,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17130,Uveal Melanoma,Blood Derived Normal,WGS,Wills Eye Institute,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17131,Uveal Melanoma,Primary Tumor,RNA-Seq,The Ohio State University,Illumina HiSeq,University of North Carolina,NO
17132,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17133,Uveal Melanoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
17134,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17135,Uveal Melanoma,Primary Tumor,RNA-Seq,Cleveland Clinic Foundation,Illumina HiSeq,University of North Carolina,NO
17136,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17137,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17138,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17139,Uveal Melanoma,Blood Derived Normal,WGS,Cleveland Clinic Foundation,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17140,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17141,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17142,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17143,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17144,Uveal Melanoma,Primary Tumor,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17145,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17146,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17147,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17148,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17149,Uveal Melanoma,Primary Tumor,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17150,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17151,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17152,Uveal Melanoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
17153,Uveal Melanoma,Primary Tumor,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17154,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17155,Uveal Melanoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
17156,Uveal Melanoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
17157,Uveal Melanoma,Blood Derived Normal,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17158,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17159,Uveal Melanoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
17160,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17161,Uveal Melanoma,Primary Tumor,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17162,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17163,Uveal Melanoma,Blood Derived Normal,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17164,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17165,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17166,Uveal Melanoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
17167,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17168,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17169,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17170,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17171,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17172,Uveal Melanoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
17173,Uveal Melanoma,Primary Tumor,RNA-Seq,Cleveland Clinic Foundation,Illumina HiSeq,University of North Carolina,NO
17174,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17175,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17176,Uveal Melanoma,Primary Tumor,RNA-Seq,University of Liverpool,Illumina HiSeq,University of North Carolina,NO
17177,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17178,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17179,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17180,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17181,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17182,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17183,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17184,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17185,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17186,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17187,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17188,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17189,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17190,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17191,Uveal Melanoma,Blood Derived Normal,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17192,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17193,Uveal Melanoma,Primary Tumor,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17194,Uveal Melanoma,Primary Tumor,RNA-Seq,Institut Curie,Illumina HiSeq,University of North Carolina,NO
17195,Uveal Melanoma,Blood Derived Normal,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17196,Uveal Melanoma,Blood Derived Normal,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17197,Uveal Melanoma,Blood Derived Normal,WGS,Institut Curie,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17198,Uveal Melanoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
17199,Uveal Melanoma,Blood Derived Normal,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17200,Uveal Melanoma,Blood Derived Normal,WGS,University of Liverpool,Illumina HiSeq,MD Anderson - Institute for Applied Cancer Science,NO
17201,Pheochromocytoma and Paraganglioma,Metastatic,RNA-Seq,Tufts Medical Center,Illumina HiSeq,University of North Carolina,NO
17202,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University Hospital Motol,Illumina HiSeq,University of North Carolina,NO
17203,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17204,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,University of North Carolina,NO
17205,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17206,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
17207,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17208,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Tufts Medical Center,Illumina HiSeq,University of North Carolina,NO
17209,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17210,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17211,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Tufts Medical Center,Illumina HiSeq,University of North Carolina,NO
17212,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University Hospital Motol,Illumina HiSeq,University of North Carolina,NO
17213,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Michigan University,Illumina HiSeq,University of North Carolina,NO
17214,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Michigan University,Illumina HiSeq,University of North Carolina,NO
17215,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
17216,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17217,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17218,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17219,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17220,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17221,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17222,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17223,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17224,Pheochromocytoma and Paraganglioma,Additional - New Primary,RNA-Seq,Translational Genomics Research Institute,Illumina HiSeq,University of North Carolina,NO
17225,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17226,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17227,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17228,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17229,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17230,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17231,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University of Minnesota,Illumina HiSeq,University of North Carolina,NO
17232,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University Hospital Motol,Illumina HiSeq,University of North Carolina,NO
17233,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17234,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Translational Genomics Research Institute,Illumina HiSeq,University of North Carolina,NO
17235,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
17236,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17237,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17238,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17239,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
17240,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17241,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Michigan University,Illumina HiSeq,University of North Carolina,NO
17242,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17243,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17244,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17245,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
17246,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17247,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17248,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Michigan University,Illumina HiSeq,University of North Carolina,NO
17249,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17250,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Michigan University,Illumina HiSeq,University of North Carolina,NO
17251,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University Hospital Motol,Illumina HiSeq,University of North Carolina,NO
17252,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17253,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17254,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17255,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17256,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17257,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17258,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University Hospital Motol,Illumina HiSeq,University of North Carolina,NO
17259,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Michigan University,Illumina HiSeq,University of North Carolina,NO
17260,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Tufts Medical Center,Illumina HiSeq,University of North Carolina,NO
17261,Pheochromocytoma and Paraganglioma,Metastatic,RNA-Seq,Michigan University,Illumina HiSeq,University of North Carolina,NO
17262,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Cleveland Clinic Foundation,Illumina HiSeq,University of North Carolina,NO
17263,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
17264,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17265,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17266,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
17267,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
17268,Pheochromocytoma and Paraganglioma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
17269,Pheochromocytoma and Paraganglioma,Solid Tissue Normal,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
17270,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17271,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17272,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17273,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
17274,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17275,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Tufts Medical Center,Illumina HiSeq,University of North Carolina,NO
17276,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17277,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17278,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17279,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Michigan University,Illumina HiSeq,University of North Carolina,NO
17280,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
17281,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17282,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17283,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17284,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17285,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
17286,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17287,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Tufts Medical Center,Illumina HiSeq,University of North Carolina,NO
17288,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17289,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17290,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Cleveland Clinic Foundation,Illumina HiSeq,University of North Carolina,NO
17291,Pheochromocytoma and Paraganglioma,Additional - New Primary,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17292,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17293,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17294,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17295,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17296,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17297,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17298,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
17299,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17300,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17301,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17302,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17303,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17304,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,University of North Carolina,NO
17305,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University Hospital Motol,Illumina HiSeq,University of North Carolina,NO
17306,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Cleveland Clinic Foundation,Illumina HiSeq,University of North Carolina,NO
17307,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Michigan University,Illumina HiSeq,University of North Carolina,NO
17308,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University Hospital Motol,Illumina HiSeq,University of North Carolina,NO
17309,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17310,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17311,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
17312,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Tufts Medical Center,Illumina HiSeq,University of North Carolina,NO
17313,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17314,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17315,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Michigan University,Illumina HiSeq,University of North Carolina,NO
17316,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
17317,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17318,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17319,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17320,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17321,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
17322,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17323,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17324,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17325,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17326,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17327,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Michigan University,Illumina HiSeq,University of North Carolina,NO
17328,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Tufts Medical Center,Illumina HiSeq,University of North Carolina,NO
17329,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
17330,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Tufts Medical Center,Illumina HiSeq,University of North Carolina,NO
17331,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17332,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17333,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
17334,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17335,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University Hospital Motol,Illumina HiSeq,University of North Carolina,NO
17336,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University Hospital Motol,Illumina HiSeq,University of North Carolina,NO
17337,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17338,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
17339,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17340,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Tufts Medical Center,Illumina HiSeq,University of North Carolina,NO
17341,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University Hospital Motol,Illumina HiSeq,University of North Carolina,NO
17342,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Michigan University,Illumina HiSeq,University of North Carolina,NO
17343,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17344,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17345,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Michigan University,Illumina HiSeq,University of North Carolina,NO
17346,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
17347,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17348,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Michigan University,Illumina HiSeq,University of North Carolina,NO
17349,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Michigan University,Illumina HiSeq,University of North Carolina,NO
17350,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Translational Genomics Research Institute,Illumina HiSeq,University of North Carolina,NO
17351,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
17352,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Michigan University,Illumina HiSeq,University of North Carolina,NO
17353,Pheochromocytoma and Paraganglioma,Additional - New Primary,RNA-Seq,Tufts Medical Center,Illumina HiSeq,University of North Carolina,NO
17354,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Michigan University,Illumina HiSeq,University of North Carolina,NO
17355,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17356,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
17357,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17358,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Michigan University,Illumina HiSeq,University of North Carolina,NO
17359,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17360,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University Hospital Motol,Illumina HiSeq,University of North Carolina,NO
17361,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17362,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,BLN UT Southwestern Medical Center at Dallas,Illumina HiSeq,University of North Carolina,NO
17363,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Michigan University,Illumina HiSeq,University of North Carolina,NO
17364,Pheochromocytoma and Paraganglioma,Solid Tissue Normal,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17365,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17366,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Tufts Medical Center,Illumina HiSeq,University of North Carolina,NO
17367,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Michigan University,Illumina HiSeq,University of North Carolina,NO
17368,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17369,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17370,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17371,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University Hospital Motol,Illumina HiSeq,University of North Carolina,NO
17372,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
17373,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17374,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
17375,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Tufts Medical Center,Illumina HiSeq,University of North Carolina,NO
17376,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
17377,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17378,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
17379,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
17380,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Medical College of Wisconsin,Illumina HiSeq,University of North Carolina,NO
17381,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University Hospital Motol,Illumina HiSeq,University of North Carolina,NO
17382,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University Hospital Motol,Illumina HiSeq,University of North Carolina,NO
17383,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,National Institutes of Health,Illumina HiSeq,University of North Carolina,NO
17384,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Michigan University,Illumina HiSeq,University of North Carolina,NO
17385,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17386,Pheochromocytoma and Paraganglioma,Primary Tumor,RNA-Seq,University Hospital Motol,Illumina HiSeq,University of North Carolina,NO
17387,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17388,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17389,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
17390,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17391,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17392,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
17393,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17394,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17395,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17396,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17397,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
17398,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
17399,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,University of North Carolina,NO
17400,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
17401,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
17402,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
17403,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
17404,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Providence Portland Medical Center,Illumina HiSeq,University of North Carolina,NO
17405,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Columbia University,Illumina HiSeq,University of North Carolina,NO
17406,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
17407,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17408,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
17409,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
17410,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17411,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Providence Portland Medical Center,Illumina HiSeq,University of North Carolina,NO
17412,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17413,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
17414,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
17415,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
17416,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
17417,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17418,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17419,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
17420,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17421,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Saint Mary's Health Care,Illumina HiSeq,University of North Carolina,NO
17422,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
17423,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17424,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
17425,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
17426,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17427,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
17428,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17429,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17430,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
17431,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Ontario Institute for Cancer Research (OICR),Illumina HiSeq,University of North Carolina,NO
17432,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
17433,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Providence Portland Medical Center,Illumina HiSeq,University of North Carolina,NO
17434,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17435,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
17436,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
17437,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17438,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17439,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,University of North Carolina,NO
17440,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
17441,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17442,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
17443,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,University of North Carolina,NO
17444,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
17445,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
17446,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
17447,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17448,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17449,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17450,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,University of North Carolina,NO
17451,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17452,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
17453,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
17454,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
17455,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17456,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17457,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
17458,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17459,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
17460,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17461,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Garvan Institute of Medical Research,Illumina HiSeq,University of North Carolina,NO
17462,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
17463,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Garvan Institute of Medical Research,Illumina HiSeq,University of North Carolina,NO
17464,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17465,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17466,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
17467,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
17468,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17469,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17470,Pancreatic Adenocarcinoma,Metastatic,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17471,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
17472,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,University of Oklahoma HSC,Illumina HiSeq,University of North Carolina,NO
17473,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17474,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17475,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
17476,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17477,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
17478,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17479,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17480,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
17481,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
17482,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17483,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17484,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17485,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,ABS - IUPUI,Illumina HiSeq,University of North Carolina,NO
17486,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
17487,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17488,Pancreatic Adenocarcinoma,Solid Tissue Normal,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,University of North Carolina,NO
17489,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Garvan Institute of Medical Research,Illumina HiSeq,University of North Carolina,NO
17490,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
17491,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
17492,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17493,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,University of North Carolina,NO
17494,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17495,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
17496,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
17497,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
17498,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
17499,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
17500,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,University of North Carolina,NO
17501,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Technical University of Munich,Illumina HiSeq,University of North Carolina,NO
17502,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17503,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17504,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
17505,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Columbia University,Illumina HiSeq,University of North Carolina,NO
17506,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17507,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
17508,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17509,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17510,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
17511,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17512,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17513,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
17514,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17515,Pancreatic Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
17516,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Garvan Institute of Medical Research,Illumina HiSeq,University of North Carolina,NO
17517,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17518,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
17519,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,University of North Carolina,NO
17520,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
17521,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
17522,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17523,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Providence Portland Medical Center,Illumina HiSeq,University of North Carolina,NO
17524,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17525,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
17526,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
17527,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Technical University of Munich,Illumina HiSeq,University of North Carolina,NO
17528,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17529,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
17530,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Cureline,Illumina HiSeq,University of North Carolina,NO
17531,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,University of North Carolina,NO
17532,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17533,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
17534,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
17535,Pancreatic Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Christiana Healthcare,Illumina HiSeq,University of North Carolina,NO
17536,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
17537,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17538,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,UNC,Illumina HiSeq,University of North Carolina,NO
17539,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17540,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Candler,Illumina HiSeq,University of North Carolina,NO
17541,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17542,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic,Illumina HiSeq,University of North Carolina,NO
17543,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17544,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Technical University of Munich,Illumina HiSeq,University of North Carolina,NO
17545,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17546,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Moffitt Cancer Center,Illumina HiSeq,University of North Carolina,NO
17547,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
17548,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17549,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,University of Oklahoma HSC,Illumina HiSeq,University of North Carolina,NO
17550,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17551,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
17552,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Garvan Institute of Medical Research,Illumina HiSeq,University of North Carolina,NO
17553,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,University of Sao Paulo,Illumina HiSeq,University of North Carolina,NO
17554,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17555,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17556,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
17557,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Asterand,Illumina HiSeq,University of North Carolina,NO
17558,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,University of North Carolina,NO
17559,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,National Cancer Center Korea,Illumina HiSeq,University of North Carolina,NO
17560,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Garvan Institute of Medical Research,Illumina HiSeq,University of North Carolina,NO
17561,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Technical University of Munich,Illumina HiSeq,University of North Carolina,NO
17562,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Stanford University,Illumina HiSeq,University of North Carolina,NO
17563,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17564,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,University of North Carolina,NO
17565,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
17566,Pancreatic Adenocarcinoma,Solid Tissue Normal,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
17567,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Technical University of Munich,Illumina HiSeq,University of North Carolina,NO
17568,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Hartford,Illumina HiSeq,University of North Carolina,NO
17569,Pancreatic Adenocarcinoma,Primary Tumor,RNA-Seq,Technical University of Munich,Illumina HiSeq,University of North Carolina,NO
17570,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Gundersen Lutheran Health System,Illumina HiSeq,University of North Carolina,NO
17571,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17572,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
17573,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
17574,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
17575,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17576,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Minnesota,Illumina HiSeq,University of North Carolina,NO
17577,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17578,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17579,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17580,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17581,Testicular Germ Cell Tumors,Additional - New Primary,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17582,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
17583,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
17584,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
17585,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17586,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17587,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17588,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17589,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17590,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
17591,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
17592,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17593,Testicular Germ Cell Tumors,Additional - New Primary,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17594,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
17595,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17596,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17597,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17598,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17599,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17600,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17601,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
17602,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17603,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17604,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
17605,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Ulm,Illumina HiSeq,University of North Carolina,NO
17606,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
17607,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
17608,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Ulm,Illumina HiSeq,University of North Carolina,NO
17609,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17610,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17611,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
17612,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
17613,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17614,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
17615,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17616,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17617,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17618,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
17619,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17620,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17621,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17622,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17623,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17624,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17625,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17626,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17627,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
17628,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,"Proteogenex, Inc",Illumina HiSeq,University of North Carolina,NO
17629,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17630,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17631,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
17632,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17633,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
17634,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17635,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,"Proteogenex, Inc",Illumina HiSeq,University of North Carolina,NO
17636,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17637,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Ulm,Illumina HiSeq,University of North Carolina,NO
17638,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17639,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17640,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
17641,Testicular Germ Cell Tumors,Additional - New Primary,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17642,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Ulm,Illumina HiSeq,University of North Carolina,NO
17643,Testicular Germ Cell Tumors,Additional - New Primary,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17644,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17645,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17646,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17647,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17648,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17649,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Baylor College of Medicine,Illumina HiSeq,University of North Carolina,NO
17650,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17651,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17652,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
17653,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17654,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,"Proteogenex, Inc",Illumina HiSeq,University of North Carolina,NO
17655,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17656,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
17657,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
17658,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17659,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17660,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17661,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17662,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
17663,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17664,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Ulm,Illumina HiSeq,University of North Carolina,NO
17665,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17666,Testicular Germ Cell Tumors,Additional - New Primary,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17667,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17668,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,ABS IUPUI,Illumina HiSeq,University of North Carolina,NO
17669,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
17670,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17671,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17672,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
17673,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17674,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Baylor College of Medicine,Illumina HiSeq,University of North Carolina,NO
17675,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
17676,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17677,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17678,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
17679,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17680,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17681,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Gundersen Lutheran Health System,Illumina HiSeq,University of North Carolina,NO
17682,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17683,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
17684,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,"Proteogenex, Inc",Illumina HiSeq,University of North Carolina,NO
17685,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17686,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Ulm,Illumina HiSeq,University of North Carolina,NO
17687,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
17688,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
17689,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17690,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17691,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17692,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17693,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17694,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Gundersen Lutheran Health System,Illumina HiSeq,University of North Carolina,NO
17695,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
17696,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17697,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
17698,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
17699,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17700,Testicular Germ Cell Tumors,Additional - New Primary,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17701,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17702,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17703,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
17704,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17705,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,BLN - Baylor,Illumina HiSeq,University of North Carolina,NO
17706,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17707,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
17708,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17709,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Ulm,Illumina HiSeq,University of North Carolina,NO
17710,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
17711,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
17712,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Cleveland Clinic Foundation,Illumina HiSeq,University of North Carolina,NO
17713,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17714,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17715,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17716,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Ulm,Illumina HiSeq,University of North Carolina,NO
17717,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17718,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17719,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17720,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17721,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,ABS IUPUI,Illumina HiSeq,University of North Carolina,NO
17722,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17723,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Erasmus MC,Illumina HiSeq,University of North Carolina,NO
17724,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
17725,Testicular Germ Cell Tumors,Primary Tumor,RNA-Seq,University of Southern California,Illumina HiSeq,University of North Carolina,NO
17726,Thymoma,Primary Tumor,RNA-Seq,Regina Elena National Cancer Institute,Illumina HiSeq,University of North Carolina,NO
17727,Thymoma,Primary Tumor,RNA-Seq,Thoraxklinik,Illumina HiSeq,University of North Carolina,NO
17728,Thymoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17729,Thymoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17730,Thymoma,Primary Tumor,RNA-Seq,Thoraxklinik,Illumina HiSeq,University of North Carolina,NO
17731,Thymoma,Primary Tumor,RNA-Seq,ABS IUPUI,Illumina HiSeq,University of North Carolina,NO
17732,Thymoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
17733,Thymoma,Primary Tumor,RNA-Seq,Yale University,Illumina HiSeq,University of North Carolina,NO
17734,Thymoma,Primary Tumor,RNA-Seq,St. Joseph's Hospital (AZ),Illumina HiSeq,University of North Carolina,NO
17735,Thymoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
17736,Thymoma,Primary Tumor,RNA-Seq,Thoraxklinik,Illumina HiSeq,University of North Carolina,NO
17737,Thymoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
17738,Thymoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
17739,Thymoma,Primary Tumor,RNA-Seq,ABS IUPUI,Illumina HiSeq,University of North Carolina,NO
17740,Thymoma,Primary Tumor,RNA-Seq,Thoraxklinik,Illumina HiSeq,University of North Carolina,NO
17741,Thymoma,Primary Tumor,RNA-Seq,Thoraxklinik,Illumina HiSeq,University of North Carolina,NO
17742,Thymoma,Primary Tumor,RNA-Seq,ABS IUPUI,Illumina HiSeq,University of North Carolina,NO
17743,Thymoma,Primary Tumor,RNA-Seq,ABS IUPUI,Illumina HiSeq,University of North Carolina,NO
17744,Thymoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
17745,Thymoma,Primary Tumor,RNA-Seq,Thoraxklinik,Illumina HiSeq,University of North Carolina,NO
17746,Thymoma,Primary Tumor,RNA-Seq,ABS IUPUI,Illumina HiSeq,University of North Carolina,NO
17747,Thymoma,Primary Tumor,RNA-Seq,Hospital Louis Pradel,Illumina HiSeq,University of North Carolina,NO
17748,Thymoma,Primary Tumor,RNA-Seq,Thoraxklinik,Illumina HiSeq,University of North Carolina,NO
17749,Thymoma,Solid Tissue Normal,RNA-Seq,ABS IUPUI,Illumina HiSeq,University of North Carolina,NO
17750,Thymoma,Primary Tumor,RNA-Seq,ABS IUPUI,Illumina HiSeq,University of North Carolina,NO
17751,Thymoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17752,Thymoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
17753,Thymoma,Primary Tumor,RNA-Seq,ABS IUPUI,Illumina HiSeq,University of North Carolina,NO
17754,Thymoma,Primary Tumor,RNA-Seq,Thoraxklinik,Illumina HiSeq,University of North Carolina,NO
17755,Thymoma,Primary Tumor,RNA-Seq,Hospital Louis Pradel,Illumina HiSeq,University of North Carolina,NO
17756,Thymoma,Primary Tumor,RNA-Seq,ABS IUPUI,Illumina HiSeq,University of North Carolina,NO
17757,Thymoma,Primary Tumor,RNA-Seq,ABS IUPUI,Illumina HiSeq,University of North Carolina,NO
17758,Thymoma,Primary Tumor,RNA-Seq,Thoraxklinik,Illumina HiSeq,University of North Carolina,NO
17759,Thymoma,Primary Tumor,RNA-Seq,BLN Baylor,Illumina HiSeq,University of North Carolina,NO
17760,Thymoma,Primary Tumor,RNA-Seq,Thoraxklinik,Illumina HiSeq,University of North Carolina,NO
17761,Thymoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
17762,Thymoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
17763,Thymoma,Primary Tumor,RNA-Seq,Thoraxklinik,Illumina HiSeq,University of North Carolina,NO
17764,Thymoma,Primary Tumor,RNA-Seq,Hospital Louis Pradel,Illumina HiSeq,University of North Carolina,NO
17765,Thymoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17766,Thymoma,Primary Tumor,RNA-Seq,ABS IUPUI,Illumina HiSeq,University of North Carolina,NO
17767,Thymoma,Primary Tumor,RNA-Seq,Thoraxklinik,Illumina HiSeq,University of North Carolina,NO
17768,Thymoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17769,Thymoma,Primary Tumor,RNA-Seq,Regina Elena National Cancer Institute,Illumina HiSeq,University of North Carolina,NO
17770,Thymoma,Primary Tumor,RNA-Seq,Thoraxklinik,Illumina HiSeq,University of North Carolina,NO
17771,Thymoma,Primary Tumor,RNA-Seq,Yale University,Illumina HiSeq,University of North Carolina,NO
17772,Thymoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
17773,Thymoma,Primary Tumor,RNA-Seq,Yale University,Illumina HiSeq,University of North Carolina,NO
17774,Thymoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
17775,Thymoma,Primary Tumor,RNA-Seq,Thoraxklinik,Illumina HiSeq,University of North Carolina,NO
17776,Thymoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17777,Thymoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17778,Thymoma,Primary Tumor,RNA-Seq,ABS IUPUI,Illumina HiSeq,University of North Carolina,NO
17779,Thymoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17780,Thymoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
17781,Thymoma,Primary Tumor,RNA-Seq,Hospital Louis Pradel,Illumina HiSeq,University of North Carolina,NO
17782,Thymoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
17783,Thymoma,Primary Tumor,RNA-Seq,Hospital Louis Pradel,Illumina HiSeq,University of North Carolina,NO
17784,Thymoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17785,Thymoma,Primary Tumor,RNA-Seq,ABS IUPUI,Illumina HiSeq,University of North Carolina,NO
17786,Thymoma,Primary Tumor,RNA-Seq,Emory University,Illumina HiSeq,University of North Carolina,NO
17787,Thymoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17788,Thymoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
17789,Thymoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17790,Thymoma,Primary Tumor,RNA-Seq,ABS IUPUI,Illumina HiSeq,University of North Carolina,NO
17791,Thymoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
17792,Thymoma,Primary Tumor,RNA-Seq,Hospital Louis Pradel,Illumina HiSeq,University of North Carolina,NO
17793,Thymoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
17794,Thymoma,Primary Tumor,RNA-Seq,Hospital Louis Pradel,Illumina HiSeq,University of North Carolina,NO
17795,Thymoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17796,Thymoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17797,Thymoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
17798,Thymoma,Primary Tumor,RNA-Seq,Thoraxklinik,Illumina HiSeq,University of North Carolina,NO
17799,Thymoma,Primary Tumor,RNA-Seq,Thoraxklinik,Illumina HiSeq,University of North Carolina,NO
17800,Thymoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
17801,Thymoma,Primary Tumor,RNA-Seq,Hospital Louis Pradel,Illumina HiSeq,University of North Carolina,NO
17802,Thymoma,Primary Tumor,RNA-Seq,Thoraxklinik,Illumina HiSeq,University of North Carolina,NO
17803,Thymoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
17804,Thymoma,Primary Tumor,RNA-Seq,Thoraxklinik,Illumina HiSeq,University of North Carolina,NO
17805,Thymoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17806,Thymoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
17807,Thymoma,Primary Tumor,RNA-Seq,Cleveland Clinic Foundation,Illumina HiSeq,University of North Carolina,NO
17808,Thymoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17809,Thymoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
17810,Thymoma,Primary Tumor,RNA-Seq,ABS IUPUI,Illumina HiSeq,University of North Carolina,NO
17811,Thymoma,Primary Tumor,RNA-Seq,Yale University,Illumina HiSeq,University of North Carolina,NO
17812,Thymoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17813,Thymoma,Primary Tumor,RNA-Seq,Thoraxklinik,Illumina HiSeq,University of North Carolina,NO
17814,Thymoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17815,Thymoma,Primary Tumor,RNA-Seq,Hospital Louis Pradel,Illumina HiSeq,University of North Carolina,NO
17816,Thymoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17817,Thymoma,Solid Tissue Normal,RNA-Seq,ABS IUPUI,Illumina HiSeq,University of North Carolina,NO
17818,Thymoma,Primary Tumor,RNA-Seq,ABS IUPUI,Illumina HiSeq,University of North Carolina,NO
17819,Thymoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
17820,Thymoma,Primary Tumor,RNA-Seq,University of New Mexico,Illumina HiSeq,University of North Carolina,NO
17821,Thymoma,Primary Tumor,RNA-Seq,Hospital Louis Pradel,Illumina HiSeq,University of North Carolina,NO
17822,Thymoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
17823,Thymoma,Primary Tumor,RNA-Seq,Thoraxklinik,Illumina HiSeq,University of North Carolina,NO
17824,Thymoma,Primary Tumor,RNA-Seq,ABS IUPUI,Illumina HiSeq,University of North Carolina,NO
17825,Thymoma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
17826,Thymoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17827,Thymoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
17828,Thymoma,Primary Tumor,RNA-Seq,ABS IUPUI,Illumina HiSeq,University of North Carolina,NO
17829,Thymoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
17830,Thymoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
17831,Thymoma,Primary Tumor,RNA-Seq,Valley Hospital,Illumina HiSeq,University of North Carolina,NO
17832,Thymoma,Primary Tumor,RNA-Seq,Thoraxklinik,Illumina HiSeq,University of North Carolina,NO
17833,Thymoma,Primary Tumor,RNA-Seq,Yale University,Illumina HiSeq,University of North Carolina,NO
17834,Thymoma,Primary Tumor,RNA-Seq,University of New Mexico,Illumina HiSeq,University of North Carolina,NO
17835,Thymoma,Primary Tumor,RNA-Seq,Thoraxklinik,Illumina HiSeq,University of North Carolina,NO
17836,Thymoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
17837,Thymoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17838,Thymoma,Primary Tumor,RNA-Seq,ABS IUPUI,Illumina HiSeq,University of North Carolina,NO
17839,Thymoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
17840,Thymoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17841,Thymoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
17842,Thymoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
17843,Thymoma,Primary Tumor,RNA-Seq,Hospital Louis Pradel,Illumina HiSeq,University of North Carolina,NO
17844,Thymoma,Primary Tumor,RNA-Seq,Regina Elena National Cancer Institute,Illumina HiSeq,University of North Carolina,NO
17845,Thymoma,Primary Tumor,RNA-Seq,Greenville Health Systems,Illumina HiSeq,University of North Carolina,NO
17846,Thymoma,Primary Tumor,RNA-Seq,Thoraxklinik,Illumina HiSeq,University of North Carolina,NO
17847,Thymoma,Primary Tumor,RNA-Seq,Thoraxklinik,Illumina HiSeq,University of North Carolina,NO
17848,Mesothelioma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
17849,Mesothelioma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
17850,Mesothelioma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
17851,Mesothelioma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
17852,Mesothelioma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
17853,Mesothelioma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17854,Mesothelioma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
17855,Mesothelioma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
17856,Mesothelioma,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17857,Mesothelioma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
17858,Mesothelioma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
17859,Mesothelioma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
17860,Mesothelioma,Primary Tumor,RNA-Seq,Brigham and Women's Hospital Division of Thoracic Surgery,Illumina HiSeq,University of North Carolina,NO
17861,Mesothelioma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
17862,Mesothelioma,Primary Tumor,RNA-Seq,Papworth Hospital,Illumina HiSeq,University of North Carolina,NO
17863,Mesothelioma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
17864,Mesothelioma,Primary Tumor,RNA-Seq,Papworth Hospital,Illumina HiSeq,University of North Carolina,NO
17865,Mesothelioma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
17866,Mesothelioma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
17867,Mesothelioma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
17868,Mesothelioma,Primary Tumor,RNA-Seq,Brigham and Women's Hospital Division of Thoracic Surgery,Illumina HiSeq,University of North Carolina,NO
17869,Mesothelioma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
17870,Mesothelioma,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17871,Mesothelioma,Primary Tumor,RNA-Seq,Asbestos Diseases Research Institute,Illumina HiSeq,University of North Carolina,NO
17872,Mesothelioma,Primary Tumor,RNA-Seq,Papworth Hospital,Illumina HiSeq,University of North Carolina,NO
17873,Mesothelioma,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17874,Mesothelioma,Primary Tumor,RNA-Seq,Papworth Hospital,Illumina HiSeq,University of North Carolina,NO
17875,Mesothelioma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
17876,Mesothelioma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
17877,Mesothelioma,Primary Tumor,RNA-Seq,Brigham and Women's Hospital Division of Thoracic Surgery,Illumina HiSeq,University of North Carolina,NO
17878,Mesothelioma,Primary Tumor,RNA-Seq,Asbestos Diseases Research Institute,Illumina HiSeq,University of North Carolina,NO
17879,Mesothelioma,Primary Tumor,RNA-Seq,Asbestos Diseases Research Institute,Illumina HiSeq,University of North Carolina,NO
17880,Mesothelioma,Primary Tumor,RNA-Seq,Papworth Hospital,Illumina HiSeq,University of North Carolina,NO
17881,Mesothelioma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
17882,Mesothelioma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
17883,Mesothelioma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
17884,Mesothelioma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
17885,Mesothelioma,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17886,Mesothelioma,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17887,Mesothelioma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
17888,Mesothelioma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
17889,Mesothelioma,Primary Tumor,RNA-Seq,Brigham and Women's Hospital Division of Thoracic Surgery,Illumina HiSeq,University of North Carolina,NO
17890,Mesothelioma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
17891,Mesothelioma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
17892,Mesothelioma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
17893,Mesothelioma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
17894,Mesothelioma,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17895,Mesothelioma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
17896,Mesothelioma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
17897,Mesothelioma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
17898,Mesothelioma,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17899,Mesothelioma,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17900,Mesothelioma,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17901,Mesothelioma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
17902,Mesothelioma,Primary Tumor,RNA-Seq,University of Chicago,Illumina HiSeq,University of North Carolina,NO
17903,Mesothelioma,Primary Tumor,RNA-Seq,International Genomics Consortium,Illumina HiSeq,University of North Carolina,NO
17904,Mesothelioma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
17905,Mesothelioma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
17906,Mesothelioma,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17907,Mesothelioma,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17908,Mesothelioma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
17909,Mesothelioma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
17910,Mesothelioma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
17911,Mesothelioma,Primary Tumor,RNA-Seq,Asbestos Diseases Research Institute,Illumina HiSeq,University of North Carolina,NO
17912,Mesothelioma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
17913,Mesothelioma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
17914,Mesothelioma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
17915,Mesothelioma,Primary Tumor,RNA-Seq,Brigham and Women's Hospital Division of Thoracic Surgery,Illumina HiSeq,University of North Carolina,NO
17916,Mesothelioma,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17917,Mesothelioma,Primary Tumor,RNA-Seq,Brigham and Women's Hospital Division of Thoracic Surgery,Illumina HiSeq,University of North Carolina,NO
17918,Mesothelioma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
17919,Mesothelioma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
17920,Mesothelioma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
17921,Mesothelioma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
17922,Mesothelioma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
17923,Mesothelioma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
17924,Mesothelioma,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17925,Mesothelioma,Primary Tumor,RNA-Seq,Johns Hopkins,Illumina HiSeq,University of North Carolina,NO
17926,Mesothelioma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
17927,Mesothelioma,Primary Tumor,RNA-Seq,Asbestos Diseases Research Institute,Illumina HiSeq,University of North Carolina,NO
17928,Mesothelioma,Primary Tumor,RNA-Seq,Washington University - NYU,Illumina HiSeq,University of North Carolina,NO
17929,Mesothelioma,Primary Tumor,RNA-Seq,Memorial Sloan Kettering,Illumina HiSeq,University of North Carolina,NO
17930,Mesothelioma,Primary Tumor,RNA-Seq,MD Anderson Cancer Center,Illumina HiSeq,University of North Carolina,NO
17931,Mesothelioma,Primary Tumor,RNA-Seq,Brigham and Women's Hospital Division of Thoracic Surgery,Illumina HiSeq,University of North Carolina,NO
17932,Mesothelioma,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17933,Mesothelioma,Primary Tumor,RNA-Seq,University of Pennsylvania,Illumina HiSeq,University of North Carolina,NO
17934,Mesothelioma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
17935,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17936,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17937,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17938,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17939,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17940,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17941,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17942,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17943,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17944,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17945,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,Translational Genomics Research Institute,Illumina HiSeq,University of North Carolina,NO
17946,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17947,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17948,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17949,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17950,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17951,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17952,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17953,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17954,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17955,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17956,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17957,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17958,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17959,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17960,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17961,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17962,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
17963,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17964,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,Translational Genomics Research Institute,Illumina HiSeq,University of North Carolina,NO
17965,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17966,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17967,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17968,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17969,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17970,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17971,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17972,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17973,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17974,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17975,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17976,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17977,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17978,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17979,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17980,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17981,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
17982,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17983,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17984,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17985,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17986,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17987,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17988,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17989,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17990,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17991,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17992,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17993,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17994,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17995,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17996,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17997,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17998,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
17999,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
18000,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
18001,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Minnesota,Illumina HiSeq,University of North Carolina,NO
18002,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University Health Network,Illumina HiSeq,University of North Carolina,NO
18003,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
18004,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
18005,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
18006,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
18007,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
18008,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
18009,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
18010,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
18011,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
18012,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
18013,Adrenocortical Carcinoma,Primary Tumor,RNA-Seq,University of Michigan,Illumina HiSeq,University of North Carolina,NO
18014,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
18015,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
18016,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
18017,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
18018,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
18019,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,Duke University,Illumina HiSeq,University of North Carolina,NO
18020,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,University of North Carolina,NO
18021,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
18022,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
18023,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
18024,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
18025,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
18026,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,Duke University,Illumina HiSeq,University of North Carolina,NO
18027,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
18028,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
18029,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,Duke University,Illumina HiSeq,University of North Carolina,NO
18030,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
18031,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,Duke University,Illumina HiSeq,University of North Carolina,NO
18032,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
18033,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
18034,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
18035,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
18036,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
18037,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
18038,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,Duke University,Illumina HiSeq,University of North Carolina,NO
18039,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,Duke University,Illumina HiSeq,University of North Carolina,NO
18040,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,University of North Carolina,NO
18041,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
18042,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
18043,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
18044,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
18045,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
18046,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
18047,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
18048,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
18049,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
18050,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,Roswell Park,Illumina HiSeq,University of North Carolina,NO
18051,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
18052,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
18053,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,Cedars Sinai,Illumina HiSeq,University of North Carolina,NO
18054,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
18055,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,MD Anderson,Illumina HiSeq,University of North Carolina,NO
18056,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
18057,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
18058,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
18059,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
18060,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,Mayo Clinic - Rochester,Illumina HiSeq,University of North Carolina,NO
18061,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,University of North Carolina,NO
18062,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
18063,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
18064,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,Duke University,Illumina HiSeq,University of North Carolina,NO
18065,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
18066,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,Washington University,Illumina HiSeq,University of North Carolina,NO
18067,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,MSKCC,Illumina HiSeq,University of North Carolina,NO
18068,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
18069,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,University of Pittsburgh,Illumina HiSeq,University of North Carolina,NO
18070,Uterine Carcinosarcoma,Primary Tumor,RNA-Seq,University of Oklahoma HSC,Illumina HiSeq,University of North Carolina,NO
18071,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18072,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
18073,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
18074,Cholangiocarcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
18075,Cholangiocarcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18076,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18077,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18078,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18079,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
18080,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18081,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Sapienza University of Rome,Illumina HiSeq,University of North Carolina,NO
18082,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18083,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18084,Cholangiocarcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18085,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18086,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
18087,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18088,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Sapienza University of Rome,Illumina HiSeq,University of North Carolina,NO
18089,Cholangiocarcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18090,Cholangiocarcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18091,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Barretos Cancer Hospital,Illumina HiSeq,University of North Carolina,NO
18092,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18093,Cholangiocarcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18094,Cholangiocarcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18095,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18096,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18097,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
18098,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18099,Cholangiocarcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
18100,Cholangiocarcinoma,Solid Tissue Normal,RNA-Seq,Spectrum Health,Illumina HiSeq,University of North Carolina,NO
18101,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Alberta Health Services,Illumina HiSeq,University of North Carolina,NO
18102,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18103,Cholangiocarcinoma,Primary Tumor,RNA-Seq,UCSF,Illumina HiSeq,University of North Carolina,NO
18104,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18105,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18106,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18107,Cholangiocarcinoma,Primary Tumor,RNA-Seq,ILSbio,Illumina HiSeq,University of North Carolina,NO
18108,Cholangiocarcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
18109,Cholangiocarcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18110,Cholangiocarcinoma,Solid Tissue Normal,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18111,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Mayo Clinic Rochester,Illumina HiSeq,University of North Carolina,NO
18112,Cholangiocarcinoma,Primary Tumor,RNA-Seq,Not available,Illumina HiSeq,University of North Carolina,NO
18113,Cholangiocarcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
18114,Cholangiocarcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
18115,Cholangiocarcinoma,Primary Tumor,RNA-Seq,University of North Carolina,Illumina HiSeq,University of North Carolina,NO
